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Thesis abstract  
This thesis deals with a technology that is increasingly being incorporated into clinical IVF 
treatment with the aim of enhancing outcomes for sub-fertile patients: Time lapse imaging 
offers a less disturbed embryo culture environment than traditional incubation and selection 
methodologies, with the additional opportunity to time stamp and study, more precisely, in 
vitro developmental events, or ‘morphokinetics’. Its relationship to preimplantation genetic 
testing for aneuploidy (PGT-A), which enables inference of embryo ploidy following embryo 
biopsy, and the preferential selection of euploid embryos, is much discussed in the context of 
time lapse morphokinetics - being considered as a non-invasive possible alternative to PGT-
A. Both technologies have been widely, but not exclusively, reported to effectively select 
embryos from a cohort with the highest chance of success, and hence, by preferential 
selection and transfer - reducing the time taken for patients to attain a live birth.  
 
This thesis considers the implementation of time lapse imaging in IVF laboratories; comparing 
approaches, impact and outcome measures of success. To meet its aims, this thesis 
incorporates a study designed to assess whether there is an association between the 
morphokinetics of the human preimplantation embryo in vitro, and its chromosomal 
complement, or ploidy. A novel algorithm is derived which, using morphokinetics, ranks 
embryos according to their risk of aneuploidy. The clinical relevance of this model is then 
assessed within this thesis and consideration is given as to how this non-invasive approach 
may enhance implantation and live birth rates in IVF. The thesis presents studies designed to 
look for novel morphokinetic markers of embryo viability with the development and use of 
objective algorithms to aid embryo selection, enhancing outcomes compared with 
conventional morphological selection. The thesis critically reviews a time lapse approach to 




predict blastulation by use of multicentre outcome analysis, as part of a collaboration and 
goes on to present proposed standard guidelines for the nomenclature and annotation of 
dynamic human embryo monitoring, and IVF laboratory performance indicators, resulting 
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1.0 General Introduction  
1.1 Infertility and IVF  
The World Health Organization definition of infertility is “a disease of the reproductive system 
defined by the failure to achieve a clinical pregnancy after 12 months or more of regular 
unprotected sexual intercourse” (Zegers-Hochschild et al., 2009). The incidence of Infertility 
or subfertility according to the National Institute of Health and (NIH) and European Society 
for Reproduction and Embryology (ESHRE) is around 1 in 6 of couples trying to conceive. 
https://medlineplus.gov/infertility.html  
 
There are many causes of infertility that can include uterine factors, endometriosis, tubal 
factor, male factor, ovulatory disorders, luteal phase defects, repeated pregnancy loss, 
idiopathic, or advanced maternal age. Treatments to alleviate infertility range from simple 
timing of intercourse, to in vitro Fertilization (IVF). Simple assisted conception treatments, 
such as intrauterine (IUI) or intracervical insemination (ICI), may be applied to patients with 
blocked fallopian tubes, sufficient motile sperm available, normal hormone profiles and a 
functional uterus. Other simple interventions include timed intercourse, clomiphene citrate 
to stimulate follicle growth, hCG administration trigger ovulation or low dose gonadotropin 
administration to encourage ovarian follicular growth. Assisted Reproductive Technology 
(ART) treatments generally refers to where oocytes and embryos are handled outside of the 
body and more complex procedures are utilised.  
 
This thesis is concerned with a specific type of ART i.e. In vitro Fertilization; IVF. The first 
reports of clinical IVF were famously Louise Brown and Alastair MacDonald in 1978 and 1979 
respectively, and the technique has gradually evolved in the intervening years, making IVF a 




routine treatment for subfertile patients. During 2017, around 75,000 IVF treatment cycles 
were performed within the UK. The recently published Human Fertilisation and Embryology 
Authority (HFEA) trends and figures report, of May 2019, showed the overall IVF birth rate 
per embryo transferred in 2017 to be 22% in the United Kingdom (UK). This has gradually 
increased since recording began in 1991 when this figure was only 7% (HFEA.gov.uk). The 
success of IVF can be broadly broken down into two key factors: the quality of the embryo 
and the quality of the uterus.  
 
IVF involves hyper-stimulating the ovaries, in a controlled fashion, and the subsequent 
retrieval of around 10-20 oocytes. To achieve this, the pituitary gland is down-regulated by 
administration of a gonadotrophin releasing hormone (GnRH) analogue (agonist or 
antagonist) to suppress endogenous hormones before the cycle begins. Exogenous 
administration of follicle stimulating hormone (FSH) and/or human menopausal 
gonadotrophin (hMG) results in multiple follicular recruitment and development. As these 
follicles grow, they each produce oestrogen, which causes the endometrium to proliferate. 
At a follicle diameter of ~17mm an artificial luteinising hormone (LH) surge is most commonly 
created by administering human Chorionic Gonadotropin (hCG) or combination of high dose 
agonist/low dose hCG which has a similar effect as LH on oocyte maturation and ovulation. If 
an embryo transfer is to occur in the stimulated cycle then exogenous progesterone is 
administered post oocyte retrieval to prepare and maintain the endometrium. For 
fertilisation to occur, insemination takes place within the laboratory whereby sperm are 
either mixed with the oocytes (IVF), or injected (intracytoplasmic sperm injection (ICSI)) into 
each mature oocyte, on the day of oocyte retrieval. Following fertilisation assessment the 




following day, the resultant embryos are kept in culture generally until the blastocyst stage 
of development.  
 
Embryo transfer typically occurs on day 5 post fertilization, at the blastocyst stage and 
supernumerary blastocysts can be cryopreserved, by vitrification. Vitrified and warmed 
embryos can later be transferred in either a natural or artificial cycle. In a natural transfer 
cycle, transfer is timed 7 days post hCG trigger or 6 days post LH surge. In an artificial cycle 
down-regulation of the pituitary gland and administration of exogenous oestrogen can be 
used to prepare the endometrium. Once the thickness and pattern of the endometrium are 
appropriate, progesterone administration can begin.  
 
1.2 Endometrial factors 
Implantation is a complex process involving both embryo and endometrial factors. Gene 
expression shows marked changes during the cycle and, at the most receptive phase, growth 
factors, cytokines, glycoproteins and immunosuppressive agents are secreted into the uterine 
cavity (Melford et al., 2014). The most receptive phase of the cycle for the endometrium is 
called the “window of Implantation” (WOI); about 5-7 days post ovulation (Lessey, 2000). 
Embryo transfer timing during an IVF cycle aims to identify the WOI, which may differ 
between patients (Mahajan, 2015; Ruiz-Alonso et al., 2013). Commercial endometrial 
receptivity assays (ERA – Igenomix, or ER Peak – Cooper Surgical) have been developed by 
analyzing an array of genes differentially expressed at different stages of the menstrual cycle. 
An algorithm has been developed and implemented to predict a personalized WOI for 
patients with repeated implantation failure (Ruiz-Alonso et al., 2012) to capture the WOI. 
Gomez et al (Gomez et al., 2015) states that the ERA has shown that one in four patients with 




repeated implantation failure have a displaced WOI and a recent randomised controlled trial, 
provides proof of principle evidence for the potential of using personalised diagnosis of the 
endometrial factors in the work up of the infertile couple, from the outset. This large study 
demonstrated a significant increase in cumulative pregnancy rate per intention to treat when 
endometrial receptivity was considered and addressed, compared with controls. (Simon et al, 
ASRM presentation 2019).  
 
This thesis is however concerned more with the quality of the embryo and whether 
techniques can be developed to select the most viable embryo more reliably than using 
simple morphological observation. 
 
1.3 Factors affecting embryo quality  
Culturing and handling embryos in vitro inevitably exposes them to potential environmental, 
and mechanical stresses, which they otherwise would not have encountered in vivo. One of 
the key challenges since the original IVF in the 1970s has been to achieve a stress-free 
environment for IVF and embryo growth, as close to physiological conditions as possible 
(Swain, 2010; Swain et al., 2016). This consideration encompasses the culture media, the 
gaseous incubation environment, the laboratory consumables, pH and temperature.  
 
Culture media in use today has been modified over the years but still is based loosely on 
mouse embryo culture media; a balanced salt solution (Chronopoulou and Harper, 2015). 
Culture media manufacturers rely on the readily available supply of mouse embryos to assess 
each batch of media as testing on human embryos is not practically possible (Quinn and 
Horstman, 1998). This standard practice has limitations, however, as mouse embryos and 




human embryos are not equivalent in their needs and sensitivity (Ackerman et al., 1985; 
Ackerman et al., 1984). The assurance to the end user by testing media on a mouse model is 
only that the media has no obvious toxins and that the media is able to support growth of 
mouse embryos to the blastocyst stage.  
 
The precise composition of commercially available culture media today are not generally 
published by culture media companies, however, they are basically a balanced salt solution 
incorporating varied concentrations of glucose, pyruvate, and lactate to facilitate embryo 
development past traditional developmental blocks (Gardner and Lane, 1996). The more 
modern formulations include amino acids, chelating agents (EDTA) and growth factors.  
 
A review by Mantikou comparing the efficacy of different culture media concluded that 
overall there was no evidence to show one medium to be superior to the others. (Mantikou 
et al., 2013). However, some studies do show differences in clinical outcomes between media. 
For example, a randomized controlled trial (RCT) by Kleijkers and colleagues  which showed 
an increase in the incidence of low birthweight offspring using once commercially available 
medium, compared with another (Kleijkers et al., 2016). Whether media constituents or 
culture environment generally affects the dynamics and rate of cell divisions and embryo 
development is not entirely clear at this stage (Ciray et al., 2012; Meseguer et al., 2012). 
 
As culture conditions have improved due to media development, improved knowledge and 
more sophisticated reliable and stable incubators being available, the ability to culture 
embryos beyond day 3, through to day 5 has led to more blastocyst stage transfers which has 




also enabled an element of “self-selection.” Nevertheless, selecting the best possible embryo 
for implantation is a challenge for all IVF and a central aspect of this thesis.  
 
1.4 Estimating embryo viability conventionally 
Given that it is a primary aim to minimize stress to the embryo in vitro, the least invasive and 
most reliable assay possible is desirable in IVF. Preimplantation genetic testing for aneuploidy 
(PGT-A), with the possible exception of sampling culture media, is invasive, as it involves the 
removal, biopsy, of part of the embryo; which will be discussed in more detail later within this 
thesis. The simplest tool currently used by embryologists to choose the best embryo for 
implantation is visual inspection or embryo morphology. Very commonly in IVF, the best 
available embryo, in terms of appearance alone, is chosen from a cohort on day 2, 3 or 5 to 
be placed into the uterus. 
 
1.4.1 Stage of embryo development and transfer 
If an embryo has successfully developed beyond day 3 when the embryonic genome is 
activated (Niakan et al., 2012) and undergone blastulation, logic dictates, and practice 
demonstrates that is has a better chance of implantation. Blastocyst morphology and growth 
rate correlates to some extent with the chromosomal constitution of the embryo and this is 
central theme of this thesis. Failure to select a viable embryo for transfer will inevitably limit 
the chance of a positive outcome in a given treatment cycle. But with highly successful 
cryopreservation programmes available in most fertility clinics, it could be considered that 
simply transferring the patients’ embryo consecutively (following vitrification and warming) 
will eventually have the same end result as selection to prioritise the embryos according to 
their expected potential to implant: At some point, the best embryo will be transferred. 




However, to minimise the emotional burden on patients and in some cases financial burden 
too, identification and selection of the most viable embryo should be a priority. Sequential 
observations can help build up a picture of the quality, or viability potential of the embryo in 
vitro and the focus should shift from embryo selection being heavily weighted on the 
embryo’s appearance at the point of selection for transfer and more account should be given 
to the embryo’s short history; its timeline through and from fertilisation. And, as many of the 
developing embryo’s morphological features are most accurately assessed in relation to time, 
the assessment of these should ideally be performed within designated, evidence-based time 
windows.  
 
 1.4.2 Non-invasive embryo assessment methods 
There are several potential non-invasive methods for assessing embryo viability but 
morphological, and more recently morphokinetic, are the most accessible and established. 
Another potential non-invasive method of embryo selection is oxygen consumption by 
embryo respiration. This method has been used to compare oxygen consumption rates 
between implanting and non-implanting human embryos. Higher respiration rates were seen 
in transferred and frozen embryos compared to discarded embryos and among the embryos 
that were transferred, higher respiration rates were seen for implanting embryos than non-
implanting embryos. Respiration rates performed close to the time of embryo transfer 
showed the strongest correlation with implantation potential (Tejera et al 2011). 
  
Over the past 25 years, researchers in the field of assisted reproduction have identified a 
number of potential metabolic markers of embryo viability but most have proved inadequate 
for the selection of embryos for transfer or cryopreservation.  




Prior to the implementation of time lapse imaging, several groups have studied pronuclear 
morphology in attempt to correlate this with embryo viability markers such as blastocyst 
formation potential, implantation potential and ploidy status (Gianaroli et al., 2003; Kattera 
and Chen, 2004; Scott et al., 2000; Zollner et al., 2002).  
 
As an assessment was being made anyway, involving disruption from the protected culture 
environment, more detailed and opportunistic assessment of the pronuclei and nucleoli was 
considered. In one study, even numbers of nucleoli in each pro-nucleus distributed during 
pronuclear abbutal was reported to predict blastocyst formation with some accuracy, and a 
positive correlation with implantation was demonstrated (Scott et al., 2000). Arroyo’s group, 
however, looked at pronuclear morphology and ploidy status of the embryo. They reported 
no correlation (Arroyo et al 2010). Gianaroli’s group studied the position of pronuclei within 
the oocyte, the pattern of nucleoli and the angle of the pronuclei from the polar bodies. A 
correlation was found between complex aneuploidies, inferred by FISH, and chaotic 
arrangements of pronuclei and nucleoli. Euploidy could not be accurately predicted and such 
studies were limited by the frequency of observations of the pronuclei (Gianaroli et al., 2003). 
Several researchers, since the dawn of IVF, have studied the embryo’s first cleavage and 
associated early cleavage with increased implantation potential (Fenwick et al., 2002; Lundin 
et al., 2001). 
 
Time lapse imaging has enabled scientists to capture in real time the formation and dynamics 
of pronuclei and of early blastomere divisions, and to study the morphology and kinetics of 
the early preimplantation human embryos and their association with viability. A recent study 
found the relative difference in male and female pronuclear area, prior to their breakdown, 




to be correlated with birth rates and proposed a method for preferential embryo selection 
(Otsuki et al 2019).  
 
1.5 Time lapse imaging and morphokinetics  
The central premise of this thesis is that human embryos in vitro are not equal in their capacity 
to make a viable pregnancy and that their particular pattern of growth; that can be monitored 
using time lapse imaging, can be predictive of developmental and viability potential. The 
observation of morphology over time (morphokinetics) as an indicator of embryonic 
competency is as old as clinical embryology itself but has become more sophisticated and 
clinically utilisable due to technological advancements (Payne et al 1997). The correlation 
between embryo morphology and implantation potential has been extensively demonstrated 
and documented but, this series of microscopic, manual assessments of morphology are 
increasingly being considered relatively poor indicators of an embryo’s potential to result in 
a healthy live birth, even if selection takes place at the blastocyst stage (Gardner et al 2015). 
 
Conventional light microscopical observations, unlike time lapse imaging, cannot allow the 
precise timings of mitoses, or the observation of anomalous cleavage events of the in vitro 
pre implantation embryo, to be recorded. Furthermore, without time lapse, transient 
characteristics such as multinucleation can easily be missed when embryos are limited to a 
single daily observation. Time-lapse imaging and analysis ensures that such phenomena are 
observed and recorded allowing embryo de-selection, where appropriate. 
The wealth of detail that can be observed and information gleaned from such time lapse 
images is remarkable. Throughout the preimplantation embryo’s development, from 
insemination to uterine transfer, new phenomena, observed using time lapse imaging and 




analysis devices, are being defined and observed as the study of human preimplantation 
embryology takes on a new direction. 
 
In contrast, conventional morphological embryo assessment typically consists of several, 
sequential, timed daily microscopic observations and ranking of them is commonly guided by 
professional body or consensus guidelines, some of which may be out-dated. Using such 
systems, the preimplantation cleavage stage embryo is assessed primarily on cell number and 
degree of cytoplasmic fragmentation, as well as developmental stage, with a demonstrated 
association with viability (Alpha and ESHRE SIG 2011, Cutting at al 2008). These swift embryo 
observations, however, employed to limit exposure to, and potential stress caused by, the 
assessment environment, provide limited information on developmental rates or patterns 
and little insight into the chromosomal complement of the embryo.  
 
This established morphological approach to human preimplantation embryo assessment and 
selection has evolved in recent years with the introduction of time lapse monitoring, enabling 
the kinetics, and transient behaviours of embryo development to also be assessed; with 
reports of improved embryo selection and clinical outcomes, using this ‘morphokinetic’ 
information (Meseguer et al 2012).  
  




1.5.1 The potential of time lapse imaging  
Several time lapse incubation devices are now commercially available for the IVF laboratory. 
They are designed to capture images of the fertilising and developing embryos at regular 
intervals (commonly 5-20 minutes apart), throughout the in vitro culture period, avoiding the 
need to remove the embryos from the protected and optimised environment, for visual, 
microscopic assessment. The EmbryoscopeTM (Vitrolife, Sweden) was the first instrument to 
provide this relatively stable, ‘uninterrupted’ incubation - combined with internal microscopy, 
as an alternative to a standard IVF incubator. The introduction of such time lapse devices has 
resulted in a plethora of reports describing human preimplantation embryo development in 
greater detail, with descriptions of both its theoretical and demonstrable impact on embryo 
selection, and clinical outcomes (Rubio et al 2012, Meseguer et al 2011, Chamayou et al 
2013).  
 
Time lapse monitoring of the dynamics of embryo development, often in association with 
conventional qualitative morphological observations, provides detailed morphokinetic 
information on individual embryos. These data, consisting of timings, morphologies, 
irregularities and durations of embryo developmental events, can be retrospectively analysed 
against outcome measures, such as blastulation, implantation, embryo ploidy or healthy live 
birth. In turn, these data can also be used to derive predictive selection models, or algorithms, 
or simple preferential selection (or deselection) criteria, for prospective use in the IVF 
laboratory. Meseguer et al., in 2012, first reported a 20% increase in pregnancy rate using 
time lapse systems, compared with standard incubation, and attributed this improvement to 
the stable culture conditions of the time lapse device, and use of morphokinetic variables for 
embryo selection (Meseguer et al 2012). More recently, several large studies, and randomised 




controlled trials have also reported improvements when time lapse algorithms were used for 
embryo selection, compared with morphology alone (Pribensky et al 2017). 
 
Figure 1: Summary of clinical results from meta analysis comparing the overall impact of 
time lapse and standard incubation and selection on clinical outcomes (Pribenszky et al 
2017) 
 
1.5.2 Cell cycles and nomenclature of time lapse imaging 
A cell cycle is a series of complex events involving cellular and nuclear processes through 
particular phases that ensure the cell’s division into two daughter cells. Mitosis consists of 
nuclear division and cytokinesis and several phases; prophase, prometaphase, metaphase, 
anaphase, and telophase. These are preceded by interphase which encompasses stages GAP-
1 (G1), Synthesis (S), and GAP-2 (G2) of what is known as the cell cycle. The duration of cell 
cycles in the human pre implantation embryo appears to be related to embryo viability 
Ramsing and Callesen 2006). Prolonged or rapid cell cycles could be associated with DNA 




repair, cellular rearrangements or failure of an embryo to undergo cell cycle checkpoints. 
Both potentially compromising embryo development (Ramos and De Boer 2011).  
 
The first cell cycle following fertilisation, has been reported in detail following a large time-
lapse study by Aguilar and colleagues (Aguilar et al 2013). In their study, they proposed some 
early time lapse terminology and described initiation of the first cell cycle as the time from 
the completion of second polar body extrusion. The length of S-phase (DNA replication) was 
defined as the time from appearance to fading of two pronuclei. In this study, embryos with 
prolonged S-phase demonstrated significantly reduced implantation rates compared with 
embryos with S-phases ranging from 5.7-13.8 hours. Completion of the first cell cycle can be 
defined as the time point that the embryo reaches the two-cell stage, such that the two 
daughter cells are discrete from each other. 
 
Post-interphase cleavages of corresponding sister blastomeres rarely occur at precisely the 
same time and so time lapse users have considered the synchronisation of cell divisions within 
a round of mitosis, particularly as this has been reported to be correlated to embryo viability 
(Meseguer et al 2011). Synchrony of the second cell cycle would be defined as the duration 
of the transition of an embryo from two cells to four cells and calculated by subtracting the 
time the embryo reached the three cell stage (t3) from the time it reached the four cell stage 
(t4). With frequent time-lapse image acquisition (in some cases up to every minute), the 
duration of each cytokinesis can also be measured from the time a cleavage furrow is first 
visible to the time that the daughter blastomeres are discrete from each other (Wong et al 
2010).  




With time lapse imaging, cell cycle duration is calculated either according to a single cell 
division or as a round of mitosis whereby the number of blastomeres doubles. For the first 
cell cycle, as development begins with the single cell, these are the same. However, the 
second cell cycle begins with two cells, both of which should subsequently divide, forming 
two daughter cells each. There are therefore two individual blastomere cell cycles but a single 
embryo cell cycle which results in the doubling from two to four cells.  
 
Although the nomenclature and annotation of time lapse variables are discussed in greater 
detail within the publications described throughout this thesis, the following schematic 
(figure 2) has been incorporated into the introduction in order to provide an overview as to 
how cell divisions and embryo development are referenced using this technology. The most 
frequently recorded morphokinetic variables follow the basic chronology of embryo 
development and mitosis, and include precise assessment of the timing of pronuclear 
appearance and fading, of increasing cell numbers, as well as assessment of fragmentation, 
cell evenness, synchronicity and nucleation, and the times to reach, and durations of, embryo 
differentiation to the morula and blastocyst stages.  
 
Annotation practice and nomenclature are based on times (t) from insemination (IVF or ICSI) 
to pronuclear fading (tPNf) through each cell division to 8 cells (t2 to t8), morula (tM), start 
of blastulation (tSB) and the full blastocyst stage (tB).  
 
Rounds of cell division are coded as embryo cell cycles ‘ECC’; when cell number doubles (e.g. 
from 4 to 8) and the blastomere cell cycles are coded as ‘cc’; the numbers representing 
sequential divisions and the letters, representing the individual blastomeres. 





Figure 2: Schematic of standard morphokinetic variables 
In: Campbell A, Fishel S, ed. Atlas of Time Lapse Embryology. Boca Raton, FL: CRC Press; 2015 
 
1.5.3 Time lapse data collection and handling 
Although automated, or semi-automated, time lapse video analysis and interpretation is likely 
to be increasingly used in the future, so far, data generated from these devices has primarily 
come from manual image assessment and recordings of the events observed (that is, by 
‘annotation’), on human review of the time lapse images viewed as videos. Due to the manual 
nature of data collection, to minimise subjectivity and maximise data quality, rigorous training 
of practitioners and quality assurance is required to assure the output and value of a clinical 
time lapse offering (Campbell et al 2013) (See appendix 3). The use of intra correlation 
coefficients enables assessment of different practitioners and reproducibility of annotations 
of the morphokinetic variables. Sundvall and colleagues considered inter and intra 
practitioner variation in annotation, using this intra-class correlation coefficient and 
demonstrated close correlation between experienced and newer time lapse users for most 




morphokinetic variables, but highlighted that some ‘static morphologic parameters’ such as 
multinucleation and blastomere evenness, were at risk of subjectivity (Sundvall et al 2013).  
 
Where there are multiple practitioners involved in time lapse data collection, the risk of 
subjectivity and inconsistency are enhanced, and intra-practitioner annotation variation may 
also exist. Minimisation of this subjectivity can be achieved by clear definition of key variables, 
and with strict annotation practice, set out within the standard operating procedure (SOP). 
Guidelines for nomenclature and annotation are available to encourage international 
consistency and to allow compilation of large data in the future (Ciray et al 2014).  
 
Selection, for intra-uterine transfer, of the most viable embryo from a cohort in assisted 
reproduction technology (ART), is essential to minimise the time taken to reach pregnancy 
and successful delivery of a healthy child. With increasing female age being the most 
negatively impactful variable associated with fertility, failure to choose the best embryo first 
time could not only prolong the patient pathway and introduce emotional and financial 
burden, it could also reduce the chances of successful outcome during future attempts at IVF 
by delaying this process, as maternal age advances.  
 
Time lapse (morphokinetic) analysis alone is considered by many to provide superior embryo 
selection to traditional and static morphology, and time lapse selection algorithms have been 
developed, published and independently evaluated, although reports of their performance, 
compared with traditional morphological selection, and their transferability between clinical 
settings is inconsistent, in part due to lack of standardisation and the heterogeneity in its 
application (Barrie 2017). 





The morphokinetic data of a specific and transferred embryo which has a known outcome is 
commonly referred to being of ‘known implantation data’ or ‘KID’. The known outcome may 
be a pregnancy test result (positive or negative), a gestational sac or foetal heart on 
ultrasound scan, a pregnancy loss or a live birth. Morphokinetic data can be compared 
between embryos giving positive or negative implantation data (KID+ or KID-), depending on 
the outcome measure used. All data can be utilised following a single embryo transfer, or a 
double embryo transfer with a negative outcome as the fate of these embryos is known. Using 
data following multiple embryo transfer that has resulted in the same number of foetal hearts 
or babies born may be problematic without the use of genetic fingerprinting to ascertain the 
chorionicity or zygoticity.  
 
KID positive rates (or ratios) can be calculated for each morphokinetic variable in order to 
consider their impact and potential use in embryo selection models which may incorporate 
optimal time values or durations, to reach developmental milestones.  
 
Recently, deep learning has been implemented in several areas of medicine. It has also been 
proposed as a superior, automated and standardised approach to facilitate embryo selection, 
using photographic data from time lapse imaging. A large multicentre retrospective analysis 
of over 10,000 embryos used a deep learning trained model to predict clinical pregnancy with 
a average area under the curve (AUC) of the receiver operating characteristic (ROC) curve of 
0.93 (95% CI 0.92-0.94). Prospective studies are required in order to assess the potential 
clinical impact of this approach that promises to offer an automated method to improve 
identification of the embryo(s) from a cohort with the highest propensity for implantation 




(Tran et al., 2019). 
 
1.5.4 Selection and deselection morphokinetic criteria 
In addition to enabling detailed, time-stamped monitoring of the morphokinetics of embryo 
development, time lapse technology also allows the identification of aberrant embryo 
cleavage events, which may not be observable using ‘snap shot’ traditional static microscopy 
methods. Potentially the most valuable example of aberrant cleavage, and one of the most 
well reported, in terms of its correlation with viability, is the phenomenon of a multi, as 
opposed to dichotomous, cleavage of a blastomere to three, or more daughter cells. Several 
studies have demonstrated the ability of time lapse to identify such aberrant cleavage 
divisions and highlight the reduced implantation potential of these embryos, compared with 
their counterparts that mitotically divide into two daughter cells. In a cohort of 1659 
transferred embryos, the incidence of this ‘direct division’ (occurring within 5 hours) was 
13.7% and the implantation rate of these embryos was markedly and statistically significantly 
lower than for embryos with a normal cleavage pattern (1.2% vs. 20.2% respectively (Rubio 
et al., 2012). Some investigations into this phenomenon have considered whether this 
erroneous cleavage phenomenon could be the cause or effect of aneuploidy within the cell 
(Zhan et al., 2016). Since the first reports of this phenomenon, the nomenclature of this 
common example of early erroneous cell division has been proposed, in an expert panel 
publication. An aberrant cleavage from a single cell directly to three daughter cells has been 
defined as trichotomous mitosis. This can be distinguished from ‘rapid’ cleavages, which 
appear as an accelerated division event, within 5 hours of the previous cell division (Ciray et 
al 2014). The hypotheses of Leese et al; that preimplantation embryos which are ‘quiet’, 
metabolically, have greater viability than those which are not, has recently been revisited 




using retrospective and prospective data on metabolic and kinetic activity of preimplantation 
embryo development. The group considered that there may be optimal ranges which may 
influence embryogenesis. They proposed that there may be a “Goldilocks zone,” within which 
embryos with maximum developmental potential can be categorized (Leese et al., 2016). This 
would sit well with what is being revealed from the increasing number of published time lapse 
studies.  
 
Recently, researchers have searched for novel indicators of embryo viability, only accurately 
recorded using time lapse imaging. A large unpublished study at CARE Fertility examined close 
to 2500 blastocysts with known implantation outcome, or KID. In this study, logistic regression 
analysis demonstrated a significantly higher clinical pregnancy rate (48.9% versus 35.9%; 
p<0.0001) when morulae were fully compacted, with no excluded material, compacted to 
their counterparts.  
 
1.5.5 Time lapse algorithms 
Early adopters of time lapse and its implementation for embryo selection were Basile, 
Meseguer and colleagues, who used a hierarchical approach to time lapse algorithm 
development whereby embryos received a classification based primarily on reaching 
developmental milestones and the relative timings associated with them Basile et al., 2014). 
They reported significant differences between implanted and not implanted embryos for six 
early morphokinetic variables. The most significant, for implantation prediction, being the 
time that the embryo reached the 5 cell stage (t5), and the duration of the second cell cycle 
(cc2). The resulting selection model also included three exclusion criteria, based on their 




negative association with implantation. These were rapid early division (from 2 to 3 cells), 
uneven blastomeres and multinucleation at the 4 cell stage. Since then, further time lapse 
models have been published with variation in both the time lapse variables of significance, 
outcome measures and the timings of specific developmental events (; Motato et al., 2016; 
Conaghan et al., 2013). 
 
1.6 Preimplantation genetic testing for aneuploidy (PGT-A)  
That human oocytes and embryos carry a significant amount of aneuploidy, and that 
aneuploidy is believed to be the single largest cause of embryo implantation failure and 
miscarriage has made it a prime candidate for analysis during IVF. (Hassold et al, 2007;  
Keskintepe et al 2007; Fragouli et al, 2011). Unlike most other embryo assessment 
approaches, aneuploidy has clear clinical relevance, may be considered binary in its 
relationship to biological significance, and is of high enough prevalence to make it a priority 
for screening. Logic determines that by detecting and eliminating aneuploid embryos each 
attempt at IVF should be more efficient; and in some cases, patients will receive important 
information about their gametes and embryos, helping them move forward in their fertility 
journey. 
 
In 2008 the CARE Fertility Group and Bluegnome (Cambridge, UK) pioneered the development 
of preimplantation genetic testing using array comparative genome hybridisation (aCGH) for 
clinical use, first considering polar bodies, then blastomeres and trophectoderm tissue for the 
assessment of the cell’s full chromosome complement (Fishel et al, 2010; Fishel et al, 2011). 
CARE Fertility Group considered polar body initially in the belief that if the oocyte is aneuploid 
the embryo will be; and early studies confirmed this, but recognising that paternally-




contributed and post-fertilisation mitotic aneuploidy will not be detected. More recently, 
with improved embryo culture and sensitive testing methodologies, the most commonly 
used, and effective method of PGT-A uses trophectoderm biopsy.  
 
Preimplantation genetic testing for aneuploidy (PGT-A) is, like morphokinetic analysis, aimed 
at optimising embryo selection, but by identifying embryo ploidy and enabling preferential 
selection of a euploid embryo for intra uterine transfer. Aneuploidy is prevalent in human 
oocytes and embryos and its incidence increases with maternal age. Depending on the age of 
the female or circumstances of the couple, more than half of their embryos are likely to be 
aneuploid (Fragouli et al., 2011). The avoidance of selecting aneuploid embryos for transfer 
during IVF treatment is a clinical imperative and the method of choice for assessing embryo 
ploidy currently is PGT-A which provides chromosome copy number from the trophoblast 
cells of the blastocyst. Various technologies have been utilised, such as microarray based 
comparative genomic hybridisation (aCGH), single nucleotide polymorphism (SNP) arrays or 
quantitative polymerase chain reaction (PCR), and next generation sequencing (NGS), which 
have confirmed the high incidence of aneuploidy in human embryos with varying, but 
nonetheless mostly positive reports of its efficacy (Fragouli et al., 2006; Munne et al., 1993; 
Yang et al., 2012). 
 
 
Identification of the most viable single embryo for transfer, has become increasingly 
important in recent years, driven by regulation (such as in the UK) and good clinical practice, 
to reduce the number of multiple pregnancies and births. Since 2010, with the first reported 
live birth after polar body biopsy and comprehensive chromosome screening, the 




identification of euploidy has been reported to have improved outcomes in specific 
circumstances, such as advanced maternal age (Fishel et al., 2010; Stevens et al., 2012; 
Anderson et al., 2019).  
 
Anderson compared PGT-A with unscreened treatments reported within the United States 
national data (SART 2016). They found that PGT-A, in their programme, outperformed the 
national average for live birth rate in all age groups. A recent multicentre randomised 
controlled trial (STAR), however, did not result in similar findings; surprising advocates of this 
technology, finding significant associations only for advanced maternal age (Munne et al., 
2019). The need to constantly consider alternative technologies for the assessment of both 
aneuploidy and overall developmental potential is therefore paramount. Despite PGT-A being 
considered effective at identifying euploid embryos, and enhancing outcomes in some (but 
not all) studies, there are nonetheless limitations of this technology, in association with 
assisted reproduction. Blastocyst biopsy, used to remove a small number of cells for 
assessment requires training, specific equipment and technical expertise, and the testing; 
often off site, remains expensive and time-consuming. Furthermore, this invasive approach 
has raised ethical concerns and meets regulatory barriers in some countries (Harper et al., 
2014).  
  




1.6.1 Aneuploidy and preimplantation embryo development 
Prior to the clinical availability of time lapse imaging, there had been reports of aneuploid 
embryos being delayed around the time of blastulation. In an early study of mosaicism, using 
fluorescence in situ hybridisation (FISH) in human blastocysts, Evsikov and Verlinsky proposed 
a process of selection against aneuploidy cells starting at the morula-blastocyst transition 
(Evsikov and Verlinsky 1998). They demonstrated that human blastocysts had a significantly 
lower degree of mosaicism than early cleavage stage embryos and postulated there being a 
threshold level of abnormal cells at which the whole embryo degenerated. 
 
Alfarawati compared blastocyst qualitative morphology with ploidy and demonstrated a weak 
association between blastocyst morphology and aneuploidy (Alfarawati et al., 2011). This 
group also considered embryo developmental rates and reported an insignificant trend 
towards aneuploid embryos showing slower progression to the most advanced blastocyst 
stages; and that embryos with complex aneuploidy were most delayed. This study was 
performed without the benefit of time lapse technology however, and the findings were not 
clinically applicable as no clear cut-off time point was given for discrimination between 
complex aneuploid embryos and euploid ones. The time or frequency of blastocyst 
morphological assessment was not discussed in that publication. 
 
The period leading up to blastulation is a period of intense cellular metabolic activity, gene 
activation, rapidly increasing cell division and differentiation. Cell division, and the mitotic 
process is a series of complex structural rearrangements involving the kinetochore - 
attachments to the microtubules, cohesion molecules - for the crucially precise separation of 
the chromosome to ensure correct alignment on the spindle - the spindle assembly complex 




and many highly specialised proteins subject to precise gene expression (Gonen et al., 2012; 
Clift and Marston., 2011; Vogt et al 2008). 
 
Although the cause of a possible temporal delay in aneuploid embryos compared to their 
euploid counterparts may be unclear, there exist error detection and repair systems within 
the cells to prevent aneuploidy (Nasmyth and Haering 2009). It is possible, therefore, that 
errors in individual cells at this stage of the rapidly developing embryo involve complex 
biochemical systems delaying karyo- and cytokinesis, which could result in the detectable 
delay in blastulation, particularly evident if time lapse imaging were used.  
 
Both ploidy analysis by PGT-A and morphokinetc variable analysis from time lapse imaging 
are techniques that, individually, in some hands, have demonstrated, to have the potential to 
improve significantly the incidence of clinical pregnancy compared with traditional embryo 
culture and selection methods. Therefore, by comparison of the morphokinetics of euploid 
and aneuploid embryos over the preimplantation cleavage period, the key question arises 
regarding whether morphokinetics of euploid embryos differ from those of aneuploid 
embryos, and whether there could be synergies between these technologies in ART.  
 
1.7. Is there an association between embryo ploidy and morphokinetics? 
The first time-lapse report of an association between early human embryo development and 
ploidy was 2012. Chavez and colleagues demonstrated that early cleavage events, up to the 
4-cell stage, were tightly clustered by timing in euploid human embryos, whereas those of 
aneuploid embryos were more diverse (Chavez et al., 2012). In this study, only 30% of 
aneuploid embryos displayed timings similar to the euploid cohort. This group used a small 




dataset to predict embryonic euploidy with 100% sensitivity and 66% specificity. A larger 
study, by Basile, analysing the chromosomal content of 504 embryos by blastomere biopsy 
on day 3, and aCGH, proposed a logistic regression derived hierarchical model to subdivide 
embryos in to 4 categories (A to D) according to expected risk of aneuploidy (Basile et al., 
2014). The algorithms consisted of the two morphokinetic variables; the time interval 
between 2 and 5 cells (>20.5 hours) and the duration of the third cleavage cycle (t5-t3) (11-
18 hours). Embryos were categorised according to whether they developed within the ranges 
and use of this model resulted in a significant decrease in the percentage of normal embryos 
with each decreasing category (A, 35.9%, B, 26.4%, C, 12.1% and D 9.8%, P<0.001).  
 
 
Several time-lapse studies have reported peri-compaction and blastulation delays in 
aneuploid, or embryos with low implantation potential, compared with euploid embryos, or 
those with high implantation potential: Minasi and colleagues, assessing a large cohort of 
1730 blastocysts, asked whether there were correlations among ploidy status, morphology 
and time lapse kinetics. They reported that euploid blastocysts exhibited higher 
morphological quality inner cells mass and trophectoderm, and a shorter time to start 
blastulation, expansion and hatching compared with aneuploid ones (Minasi et al. 2016). 
More recently, Mumusoglu and colleagues, using a clustered data analysis, reported a low to 
moderate ability to predict euploidy when patient related factors and ovarian stimulation 
were considered. They reported a small number of late morphokinetic variables to be 
significantly different when comparing euploid and aneuploid embryo development. Later 
stage delays from t9 and through to expanded blastocyst stage was reported in the aneuploid 
cohort (Mumusoglu et al., 2017). 





Time lapse studies considering and comparing the morphokinetics of euploid and aneuploid 
embryos are heterogenic in their design and approach. However, most have not identified an 
association between early cleavage stage morphokinetic markers and ploidy, suggesting that 
euploid and aneuploid embryos develop similarly up until around the time of compaction, or 
around the maternal to zygotic genomic transition.  
 
A systematic review, in 2018, asking whether time lapse parameters predict embryo ploidy, 
considered 13 publications between 2012 and 2017. The review also highlighted the 
heterogeneity of studies published to date on this topic. The 13 studies varied in stage of 
embryo biopsy, clinical indications for PGT-A, embryo culture conditions, statistical 
approaches and outcome measures. The authors concluded that in most studies considering 
ploidy and morphokinetics, the intervals between cellular cleavages were of more relevance 
than cleavage timings in the selection of euploid embryos. It also stated that most of the 
studies with biopsy conducted at the blastocyst stage, reported significant differences 
between the morphokinetics of aneuploid and euploid embryos at later (peri-blastulation) 
stages, and did not find early parameters as predictors of embryo ploidy (Reignier et al., 
2018).  However, all researchers did not comprehensively compare durations between 
morphokinetic variables. The systematic review concluded that more large-scale studies are 
needed to elucidate fully the putative association between ploidy and morphokinetic 
parameters. Further publications have since supported, and rejected, the overall findings of 
this review. Desai et al assessed 767 biopsied blastocysts and reported that the presence of 
two or more dysmorphisms was associated with an overall lower euploidy rate, and that 
ploidy status correlated significantly with starting blastulation, expansion and the tEB to tSB 




interval (Desai et al., 2018). Zhang et al., however, did not find any morphokinetic variables 
to be associated with ploidy but did report that a combination of PGT-A and time lapse 
monitoring improved implantation rate and ongoing pregnancy rate for PGT-A (Zhang et al., 
2017). The time lapse studies assessing morphokinetic markers of embryo ploidy are 
summarised in table 1 below. 
  





First Author and year 
of publication 




with ploidy status  
 
Evidence for potential 
morphokinetic 
markers of embryo 
ploidy? 
Chavez et al 2012 Early cleavage stage cc2, s2 ✓ 
Basile et al 2014 Early cleavage stage t5-t2, t5, cc3 ✓ 
Chawla et al 2015 Early cleavage stage t5-t2, cc3 ✓ 
Del Carmen Nogales et 
al 2017 
Early cleavage stage t5-t2, t3 ✓ (high risk 
aneuploidies) 
Campbell et al  
2013  
and thesis section 2 
Blastocyst stage tSC, tSB, tB ✓ 
Kramer et al 2014 Blastocyst stage None found  
Yang et al 2014 Blastocyst stage None found  
Rienzi et al 2015 Blastocyst stage None found  
Minasi et al 2016 Blastocyst stage tSB, tB, tEB, tHB ✓ 
Patel et al 2016 Blastocyst stage t5-t2, cc3 ✓ 
Mumusoglu et al 2017 Blastocyst stage t9, tM, tSB, tB, tEB ✓ 
Desai et al 2018 Blastocyst stage >/= 2 early stage 
dysmorphisms 
tSB, tEB, tEB-tSB 
 
✓ 
Zhang et al 2018 Blastocyst stage None found  
 
Table 1:  Summary of studies assessing the relevance of morphokinetic variables to predict 
embryo ploidy 
 
Whether pre embryonic genome activation events, such as cleavage morphokinetics prior to 
the 8-cell stage, or later morphokinetic information representing the activated embryonic 
genome will give the most reliable selection criteria needs further study. Most of the earlier 
time lapse publications focussed on events up to the five cell stage, and as a prognosticator 
for blastulation, or implantation, rather than live birth. Whilst it is recognised that maternal 
effects may mitigate against the survival of a potentially viable embryo, and not least because 
aneuploidy is the largest single cause of failure – live birth outcome, in relation to 
morphokinetics as a selection tool, is considered the gold standard outcome measure. Whilst 
early time lapse markers may be easier, and therefore more objectively interpreted and 
assessed during annotation (or automated image analysis) they may not be as reliably 




representative of onward embryo development and potential following activation of the 
embryonic genome, as later morphokinetic variables.  
 
This area of clinical research is challenging, not only due to the heterogeneity of patient 
populations and clinical approaches, but also because embryo ploidy is not binary, and 
mosaicism exists within the human embryo. Furthermore, there is increasing evidence to 
suggest that laboratory factors, such as humidity, culture media or oxygen tension, could 
impact embryo aneuploidy (Swain et al., 2019).  
 
1.8 Are there synergies between time lapse imaging and PGT-A? 
In jurisdictions where PGT-A is permissible and performed, the use of time lapse imaging may 
compliment this treatment, both practically and clinically. The time lapse incubation system 
minimises the need to remove the embryo culture dish from the protected and controlled 
incubation environment. This has general advantages but for PGT-A, time lapse can add 
particular value. Continuous embryo monitoring provides the embryologist, preparing to 
undertake the trophectoderm biopsy procedure, more information about the relative 
developmental stages of the cohort of embryos, in order to set and optimise the timing of 
this technically challenging microsurgical procedure. Without the facility of time lapse 
imaging, the embryologist would be required to remove the culture dish from the incubator 
in order to assess the blastocysts, and their suitability for biopsy, with little or no knowledge 
of where they actually are in the process of development; expansion or contraction, for 
example. This information may also be helpful to set patient expectations on the quality and 
number of embryos available. In addition, this morphokinetic information, in experienced 
hands could be utilised to prioritise blastocysts for biopsy, if the number was restricted due 




to capacity or cost. There is also a case for ranking euploid embryos for transfer using 
morphokinetic information, particularly where validated algorithms are applied, when 
patients are fortunate to have multiple euploids available.  
  




1.8.1 Patient perspectives and time lapse imaging 
The impact for the IVF patient, of incorporating time lapse monitoring of embryo 
development, goes beyond clinical outcome. The additional information provided to patients 
by IVF professionals regarding their embryos’ developmental patterns and timings, is more 
informative than standard methodology and being able to see the images generated from this 
technology may enhance patient understanding and acceptance of their subfertility. Patient 
feedback has indicated that time lapse technology positively aids their understanding of 
events inside the embryology laboratory. When asked, 82% of patients reported that they 
agreed or strongly agreed with the statement; ‘The use of time lapse monitoring has 
improved our understanding of what happens within the IVF laboratory’. (Unpublished CARE 
Fertility data, n=363 patients) (Figure 4). The facility to download and view the video of their 
transferred embryo’s first few days of development is also very well received. 
 








The use of time lapse monitoring has 
improved our understanding of what 
happens in the IVF laboratory
Agree Disagree
Strongly Agree Strongly Disagree
No Opinion




1.9 Perspective and thesis aims 
From the literature, it is clear that time-lapse imaging in the context of improving IVF in 
general, and in terms of its relationship to aneuploidy, is a vibrant and continuously emerging 
field that could benefit many patients. The purpose of this study was to take a leading role in 
the development and application of time-lapse and morphokinetic analysis, and in educating 
the scientific community of its application and potential benefits. This was achieved through 
pursuit of the following specific aims, dealt with in 5 sections of this thesis: 
 
1. To perform a retrospective time lapse analysis of euploid and aneuploid human embryos 
to identify any differences in their morphokinetic profiles and to develop a classification 
model to rank embryos according to their risk of aneuploidy. 
 
2. To assess the clinical relevance of the aneuploidy risk model to aid non-invasive embryo 
selection to enhance implantation and live birth rates, without PGT-A. 
 
3. To amass time lapse data during clinical IVF treatments to make novel observations and to 
develop in house embryo selection algorithms to predict implantation and live birth, and to 
compare the efficacy of such algorithms with conventional morphological selection. 
 
4. To collaborate to perform a multicentre outcome analysis to consider the limitations of a 
time-lapse blastocyst prediction model. 
 
5. To establish best laboratory practice for time lapse imaging, a) by engaging with the 
scientific community to develop and propose guidelines on the nomenclature and annotation 




of dynamic human embryo monitoring; and b) by developing a resource for embryologists 
using time lapse imaging and c) by helping to develop international IVF laboratory 
performance indicators and IVF culture conditions in general. 
 
  




2.0 Specific aim 1.  
To perform a retrospective time lapse analysis of euploid and aneuploid human embryos to 
identify any differences in their morphokinetic profiles and to develop a classification 
model to rank embryos according to their risk of aneuploidy. 
 
Encapsulated in this specific aim is the published study below which was the journal 
frontispiece, received runner up position in the Robert Edwards prized paper award 2013, 
was reported as the most cited article in RBMO in 2016 and received much media interest 
(See appendix 1).  
Campbell A, Fishel S, Bowman N, Duffy S, Sedler M, Hickman CF. Modelling a risk classification 
of aneuploidy in human embryos using non-invasive morphokinetics. Reprod Biomed Online. 
2013 May; 26(5):477-85. doi: 10.1016/j.rbmo.2013.02.006. Epub 2013 Feb 19. Erratum in: 
Reprod Biomed Online. 2013 Jul;27(1):107. PubMed PMID: 23518033. 
 
In this study, my personal contribution was: 
• Devising the operating procedure (SOP) for assessing and recording (annotating) the 
morphokinetic variables on human embryos in vitro using a time lapse incubation 
device (EmbryoScope). (See thesis section 6) 
• Training of Embryologists to collect these data. 
• Time lapse video annotation and laboratory work 
• Data compilation and cleansing. 
• Design of the study. 
• Interpretation of statistical analyses. 
• Manuscript preparation: writing of the first draft and amendments following review. 
This article appeared in a journal published by Elsevier. The attached
copy is furnished to the author for internal non-commercial research
and education use, including for instruction at the authors institution
and sharing with colleagues.
Other uses, including reproduction and distribution, or selling or
licensing copies, or posting to personal, institutional or third party
websites are prohibited.
In most cases authors are permitted to post their version of the
article (e.g. in Word or Tex form) to their personal website or
institutional repository. Authors requiring further information
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Abstract This study determined whether morphokinetic variables between aneuploid and euploid embryos differ as a potential aid
to select euploid embryos for transfer. Following insemination, EmbryoScope time-lapse images from 98 blastocysts were collected
and analysed blinded to ploidy. The morphokinetic variables were retrospectively compared with ploidy, which was determined fol-
lowing trophectoderm biopsy and analysis by array comparative genomic hybridization or single-nucleotide polymorphic array.
Multiple aneuploid embryos were delayed at the initiation of compaction (tSC; median 85.1 hours post insemination (hpi); P = 0.02)
and the time to reach full blastocyst stage (tB; median 110.9 hpi, P = 0.01) compared with euploid embryos (tSC median 79.7 hpi,
tB median 105.9 hpi). Embryos having single or multiple aneuploidy (median 103.4 hpi, P = 0.004 and 101.9 hpi, P = 0.006, respec-
tively) had delayed initiation of blastulation compared with euploid embryos (median 95.1 hpi). No significant differences were
observed in first or second cell-cycle length, synchrony of the second or third cell cycles, duration of blastulation, multinucleation
at the 2-cell stage and irregular division patterns between euploid and aneuploid embryos. This non-invasive model for ploidy clas-
sification may be used to avoid selecting embryos with high risk of aneuploidy while selecting those with reduced risk. RBMOnline
ª 2013, Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
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Introduction
Aneuploidy is prevalent in human oocytes and resulting
embryos and its incidence increases with maternal age.
Depending on the age of the female or the particular
circumstance of the couple, more than half of their embryos
are likely to be aneuploid (Fragouli and Wells, 2011). Avoid-
ing the selection of aneuploid embryos for transfer after IVF
is a clinical imperative. The only method available for
assessing embryo ploidy uses invasive and expensive
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preimplantation genetic screening (PGS), which provides
accurate full chromosome copy number of a biopsied blasto-
mere from the early embryo, trophoblast cells of the blasto-
cyst or the polar bodies of the oocyte and zygote. Various
robust and reliable technologies have been recently intro-
duced, such as array comparative genomic hybridization,
single-nucleotide polymorphism arrays or quantitative PCR,
which have confirmed the high incidence of aneuploidy in
human oocytes and embryos (Fragouli et al., 2006, 2010;
Kamiguchi et al., 1993; Munne et al., 1993). One of the main
causal factors of aneuploidy is believed to be premature
pre-division of chromatids and non-disjunction during meio-
sis, but several other contributory factors such as paternal
or mitotic aneuploidy have been implicated. Aneuploidy in
human embryos results in miscarriage, implantation failure
or the birth of an affected child. PGS provides couples at
high risk of embryo aneuploidy the opportunity for clinics
to selectively transfer a euploid embryo, if available.
Recently, it has been shown that the incidence of live birth
in young, good-prognosis women, with a theoretically low
risk of embryo aneuploidy is enhanced by PGS (Yang
et al., 2012). Furthermore, where there is the need to trans-
fer only a single or a maximum of two embryos, either by
regulation (such as in the UK) or good practice, the selection
of embryos from either euploid oocytes or embryos has
improved outcome in specific circumstances (Fishel et al.,
2010, 2011; Potter et al., 2012; Schoolcraft et al., 2012).
The development of commercially available time-lapse
devices for the IVF laboratory during recent years has
enabled embryologists to observe and study the develop-
ment of human embryos continuously and, therefore, more
precisely than was possible previously. Such monitoring of
the dynamics of embryo development, in addition to tradi-
tional qualitative morphological observations, often
referred to as morphokinetics, provides a plethora of infor-
mation on the development of individual embryos. These
data, generated by the manual or automatic recording or
annotation of images collected over precise time points,
can be retrospectively analysed against outcome variables,
such as blastulation, implantation, ploidy or live birth in an
attempt to identify prospective selection algorithms for
embryo transfer. Morphokinetic analyses promise to provide
IVF practitioners with novel markers of embryo viability.
Recent studies (Dal Canto et al., 2012; Meseguer et al.,
2011, 2012; Pribensky et al., 2010; Wong et al., 2010) have
discussed the potential value of morphokinetic variables
measured by time-lapse monitoring for improved embryo
selection.
The application of time-lapse embryo monitoring in a
clinical IVF setting avoids the need to remove embryos from
incubation conditions to make a daily observation. It allows
embryologists to rewind or freeze images in order to con-
sider the detail and context of embryo development with
practical flexibility. The EmbryoScope is the first instrument
to provide a safe, stable incubation environment (with low
incubation volume and direct heat transfer) combined with
internal microscopy. Meseguer et al. (2012) observed a 20%
increase in pregnancy rate compared with standard incuba-
tion and attributed this improvement to the EmbryoScope’s
stable culture conditions and use of morphokinetic variables
for embryo selection. This study centre’s experience is sim-
ilar and this was the reason for the EmbryoScope being
selected for this study.
As both ploidy analysis from PGS and morphokinetic vari-
ables from time-lapse imaging are two techniques that,
individually, have been demonstrated to have the potential
to significantly improve the incidence of clinical pregnancy
compared with traditional culture and selection methods,
this study examined whether euploid or aneuploid embryos
display differing morphokinetic variables over the preim-
plantation cleavage period. Using trophectoderm biopsy
subsequent to controlled culture conditions, the objective
of this study was to determine whether embryos with a sin-
gle or multiple aneuploidy displayed temporal morphokinet-
ic variables that were significantly different from euploid
embryos. If any variants were established, a further objec-
tive was to develop a model to categorize the risk of aneu-
ploidy in embryos based on this non-invasive morphokinetic
data.
Materials and methods
Data obtained for this research were obtained from the
treatment of 25 couples attending an independent IVF clinic
(CARE Fertility, Manchester, United Kingdom) from May
2011 to July 2012. All protocols complied with UK regulation
(Human Fertilisation and Embryology Act, 1990, 2008). The
study did not require ethical or institutional review board
approval, having been performed according to previously
validated procedures. This was a retrospective cohort study
blinded to ploidy, with recording of embryo development
using time-lapse technology (EmbryoScope; Unisense Fertil-
itech, Denmark) and strict adherence to annotation proto-
cols for the variables defined in Table 1.
Criteria for patients for pre-genetic screening
The couples selected for this study requested or were rec-
ommended PGS due to a history of recurrent implantation
failure following IVF (defined as more than two failed IVF
attempts), recurrent miscarriage (defined as more than
two spontaneous miscarriages), severe male factor infertil-
ity, previous aneuploidy or advanced female age (defined as
>37 years). Female age ranged from 31 to 47 years
(mean ± standard deviation 38.6 ± 3.6 years).
Ovarian stimulation
Pituitary suppression and ovarian stimulation was per-
formed in 75% of patients with a gonadotrophin-releasing
hormone agonist (Suprecur; 0.5 ml subcutaneously daily;
Sanofi Aventis, UK) or antagonist for the remainder (Cetro-
tide; 0.25 mg daily; Merck Serono, UK). Ovarian stimulation
was achieved using human menopausal gonadotophin
(Menopur, Ferring, UK) and/or recombinant FSH (Gonal-F;
Merck Serono), with doses ranging from 150 to 600 IU per
day according to patient type and response. No differences
were observed in ploidy for the stimulation regimens or
doses (data not shown).
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Oocyte retrieval, denudation and ICSI
With the female patient under sedationwith a combination of
propofol (Braun, Germany), fentanyl (Auden McKenzie, UK)
and midazolam (Hamelyn, UK), transvaginal ultra-
sound-guided oocyte retrieval took place 36 h post human
chorionic gonadotrophin injection (10,000 IU; Pregnyl; Orga-
non,UK; orOvitrelle; Merck Serono) or agonist trigger, using a
dual lumen aspiration needle (Swemed; Vitrolife, UK)
connected to a vacuum pump (Rocket Medical, UK).
Oocyte–cumulus-complexes were recovered from follicular
aspirates using a stereomicroscope in a class II hood with a
heated stage, washed and cultured in Ferticult IVF medium
(Fertipro, Belgium) at 5% carbon dioxide in air, 37.0C, max-
imum humidity, for between 2 and 4 h before cumulus cell
denudation with 15–20 IU/ml cumulase (Origio, Denmark)
in the same medium and complete removal of the coronae
radiataewith a 140 lmpipette (EZ Squeeze; Research Instru-
ments, UK). Oocytes at the metaphase-II stage underwent
insemination by intracytoplasmic sperm injection (ICSI).
Embryo culture and incubation
Following ICSI, oocytes were placed individually in micro-
wells of EmbryoSlides (Unisense Fertilitech) in 25 ll Global
IVF medium (LifeGlobal) supplemented with 10% dextran
serum supplement (Irvine Scientific) and were overlaid with
1.4 ml mineral oil (Fertipro, Belgium) in the EmbryoScope.
EmbryoSlides were prepared around the time of oocyte
recovery with medium and oil that had equilibrated
overnight.
Once loaded with the inseminated oocytes, EmbryoSlides
were placed into the EmbryoScope time-lapse incubator at
37C in 5.5% CO2, 5% O2 and 89.5% N2 for at least 5 days. Cul-
ture was temporarily interrupted on day 3 in order to
re-fresh the medium. This was performed by removing 20 ll




daily up to the point of
trophectoderm biopsy
tPNfaded Time when both pronuclei had faded
tn Time from insemination to completion of division to n cells
tSC Time from insemination to when the first cells of the embryo began to join
together and compact (images could be rewound in order to establish the earliest
signs of compaction)
tM Time from insemination to formation of a morula, where all the cells had
undergone the compaction process and cell boundaries were unclear
tSB Time from insemination to start of blastulation, when the first signs of a cavity
were visible (images could be rewound in order to establish the earliest signs of
cavitation)
tB Time from insemination to formation of a full blastocyst; when the blastocoele
filled the embryo with <10% increase in its diameter
tEB Time from insemination to expanded blastocyst; when the blastocyst had
increased in diameter by more than 30% and the zona pellucida started to thin
tHB Time from insemination to hatching blastocyst, when trophectoderm herniation
through the zona pellucida was first observed
MN2 Multinuclearity at the 2-cell stage
MN4 Multinuclearity at the 4-cell stage
Variables of duration, calculated from the
morphokinetic parameters
cc2 Time of second cell cycle (t3–t2), from 2 to 3 cells
cc3 Time of third cell cycle (t5–t3), from 3 to 5 cells
s2 Time of synchrony of the second cell cycle (t4–t3), from 2 to 4 cells
s3 Time of synchrony of the third cell cycle (t8–t5), from 4 to 8 cells
Blastulation Time of blastulation, from start of blastulation to formation of a full blastocyst
(tB–tSB)
1 fi 3 Direct or rapid (<5 h) cleavage from 1 to 3 cells, referred to as irregular division
pattern
2 fi 5 Direct or rapid (<5 h) cleavage from 2 to 5 cells, referred to as irregular division
pattern
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of culture medium from each microwell and replacing it
with fresh, pre-equilibrated medium. The built-in micro-
scope was used to acquire images of each fertilized oocyte
every 20 min through seven focal planes.
Trophectoderm biopsy and pre-implantation
genetic screening
Of the blastocysts in this study, 69 (70.41%) of them
underwent a series of three 4-lm diameter laser pulses
(Saturn Active laser and Integra micromanipulator;
Research Instruments) to breach the zona pellucida on
day 3 of culture in order to facilitate trophectoderm her-
niation for biopsy. For the remaining 29 (29.59%) blasto-
cysts, laser breaching was performed at the time of the
biopsy procedure. No differences were observed in time
from insemination to start of blastulation (tSB) or time
from insemination to formation of a full blastocyst (tB)
between embryos which underwent this procedure and
those which did not.
The timing of the procedure and the stage of blasto-
cyst development when trophectoderm biopsy was under-
taken varied in this study as they were performed in a
minimum number of cohorts to reduce disruption to the
incubation and for efficient working practice. All biopsies
were performed on blastocyst-stage embryos on day 5 or
6 post oocyte recovery. The minimum stage and quality
criteria for selection of blastocysts for biopsy and vitrifi-
cation in this study were embryos that were at least full
blastocysts, with at least a fair, easily discernible inner
cell mass and at least a few cells forming a loose troph-
ectoderm (equivalent to stage 2 grade 2; Alpha and
ESHRE, 2011a,b).
The time of hatching could not be reliably assessed in
the embryos where a facilitative breach was made in the
zona pellucida. Where observed, the time from insemina-
tion to start of blastulation was recorded for the first
expansion episode only and only when expansion occurred
prior to biopsy. The cycles of collapse and expansion,
although observed in some of the blastocysts, were not
recorded.
Up to three blastocysts per patient were biopsied in
one dish in individually labelled 20-ll microdrops of
G-MOPS buffered medium (Vitrolife, Sweden) using a
33–37-lm inner diameter blastomere biopsy micropipette
(Humagen, Origio). Where required, the zona pellucida
was breached using a series of 4-lm laser pulses and 5–10
trophoblast cells aspirated into the biopsy pipette. Stron-
ger laser pulses of up to 15 lm were used with aspiration
and mechanical pressure to remove the cells from the
blastocyst. In compliance with UK regulation and good
practice, witnessing was performed at every stage by
manual witnessing or Matcher barcode electronic witness-
ing (IMT International). Time-lapse monitoring ceased for
the particular blastocysts that were removed from the
EmbryoScope for biopsy. Following biopsy, the biopsied
cells were placed into 0.2 ml thin walled-tubes and sealed
and frozen by placing them into a freezer at 20C prior
to genetic screening and the blastocysts vitrified
(Kitazato; Hunter Scientific, UK).
Trophectoderm biopsies of 98 blastocysts were ampli-
fied and analysed by either whole-genome amplification
and array comparative genomic hybridization (n = 37; Gen-
esis Genetics Europe, Nottingham, UK) or by single-nucle-
otide polymorphism microarray (n = 61; Natera, California,
USA). Embryos were categorized as ‘single’ or ‘multiple’
aneuploid depending on the number of chromosomes
affected.
The method by which analysis of trophectoderm
biopsies via single-nucleotide polymorphism microarray
occurred has previously been described (Johnson et al.,
2010a,b). Briefly, biopsies were lysed and heat inactivated
prior to DNA amplification. In order to determine the
source of aneuploidy, parental buccal swabs or blood sam-
ples were collected. Genomic DNA was isolated and the
standard Infinium II protocol (Illumina, San Diego, CA,
USA) was used for analysis of these samples. The geno-
type of the biopsy samples was determined using Infinium
II genotyping microarrays (CytoSNP-12 chips). Chromo-
some imbalances were determined using a specific algo-
rithm, described in Johnson et al. (2010b), which used
the information gained from the parental genotype and
the biopsy sample to determine both whole-chromosome
imbalances and structural abnormalities, along with the
parental source of the aberration.
The method by which analysis of trophectoderm biop-
sies via array comparative genomic hybridization occurred
as has previously been described (Fishel et al., 2011).
Briefly, DNA was amplified from the biopsied cells using
the SurePlex DNA Amplification System (BlueGnome, Cam-
bridge, UK) according to the manufacturer’s instructions.
Amplification was assessed by DNA gel electrophoresis
and only samples generating amplified product were
labelled. Test and control sample product and SureRef
Male DNA (BlueGnome) were labelled with Cy3 and Cy5,
respectively, using the BlueGnome fluorescent labelling
system, according to the manufacturer’s instructions.
Labelled test and control sample and SureRef Male DNA
were co-hybridized using 24Sure microarrays version 2
(BlueGnome). The resulting 24Sure microarrays were
hybridized, washed and scanned according to the manufac-
turer’s protocol. Scanned images were analysed and quan-
tified and whole-chromosomal copy number ratios were
reported using the Cytochip algorithm fixed settings in
BlueFuse Multi Software (BlueGnome).
Evaluation of time-lapse images
Time-lapse images were collected for the duration of the
culture period, to the point of biopsy and were used for
the assessment of fertilization and embryo development.
The time of insemination by ICSI was programmed into
the EmbryoScope when the slide was loaded, as the time
point midway through the ICSI procedure. The Embryo-
Viewer image analysis software was used to log and dis-
play the precise timing of developmental events as they
were annotated by the embryologists studying the
time-lapse images. Table 1 outlines the definitions of
morphokinetic variables that were recorded in this study
of 2 pronuclei embryos up to the point of trophectoderm
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biopsy. All times were recorded in hours post insemina-
tion (hpi). All annotations were made prior to the result
of the biopsy analysis and were therefore blind. Example
images show how the start and completion of blastulation
were identified (Figure 1).
Data analysis
Embryos with incomplete annotations, failed amplification
and/or abnormal or lack of fertilization were excluded from
analysis. The time variables were tested for normality using
Shapiro–Wilks test for normality. Since most variables were
foundnot tobenormallydistributed,non-parametric testswere
used to determine whether differences were significant. The
Mann–Whitney–Wilcoxon test was used to test differences in
morphokinetic variables, whilst Fisher’s test (odds ratio differ-
ent toone)wasused to test differences in incidence rateofmul-
tinuclearity and irregular cleavage patterns. The statistical
analyses were performed using R statistical software version
2.15.0 (R Foundation for Statistical Computing).
Algorithm using non-invasive morphokinetics to
categorize the risk of aneuploidy
Morphokinetic variables found to differ between euploid
and aneuploid embryos (single and multiple aneuploid
combined) were used to build a decision tree model by
recursive partitioning to partition the embryos into groups
depending on the value of the variables tSB and tB. The
recursive partitioning was optimized by the logWorth
value. The partitioning process stopped when all new
steps had a logWorth value below one (non-significant
splits). The model classified embryos into three classes
of aneuploidy risk: low, medium or high risk. The recur-
sive partitioning and the probability of a random embryo
in a particular risk class being aneuploid were calculated
in JMP version 10.0 (SAS Institute).
Results
The time of initiation of compaction (tSC) was significantly
delayed (P = 0.02) for multiple aneuploid embryos (median
85.1 hpi, range 64.9–113.0 hpi) compared with euploid
embryos (median 79.7 hpi, range 56.3–107.6 hpi). The time
of initiation of blastulation (tSB) was significantly delayed
(P = 0.004 and 0.006) more than 6 h for both single aneuploid
embryos (median 103.4, range 79.8–121.5 hpi) and multiple
aneuploid embryos (median 101.9 hpi, range 86.8–129.4 hpi)
compared with euploid embryos (median 95.1 hpi, range
85.2–113.9 hpi). The time of full blastulation (tB) was signifi-
cantly delayed (P = 0.01) for 5 h formultiple aneuploid embryos
(median 110.9 hpi, range 90.1–137.0 hpi) compared with
euploid embryos (median 105.9, range 86.8–122.3 hpi). All
other timings testedwere not significantly different (Table 2).
No significant differences were observed between aneu-
ploid and euploid embryos in the length of the first or sec-
ond cell cycle, synchrony of the second or third cell cycle,
or the duration of blastulation (Table 3). No significant dif-
ferences were observed between aneuploid and euploid
embryos in multinucleation at the 2-cell stage or irregular
division patterns (direct or rapid division defined as <5 h)
cleavage from 1 fi 3 or from 2 fi 5 cells (Table 4).
Modelling
Since tSB and tB were found to differ significantly between
euploid and aneuploidy embryos, these variables were
selected for the simple classification model with three risk
classes of aneuploidy (Table 5 and Figure 2).
The following algorithm was derived using the recursive
partitioning method in R: low risk, tB <122.9 hpi and tSB
< 96.2 hpi; medium risk, tB < 122.9 hpi and tSB  96.2 hpi;
high risk, tB  122.9 hpi. When the data were divided into
the three different classes the area under the receiver
operating characteristic curve was 0.72.
(A) Start of blastulation (tSB)    
250µm
25µm
(B) Blastocyst (tB) 
Figure 1 Time-lapse images of the same embryo demonstrating its appearance at specific time points as utilized in this study. (A)
Human embryo at 106.8 hpi, with the start of a cavity forming (arrow), at tSB. (B) Human blastocyst at 112.1 hpi, with a blastocoele
filling the embryo with <10% increase in its diameter, at tB.
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Table 2 Timing of divisions for euploid, single aneuploid and multiple aneuploid embryos.





























tPNfaded 20.8 23.2 25.2 32 21.2 23.1 24.8 26 NS 20.8 22.6 23.9 30 NS
t2 23.2 25.1 27.5 38 23.5 25.1 27.4 30 NS 23.3 24.9 26.9 30 0 NS
t3 31.1 35.0 38.3 38 33.4 36.9 39.2 30 NS 33.2 35.6 37.4 30 NS
t5 43.7 48.5 51.5 38 44.9 50.2 52.2 30 NS 43.9 47.7 50.6 30 NS
t8 52.6 56.1 63.1 35 51.2 56.2 60.1 27 NS 48.8 54.0 60.3 27 NS
tSC 74.1 79.7 85.4 35 75.3 80.7 86.7 30 NS 80.1 85.1 89.6 28 0.02
*
tM 79.6 83.5 87.8 32 80.5 87.9 93.6 29 NS 83.9 88.2 94.7 27 NS
tSB 91.7 95.1 101.5 38 96.4 103.4 110.2 30 0.004
* 97.0 101.9 107.3 30 0.006**
tB 101.2 105.9 111.3 38 102.6 109.2 116.0 30 NS 105.9 110.9 116.3 29 0.01
*
tEB 104.5 110.6 114.0 18 105.3 109.2 113.3 13 NS 107.5 115.3 124.9 9 NS
tHB 107.5 109.9 116.6 15 107.3 116.5 120.8 9 NS 114.5 115.4 118.4 6 NS
Mann–Whitney–Wilcoxon test, P-values of the two types of aneuploidy against the euploid: *P < 0.05; **P < 0.01.
hpi = hours post insemination; n = number of embryos: see Table 1 for other definitions.
Table 3 Times of of developmental periods for euploid, single aneuploid and multiple aneuploid embryos.




















cc2 9.8 10.7 11.8 38 10.3 11.4 11.9 30 9.4 11.3 12.0 30
cc3 10.8 12.5 14.0 38 11.7 12.6 13.7 30 11.3 12.3 14.3 30
s2 0 1.0 4.0 38 0 0.5 1.5 30 0 1.0 4.0 30
s3 2.6 8.7 15.9 35 3.0 6.7 10.4 27 2.5 4.0 13.9 27
Blastulation 6.8 8.3 11.0 38 3.6 6.9 10.9 30 5.3 9.7 12.3 29
Mann–Whitney–Wilcoxon test, P-values of the two types of aneuploidy against the euploid: No statistically significant differences were found (P  0.05).
















As far as is known, this is the first paper demonstrating an
association between human embryo ploidy and morphoki-
netics derived from time-lapse technology. The recent ret-
rospective study by Meseguer et al. (2012), which set out to
quantify the effect of using stable time-lapse culture
conditions and morphokinetic variables for embryo selec-
tion, used clinical pregnancy as the end point. This was
defined by the presence of gestational sacs with fetal heart-
beat during week 7 of gestation. However, it is likely that a
proportion of these early IVF pregnancies will be aneuploid.
Fragouli and Wells (2011) discussed the landscape of blasto-
cyst comprehensive cytogenetic analysis and reported over-
all aneuploidy rates in blastocysts to be greater than 50%.
They suggest that the majority of biological selection
against aneuploidy and genetic anomalies occurs at or after
the time of implantation. It is widely accepted that a major
cause of failed implantations or miscarriage following
embryo transfer is the (unknowing) transfer of aneuploid
embryos. Up until now, the only means available to IVF
centres for assessing ploidy in embryos has been polar body,
blastomere or trophoblast biopsy with PGS. Ploidy of the
embryos in this study was assessed by screening of the
trophectoderm to give full chromosome copy number,
which is considered to give high concordance with the inner
cell mass, but may still not be 100% accurate.
Alfarawati et al. (2011) previously compared blastocyst
qualitative morphology with ploidy and demonstrated only
a weak association between blastocyst morphology and
aneuploidy. They reported that, concerning the growth rate
of blastocysts, there was an insignificant trend toward aneu-
ploid embryos showing slower progression to the most
advanced blastocyst stages and that embryos with complex
aneuploidy were most delayed. This study was performed
without the benefit of time-lapse technology and the
Table 4 Incidence rates of multinuclearity and irregular division patterns for
euploid, single aneuploid and multiple aneuploid embryos.
Euploid Single aneuploid Multiple aneuploid
Incidence (%) n Incidence (%) n Incidence (%) n
MN2 13 38 16 30 10 30
MN4 0 38 0 30 0 30
1 fi 3 18 38 0 30 10 30
2 fi 5 2 38 3 30 13 30
Fisher’s test for significant differences between the two types of aneuploidy
against the euploid: no significant differences were found.
n = number of embryos; see Table 1 for other definitions.
Table 5 A time-lapse derived model for the classification of ploidy with
associated incidence rates and probabilities of aneuploidy.
Risk class Definition n Incidence Probability
Low tB <122.9 hpi and tSB <96.2 hpi 36 0.36 0.37
Medium tB <122.9 hpi and tSB 96.2 hpi 49 0.69 0.69
High tB 122.9 hpi 12 1.00 0.97
All 97 0.61 0.61
Corrected Akaike information criterion is 296; area under the receiver operating
characteristic curve is 0.72; imputes = 1.
hpi = hours post insemination; n = number of embryos; incidence = incidence rate
of aneuploidy embryos; probability = probability estimated using recursive par-
titioning-derived risk classification of an embryo being aneuploid; see Table 1 for
other definitions.
tB, (hpi)


















Figure 2 The three classes of aneuploidy risk (low, medium
and high) based on time from insemination to a full blastocoele
where the blastocyst has not yet started expansion (tB) and
time from insemination to start of blastulation (tSB). Area under
the receiver operating characteristic curve is 0.72. hpi = hours
post insemination.
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findings were not clinically applicable as no clear cut-off
time point was given for discrimination between complex
aneuploid embryos and euploid ones. The time or frequency
of blastocyst morphological assessment was not discussed in
that paper.
From the cohort of blastocysts that underwent PGS in
this study, the overall incidence rate of aneuploidy was 61%.
The model used the morphokinetic variables tSB and tB of
these embryos of known ploidy to classify a blastocyst’s risk
of aneuploidy. The model can therefore be used to rank
individual and unscreened blastocysts as having low (proba-
bility 0.37), medium (probability 0.69) or high risk (probabil-
ity 0.97) of aneuploidy. Especially where there is a choice of
embryos available, the model could be useful in reducing
the chance of selecting an aneuploid embryo. The classifica-
tion from this model may, therefore, be used clinically to
rank embryos for transfer and could also be used alongside
PGS in order to prioritize embryos for biopsy and screening,
particularly where costs are based on the number of
embryos screened. Additional data may facilitate the fine
tuning of this algorithm.
Embryos with rapid cleavage from 2 to 3 cells in less than
5 h have been reported to have a significantly lower implan-
tation potential than embryos with a normal cell cycle
length (Rubio et al., 2012). The normal cell cycle time has
been established to be 10–12 h (Cummins et al., 1986)
and therefore there is sufficient time for DNA replication.
It is unknown if a causal relationship to ploidy exists in all
cases of such anomalous cleavage: whether rapid cleavage
provides insufficient time for complete genome replication
resulting in aneuploidy or whether a particular existing
aneuploidy results in erroneous cleavage patterning. For
example, some aneuploidies are lethal during the preim-
plantation stage, such as many monosomies, whilst some,
such as trisomies 13, 18 and 21, are compatible with
full-term delivery. Somfai et al. (2010) reported a high fre-
quency of chromosomal anomalies in bovine embryos which
developed from zygotes that exhibited direct division to
three from one cell, although rapid cleavage was observed
in a small proportion of both euploid (18%) and aneuploid
embryos (5% overall) in the present study. The incidence
of such rapid cleavage was not assessed in embryos with
arrested development in this study and further research into
such cleavage patterning, such as reverse cleavage, is
underway.
This study developed a model based on this study cen-
tre’s own culture systems, in which all controllable environ-
mental factors have been standardized and with a strict
annotation policy followed by laboratory staff. This gener-
ated two precise time points, the start of blastulation and
the time that the embryo reached the full blastocyst stage,
as important markers in this model for classifying the risk of
ploidy. With standard incubation, embryologists will be
unable to annotate these timings precisely without tremen-
dous disruption and compromise to incubation and working
practice. Whilst a daily observational procedure could be
applied on day 4 at around the same time of day as the
insemination occurred (96 hpi) and another on day 5 at a
similar time (120 hpi) in an attempt to align with the tempo-
ral values in this model, the facility to study and rewind
time-lapse images to identify the point of blastulation initi-
ation (tSB) and completion of blastulation (tB) is essential to
this modelling to permit a high degree of confidence in this
data. Furthermore, the accuracy of the model is dependent
on the 20-min imaging interval (i.e. capable of generating
19 images in 6 h) It is unknown at this time whether specific
time points from this model can be applied to a different
culture system, culture media, plastic ware, gas mix, air
purity, etc., even with time-lapse technology.
This model for categorizing the risk of aneuploidy using
non-invasive methods should improve clinical outcome.
Other systems that simply predict the occurrence of an
embryo to undergo blastulation (Wong et al., 2010) are
unlikely to be as clinically robust given that all aneuploid
pregnancies, miscarriages and live births, ipso facto, devel-
oped to and beyond the blastocyst stage, as did the many
aneuploid blastocysts that failed to become pregnancies.
The high incidence of aneuploidy in blastocysts (61% in this
study), confirms the clinical limitations of time-lapse sys-
tems used only to select embryos that are predicted to
become blastocysts.
The period leading up to blastulation is a period of
intense cellular metabolic activity, gene activation, rapidly
increasing cell division and differentiation. Cell division and
the mitotic process is a series of complex structural rear-
rangements involving the kinetochore attachments to the
microtubules (Gonen et al., 2012), cohesion molecules for
the crucially precise separation of the chromosome to
ensure correct alignment on the spindle (Clift and Marston,
2011), the spindle assembly complex and many highly spe-
cialized proteins subject to precise gene expression (Vogt
et al., 2008). Although the cause of a temporal delay in
aneuploid embryos compared with their euploid counter-
parts is not yet fully explained, there exist error detection
and repair systems within the cell to prevent aneuploidy
(Nasmyth and Haering, 2009). It is highly probable, there-
fore, that mitotic errors in individual cells at this stage of
the rapidly developing embryo involve complex biochemical
systems delaying karyo- and cytokinesis, which result in the
gross observation of delayed blastulation.
Time-lapse photography in a closed incubation system
such as the EmbryoScope, when used precisely to measure
the initiation and completion of blastulation, appears to be
the most reliable non-invasive method of ranking the risk of
aneuploidy in advanced-stage embryos. It is unlikely ever to
be as absolute as gaining accurate chromosome copy number
from biopsied cells, but it is an important tool to enhance the
chances of a live birth following IVF by non-invasive means.
Further studies are underway to quantify further morphoki-
netic variables, to observe the impact of specific aneuploidy
data and to prospectively test this model.
This study indicates that, with time-lapse monitoring of
embryo development to blastocyst in a closed incubation
system, it is possible, where there are alternative embryos
available within a cohort, to avoid the selection of embryos
having a high risk of aneuploidy and to preferentially select
embryos with a greatly reduced risk of aneuploidy based on
morphokinetic timing.
This non-invasive approach may be offered to patients as
an alternative to PGS or, indeed, as a complementary sys-
tem. This model for classifying the risk of aneuploidy
requires time-lapse technology to enable identification of
specific time points for embryo development up to the
blastocyst stage. This accessible and non-invasive embryo
484 A Campbell et al.
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selection model may be used for patients electing against
invasive genetic screening technology or for clinics without
the skills or access to PGS.
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Aneuploidy is a key causal factor of delays
in blastulation: author response to
‘A cautionary note against aneuploidy risk
assessment using time-lapse imaging’
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Abstract In a previous paper, we had reported use of time-lapse monitoring to develop an aneuploidy risk classification model after
identifying significant periblastulation delays in aneuploid embryos compared with euploid embryos. The model was validated sub-
sequently in a second paper by retrospective assessment of transferred blastocysts that had also undergone time-lapse monitoring in
which clinical pregnancy or live birth outcomes were established. A significant difference was seen for both outcome measures
between embryos classified as low and medium risk by the model. Here we respond to the commentary entitled ‘A cautionary note
against embryo aneuploidy risk assessment using time-lapse imaging’, which presented a case for our conclusions being unsound on
the basis that maternal age, rather than aneuploidy, might be the cause of the developmental delays observed. We demonstrate
that this is not the case and strengthen the argument that ploidy is a key factor influencing morphokinetics of blastulation. We also
describe why the arguments made in the commentary based on comparisons between static standard observations and timings of the
preimplantation embryo compared with those obtained from dynamic or time-lapse methodologies are inexact. RBMOnline
ª 2013, Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
KEYWORDS: age, blastulation, IVF, morphokinetics, ploidy, time lapse
In the commentary ‘A cautionary note against embryo
aneuploidy risk assessment using time-lapse imaging’, Otto-
lini et al. (2013) provide no information on their method or
frequency of observations used, and so we must stress the
shortcomings of describing an embryo as ‘day 5’ or ‘day 6’
when disputing the validity of a time-lapse study which
records images at a rate of at least three times per hour
throughout the in-vitro culture period. The delays that were
reported and used to develop the aneuploidy risk classifica-
tion model could not be detected without time-lapse analy-
sis, nor can they be translated to standard practice
(Campbell et al., 2013a).
Ottolini et al. (2013) reference the work of Kroener et al.
(2012), suggesting that it ‘clearly showed that delayed
blastulation was not associated with increased aneuploidy
rates’; however, this study did not use time lapse to mea-
sure precise timings and is confounded by the fact that it
utilized blastomere biopsy for ploidy assessment which in
itself has been demonstrated to affect subsequent embryo
development, possibly delaying compaction (Kirkegaard
et al., 2012). Furthermore, Alfarawati et al. (2011), using
trophectoderm biopsy but also standard embryo assessment
methods at unspecified time or frequency, reported a trend
towards aneuploid embryos, showing slower progression to
the most advanced blastocyst stages. Interestingly, the
‘unpublished observations’ cited by Ottolini et al. (2013)
also represent a similar trend; the incidence of aneuploidy,
on ‘day 6’ was 60.2%, compared with 53.4% on ‘day 5’.
1472-6483/$ - see front matter ª 2013, Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
http://dx.doi.org/10.1016/j.rbmo.2013.11.016
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Since the publication of our articles under discussion,
Hong et al. (2013) have reported a significant correlation
between early times to cavitation, from the first cytokinesis
and from 5 cells, and reduced prevalence of aneuploidy.
Aneuploidy is prevalent in human oocytes and resulting
embryos and it has been widely demonstrated that its inci-
dence increases with maternal age. Ottolini et al. (2013)
argue that it is maternal age, and not embryo aneuploidy
specifically, which causes the delays described in our
articles.
We respectfully suggest that Ottolini et al. (2013) mis-
represent the reported impact of maternal age on blasto-
cyst development by stating that it is ‘well established
that blastocyst formation and hatching are negatively corre-
lated with maternal age’ (Porter et al., 2002). Porter’s
study, on supernumerary blastocysts, demonstrated a statis-
tically insignificant negative correlation between blastocyst
formation and hatching and increasing maternal age. To our
knowledge, there are limited studies that consider age and
morphokinetics. Hickman et al. (2013) demonstrated in 348
embryos that maternal age did not affect morphokinetic
timings up to the morula stage but that in women aged
36 years, embryos reached the later developmental stages
significantly faster than in the those >36 years.
We examined over 1200 individual embryos, monitored
by time lapse to the blastocyst stage, combined from four
of our centres, where embryo culture and laboratory
practice is aligned, to correlate maternal age with the mor-
phokinetic variables used in our published model (Campbell
et al., 2013a). These variables were the start of blastulation
(tSB) and the time to reach the blastocyst stage (tB). The
embryos were all from cycles with an autologous oocyte
source.
Figure 1 confirms a positive but not a close correlation
between age and both tB and tSB, which could lead to the
assumption that age is controlling these morphokinetic vari-
ables. However, it is apparent that other factors are influ-
encing these variables, as data are scattered, with the
95% prediction interval being around 20 h on either side of
the trend or linear regression lines. The mean increase in
tSB over the range of maternal ages (25–45 years) is 5 h,
whereas the interval where 95% of any future embryos are
expected to fall (95% prediction interval) for a specific
age is ±20 h. A similar pattern is seen for tB. Age alone can-
not account for these differences.
The question remains: does maternal age directly influ-
ence embryo morphokinetics or is it the differing propor-
tions of competent (such as euploid) embryos which are
controlling the apparent correlation between age and the
average timing of late morphological events? Our work
would suggest that embryo ploidy status is a key factor con-
trolling these morphokinetics. Due to this, a prediction of
the relative risk of aneuploidy and also of the relative
chance of implantation can be calculated by the model we
have described (Campbell et al., 2013a).
The model has since been further validated by Unisense
FertiliTech on independent implantation data from 27 clin-
ics under an agreement with Unisense FertiliTech (unpub-
lished data). This analysis was based on 536 embryos with
implantation information. The results are in concordance
with our findings, indicating validity of the proposed model
and supporting the practical usability of the model to assist
in the embryo selection process. Blastocysts categorized as
having the lowest risk of aneuploidy by retrospective appli-
cation of the model gave the highest clinical pregnancy
rate, which was demonstrated to decrease as aneuploidy
risk increased, by class.
Ottolini et al. (2013) accept that we have identified
developmental time points which relate to an embryo’s
implantation potential in our system and we would suggest,
in light of increasing evidence, that these two variables may
also have relevance in other settings.
The ultimate embryo selection model, however, will use
healthy euploid live birth as the outcome measure, rather
than clinical pregnancy or ploidy status, as the absolute
accuracy of the latter might be limited by trophoblast mosa-
icism. Implantation failure and biochemical pregnancy or
miscarriage may also confound morphokinetic studies.
Ottolini et al. (2013) argue that the original analysis of 97
embryos is underpowered (Campbell et al., 2013a). In the
original work, two statistical methods were applied to the
data: (i) the difference in timings were tested between
the euploid, single aneuploid and multiple aneuploid
embryos; and (ii) the area under the curve (AUC) and the
receiver operating characteristic (ROC) curve, were used
as a measure of the classification power of the model. For
the relevant variables (tSB and tB), the tests of differences
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Figure 1 The time to start of blastulation (A, n = 1517) and to
full blastocyst (B, n = 1271) in hours versus the age in years of
the patients at the time of autologous oocyte retrieval. The
black line is the trend (linear regression) line, the blue lines
indicate the 95% confidence interval and the green lines
indicate the 95% prediction interval. hpi = hours post insemi-
nation; tB = time from insemination to a full blastocoele where
the blastocysts has not yet started expansion; tSB = time from
insemination to start of blastulation. (For interpretation of the
references to color in this figure legend, the reader is referred
to the web version of this article.)
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were significant, with power between 0.96 and 0.98
(P < 0.05; Hintze, 2013). AUC, which was 0.72 in the
original work, was significantly different from 0.5 (which
is the no-effect value of AUC) with power 0.97 (P < 0.05;
Hintze, 2013).
Ottolini et al. (2013) question whether it is necessary to
include both tSB and tB in the aneuploidy risk classification
model due to the two variables being apparently linked.
The method applied in the original work was to make a
recursive partitioning model with the variables that had
proven to be significantly different between euploid and
aneuploid embryos and only to include significant splits.
Whist statistically it may be effective to utilize only a single
variable (in this case the strongest being tSB), from a biolog-
ical perspective we elected to incorporate tB into the recur-
sive partitioning model as it is important to distinguish
< 
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Figure 2 Three classes of aneuploidy risk (low, medium and high) based on time from insemination to a full blastocoele where the
blastocysts has not yet started expansion (tB) and time from insemination to start of blastulation (tSB) with revised limits. Data are
divided into patient age at the time of oocyte retrieval – <40 (A) and 40 years (B) – demonstrating how the risk classification
model is effectively applied for patients in these two different age categories. hpi = hours post insemination.
Aneuploidy and delayed blastulation 281
Author's personal copy
between embryos which initiated blastulation but either
had a very extended blastulation phase or did not reach
the blastocyst stage (tB) at all. Additionally, the pool of data
that are allocated to the high-risk group could not be as
effectively isolated using tSB, since tSB for most of the data
in the high-risk group is equivalent to the medium range
with regard to tSB.
Since the publication of our work earlier this year, we
have doubled the size of the dataset to 195 embryos allow-
ing for fine tuning of the aneuploidy risk classification. A
new analysis has moved the boundary for tB in the high-risk
class from 122.9 to 118.1 h post insemination and the
boundary for tSB between the low- and medium-risk classes
from 96.2 to 96.6 h post insemination. The aneuploidy rate
for the updated low-, medium- and high-risk classes is
45.8%, 65.9% and 95.8%, respectively. The AUC of the ROC
curve is 0.67, which is significantly different from 0.5 with
a power of 0.99 (P < 0.05) (Hintze, 2013). The difference
between the medium- and low-risk groups were significant
(P = 0.01) and the power was 0.80 (P < 0.05).
The revised model has been further split by two age
groups: <40 and 40 years (Figure 2). The incidence rate
of aneuploidy of each group gives reason to be confident
in the ranking power of the model even with narrower age
categories. It also demonstrates that the levels of aneuploi-
dies may vary greatly in different age groups, underlining
that the aneuploidy risk classification model should not be
used to determine the actual risk of aneuploidy (e.g. 65.6%
chance of aneuploidies) but to assess the relative risk of
aneuploidies (e.g. embryo X has a greater risk of being aneu-
ploid compared with embryo Y).
In response to the comments by Ottolini et al. (2013), we
applied a logistic regression model to our data. Table 1
shows a combined model for the effect of tSB (the strongest
variable in the aneuploidy risk classification model) and age.
The required number of embryos for a logistic regression
analysis with intercept and one covariate (e.g. tSB) with
P < 0.05 and power 0.8 and the levels of probabilities
observed here is 274 (Hintze, 2013). Therefore, analysis
with the logistic regression model shown in Table 1 does
not have the required power. The combined model of tSB
and age, however, has a significant effect of tSB in the
model (the AUC of the full model is lower than if the effect
of tSB was removed). From the logistic regression model, it
can be seen that, for each year, the patient age increases,
the odds (1/(1  P) where P is the probability) of having an
aneuploid embryo increases by 18% and that, for each hour,
the value of tSB increasing the odds of getting an aneuploid
embryo increases by 5%.
For a specific patient in a specific treatment cycle, in
which age is constant, we can expect the odds of aneuploidy
to increase 5% per hour that tSB increases. These results
should however be treated with caution, since larger num-
bers are required to perform the logistic regression analysis.
Future analysis with more data may confirm these findings.
But it underlines again that both age and morphokinetics are
important when determining the actual risk of aneuploidy.
The aneuploidy risk classification model (Campbell et al.,
2013a) was developed to evaluate the relative risk of aneu-
ploidy for any embryo within a patient cohort. As the model
is used to rank embryos for a specific patient, age does not
change and should not be considered.
In conclusion, our position remains unchanged; indeed, it
is strengthened by the statistical evaluation presented here.
Although incidence of aneuploidy is increased with maternal
age and age is correlated to the morphokinetic variables
identified, this correlation is not strong. We do not consider
the likely causal factor of observed periblastulation delays,
to be maternal age and reject the challenges made by
Ottolini et al. (2013) regarding this association. Our data
clearly suggests that the delays are strongly associated with
aneuploidy itself. We believe that this accessible and nonin-
vasive embryo selection model may be used to classify the
relative aneuploidy risk for embryos from a given patient
electing against invasive genetic screening technology or
for clinics without the skills or access to preimplantation
genetic screening (PGS) (Campbell et al., 2013b). Alterna-
tively, as Montag suggests (2013), the model could be used
as an economic approach to prioritize low-risk blastocysts
initially, for PGS. Euploid live birth data could enhance this
model for prospective embryo selection and we believe that
this should be the ultimate outcome measure. Again, we
advise a cautious approach when considering transferring
such morphokinetic embryo selection models between cen-
tres without prior validation.
We respectfully thank Ottolini, Rienzi and Capalbo for
their interest in our recent articles and we encourage
debate into this fascinating area of clinical embryology.
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Since the advent of successful human IVF, fertilization and
subsequent embryo culture has moved from the test-tube,
held in sealed glass desiccators in ‘warming cabinets’, to
the Petri dish in conventional culture incubators (Fishel and
Edwards, 1982; Steptoe and Edwards, 1978), the latter being
used clinically worldwide for more than three decades.
Recently the introduction of time-lapse imaging had permit-
ted the observation of zygotes and embryos as they pass
through fertilization and syngamy to cleavage, compaction,
blastulation and even eventual hatching. This novel technol-
ogy permits the recording and retrospective analysis of tem-
poral morphokinetic variables (Meseguer et al., 2011), not
only in varying culture conditions but in a range of clinical
scenarios. However, only one commercially available system,
the EmbryoScope, provides for uninterrupted culture, for up
to 6 days if required, therefore standardizing this variable.
Cruz et al. (2011), following a safety evaluation of this
time-lapse system, concluded that the periodic light expo-
sure required for image acquisition in the EmbryoScope did
not impair embryo quality or reproductive outcome. It has
since been demonstrated that culturing in this system
improves the incidence of clinical pregnancy (Meseguer
et al., 2012). Also, very recently it was demonstrated using
this system that aneuploid and euploid embryos have differ-
ing morphokinetic variables under standardized IVF culture
conditions (Campbell et al., 2013).
The vital decision as to which of a patient‘s embryos
should be preferentially selected for transfer following IVF
treatment has to date been based primarily on a sequence
of two to six chronological observations of the developing
embryos. Standard IVF practice currently requires the
removal of the culture dish containing the embryos from
the incubator into suboptimal ambient conditions, in order
for the embryologists to assess each embryo using light
microscopy and record their observations relating to the
number of cells, the stage of development and morpholog-
ical features. This is typically performed once daily to min-
imize disturbance of the embryos in culture. For the vast
majority of IVF clinical treatments worldwide, it is the
scribed record of this series of static observations along
with the status of the embryo at the time of the transfer
procedure that dictates which embryo is selected. Various
grading schemes exist and a consensus document for
embryo grading was recently published in the hope of pro-
viding evidence-based guidelines and standard terminology
for the accurate reporting of embryo development (Alpha
and ESHRE, 2011a,b).
However, the viability of embryos is compromised by a
significant incidence of aneuploidy, both meiotic (gametes)
or mitotic (post fertilization) derived, which is a major
cause of IVF failure and miscarriage (Fragouli and Wells,
2011; Kuliev et al., 2011). Furthermore, despite the ability
to assess chromosome copy number (CCN), to date there
has been no proven significant correlation between aneu-
ploidy versus euploidy based on static morphological assess-
ment of embryo preimplantation development for reliable
clinical application (Fishel et al., 2010). To assess embryo
ploidy with >95% accuracy, invasive biopsy of the embryo
is required followed by expensive preimplantation geneticPlease cite this article in press as: Campbell, A et al. Retrospective analysi
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ics-based technologies to acquire detailed knowledge of
each individual CCN (Fishel et al., 2011; Johnson et al.,
2010).
Recent work has demonstrated that aneuploidy screening
as a mode of embryo selection in IVF can improve treatment
outcome even for patients with the lowest risk of aneu-
ploidy. A randomized pilot study reported a significant
increase in clinical pregnancy rate in good-prognosis
patients whose embryos were screened for aneuploidy com-
pared with the control group whose embryos were selected
for transfer based on morphology alone (Yang et al., 2012).
The purpose of the current study was to evaluate the effec-
tiveness and potential impact of a previously established,
morphokinetic-based aneuploidy risk classification model
(Campbell et al., 2013) for unselected non-PGS IVF patients
through time-lapse imaging.
Materials and methods
Data for this research were obtained from the treatment of
69 couples attending an independent IVF clinic (CARE Fertil-
ity, Manchester, UK) from April 2011 to December 2012. All
protocols complied with the UK regulation (Human Fertilisa-
tion and Embryology Act, 1990, 2008). The study did not
require ethical or institutional review board approval, hav-
ing been performed according to previously validated proce-
dures. This was, necessarily, a retrospective cohort study
utilizing time-lapse technology (EmbryoScope, Unisense
FertiliTech, Denmark) for the recording of embryo develop-
mental variables and treatment outcome data.
Patient criteria
All patients with a known outcome – fetal heart beat (FHB),
live birth (LB) or failed implantation – following intracyto-
plasmic sperm injection (ICSI), EmbryoScope culture and
blastocyst embryo transfer were included in this study.
Those where the fate of the embryo could not be confirmed,
such as a double-embryo transfer resulting in a singleton
pregnancy, were excluded. Female age ranged from 25 to
47 years (mean ± SD 36Æ6 ± 5Æ1 years).
Ovarian stimulation
Pituitary suppression was performed with a gonadotro-
phin-releasing hormone agonist (Suprecur, 0.5 ml s.c. daily;
Sanofi Aventis, UK) or antagonist (Cetrotide, 0.25 mg daily;
Merck Serono, UK). Ovarian stimulation was achieved using
human menopausal gonadotrophin (Menopur; Ferring, UK)
and/or recombinant FSH (Gonal-F; Merck Serono), with
doses ranging from 150 to 600 IU per day according to
patient type and response.
Oocyte retrieval and embryology
The detailed methodology for oocyte collection, ICSI and
embryo culture using the Embryoscope has been described
previously (Campbell et al., 2013). Briefly, ultrasound-guided
oocyte collection was performed under sedation ands of outcomes after IVF using an aneuploidy risk model derived from
), http://dx.doi.org/10.1016/j.rbmo.2013.04.013
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2–4 h following harvesting. Following ICSI, oocytes were
placed individually in microwells of the EmbryoSlide, loaded
into the EmbryoScope and cultured until 5 or 6 days after
oocyte collection and ICSI. The integrated microscope of
the EmbryoScope was programmed to acquire images of each
fertilized oocyte every 20 min through seven focal planes.
These time-lapse imageswere used for the assessment of fer-
tilization and embryo development up to the point of embryo
transfer. The time of insemination by ICSI was programmed
into the EmbryoScope when the slide was loaded as the time
point midway through the ICSI procedure. The EmbryoViewer
image analysis software was used to log and display the pre-
cise timing of developmental events as they were assessed
by the embryologists studying the images. All times were
recorded in hours post insemination by ICSI and the ‘annota-
tions’ (detailed recordings of embryo development) were
completed prior to embryo transfer. All data were, there-
fore, blind to outcome.
The two morphokinetic variables used in the aneuploidy
risk classification model that was retrospectively applied
to the blastocysts in this study were defined as: (i) tSB,
the time from insemination to the start of blastulation,
when the first sign of a blastocoele cavity forming was visi-
ble; and (ii) tB, the time from insemination to the formation
of a ‘full blastocyst’, when the blastocoele cavity filled the
embryo, the inner cell mass and trophectoderm tissues were
distinguishable from each other and there was no more than
10% increase in the outer diameter of the zona pellucida.
Embryos were selected for transfer according to a combina-
tion of standard morphological grading and clinic-defined
novel morphokinetic exclusion criteria which are not corre-
lated to tSB or tB. tSB and tB were not used as selection
criteria but were studied retrospectively in relation to the
outcome of the embryo transfer.Table 1 The previously estab-
lished three-class aneuploidy risk
model based on trophectoderm
biopsy data.
Risk class Definition
tB (hpi) tSB (hpi)
Low risk <122.9 <96.2
Medium risk <122.9 96.2
High risk 122.9 –
Source: Campbell et al. (2013).
hpi = hours post insemination;
tSB = time from insemination to the
start of blastulation; tB = time from
insemination to the formation of a
‘full blastocyst’.Outcome measures
Clinical pregnancy was defined by the presence of a gesta-
tional sac with FHB during weeks 6–8 of gestation. LB was
confirmed by patient completion of a clinic delivery out-
come form with birth details that, by regulation, are
reported to the UK regulative body, the Human Fertilisation
and Embryology Authority.
Embryos with known implantation outcome confirmed by
LB, FHB or failed implantation (defined as negative preg-
nancy test) consisted of all single-blastocyst transfers or
double-blastocyst transfers with either a negative preg-
nancy test or at least two fetal hearts. The data acquired
relating to the implantation status of these embryos were
defined as known implantation data (KID). A KID value of 1
was given when the outcome for an embryo was positive
and 0 when the outcome for an embryo was negative, for
FHB and for LB, which were analysed separately. Rates were
calculated for comparison according to the following for-
mula, KID positive/(KID positive + KID negative) · 100%.
The KID rate was calculated for FHB and for LB.
Due to the time lag in receiving obstetric outcome infor-
mation following FHB detection, the number of LB KID in
this dataset is relatively low compared with the number of
FHB KID. Reporting of live birth (positive LB KID) occurs,Please cite this article in press as: Campbell, A et al. Retrospective analysi
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tional period plus a delay in the clinic receiving outcome
feedback). In order to give the most realistic value for live
birth, only KID negatives where the time of transfer was 10
months earlier than the statistical analysis were included in
the calculation of LB KID rate.
Aneuploidy risk classification model
The aneuploidy risk classification model variables (tSB and
tB) were previously established on a data set where the
ploidy status of each embryo was assessed by trophecto-
derm biopsy and molecular analysis of CCN by either array
comparative genomic hybridization or single-nucleotide
polymorphism array (Table 1; Campbell et al., 2013). This
model was retrospectively applied to the KID data set of
standard ICSI blastocyst-transfer cycles, without trophecto-
derm biopsy, in order to perform an independent validation
of the potential benefit of the risk classification model. The
model was used to retrospectively classify the risk of aneu-
ploidy (low, medium or high) for each transferred embryo
with a KID value (positive or negative).
Statistical analysis
The statistical software package R version 2.15.0 (The R
Foundation for Statistical Computing) was used to calculate
the means, variances and area under the receiver operating
characteristic (ROC) curve. A Fisher‘s Exact test for count
data was used to test if the classes had different incidences
of positive and negative outcome.
Results
When the aneuploidy risk classification model was applied
to the KID data set, the medium- and low-risk classes for
aneuploidy were significantly different from each other with
respect to known implantation rates for FHB (P < 0.0001)
and LB (P = 0.01) (Table 2). Of the few embryos classified
as high risk subsequent to transfer, none implanted. The
aneuploidy risk classification model, therefore, indicated
the predictive power for successful implantation and LB,s of outcomes after IVF using an aneuploidy risk model derived from
), http://dx.doi.org/10.1016/j.rbmo.2013.04.013
Table 2 Known implantation data rates for fetal heart beat and live birth for each
aneuploidy risk class.
Risk class FHB KID LB KID
No. of embryos FHB KID rate No. of embryos LB KID rate
All 88 42.0 46 39.1
Low 33 72.7a 18 61.1b
Medium 51 25.5a 26 19.2b
High 4 0 2 0
Area under the ROC curve 0.75 0.74
LB KID data were calculated only from treatments where the information could have been obtained
(over 10 months from time of embryo transfer).
FHB = fetal heart beat; KID = known implantation data; LB = live birth.
aP < 0.0001.
bP < 0.01.
4 A Campbell et al.demonstrated by the area under the ROC curve being 0.75
for FHB and 0.74 for LB.
The incidence of positive FHB in the low-risk class was
72.7%, which represents a relative increase of 74% com-
pared with the overall rate across all classes of embryos
(42.0%). Correspondingly, the incidence of positive LB in
the low-risk class was 61.1%, representing a relative
increase of 56% when compared with the LB rate overall
(39.1%).
To date, there has been one miscarriage reported follow-
ing detection of a positive (single) FHB. The remaining FHB
KID positives in this dataset were at least at 16 weeks of ges-
tation. It is anticipated that the final relative increase in the
low-risk class compared with overall LB rate will be higher
than is currently reported, due to outstanding obstetric out-
come data and based on the clinic’s overall data (blastocyst
transfer data 2009–2011: 11.6% miscarriage rate
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depicting the temporal boundaries derived from the aneu-
ploidy risk classification model according to their tSB and
tB values (Figures 1 and 2).
Discussion
FHB and LB outcomes following the transfer of blastocysts,
selected without the use of the PGS or the morphokinetic
variables tSB and tB, were used to retrospectively evaluate
the potential impact of a published aneuploidy risk classifi-
cation model (Campbell et al., 2013). The current study
demonstrates for the first time, as far as is known, that
time-lapse imaging using defined morphokinetic data within
a closed system for uninterrupted culture can be used to
classify human preimplantation embryos according to their
risk of aneuploidy, without performing biopsy and PGS,
and that this correlates well with clinical outcome. Theost insemination)




odel applied to embryos with known fetal heart beat outcome
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Figure 2 The previously established three-class aneuploidy risk model applied to embryos with known live birth outcome. Data
were calculated only from treatments where the information could have been obtained (over 10 months from time of embryo
transfer). Blue crosses represent live birth embryos and red lines represent embryos that did not result in a live birth. Area under the
ROC curve is 0.74. tSB = time from insemination to the start of blastulation; tB = time from insemination to the formation of a ‘full
blastocyst’.
Retrospective analysis of IVF outcomes using an aneuploidy risk model 5opportunity to identify and avoid selecting embryos at high
risk of implantation failure using non-invasive objective cri-
teria has been the main driver behind a welter of algorithms
and static morphometric grading schemes for more than
three decades (Fishel and Edwards, 1982; Fishel, 1986;
Alpha and ESHRE, 2011a,b). The importance of linking this
work to ploidy is that aneuploid embryos represent the larg-
est single cause of failure and miscarriage following IVF.
Without time-lapse imaging and appropriate morphoki-
netic algorithms of the later stages of in-vitro embryo
development, aneuploidy risk classification of blastocysts
by any other non-invasive assessment has inadequate statis-
tical power for clinical use. During the early post-fertiliza-
tion period, there are mixed reports on the morphokinetic
developmental criteria of embryos. Davies et al. (2012),
using polar body biopsy for assessing CCN, described
delayed early cleavage divisions of aneuploid compared
with euploid embryos, and Chavez and colleagues (2012)
reported a correlation between some early developmental
parameters of 4-cell embryos and their CCN from individual
blastomeres. The current study group using time-lapse
imaging revealed that aneuploid and euploid embryos
develop similarly at least until embryonic genome activa-
tion at around the 8-cell, day-3 stage, but during the peri-
blastulation phase, aneuploid embryos have a significant
delay in development compared with euploid embryos
(Campbell et al., 2012).
CCN as defined by PGS technologies gives highly accurate
data on embryo ploidy, although there is debate as to when
the embryo biopsy should be performed for optimal clinical
outcome. False positives and negatives are still apparent in
some cases due to factors such as developmental arrest,
mosaicism and putative repair mechanisms (Cater et al.,
2012; Nasmyth and Haering, 2009). Determining embryo
CCN is increasingly being considered as more reliable usingPlease cite this article in press as: Campbell, A et al. Retrospective analysi
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than a single blastomere of an 8-cell embryo on day 3, or
inference of oocyte or zygote ploidy status from polar body
biopsies. Aneuploidy is reported to be as high as 80% in early
cleavage embryos of good morphology, deemed suitable for
transfer, and even higher in those rarely chosen for transfer
based on morphology (Jaroudi et al., 2012). The risk classi-
fication of aneuploidy in embryos is also most reliably per-
formed at the periblastulation stage for IVF patients due
to insignificant differences in a range of morphokinetic vari-
ables between the aneuploid or euploid status of early
cleavage embryos (Campbell et al., 2013). Using conven-
tional microscopy with static imaging, Alfarawati et al.
(2011) demonstrated a weak association between blastocyst
morphology and aneuploidy and reported an insignificant
trend toward aneuploid embryos showing slower progression
to the most advanced blastocyst stages. Their study also
saw more pronounced delays in embryos with complex or
multiple, compared with simple or single, aneuploidy.
Precise morphokinetic criteria using time-lapse imaging
were required to develop the aneuploidy risk classification
model as applied in this study, but additional variables iden-
tifiable from time-lapse imaging that correlate with embryo
ploidy may yet be discovered. To date, cell evenness, mul-
tinucleation and cell-cycle length have all been assessed
and compared using time-lapse imaging between aneuploid
and euploid embryos screened at different stages of devel-
opment, but only tSB and tB were used in a predictive algo-
rithm to classify risk of aneuploidy effectively.
This group’s examination of embryo development with
time-lapse imaging from fertilisation through to blastocyst
where ploidy was confirmed by trophectoderm biopsy, sug-
gests that fragmentation is a dynamic process which contin-
ually changes and may be a completely random process.
Fragmentation was observed equally in euploid and aneuploids of outcomes after IVF using an aneuploidy risk model derived from
), http://dx.doi.org/10.1016/j.rbmo.2013.04.013
6 A Campbell et al.embryos and incidence or patterning was not correlated to
ploidy.
Due to intrinsic and extrinsic factors, it is likely that
selection algorithms and models developed using time-lapse
imaging systems may not be directly transferable between
clinics or even between the wide spectrums of patient pop-
ulations. Optimal morphokinetic variables may alter accord-
ing to indication for IVF treatment, endocrinological profile
or age (Leibenthron et al., 2012), for example, and differ
according to gas tension or media used for embryo culture
(Ciray et al., 2012; Kirkegaard et al., 2013). For these rea-
sons, despite the likelihood that delays in aneuploid
embryos, compared with euploid, will be seen during the
periblastulation period generally, the values for tSB and tB
used in the model that Campbell et al. (2013) developed
and tested on independent embryo data may not be directly
applicable and will need to be assessed in other settings. To
ensure reliable data, it is also essential that strict adher-
ence to standard policies (operating procedures) is
required. However, as has been demonstrated, locally
defined conditions with strict adherence to protocol can
provide predictive algorithms which promise an improved
incidence of live birth following IVF.
Larger data are required to test whether the aneuploidy
risk classification model is more effective for particular
patients or embryos than others and whether particular
and specific numerical chromosomes have differing effects
on embryo development, aneuploidy risk classification and
fate. Miscarriage rates were considered within each risk
classification and, within this dataset, there was one mis-
carriage reported following FHB confirmation. This was
from the transfer of a blastocyst classified as medium-risk
aneuploidy. Larger studies assessing miscarriage incidence
within these aneuploidy risk classes would be of clinical
interest.
This risk classification of aneuploidy in blastocysts could
be used in conjunction with PGS to prioritize embryos for
screening or as an alternative or routine selection method
for enhancing live birth outcome where PGS is unavailable,
either because it is not permitted due to local regulation or
where a non-invasive approach is desired. Aneuploidy
screening during IVF treatment is most commonly offered
to a small group of patients considered to be at highest risk,
usually with advanced female age, but with the increasing
availability of safe and non-invasive time-lapse technology,
a balanced view should be taken by patients and practitio-
ners as to the most appropriate, effective and efficient
method of embryo screening for them. Whilst the technol-
ogy for genetic screening is widely available, patient access
to it may also be limited by the lack of technical expertise in
IVF laboratories, the low proportion of IVF centres that have
established PGS programmes and its high cost. The possibil-
ity of being able to classify the risk of aneuploidy in an
embryo using non-invasive imaging only provides any clinic
and their patients an accessible lower cost alternative
which avoids additional handling and biopsy of the embryo
during its preimplantation development. Embryo selection
based predominantly on specific time-lapse derived algo-
rithms could rapidly become routine in IVF treatment. This
study group believes that using this non-invasive technology
to screen out embryos with the highest risk of aneuploidy –
a major cause of IVF failure – will result in a paradigm shiftPlease cite this article in press as: Campbell, A et al. Retrospective analysi
time-lapse imaging without PGS. Reproductive BioMedicine Online (2013in the clinical practice of human conception in vitro and
improve the incidence of live birth for most patients.
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4.0 Specific aim 3.  
To collaborate to perform a multicentre outcome analysis to consider the limitations of a 
time-lapse blastocyst prediction model. 
Encapsulated in this specific aim is the article demonstrating the limitations of a blastocyst 
prediction model and discussion of the advantages of developing time lapse algorithms 
predictive of live birth potential. 
  
Kirkegaard K, Campbell A, Agerholm I, Bentin-Ley U, Gabrielsen A, Kirk J, Sayed S, Ingerslev 
HJ. Limitations of a time-lapse blastocyst prediction model: a large multicentre outcome 
analysis. Reproductive biomedicine online. 2014 Aug 1;29(2):156-8. 
 
In this study, my personal contribution was preparation of a large proportion of the data 
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Abstract The goal of embryo selection models is to select embryos with the highest reproductive potential, whilst minimizing the
rejection of viable embryos. Ultimately, any embryo selection model must be tested on clinical outcome. We therefore retrospec-
tively tested a published blastocyst prediction model on a large combined set of transferred embryos with known clinical outcome.
The model was somewhat effective in that we found a relative increase of 30% for implantation in the model-selected group of embryos.
There was, however, a concomitant large rejection of embryos from our test cohort, which actually resulted in pregnancy. This hy-
pothetical experiment highlights the limitations of predicting blastulation only. Crucially, it illustrates that both sensitivity and speci-
ficity are important parameters when developing embryo selection models for prospective clinical use.
© 2014 Reproductive Healthcare Ltd. Published by Elsevier Ltd.
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Introduction
Time-lapse imaging of human preimplantation embryos has
become rapidly integrated in IVF laboratories. The pro-
posed advantages, such as uninterrupted embryo culture, flex-
ibility in timing, improvement of documentation procedures,
quality control and management and, in particular, the in-
troduction of dynamic markers of embryo quality, have
altogether stimulated a profound interest in time-lapse
technology. While a large number of publications
consolidate that timing of development differs between viable
and nonviable embryos (Herrero and Meseguer, 2013), only
a few publications offer clinically applicable models of embryo
selection (Campbell et al., 2013; Conaghan et al., 2013;
Meseguer et al., 2011). Yet, as recently demonstrated, a pro-
posed multivariate hierarchical selection model was not trans-
ferable from one clinical setting to another without
modification (Best et al., 2013). It has been speculated that
a less-complex model, such as the one recently developed and
applied by Conaghan et al. (2013) that categorized embryos
http://dx.doi.org/10.1016/j.rbmo.2014.04.011
1472-6483/© 2014 Reproductive Healthcare Ltd. Published by Elsevier Ltd.
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into groups with either high or low likelihood of forming ‘usable
blastocysts’, could be applicable to other clinics. The model
has, however, not been evaluated with regard to clinical
outcome. To test this hypothesis and correlation between the
published time intervals and clinical outcome, we retrospec-
tively applied the same model to a large set of transferred
embryos from independent clinics.
Retrospective testing of a blastocyst
prediction model
Seven clinics from three different countries participated by
contributing data on clinical outcome following embryo trans-
fer (fetal heart beat) and timing of cellular divisions until
day 3, obtained using time-lapse monitoring (EmbryoScope,
FertiliTech, Denmark). The first division was annotated t2,
second division t3 and the third division t4.
A total of 1519 transferred embryos with known outcome
for implantation from cycles with single (n = 517) or double
(n = 501) embryo transfer were included. In order to be able
to relate each embryo’s fate after transfer with its indi-
vidual morphokinetic profile, only cycles with two or no fetal
heart beats were included where double-embryo transfers
were performed. This implies that the presented pregnancy
rates are lower and not directly comparable with treatment
success rates. Patient stimulation, IVF/intracytoplasmic sperm
injection and embryo culture was performed according to stan-
dard procedures at each site. Embryos were graded and se-
lected according to each clinic’s routine methodology and one
or two embryos were selected for transfer. Embryo transfer
was predominantly performed on day 2 or day 3.
In order to test whether time intervals published in
Conaghan et al. (2013) correlated with clinical outcome, we
retrospectively grouped the transferred embryos into usable
and nonusable embryos based on the model’s values for these
time-lapse intervals. The model was found to predict a high
chance of usable blastocyst formation (defined as a blasto-
cyst suitable for either transfer or freezing) if time between
first and second cytokinesis (t3 – t2) was 9.33–11.45 h and time
between second and third cytokinesis (t4 – t3) was 0–1.73 h.
Likewise, embryos were predicted to have a low chance of
forming usable blastocysts if t3 – t2 and t4 – t3 were longer
than these time intervals. We calculated the relative differ-
ence in implantation (%) between the usable group and the
entire cohort, odds ratio for implantation in the usable com-
pared with the nonusable group and the percentage of
nonusable embryos that resulted in implantation. Data were
used to generate a receiver operating characteristic curve and
to calculate area under the curve for implantation.
Data for implantation are presented in Table 1. The rela-
tive difference in implantation rate between the entire cohort
and the embryos categorized as usable by the test model was
30.0%. The odds ratio for implantation between usable and
nonusable was 1.60. The sensitivity was 0.50 and the speci-
ficity was 0.65. Furthermore, 50.6% of the embryos that re-
sulted in pregnancy were categorized as nonusable according
to the model. The area under the curve for prediction of im-
plantation was 0.57 (Figure 1).
In other words, applying the test model retrospectively to
transferred embryos from the independent clinics would have
provided an increase of 30.0% in implantation rate for embryos
grouped as usable compared with the entire test cohort.
Notably, out of the embryos that actually implanted, 50.6%
were categorized as having low chance of being usable. This
indicates that relying on such a model would bring a substan-
tial risk of deeming viable embryos nonusable.
The ultimate goal of embryo selection models is to posi-
tively select embryos with the highest reproductive poten-
tial, notably without rejecting viable embryos. The premise
of this hypothetical experiment is that the test model pre-
dicts the formation of usable blastocysts i.e. blastocysts to
be either transferred or frozen. If embryos are selected for
transfer/freezing on day 3 (as suggested by the authors), it
ultimately follows that blastocysts with a low chance of being
usable are to be discarded if the model is applied uncriti-
cally. Principally, embryos from this study population that have
implanted would have been discarded with day-3 transfer and
application of the time-lapse-based selection model.
This hypothetical experiment illustrates the risks of de-
fining too narrow time intervals for optimal division in
order to achieve a high specificity at the expense of a low
Table 1 Implantation data for embryos categorized as usable





Usable 131 445 22.7
Nonusable 134 809 14.2
Entire cohort 265 1254 17.4
Values are n or %.
Usable: t3 – t2 = 9.33–11.45 h and t4 – t3 = 0–1.73 h. Unusable: t3 – t2
outside 9.33–11.45 h and t4 – t3 outside 0–1.73 h.
Figure 1 Receiver operating characteristic curve for predic-
tion of pregnancy by the parameters t3 – t2 and t4 – t3 from the
test model.
157Testing an blastocyst prediction model on clinical outcome
sensitivity. It thus underlines the importance of carefully con-
sidering that a model must not only provide a substantial in-
crease in implantation but also, equally important, that a low
rejection rate of viable embryos is secured. This very impor-
tant point is demonstrated by applying the time-lapse crite-
ria on an unprecedented large set of transferred embryos with
a known outcome.
From blastocyst to pregnancy and beyond
The test model was developed in order to identify viable
embryos from a cohort, while the study population is consti-
tuted by embryos selected for transfer with clinical outcome
as the endpoint. Thus, both the endpoint and the study popu-
lation differ between the two studies. It would be expected
that a model that predicts blastocyst development would be
different from a model that predicts clinical outcome. In our
opinion, it would, however, be expected that a model that
predicts blastocyst development would positively select more
embryos than a selection model predictive of implantation
and clinical pregnancy, as embryos resulting in pregnancy
would constitute a subgroup of embryos that develop into blas-
tocysts. We do not, however, find any explanation, neither
in the different study populations nor in the different end-
points, as to why a large proportion of embryos which were
rendered ‘unusable’ by the model as they fell outside the
model selection criteria resulted in implantation. In our
opinion, the most likely explanation is the narrow time in-
tervals for optimal cellular division.
Ultimately, any embryo selection model must be tested
on clinical outcome, as blastocyst development is a surro-
gate endpoint, preferably in a prospective study. We believe
that the approach of retrospectively testing the criteria on
transferred embryos with known outcome is justified in this
case, as it aids the design of future prospective studies.
Our study supports an approach where models are devel-
oped with appropriate concern for low rejection of viable
embryos, where clinical outcome is used as an endpoint and
where the model is individually adjusted to specific settings
and validated prior to implementation.
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5.0 Specific aim 4.  
To amass time lapse data during clinical IVF treatments to make novel observations and to 
develop in house embryo selection algorithms to predict implantation and live birth and to 
compare the efficacy of such algorithms with conventional morphological selection. 
 
Encapsulated in this specific aim are the studies below describing the evolution of time lapse 
algorithm development and the identification of novel variables. 
 
Fishel S, Campbell A, Montgomery S, Smith R, Nice L, Duffy S, Jenner L, Berrisford K, Kellam L, 
Smith R, D'Cruz I, Beccles A. Live births after embryo selection using morphokinetics versus 
conventional morphology: a retrospective analysis. Reprod Biomed Online. 2017 
Oct;35(4):407-416. doi: 10.1016/j.rbmo.2017.06.009. Epub 2017 Jun 23. PubMed PMID: 
28712646. 
 
Fishel S, Campbell A, Montgomery S, Smith R, Nice L, Duffy S, Jenner L, Berrisford K, Kellam L, 
Smith R, Foad F, Beccles A. Time-lapse imaging algorithms rank human preimplantation 
embryos according to the probability of live birth. Reprod Biomed Online. 2018 Sep;37(3):304-









Fishel S, Campbell A, Foad F, Davies L, Best L, Davis N, Smith R, Duffy S, Wheat S, Montgomery 
S, Wachter A. Evolution of embryo selection for IVF from subjective morphology assessment 
to objective time lapse algorithms improves chances of live birth. Reprod Biomed Online. 2019 
in press  
 
Kellam L, Pastorelli LM, Bastida AM, Senkbeil A, Montgomery S, Fishel S, Campbell A. 
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imaging. Reprod Biomed Online. 2017 Dec;35(6):646-656. doi: 10.1016/j.rbmo.2017.09.004. 
Epub 2017 Sep 28. PubMed PMID: 29074360. 
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• To present the results of several small studies in the form of abstract presentations at 
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KEY MESSAGE
Incidence of live birth after embryo transfer using morphokinetic algorithms during uninterrupted culture to select
embryos was increased by 19% compared with conventional morphology and standard incubation in women younger
than 38 years. Incidence of aneuploidy may limit their effectiveness in women older than 37 years.
A B S T R A C T
The increasing corpus of clinical studies using time-lapse imaging for embryo selection demonstrates considerable variation in study protocols and
only limited-sized study cohorts. Outcome measures are based on implantation or clinical pregnancy; some predict blastulation from early cleavage-
stage data, and few have evaluated live birth. Erroneously, most studies treat the embryos as independent variables and do not include patient or treatment
variables in the statistical analyses. In this study, cohort size was 14,793 patients and 23,762 cycles. The incidence of live birth (n = 973 deliveries) after
embryo selection by objective morphokinetic algorithms was compared with conventional embryology selection parameters (n = 6948 deliveries). A
19% increase in the incidence of live birth was observed when morphokinetic data were used to select embryos for the patient cohort aged younger
than 38 years (OR 1.19 with 95% CI 1.06 to 1.34) using their own eggs, and an increase of 37% for oocyte recipients aged over 37 years (OR 1.370; 95%
Cl 0.763 to 2.450). This is the largest study of the prospective use of time-lapse imaging algorithms in IVF reporting on live birth outcome, although the
nature of purely a closed system versus standard incubation could not be assessed.
© 2017 Published by Elsevier Ltd on behalf of Reproductive Healthcare Ltd.
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Introduction
The success of IVF during the last 35 years has evolved from
aspirational live birth rates of around 15% (Edwards et al., 1984;
Fishel et al., 1984, 1985) to rates of between 35 and 60% (HFEA, 2013).
This is largely dependent on female age, and is a result of advances
in follicular stimulation regimens, multiple embryo transfer and
improvements in the culture and selection of the human embryo
for transfer. In recent years, with the more responsible adoption of
single- or double-embryo transfer after IVF, permitted by further im-
provements in culture media, the need for embryo-selection tools has
been ever more pressing to ensure high live birth rates. Human con-
ception is inefficient, with estimates of up to 70% of human zygotes
being non-viable in their progression to a healthy full-term delivery
(Zinaman et al., 1996). The first in-vitro evidence for aneuploidy as a
potential cause of human embryo failure was published in the early
1980s (Angell et al., 1983, 1986). Irrespective of chromosome copy
number, since the origins of IVF, human morphokinetics was enor-
mously important in predicting viable embryos (De Neubourg et al.,
2004; Edwards et al., 1984; Fishel et al., 1983). For many clinics, the
goal is single embryo transfer while still improving the incidence of
healthy live birth outcomes to levels unimaginable only 2 decades ago,
thereby minimizing the unacceptable risk of high-order multiple preg-
nancies. For the highest chance of success per cycle, however, IVF
practice involves ovarian stimulation usually resulting in several
embryos, from which one, or at most two, are selected for transfer.
Confidence in the elective transfer of a single embryo has been
achieved, in part, by advances in embryo culture and technology. The
development of time-lapse imaging (TLI) in recent years (Lemmen
et al., 2008; Meseguer et al., 2011) has enabled better embryology
laboratory practice in several domains: workflow, consistent objec-
tive selection, and zygote and embryo protection as part of the putative
improved culture conditions using continuous, undisturbed culture
system.
The evidence for using sophisticated time-lapse systems for
morphokinetic algorithms that are predictive of successful outcome,
however, is limited (Kaser and Racowsky, 2014). In this retrospec-
tive analysis of treatments undertaken from January 2010 to January
2015, live birth outcome of a large cohort using our time lapse imaging
protocols as a prospective selection tool for embryo transfer was com-
pared with those patients undergoing conventional embryology. The
time-lapse system used closed incubation (EmbryoScope), and gen-
erated the algorithms from morphokinetic data for the embryo
selection, compared with standard incubation and the use of con-
ventional morphological embryo selection according to The Istanbul
Consensus (Alpha Scientists in Reproductive Medicine and ESHRE
Special Interest Group of Embryology, 2011).
Materials and methods
This multicentre study included 14,793 patients from six CARE Fer-
tility centres from January 2010 to January 2015: CARE Nottingham,
CARE Northampton, CARE Manchester, CARE Sheffield, Beacon CARE
Fertility Dublin and CARE London; representing a total of 21,235 treat-
ment cycles in the standard treatment group and 2527 in the
EmbryoScope treatment group, with 6948 (32.7%) and 973 (38.5%) live
births observed, respectively . ‘Patients’ or ‘non-recipients’ (n = 21,466
cycles) comprised those who used all their own oocytes (n = 20,664)
and patients who were also oocyte-share donors (n = 802); ‘recipi-
ents’ comprised those women undergoing oocyte donation (n = 2296
cycles). All protocols for patient treatments complied with UK
regulation (Human Fertilisation and Embryology Act, 1990, 2008)
and all UK facilities are regularly inspected by the Human Fertilisation
and Embryology Authority (HFEA). The retrospective analysis, or
the use of time-lapse imaging algorithms for embryo selection, did
not require ethical or institutional review board approval, as it
was carried out according to previously validated procedures, and
practised under license from the HFEA. All patients were coun-
selled and gave signed consent. Time lapse imaging (TLI) was
undertaken using the EmbryoScope (Vitrolife, Sweden) with strict ad-
herence to annotation protocols, and all embryos were selected for
transfer based on their in-house derived TLI algorithm score for
each stage of transfer; patient choice dictated whether they used
EmbryoScope associated with morphokinetic algorithm for embryo
selection or standard incubation. The primary end-point of this study
was live birth events; that is, the number of patients achieving a de-
livery of a live born infant. Only ‘fresh’ embryo transfer cases were
included, and all pre-genetic implantation screening cases were
excluded.
The following clinical variables were categorized for inclusion in
the analysis: patient age, day of embryo transfer, number of embryos
transferred, donor age (where applicable), body mass index (BMI), anti-
Müllerian hormone (AMH), antral follicle count (AFC), gonadotrophin
type, gonadotrophin dosing days, and gonadotrophin total dose. The
groupings applied are presented for each variable in Table 1. Patient
age was considered as a binary variable in the modelling (younger
than 38 years and 38 years and over), corresponding to the common
grouping used by HFEA, which is familiar to patients. The groupings
for categorizing BMI, AMH, and AFC were chosen to correspond to
clinically meaningful categories, i.e., to reflect what might be con-
sidered to be above, below or within a normal or healthy range. The
donor ages (less than 29 years, 29–32 years and 33 years and over),
gonadotrophin number of days of dosing and the total dose vari-
ables were categorized on the basis of quantiles of the observed
distribution to ensure that sufficient information was present in each
of the categories for a robust analysis.
The following definitions were used for the BMI, AMH and AFC
categories, relating to the data presented: BMI less than 18.5 (un-
derweight), 18.5 and less than 25 (healthy weight), 25 and less than
30 (overweight), 30 and less than 40 (obese), and 40 upwards (ex-
tremely obese); AMH (pmol/L): less than 6 (low), 6 and less than 24
(normal), 24 and less than 70 (high), 70 upwards (very high); AFC
(number of follicles seen on ultrasound scan): less than 4 (ex-
tremely low), 4 and less than 10 (low), 10 and less than 14 (somewhat
low), 14 and less than 22 (normal), 22 and less tha 35 (high), 35
upwards (very high).
Ovarian stimulation protocols
Pituitary suppression for ovarian stimulation was carried out either
with gonadotrophin-releasing hormone agonist (Suprecur; 0.5 ml sub-
cutaneously daily; Sanofi Aventis, UK) or antagonist (Cetrotide; 0.25 mg
daily; Merck Serono, UK). Ovarian stimulation was achieved using
human menopausal gonadotrophin (Menopur, Ferring, UK), recom-
binant FSH (Gonal-F; Merck Serono), or both (as previously described
(Campbell et al., 2013b; Fishel et al., 2016).
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Table 1 – Clinical data available for the cycles in each treatment arm (EmbryoScope/standard).a






Patient age, years <38 13447 (63.3) 1414 (56.0) 14861 (62.5)
38 + 7788 (36.7) 1113 (44.0) 8901 (37.5)
Day of embryo transfer 2 4150 (19.5) 234 (9.3) 4384 (18.4)
3 8790 (41.4) 924 (36.6) 9714 (40.9)
4 419 (2.0) 146 (5.8) 565 (2.4)
5 or 6 7876 (37.1) 1223 (48.4) 9099 (38.3)
Number of embryos transferred 1 10118 (47.6) 1057 (41.8) 11175 (47.0)
2 10463 (49.3) 1470 (58.2) 11933 (50.2)
3 654 (3.1) 0 (0.0) 654 (2.8)
Patient type Oocyte share donor 774 (3.6) 28 (1.1) 802 (3.4)
Donor recipient 1810 (8.5) 486 (19.2) 2296 (9.7)
Standard 18651 (87.8) 2013 (79.7) 20664 (87.0)
Donor age, years <29 585 (2.8) 182 (7.2) 767 (3.2)
29–32 649 (3.1) 165 (6.5) 814 (3.4)
33 + 576 (2.7) 139 (5.5) 715 (3.0)
Not applicable 19425 (91.5) 2041 (80.8) 21466 (90.3)
ICSI No 10515 (49.5) 763 (30.2) 11278 (47.5)
Yes 10720 (50.5) 1764 (69.8) 12484 (52.5)
Intralipid No 19364 (91.2) 2214 (87.6) 21578 (90.8)
Yes 1871 (8.8) 313 (12.4) 2184 (9.2)
BMIa, kg m2 Underweight 167 (0.8) 24 (0.9) 191 (0.8)
Healthy 6933 (32.6) 799 (31.6) 7732 (32.5)
Overweight 3952 (18.6) 355 (14.0) 4307 (18.1)
Obese 1322 (6.2) 152 (6.0) 1474 (6.2)
Extremely obese 30 (0.1) 2 (0.1) 32 (0.1)
Unavailable 8831 (41.6) 1195 (47.3) 10026 (42.2)
AMH, pmol/La Low 1071 (5.0) 139 (5.5) 1210 (5.1)
Normal 1900 (8.9) 264 (10.4) 2164 (9.1)
High 790 (3.7) 109 (4.3) 899 (3.8)
Very high 57 (0.3) 6 (0.2) 63 (0.3)
Unavailable 17417 (82.0) 2009 (79.5) 19426 (81.8)
AFC number of follicles seen on
ultrasound scana
Extremely low 484 (2.3) 59 (2.3) 543 (2.3)
Low 1797 (8.5) 238 (9.4) 2035 (8.6)
Somewhat low 1667 (7.9) 185 (7.3) 1852 (7.8)
Normal 2539 (12.0) 213 (8.4) 2752 (11.6)
High 1978 (9.3) 174 (6.9) 2152 (9.1)
Very high 1111 (5.2) 67 (2.7) 1178 (5.0)
Unavailable 11659 (54.9) 1591 (63.0) 13250 (55.8)
Gonadotrophin type Other 353 (1.7) 63 (2.5) 416 (1.8)
Gonal-F 2994 (14.1) 482 (19.1) 3476 (14.6)
Menopur 9929 (46.8) 1452 (57.5) 11381 (47.9)
Unavailable 7959 (37.5) 530 (21.0) 8489 (35.7)
Gonadotrophin dosing days <10 2178 (10.3) 412 (16.3) 2590 (10.9)
10–11 3156 (14.9) 569 (22.5) 3725 (15.7)
12 + 8227 (38.7) 1035 (41.0) 9262 (39.0)
Unavailable 7674 (36.1) 511 (20.2) 8185 (34.4)
Gonadotrophin total dose, iuiu iu <1800 1973 (9.3) 420 (16.6) 2393 (10.1)
1800–2699 3929 (18.5) 576 (22.8) 4505 (19.0)
2700–3599 3822 (18.0) 464 (18.4) 4286 (18.0)
3600 + 3442 (16.2) 532 (21.1) 3974 (16.7)
Unavailable 8069 (38.0) 535 (21.2) 8604 (36.2)
Total previous cycles Mean (SD) 2.4 (1.82) 2.5 (1.78) 2.4 (1.81)
Median (range) 2.0 (0–25) 2.0 (0–18) 2.0 (0–25)
Total numbr of previous live births Mean (SD) 0.3 (0.63) 0.3 (0.58) 0.3 (0.62)
Median (range) 0.0 (0–9) 0.0 (0–6) 0.0 (0–9)
Total number miscarriages Mean (SD) 0.4 (0.88) 0.5 (0.89) 0.4 (0.88)
Median (range) 0.0 (0–15) 0.0 (0–7) 0.0 (0–15)
Duration of infertility Mean (SD) 3.6 (2.85) 3.4 (2.63) 3.6 (2.83)
Median (range) 3.0 (0–31) 3.0 (0–25) 3.0 (0–31)
Total number of ectopics Mean (SD) 0.1 (0.35) 0.1 (0.28) 0.1 (0.34)
Median (range) 0.0 (0–5) 0.0 (0–3) 0.0 (0–5)
Number of eggs collected Mean (SD) 9.6 (4.98) 10.1 (5.20) 9.7 (5.02)
Median (range) 9.0 (1–38) 9.0 (1–41) 9.0 (1–41)
(continued on next page)
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Oocyte retrieval, denudation and intracytoplasmic sperm
injection
Female sedation was achieved with a combination of propofol (Braun,
Germany), fentanyl (Auden McKenzie, UK) and midazolam (Hamelyn,
UK), and transvaginal ultrasound-guided oocyte retrieval took place
about 36 h after HCG injection (10,000 IU; Pregnyl; Organon, UK; or
Ovitrelle; Merck Serono) or agonist trigger (Buserelin 0.5 ml sc;
Suprefact, Sanofi S.A, France), using an aspiration needle (Vitrolife,
Sweden) connected to a vacuum pump (Rocket Medical, UK). Oocyte–
cumulus complexes were recovered from follicular aspirates using
a stereomicroscope in a class II hood with a heated stage, washed
and cultured in Ferticult IVF medium (Fertipro, Belgium) at 5% CO2
in air, 37.0 0C, maximum humidity, Oocytes allocated for ICSI were
cultured for 2–4 h before cumulus cell denudation with 15–20 IU/ml
cumulase (Origio, Denmark) in the same medium and complete
removal of the coronae radiatae with a 140 µm pipette (EZ Squeeze;
Research Instruments, UK). Oocytes at the metaphase-II stage un-
derwent insemination by intracytoplasmic sperm injection (ICSI) within
2 h of denudation. Oocytes allocated for IVF were inseminated after
preparation using SupraSperm density gradient (Origio, Denmark) and
washing in Ferticult IVF medium (Fertipro, Belgium) at a concentra-
tion of 0.2 M/ml, between 3 and 6 h after oocyte recovery and cultures
in standard incubators for 18 + /– 1 h before fertilization was assessed.
Embryo culture and incubation
For time-lapse imaging, after ICSI or IVF, oocytes or zygotes, re-
spectively, were placed individually in microwells of EmbryoSlidesTM
(Vitrolife, Sweden)) in 25 µl Global IVF medium (LifeGlobal) supple-
mented with 10% dextran serum supplement (Irvine Scientific) and
were overlaid with 1.4 ml mineral oil (Fertipro, Belgium) and placed
in the EmbryoScope. EmbryoSlides were prepared with medium and
oil that had equilibrated overnight. Once loaded with the ICSI-
inseminated oocytes, or zygotes after IVF, EmbryoSlides were placed
into the EmbryoScope time-lapse incubator at 37.00C in 5.5–6.0% CO2,
5% O2 and 89.5% N2 for up to 6 days. The built-in microscope was
used to acquire images of each fertilized oocyte every 10–20 min
through seven focal planes.
For standard incubation, fertilization and embryo culture was
carried out in small volume box, or flatbed incubators (Galaxy
48R, New Brunswick, UK; Miri, ESCO, Japan), using the same media,
mineral oil as described for the EmbryoScope (Vitrolife (Sweden) CE
marked plasticware and 25 µl culture drops). As this was a multicentre
study, up to 2012, less than 25% of standard incubation was atmo-
spheric O2 with an increasing switch to 5% O2, resulting in the last
18 months of the study being 100% low O2. Analysis of the data showed
no significant effect of atmospheric O2 on the analyses (data not shown).
During the early phase of this work, the culture medium was re-
freshed on day 3 but after CARE pilot studies, this step was no longer
used. All embryos were cultured singly in culture drops, irrespec-
tive of incubation method. Selection of the embryos from standard
incubation was based primarily on morphological criteria (Alpha
Scientists in Reproductive Medicine and ESHRE Special Interest Group
of Embryology, 2011).
Evaluation of time-lapse images
Time-lapse images were collected for the duration of the culture
period, to the point of embryo transfer, and were used for the as-
sessment of fertilization after ICSI and during all in-vitro embryo
development. The time of insemination by ICSI was programmed
into the EmbryoScope when the slide was loaded, as the time point
midway through the ICSI procedure. For IVF, the time of insemina-
tion was recorded as the time sperm was added to the oocytes. The
EmbryoViewer® image analysis software (Vitrolife) was used to log
and display the precise timing of developmental events as they were
annotated by the embryologists studying the time-lapse images. The
definitions of morphokinetic variables has been described in detail
previously (Campbell et al., 2013a, 2013b). For the present study, the
early cleavage model avoided the selection of embryos where irregu-
lar or rapid division occurred cc2 < 2h and cc2>/=2 h or cc3<5 h and
cc3>/=5 h and where t2>/=27.1 h and t2 <27.1 h. All times were after
ICSI insemination, and a 1.95 h adjustment was made for IVF (based
on our in-house data, unpublished data). The duration of cc2 (t3–t2)
relative to cc2+cc3 (t5–t3) {relcc2} was an effective splitting criterion
if the aforementioned irregular or rapid divisions were not present.
The optimum value for relCC2 was more than 0.44 and less than 0.47.
Table 1 – (continued)






Number of eggs inseminated Mean (SD) 7.9 (4.34) 8.6 (4.71) 8.0 (4.40)
Median (range) 7.0 (1–35) 8.0 (1–41) 7.0 (1–41)
Ratio of mature (metaphase 2) to total eggs collecte Mean (SD) 0.3 (0.54) 0.2 (0.42) 0.3 (0.53)
Median (range) 0.1 (0–12) 0.1 (0–7) 0.1 (0–12)
Number of eggs fertilized Mean (SD) 5.2 (3.27) 5.9 (3.60) 5.3 (3.33)
Median (range) 5.0 (0–26) 5.0 (1–30) 5.0 (0–30)
Patient age Mean (SD) 35.5 (5.17) 36.7 (4.80) 35.6 (5.15)
Median (range) 36.0 (19–54) 37.0 (22–50) 36.0 (19–54)
Recipient patient age Mean (SD) 40.7 (4.92) 41.4 (4.40) 40.8 (4.83)
Median (range) 41.0 (21–50) 42.0 (24–50) 42.0 (21–50)
Donor age (where applicable) Mean (SD) 30.1 (3.91) 29.5 (4.05) 29.9 (3.94)
Median (range) 31.0 (18–45) 30.0 (19–42) 30.0 (18–45)
a Cross-tabulations, showing the number (and percentage) of observations in each group, are provided for the binary or categorical variables considered in
the analysis versus treatment. Summary statistics, mean (and SD) and median (and range), are provided for each count variable by treatment. Continuous
summaries of patient age, donor age (where applicable) and patient age by donor status are also provided for completeness. antrFor definition so fhte cat-
egories see Materials and Methods.
AFC, antral follicle count; AMH, anti-Müllerian hormone; BMI, body mass index; ICSI, intracytoplasmic sperm injection.
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Embryos with multinucleation at the four-cell stage or smooth en-
doplasmic reticulum clusters were also avoided. For blastocysts, these
were preferentially selected with a tSB (time to the start of blastu-
lation in hours after insemination) ≤ 93.1. If this criterion was not met,
preference was given to embryos where dB (tB–tSB) ≤ 12.5 h.
All times were recorded in hours after insemination. All annota-
tions were made before any decision on embryo transfer, with the
annotation criteria outlined above being the arbiter of which embryo
to transfer.
Embryology annotation protocols and quality control
After training in annotation and competency assessment, CARE em-
bryologists participate in regular quality assurance exercises and use
a centralized annotation quality-assurance protocol whereby example
embryos are annotated by each practitioner and their values com-
pared with those of their colleagues. Intra-correlation coefficients are
calculated for each morphokinetic value. Annotation quality is con-
sidered assured where the intra-correlation coefficients are greater
than 0.9, demonstrating close correlation between practitioners, and
competent annotation.
Embryo selection
After TLI, embryos were objectively selected using user defined time-
lapse algorithms programmed into the ‘Compare and Select’ software
(EmbryoViewer®, Vitrolife, Sweden – Class 1 Medical Device). Model
scores were used to rank embryos according to their implantation or
live birth potential. An evolving series of models were used during this
study period as they were fine-tuned based on increasing outcome data.
Models differed according to insemination method and day of trans-
fer. IVF models were developed using an adjustment of 1.95 h for the
time taken for the sperm to fertilize the oocytes. Early cleavage stage
models used morphokinetic variables t2, duration of the second cell cycle
(t3–t2) and a calculated variable (t2/t5–t2). Blastocyst models were similar
to the published aneuploidy risk classification model using tSB and du-
ration of blastulation to rank embryos using the calculated variables
cc2 (t3-t2), cc3 (t5-t3), dB (tB [time to blastulation from insemination]-
tSB). A Wallace (UK) embryo transfer catheter under ultrasound guidance
was used for embryo transfer.
Statistics
Descriptive statistics were calculated to summarize the clinical data avail-
able for the cycles in each treatment arm (EmbryoScope/standard). For
the binary and categorical variables, cross-tabulations of the frequen-
cies compared with treatment were produced. For the count variables,
summary statistics (including measures of central tendency and dis-
persion) split by treatment were calculated. Continuous summaries of
patient age, donor age (where applicable) and patient age by donor status
were also calculated for completeness. A mixed-effects logistic re-
gression model (Agresti, 2013; Jiang, 2007) was fitted to the live birth
event outcome, modelling the probability of the binary outcome as a func-
tion of the explanatory variables. To account for the fact that multiple
treatment cycles were observed for individual patients included in the
study, a patient random effect was included in the model. Generalized
linear models assume that observations are independent, whereas results
from the same patient will be related. To account for the fact that mul-
tiple treatment cycles were observed for individual patients included in
the study, a patient random effect was included in the model. This ap-
propriately accounts for non-independence by modelling the correlation
among patients’ multiple outcomes, preventing an artificial increase in
the sample size. To explicitly control for differences in the patient popu-
lations between the treatment arms, potential confounding variables
from the available clinical data were also considered as other explana-
tory variables in the model (as fixed effects). To choose which of the
available variables to include as fixed effects in the model, a stepwise
variable selection procedure was undertaken. Starting with an initial model
that included just the patient effect, new explanatory variables were added
one at a time to look for the model that has the best value of the Akaike
information criterion. This stepwise selection procedure carries on adding
variables until no further improvement in the Akaike information cri-
terion (a measure of model fit that has a penalty term for the number
of parameters in the model) can be achieved (Table 2).
A number of interactions that allow the level of one or more vari-
ables to change the effect of another variable were made available
to the variable selection procedure. Any combination of variables may
Table 2 – Variables offered to the model during the stepwise




Patient age (<38/38+), years Y
Day of embryo transfer Y
Numbr of embryos transferred Y
Patient type (standard/oocyte share donor/
donor recipient)
Y
Donor age (where applicable) Y
Total previous cycles Y
Total number of previous live births Y
ICSI (y/n) N
Total number of miscarriages Y
Intralipid (y/n) Y
Duration of infertility Y








Gonadotrophin type (other/Gonal-F/Menopur/unavailable) Y
Gonadotrophin dosing days (<10/10 to 11/12 + /unavailable) Y
Gonadotrophin total dose (<1800 iu/1800 to 2699 iu/
2700 to 3599 iu/3600 iu +/ unavailable)
Y
Number of eggs collected N
Numbr of eggs inseminated N
Ratio of metaphase 2 (mature) to total eggs N
Number of eggs fertilized Y
Patient age/donor recipient interaction Y
Day of embryo transfer/number of embryos
transferred interaction
Y
Embryoscope/patient age interaction Y
Embryoscope/donor recipient interaction Y
Embryoscope/patient age/donor recipient interaction Y
Embryoscope/donor age interaction N
Embryoscope/day of embryo transfer interaction N
Embryoscope/number of embryos transferred interaction N
Embryoscope/day of embryo transfer/number of embryos
transferred interaction
AFC, antral follicle count; AMH, anti-Müllerian hormone;
BMI, body mass index; ICSI, intracytoplasmic sperm
injection.
N
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interact with each other; therefore, as the number of potential in-
teractions is enormous, we limited the available interactions to
the following: patient age with donor recipient status, to allow for the
effect of the patient’s age to vary with whether they are an oocyte re-
cipient; the day of embryo transfer with the number of embryos
transferred, allowing the effect of the number of embryos to vary by
transfer stage; the EmbryoScope variable, i.e. treatment effect, with
each patient’s age, oocyte recipient indicator, donor age (where ap-
plicable), day of embryo transfer and the number of embryos
transferred; three-way interactions between EmbryoScope, recipi-
ent and patient age, and between EmbryoScope, day of embryo transfer
and the number of embryos transferred. These were included as the
corresponding two-way interactions without EmbryoScope were in-
cluded. Importantly, these interactions were included to allow for the
possibility that the size and direction of the EmbryoScope effect varied
for different groups of patients.
The model-estimated effect sizes (presented as odds ratios that
describe the relative difference in the odds of a live birth between dif-
ferent treatment cycles) are accompanied by confidence intervals that
quantify the uncertainty in the odds ratio estimates arising from the
sample data. The confidence intervals are constructed using case boot-
strapping to achieve appropriately conservative estimates for the
statistical significance of the effects of interest and sensible esti-
mates for their uncertainty, where no analytically tractable formulas
are available for the standard errors (Booth, 1995; Carpenter and
Bithell, 2000; Thai et al., 2013). The observed data are resampled (with
replacement) to obtain a large number of pseudo datasets (n = 1000).
For each pseudo-dataset the final model is refitted and the effect size
of interest calculated. The result is a large sample of estimates of
the effect size that mimics the variability that we would expect to
observe if we were to repeat the study many times on new sets of
similar patients. The confidence interval is derived from the percen-
tiles of the sample of estimates.
Finally, likelihood ratio tests were carried out for each of the ex-
planatory variables that were considered but not retained in the model,
after the stepwise variable selection procedure. These tests evalu-
ate the null hypothesis that including the variable in question does
not improve the model fit as measured by the likelihood.
The statistical software package R version 3.3.1 (R Core Team, 2016)
was used for analyses. The lme4 package was used to implement the
generalized linear mixed effects modelling (Bates et al., 2015).
Results
The summary statistics for each clinical variable considered in the
analysis versus treatment (standard/embryoscope) are shown in
Table 1; the variables selected for inclusion in the final model are
presented in Table 2. The interactions between the EmbryoScope and
each of donor age, day of embryo transfer, number of embryos trans-
ferred, and the three-way interaction between EmbryoScope, day of
embryo transfer and number of embryos transferred were omitted
after carrying out the likelihood ratio tests for each, which returned
a P-value larger than 0.1 for each of these cases, indicating no
evidence to reject the null hypothesis (Table 3); hence, no evidence
was found that the EmbryoScope morphokinetic algorithm effect
varies with donor age, day of embryo transfer, the number of oocytes
recovered in total, as a ratio of mature (metaphase 2) to total or
the number of embryos transferred. In each case, however, the
corresponding main effects were included in the model, as these vari-
ables did affect the incidence of live birth events.
The estimated odds ratio for patients younger than 38 years using
their own eggs is 1.19, with 95% CI of (1.06 to 1.34), indicating strong
evidence that the use of the EmbryoScope with the morphokinetic al-
gorithm in this group is more likely to result in a live birth than
standard treatments. The mean (SD) and median (range) for patient
age for standard incubation were 35.5 (5.17) and 36.0 (19–54); and for
Embryoscope 36.7 (4.80) and 37.0 (22–50), respectively. The total data
were 35.6 (5.15) and 36.0 (19–54), respectively.
EmbryoScope treatment in which a single blastocyst is trans-
ferred was compared with standard treatment in which two blastocysts
were transferred, which needed to take account of the effect of the
number of embryos transferred. For the age group younger than 38
years using their own eggs, there is some evidence that transfer of
a single blastocyst after EmbryoScope is associated with fewer live
births than transfer of two blastocysts after standard treatment (OR
0.854; 95% CI 0.735 to 1.000).
For non-recipients in the group aged 38 years and over, there is
strong evidence that transfer of a single blastocyst after EmbryoScope
is associated with fewer live births than transfer of two blastocysts
after standard treatment (OR 0.603; 95% CI 0.478 to 0.748). For
recipients in the group aged 38 years and over, no evidence was
found of a difference between transfer of a single blastocyst after
EmbryoScope and transfer of two blastocysts after standard treat-
ment (OR 0.981, 95% CI 0.557 to 1.750). These data are important,
especially in the context of multiple pregnancies in which the data
demonstrated a highly elevated risk of multiple pregnancy in all groups
when two embryos where transferred (Table 4).
Discussion
In summary, the results demonstrate an 19% increase in live birth
rate with EmbryoScope and morphokinetic algorithm embryo selec-
tion for patients younger than 38 years, and a 37% increase in live
birth rate for recipients aged over 37 years. Recipients aged over 37
years did equally well in live birth outcome, with only a single blastocyst
Table 3 – P-values returned by likelihood ratio tests for
including the listed variables in the model.
Variable LRT P-valuea
ICSI (y/n) 0.616




AMH (low/normal/high/very high/unavailable) 0.153
Embryoscope/donor age interaction 0.476
Embryoscope/day of embryo transfer interaction 0.553
Embryoscope/number of embryos transferred
interaction
0.179
Embryoscope/day of embryo transfer/number of
embryos transferred interaction
0.125
Number of eggs collected 0.245
Number of eggs inseminated 0.458
Ratio of metphase II (mature) to total number of eggs 0.257
a P > 0.1 indicate that there is no evidence to reject the null hypothesis.
AMH, anti-Müllerian hormone; BMI, body mass index; ICSI, intracytoplas-
mic sperm injection; LRT, likelihood ratio test.
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from the EmbryoScope compared with two after standard treat-
ment. The gain of increased incidence of live birth by transferring two
embryos needs to be balanced against the increased risk of a mul-
tiple pregnancy by about 30– 40%. It is recognised, however, that one
of the limitations of such comparative studies is the distinction of the
use of algorithms generated by TLI compared with any benefits ac-
cruing from the sole use of closed incubation systems; and conversely
the use of algorithms of morphokinetic development derived in open
culture systems. No adequate study has yet been conducted to evalu-
ate and distinguish these possibilities fully.
The introduction of time-lapse imaging is a recent innovation in
IVF (Hlinka et al., 2012a, 2012b; Lemmen et al., 2008; Meseguer et al.,
2011), especially since the development of wholly enclosed systems.
The key theoretical benefits of using time lapse in human IVF treat-
ment are twofold: providing images, not specifically related to kinetics,
that permit assessment of human embryos in unparalleled detail within
small (10–20 min) time frames, without disturbing the controlled culture
environment (closed system) (Campbell and Fishel, 2015); and to provide
detailed morphological and its related kinetic information. The value
of both elements of time-lapse in clinical outcome are currently being
assessed by many groups. Cruz et al. (2012), working with donor oocytes,
used the EmbryoScope time lapse incubator (Vitrolife, Sweden) to
compare clinical outcome between standard incubators and the closed
incubation provided by the EmbryoScope, without consideration of the
additional ‘morphokinetic’ information acquired and selection of
embryos based solely on conventional morphological criteria. Embryos
were randomly distributed between the incubators, and the authors
reported no differences in their development, blastocyst viability or
ongoing pregnancy rate. More recently, a randomized controlled trial
(Park et al., 2015) confirmed no significant difference in the mean
number of good-quality embryos or ongoing pregnancy rates when
comparing closed and conventional incubation, although this study
was limited by the short incubation time and day 2 transfer.
Such technology has captured the imagination of practitioners as
both a research tool (Costa-Borges et al., 2016; Hardarson et al., 2015;
Mölder et al., 2015), comparing embryos resulting from various clini-
cal conditions (Balakier et al., 2016; Gurbuz et al., 2016; Hashimoto et al.,
2016; Kaihola et al., 2016; Lindgren et al., 2016), and as a potential prog-
nosticator in clinical practice (Adamson et al., 2016; Chen et al., 2016;
Kong et al., 2016; Liu et al., 2016; Milewski et al., 2015; Mizobe et al.,
2016; Rubio et al., 2014; VerMilyea et al., 2014; Wu et al., 2016a, 2016b;
Yang et al., 2014), although some studies negate this (Freour et al., 2015;
Wu et al., 2016a, 2016b). Bronet et al. (2015) even found distinctive
morphokinetic differences between male and female embryos. A few
studies have purported to relate discriminating morphokinetics of euploid
and aneuploid embryos (Campbell et al., 2013a, 2013b; Minasi et al., 2016;
Vera-Rodriguez et al., 2015), although this has been disputed (Rienzi
et al., 2015). Much complexity arises in the analysis of embryo
morphokinetics and attempting to compare such with clinical outcome.
It is important to have consistent ambient conditions for embryo cleav-
age, but most studies ignore patient and treatment variables that have
an effect and are so vital to meaningful analyses (Kirkegaard et al., 2016);
some studies also only consider morphokinetics as a prognosticator for
blastulation (Conaghan et al., 2013). Kirkegaard et al. (2014) showed that
about 50% of embryos classified as non-usable were in fact viable; and
further studies have shown such an approach to be no better than mor-
phology assessment (Kieslinger et al., 2016). Other studies are inadequate
in relation to number of cases, comparative controls, including the as-
sessment of quality control for annotation, and end-points (Wu et al.,
2016a, 2016b). Much of this has been discussed in an excellent review
by Kaser and Racowsky (2014).
In clinical practice, it is incumbent on practitioners to continue to
improve protocol according to new data. During this period of analysis,
it was necessary to use an evolving series of selection models, by which
the transferred population is continuously narrowed, in morphokinetic
terms, such that the ratio between positive and negative known im-
plantation data may reach a plateau, as well as the area under the
receiver operator characteristic curve, commonly used to measure the
prognosticative power of a model. When each model was derived, no
assumptions were made about the morphokinetic variables to be used.
Information was used to derive the models and ‘holdback data’, not used
in model derivation, was used to test before introducing prospectively.
As far as is known, the data presented here are the largest to date
investigating the use of TLI algorithms for embryo selection and its effect
on the incidence of live birth, with comprehensive morphokinetic vari-
ables assessed during embryo cleavage and in relation to other patient
and treatment-related factors. It is highly probable that the increas-
ing incidence of aneuploid embryos with age (Lee et al., 2015) has a
negating effect of discriminatory morphokinetic factors in woman aged
over 37 years.
As the ploidy status of human embryos is critical to successful
outcome, early clinical studies were undertaken with TLI to assess
any correlation between embryo aneuploidy and morphokinetic pa-
rameters. The studies by Campbell et al., (2013a, 2013b) and Campbell
(2014) indicated the possibility of ranking embryos in relation to ploidy,
but such hierarchical data are only risk-based. Only by evaluating chro-
mosome copy number directly using invasive biopsy procedures would
the most accurate knowledge of embryo ploidy be provided. Such
studies comparing embryo ploidy and morphokinetics, however, are
still fraught with complexity, not least the type of aneuploidy be it one
compatible with full-term delivery such as trisomy 21; to those not
compatible with implantation, such as many monosomies; and complex
versus simple aneuploidy, mosaicism and segmental aneuploidies may
well have additional effects on morphokinetics. Additionally, simply
having closed systems throughout cleavage in vitro as distinct from
any morphokinetic differential may have a beneficial effect.
Kong et al. (2016) using time-lapse imaging reported a relation-
ship between early cell division behaviour and developmental potential
with elongation or shortening of the cell cycle affecting cell number,
respectively. This study concluded that, by excluding such embryos,









Single embryo transfer (%) 0.8 1.5 0.7 0.0
Double embryo transfer (%) 31.1 24.2 30.7 26.7
Single blastocyst (%) 0.8 1.5 0.9 0.0
Double blastocyst (%) 38.3 34.7 40.9 35.0
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the incidence of implantation and live birth after day 3 transfer of
embryos increased when the cell number of the embryo was maximal.
In assessing the limitations of this study, the EmbryoScope is a
closed system for embryo culture and in itself may procure benefit;
this was not assessed. Given that patient factors and some treat-
ments per se affect embryo morphokinetics, not all possibilities have
been fully explored. In the pragmatic world of patient treatment, we
were unable to use morphokinetic data as a blinded randomized control
study. Patients were not randomly allocated to EmbryoScope or stan-
dard incubation and selection. It is not possible to account for any
differences not contained within the available data, and therefore elimi-
nation of all confounding effects in a non-randomized study can never
be guaranteed. Larger studies using donor oocyte recipients are
needed to further evaluate the findings here. The evaluation is based
on live birth per embryo transfer to focus on the value of morphokinetic
data. Embryo implantation and successful progression to live birth
also requires a receptive endometrium and functional placenta.
In summary, many factors feed into embryo morphokinetics that
need to be controlled for, and data need to be presented on live birth
outcome with sufficiently powered studies that take into account patient
and treatment factors. Ideally, prospective randomized controlled
studies are needed, but pragmatic difficulties exist in undertaking such
studies, not least to obtain sufficient patient recruitment, and for
prospective annotation data to be ignored. The present study used
morphokinetic data for selection of embryos for transfer; a 19%
increase in live birth was observed for women younger than 38
years using their own oocytes. The advantage of the EmbryoScope
morphokinetic data was evident too for recipients aged over 37 years,
demonstrating that the transfer of a single blastocyst had the same
chance of a live birth as two transferred after standard treatment without
the risk of multiple pregnancy. Finally, it must always be recognized
that such analyses cannot account for all factors affecting success-
ful pregnancy outcome, particularly in the IVF population cohort; normal
placental function (Fishel et al., 2016) and endometrial receptivity
(Miravet-Valenciano et al., 2015; Nejat et al., 2014) are also essential.
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KEY MESSAGE
Perivitelline threads are observed during human zygote cleavage. Spanning the perivitelline space, they appear
as the cytoplasmic membrane withdraws from the zona pellucida. They are observed in 56% of embryos, and
are associated with fragmentation. We postulate that they have a role in the mechanics of cytokinesis and
fragmentation.
A B S T R A C T
Time-lapse imaging of the human preimplantation embryo in vitro has revealed a transient phenomenon involving the appearance of perivitelline threads,
commonly observed at the two-cell stage. These threads span the perivitelline space, arising at the specific area where the cytoplasmic membrane
contacts the zona pellucida, before any perivitelline space is formed. The threads persist as the cytoplasmic membrane retracts from the zona pellu-
cida to form the first cleavage furrow. In this observational report, these structures and their incidence are described. A total of 834 time-lapse videos
from IVF treatment cycles, one per patient, were retrospectively analysed for perivitelline threads, from pronuclear formation until completion of the
first cell cycle. Threads were observed in 56.4% (470/834) of embryos and varied from a single to an array spanning an area of the zona pellcida. A
total of 91.9% (432/470) were seen to form after cytoplasmic membrane–zona-pellucida contact. A total of 76.4% (359/470) were visible at the first cleav-
age furrow; 77% (362/470) were associated with cytoplasmic fragments at the two-cell-stage. Presence or absence of threads did not affect embryo
development. This descriptive study is limited; further characterization of these structures is needed to elucidate their potential role in early human
embryo development.
© 2017 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
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Introduction
Communication between the oocyte and its surrounding granulosa
cells is vital during maturation. To allow gap junction communica-
tion to occur, the zona pellucida is pierced by specialized granulosa
trans-zonal projections (TZP) that reach the oolemma (Gilchrist et al.,
2008). Like filopodia, they can be rich in F-actin, or composed pri-
marily of microtubules (Li and Albertini, 2013). The reduction of these
processes as the oocyte matures may contribute to the formation of
the perivitelline space (PVS) (Inoue et al., 2007). The PVS of the oocyte
contains a hyaluronan-rich extracellular matrix, not visible with light
microscopy. The size of the PVS is significant, affecting the inci-
dence of polyspermy, fertilization rate and pronuclear morphology
(Rienzi et al., 2005; Yoshida and Niimura, 2011).
In many species, the orientation of the first cell division depends
on the positioning of the mitotic spindle relative to an axis of polar-
ity (Siller and Doe, 2009) (Lu and Johnston, 2013). In the human, no
direct data are available on the mechanisms involved in polarity es-
tablishment or division plane orientation during cleavage; however,
it is likely that this is governed by interactions between the cytoskel-
eton, proteinase-activated receptor signalling and cell-to-cell
communication analogous to those reported in other species (Ajduk
and Zernicka-Goetz, 2016).
In early embryonic development, the appearance of fragmenta-
tion is well known to affect embryo quality, but the mechanism of
fragmentation is not fully understood. Hypotheses concerning the
factors controlling fragmentation have included telomere length, ma-
ternal age, association with lipoproteins and reactive oxygen species
(Fujimoto et al., 2011). Previous time-lapse imaging studies have shown
that most fragments appear at the two-cell-stage, and some can be
resorbed and disappear in the next cleavages (Mio and Maeda, 2008).
In this time-lapse imaging study, the incidence of perivitelline
threads in human embryos and their association with the first cleav-
age furrow, fragmentation, embryo ploidy and implantation potential
is investigated.
Materials and methods
Data for this research were obtained from 834 treatment cycles across
two CARE Fertility IVF clinics (CARE Fertility Nottingham and CARE
Fertility Tunbridge Wells), using the same laboratory operating pro-
cedures between 11 November 2014 and 1 December 2016. All
operating procedures and protocols complied with UK regulations (The
Human Fertilisation and Embryology Act, 1990, 2008). The study did
not require ethical or institutional review board approval, as it was
conducted according to previously validated procedures. This was a
retrospective observational study, blinded to embryo developmen-
tal or clinical outcome, using time-lapse imaging (EmbryoScope™,
Vitrolife, Sweden) for the recording of fertilization, presence, appear-
ance and dynamics of threads, and the morphokinetics of early
cleavage events.
Patient criteria
For each of the 834 fresh clinical IVF or intracytoplasmic sperm in-
jection (ICSI) cycles, a time-lapse video, representing a single embryo
per patient, was randomly selected by the roll of a die, which then
dictated the number of culture well to assess, regardless of fertil-
ization status or embryo fate. Each embryo was assessed from
pronuclear formation until completion of the first cell cycle. Female
patient age ranged from 24–47 years, and mean female age was 35.98
(±4.36 SD).
Ovarian stimulation
Pituitary suppression was achieved with a gonadotrophin-releasing
hormone agonist (Suprecur® 0.5 ml subcutaneously daily; Sanofi
Aventis, UK) or antagonist (Cetrotide 0.25 mg daily; Merck Serono,
UK). For ovarian stimulation, recombinant FSH (Gonal-F, Merck Serono,
UK), human menopausal gonadotophin (Menopur, Ferring, UK), or both,
were used. Dosage of FSH ranged from 150 IU to 600 IU per day ac-
cording to individual patient response.
Oocyte retrieval and embryology
The methodology for oocyte retrieval, insemination and embryo culture
using the EmbryoScopeTM (Vitrolife, Sweden) has been described pre-
viously (Campbell et al., 2013). In brief, after retrieval and insemination,
oocytes were placed individually in microwells of the EmbryoSlide,
loaded into the EmbryoScope™ on day zero for ICSI (after injection)
and on day 1 for IVF embryos and cultured until day 5 or 6 of devel-
opment. Time-lapse images of each oocyte, with at least a single
pronucleus, were acquired every 10 min through seven focal planes
on the Z axis, 15 µm apart. EmbryoScope™ images were acquired by
a 12-bit monochrome complementary metal-oxide semiconductor
camera and a custom-made Hoffman modulation contrast with a X20
objective, giving a resolution of 3 pixels per µm and images between
800 × 800 to 1000 × 1000 pixels (scaled to 800 × 800 pixels for export).
The time-lapse images were used for assessing pronuclei, threads
and embryo development. Selected embryos were transferred into
the uterus, cryopreserved or discarded, as per standard clinical pro-
tocol. Images were annotated (described and recorded by time and
embryo stage at observation) using the EmbryoViewer® image analy-
sis tools and software by embryologists with demonstrated
competency.
Preimplantation genetic screening
Preimplantation genetic screening was carried out using trophecto-
derm biopsy on day 5 or day 6 and next-generation sequencing.
Amplified samples for next-generation sequencing were processed
with VeriSeq PGS kit (Illumina). Blastocysts were vitrified after biopsy
and warmed on the same day as embryo transfer.
Assessment and description of perivitelline threads
The presence or absence of threads was determined by carefully fo-
cusing through all Z-plane images from the time of pronuclear
formation until completion of the first cytokinesis. The time-lapse
images of the randomly selected embryos were retrospectively studied,
and the following details of the threads were annotated: time of ap-
pearance, abundance, relationship to the zona pellucida, association
with fragments and location. Embryologists conducting these anno-
tations were blinded to downstream developmental fate or clinical
outcome. Annotations and definitions associated with threads are pre-
sented in Table 1.
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Annotation criteria and classification of perivitelline thread
appearance
Threads were identified as present or absent and, if observed, they
were categorized according to number as follows: single or double
threads (class I); a group of three to five threads (class II); or an array
of many threads spanning a large surface area of the zona pellu-
cida (class III) (Figure 1).
In cases in which threads were positively identified, it was ascer-
tained whether they appeared after cytoplasmic membrane–zona
pelluicida contact, whether they were located at the cleavage furrow,
and whether they were associated with fragmentation.
Assessment of thread–cleavage furrow association was consid-
ered positive if threads appeared to connect the invagination of the
cytoplasmic membrane with the zona pellucida, becoming more promi-
nent as the cleavage furrow deepened.
Table 1 – Annotation of perivitelline threads.






If at least one perivitelline
thread observed.
If present, threads classified
by quantity
When perivitelline space





orientation or position in well/
well shadowing.





from an observed area of
contact between cytoplasmic
membrane and zona pellucida.
Perivitelline threads observed
following no prior contact
between cytoplasmic
membrane and zona pellucida.
Images obscured as described
above. Contact area may be
out of focal plane.
Association with fragments Perivitelline threads
connected to fragments, which
localize to region of the
perivitelline space where the
threads are first observed.
Perivitelline threads observed
with no association to
fragments. Either fragments
not present or observed
without threads attached.
Images obscured as above, or





observed with first cleavage
furrow connecting the
invagination of the cleavage
furrow to zona pellucida.
Perivitelline threads distinct
from point of cleavage furrow.
Appear to originate elsewhere
along the cytoplasmic
membrane.
As previously described above
or orientation of cleavage in
different focal plane. i.e.
Perpendicular to camera
position.
Figure 1 – Classification of perivitelline threads, with timelapse image examples. Threads were classified into three groups, based on their
quantity: one or two individual threads (I), three to five threads (II) and more than five threads (III). Class III included observations of large
arrays spanning a high proportion of the internal zona.
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Association with fragmentation was indicated when threads ap-
peared to be physically connected to cytoplasmic fragments at any
time during their appearance.
The degree of fragmentation was routinely assessed and re-
corded by an embryologist; competency was assessed for this task
before the retrospective analysis of the time-lapse videos, using the
software of the time-lapse incubator. According to standard operat-
ing procedure, fragmentation was annotated only when cytokinesis
was complete, and the two blastomeres were rounded and fully
formed. The degree of fragmentation was expressed as 0–10%, 10–
20%, 20–50%, and over 50%.
In all cases, where the time-lapse images did not result in a clear
view of the cytoplasmic membrane–zona pellucida contact point and
first cleavage furrow sufficient to identify the presence or absence
of threads, the embryo was scored as ‘inconclusive’. Inconclusive ob-
servations were possibly due to the transient nature of the threads,
and limitations of the 10-min image frequency. Therefore, definitive
absence of threads could not be determined. For a similar reason,
in some cases, formation of the cleavage furrow was not captured.
Observations were also considered inconclusive if the first cleavage
plane orientation or shadowing caused by an off-centre position in
the culture well, hindered visibility of the perivitelline space.
Measurement of perivitelline threads
Measurements were taken of the longest thread in each of 50 embryos,
randomly selected from the original data set, using time-lapse imaging
software. The measurements represent ‘snap-shot’ values, as the
threads appeared to be dynamic structures showing extension and
retraction.
Outcome measures
Insemination type, ploidy status, early morphokinetics, final dispo-
sition and implantation data of embryos were analysed. Implantation
rate is reported for embryos with known implantation data (KID). That
is, only transferred embryos where the fate was traceable to an in-
dividual embryo were included. Implantation was confirmed by the
presence of a fetal heart beat at ultrasound scan at 7 ± 1 week ges-
tation. Implantation rates for KID embryos were calculated as follows:
(number of implanted KID embryos /total number of KID embryos)
× 100%.
Statistical analysis
Statistical significance was determined using chi-square 2 × 2 analy-
ses. P < 0.05 was considered significant.
Results
Classification of perivitelline threads
Using a classification system to describe the number of threads ob-
served (Figure 1), the three classes were detected in similar
frequencies; class I threads were observed in 35.2% (165/469) of
embryos analysed, compared with 38.6% (181/469) of class II and 26.2%
(123/469) displaying class III threads. One embryo with threads could
not be classified accurately owing to the orientation of the cleavage
furrow and was excluded from this data set.
Incidence and association of perivitelline threads
Of the 834 randomly selected embryos annotated, threads were visible
in 56.4% (470/834) of embryos, not visible in 21.9% (183/834), and in-
conclusive in 21.7% (181/834).
A total of 134 embryos observed in this study were derived after
IVF insemination, and 700 from ICSI. No significant difference was
found in the incidence of threads between insemination methods or
pronuclear status of the embryos included in this study (Table 2).
The fate of the 762 normally fertilized embryos available for clini-
cal treatment was investigated for the apperance of threads. The
proportions of embryos in which threads were seen and trans-
ferred, vitrified or discarded were 56.9%, 61.8% and 53.1%, respectively.
Transferred embryos were of varying quality; however, only top-
quality blastocysts were vitrified. No significant difference was observed
in the occurrence of threads between vitrified embryos (top quality)
and discarded embryos (not suitable for vitrification) (Table 3).













IVF (n = 134) 71 30 33
(53.0a) (22.4) (24.6)
ICSI (n = 700) 399 153 148
(57.0a) (21.9) (21.1)
Pronulclear status
1PN (n = 47) 27 9 11
(57.4a) (19.1) (23.4)
2PN (n = 762) 428 168 166
(56.2a) (22.0) (21.8)
3PN (n = 21) 11 6 4
(52.4a) (28.6) (19.0)
4PN (n = 4) 4 0 0
(100.0)
ICSI, intracytoplasmic sperm injection.
a No significant difference.























total (n = 322)
171 67 84
(53.1a) (20.8) (26.1)
a No significant difference.
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Zona pellucida–cytoplasmic membrane contact and
perivitelline thread appearance
Perivitelline threads appeared from the region of the cytoplasmic
membrane–zona pellucida contact area. This is the region of the zygote,
observed before first cleavage, where no PVS exists and the cyto-
plasmic membrane appears to touch the inner zona pelluicida. As the
zygote retracted from the zona pellucida, at the start of cleavage,
threads were observed extending between the cytoplasmic membrane
and zona pellucida (Figure 2, Figure 3 and Supplementary Video 1).
This association was seen in 91.9% (432/470) of embryos, whereas
4.3% (20/470) did not show such association and 3.8% were incon-
clusive (18/470).
Threads were observed in 76.4% (359/470) of embryos specifi-
cally at the invagination of the first cleavage furrow. In 10% (47/470)
of embryos, threads were observed in other areas of the developing
perivitelline space, not in association with the furrow. A total of 13.6%
(64/470) were considered inconclusive. Threads were also observed
Area of membrane–zona contact Even  perivitelline space 
A B C D
Figure 2 – The sequence of events leading to the appearance of perivitelline threads. When the zygote is positioned centrally within the
perivitelline space (A) no perivitelline threads are visible; (B) the zygote moves towards the inner edge of the zona pellucida (dashed arrow)
making proximal contact; (C) as cytokinesis occurs the threads appear in the newly formed perivitelline space as the embryonic membrane
withdraws from the contact area (arrow head); (D) perivitelline threads are seen to extend as cytokinesis progresses.
Figure 3 – Perivitelline threads observed in the perivitelline space as the cytoplasmic membrane withdraws from the zona pellucida.
Perivitelline threads appear to follow the line of the cleavage furrow and extend as the membrane moves into the furrow (Supplementary
Video 1).
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before the first cleavage event (Figure 4): a small number of zygotes
were seen to have a ‘ripple’ or ‘wave’ of threads along the inner zona
pellucida creating transient regions of contact between the mem-
brane and zona pellucida (Figure 5) (Supplementary Videos 2a and
2b).
Perivitelline threads and fragmentation
Fragmentaion was observed in 470 embryos. Perivitelline threads were
positively associated with the appearance of fragments in 77% (362/
470) of these embryos, regardless of pronuclear status. In 15.5%
Figure 4 – Before pronuclear fading, and the first cleavage, the membrane withdraws from close proximity to the zona pellucida (black
arrows), and an array of perivitelline threads appears, connecting the membrane to the zona pellucida, elongating with time.
(Supplementary Video 2b).
50 µm 
50 µm 50 µm 50 µm 
50 µm 50 µm 
Figure 5 – An array of perivitelline threads appear as a ‘wave’ in the perivitelline space, formed in association with the zygote cytoplasmic
membrane (Supplementary Video 2a).
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(73/470) of the fragmented embryos, the cleavage furrow orienta-
tion prevented clear assessment of threads, so these were scored
‘inconclusive’.
In 7.4% (35/470) of embryos with fragmentation, no association
was found between thread and fragment appearance. Of the 470
embryos in which threads were observed in the perivtelline space,
3.0% (14) showed no fragments.
After pronuclei fading, the zygote typically shifts within the
perivtelline space, coming into contact with the zona pellucida
(Figure 6B, black arrow). The cleavage furrow was observed to ini-
tiate in the region directly opposite this area of contact (Figure 6C,
small arrow head). Threads appeared to extend along this axis, seem-
ingly drawing the cytoplasmic membrane inwards towards this area
of contact (Figure 6D). As cytokinesis progressed, the threads ap-
peared to pull out fragments from the cytoplasmic membrane at the
cleavage furrow (Figure 6E). The fragments did not appear to detach
fully from the membranes, remaining amassed in the furrow (Figure 7
and Supplementary Videos 3a–3d).
The relationship between the number of threads (classes I–III) and
the percentage of fragmentation is shown in Table 4. Five out of the
six embryos with the highest degree of fragmentation displayed class
III threads.
Threads were not observed, despite good visualization of the cleav-
age furrow, in 183 (21.9%) of embryos. A total of 91.8% (168/183) were
normally fertilized zygotes (two pronuclei); these were assessed for
degree of fragmentation and compared with those with threads
(Table 5). No differences were observed in the degree of fragmen-
tation among the embryos with and without threads.
Perivitelline threads and embryo ploidy
Of the randomly selected embryos in this study, 30 normally fertil-
ized embryos had undergone preimplantation genetic screening (PGS).
Figure 6 – (A) Observation of perivitelline threads and their association with fragmentation and cleavage orientation. After pronuclear
fading, the zygote moves towards the inner surface of the zona pellucida (dashed arrow) to form a direct contact area (B, arrow). The
cleavage furrow is initiated from the most distal region of the zygote (C, arrow head), directly opposite this area of contact (arrow).
Perivitelline threads are thought to extend along this axis, directing cleavage in a ‘purse string’ effect drawing the distal cytoplasmic
membrane inwards towards this area of membrane – zona pellucida contact (D). As the cleavage furrow deepens the perivitelline threads
are observed in the perivitelline space (E). As cytokinesis progresses, the threads are observed attached to extra-embryonic cytoplasm,
which is drawn out as fragments (E and F).
Figure 7 – Magnified images of the cleavage furrow in association with fragments and perivitelline threads. Fragments appear in a purse-
string like manner (Supplementary Video 3a).










0–10 87 (33) 108 (41) 69 (26)
10–20 19 (33) 23 (40) 15 (26)
20–50 0 1 5
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Of the 28 reported as aneuploid, 19 showed threads at two-cell-
stage. This is not significantly different from the incidence of threads
in the unscreened two pronuclei embryo group (56.2%) (Table 2). Only
two embryos were euploid, both of which had threads. Five of 28 PGS
embryos did not have threads and four were considered inconclu-
sive for thread assessment.
Perivitelline threads and blastocyst development
For a subset of 125 randomly selected embryos, the presence of peri-
vitelline threads was assessed up to the blastocyst stage. A total of
58.4% of embryos (73/125) displayed threads, 90.4% were observed
at first cleavage, the latest during blastocyst collapse and re-
expansion. In 16.4% of embryos, threads were seen more than once
during development. A total of 82.2% of threads (60/73) were asso-
ciated with the appearance of fragments. Increasing cell number and
fragmentation, however, made annotating beyond the two-cell-
stage more challenging.
Early morphokinetics and perivitelline threads
As most threads were observed during the time of the first cleav-
age, the time from pronuclear fading (tPNf) to completion of the first
cleavage (t2) was analysed (t2-tPNf) for the incidence of threads. No
association was seen between the incidence of threads and the time
from pronuclear fading to completion of the first division (Table 6).
No significant difference was seen in the incidence of threads in 79
embryos that underwent a trichotomous first division (dividing di-
rectly from one to three cells), and those that divided into two cells
(Table 6).
Perivitelline threads and implantation
Of all embryos transferred, embryos with known implantation status
(n = 169) were identified from the data. For KID embryos that did not
exhibit threads, the implantation rate was 40% (22/55); for KID embryos
exhibiting threads, the implantation rate was 32.5% (37/114). Im-
plantation rates for KID embryos were calculated for each of the three
classes of threads (Figure 8).
Table 5 – Degree of fragmentation with and without threads in









0–10 337/422a (79.9b) 137/168 (81.5b)
10–20 74/422a (17.5b) 27/168 (16.1b)
20–50 11/422a (2.6b) 4/168 (2.4b)
a Six embryos were not annotated for fragmentation at two-cell stage and
are excluded from these data.
b No significant difference.











Morphokinetic timings (h) pronuclear (PN) fade to wo-cell [t2-tPNf] 741
1.8–2.4 159 63 48
270 (58.9a) (23.3) (17.8)
2.4–3.0 166 60 62
288 (57.6a) (20.8) (21.5)
>3.0 88 45 50
183 (48.1a) (24.6) (27.3)
Direct cleavage to three-cell
t3–t2 = 0 43 17 19
79 (54.4b) (21.5) (24.1)
a No significant difference.
b No significant difference compared withs 0- to two-cell cleavage.
Figure 8 – Implantation rates for embryos with known implantation status stratified for embryos with (n = 114) and without perivitelline
threads (n = 55) and for those with perivitelline threads for each of the classifications of threads (I–III). Class I (n = 41); class II (n = 43);
class III (n = 46).
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Length of perivitelline threads
Measurements of 50 threads gave a mean maximum length of 25.3 µm
(±9.50 SD), and a range from 9–62 µm. Because of limitations of the
image resolution, diameters were only estimated at less than 1 µm.
Discussion
This observational study describes structures referred to as ‘perivi-
telline threads’, that appear to span the PVS during early cleavage
of many human embryos in vitro. They exist transiently, measuring
up to 62 µm in length, seemingly connecting the cytoplasmic mem-
brane to the zona pellucida. They present either singly or as an array,
and most commonly at the site of prior cytoplasmic membrane and
zona pellucida contact. Retrospective analysis of time-lapse videos
in a clinical IVF setting has revealed this previously unreported
phenomenon.
At present, the constitution and origin of the threads remains
unknown. This study focuses on the incidence and visual descrip-
tion of these threads and their association with the first cleavage furrow
and fragmentation.
Previously characterized structures with similar morphological
characteristics as the threads reported here include filopodia and TZP.
Specialized filopodia have been reported in the mouse embryo at com-
paction from the eight-cell stage, and spanning the blastocoel cavity
connecting the trophectoderm to the inner cell mass of blastocysts
(Fierro-González et al., 2013; Salas-Vidal and Lomelí, 2004). The ini-
tiation and elongation of filopodia depend on the precisely regulated
polymerization, convergence and crosslinking of actin filaments (Mattila
and Lappalainen, 2008). Filopodia are involved in a multitude of cel-
lular processes including cell–cell communication, over both short
and long distances (Danilchik et al., 2013; Sagar et al., 2015; Salas-Vidal
and Lomelí, 2004). They have been demonstrated to facilitate the in-
ternal cellular transport of proteins, including the actin dependant
migration of cortical granules to the outer plasma membrane in the
oocyte at fertilization (Ajduk and Zernicka-Goetz, 2016; Antczak and
Van Blerkom, 1999; Bauer et al., 2008; Cheeseman et al., 2016). It is
possible that the threads reported in this study are filopodia, al-
though this is purely speculative and based on morphology alone.
Alternatively, the threads might be remnants of the corona radiata
cytoplasmic projections or TZP. The latter are known to penetrate the
zona pellucida during oogenesis and provide the structural basis for
more complex patterns of intercellular communication that emerge
at later stages of follicle development (Carabatsos et al., 1998;
Shuhaibar et al., 2015). The role of TZP is to support oocyte growth,
and they are also involved in nutrition and RNA trafficking (Albertini
and Barrett, 2003; Macaulay et al., 2016; Makabe et al., 2006). At least
two types of TZP have been described: actin rich projections into the
zona pellucida, which form gap junctions at the oocyte plasma mem-
brane, and coiled projections, which form adherens junctions at deep
invaginations at the oocyte surface (Albertini and Barrett, 2003). These
structures support active organelle movement from somatic cells
towards the oocyte surface. This dialogue coordinates oocyte growth
and cell cycle progression.
It is possible that perivitelline threads observed in this study are
TZP remnants; however, this is challenged by the fact that the threads
were not observed in the PVS in oocytes after denudation, during ICSI
or any other time during time-lapse incubation (data not shown). A
small number of zygotes were seen to have a ‘ripple’ or ‘wave’ of
threads within the PVS, creating transient regions of contact between
the zygote membrane and zona pellucida (Supplementary Videos 2a
and 2b). This behaviour may be more akin to filopodia than TZP, and
suggests that threads are not only present when a larger perivitel-
line space is visualized at early cleavage.
Stringent restrictions on human embryo experimentation, to-
gether with the transient appearance of the threads make live cell
monitoring or additional studies to characterize these structures chal-
lenging. Examination by electron microscopy or immunofluorescence
microscopy, as well as functional studies using inhibitors and gene
knock out models using rodent embryos, may provide further insight.
Molecular and gene expression experiments are necessary to de-
termine if there are any associations with known motor proteins such
as myosin motors, kinesins and dyneins. This may help determine
whether the threads are involved in transporting cellular compo-
nents from the cytoplasm (Halvaei et al., 2016). The use of live cell
imaging, or at least high-resolution and rapid frequency, compared
with snap shot, time-lapse image collection, is required to mini-
mize ‘inconclusive’ categorization and to determine whether thread
disassociation occurs after completion of cytokinesis, or if the threads
persist throughout the multiple cycles of cell division as observed in
the xenopus embryo (Danilchik et al., 2013). The observation of peri-
vitelline threads as late as the blastocyst stage in this study poses
the possibility that they are preserved throughout development. Ob-
servations of threads in the early embryo and then later in the resulting
blastocyst, however, were uncommon (<10% of embryos), but this may
warrant further analysis.
Perivitelline threads were confirmed in more than one-half of the
embryos examined in varying degrees as noted by the use of three
classifications (Figure 1). The relationship between the number of
threads and the percentage of fragmentation, however, cannot be as-
certained owing to the low numbers in each data set.
Nearly one-quarter of embryos did not display threads despite good
visualization of the events leading up to first cleavage. The pres-
ence of threads did not appear to be correlated with developmental
success at later stages, appearing in similar frequencies in both poor-
and top-quality embryos, suggesting they are not a predictor of embryo
quality. Implantation data from the study is limited, yet among the
embryos with known implantation status, implantation rates were mar-
ginally higher when threads appeared to be absent in the transferred
embryos, compared with when they were identified. Larger cohorts,
with live birth data, are needed to determine possible clinical sig-
nificance. Threads were observed in similar frequencies regardless
of ploidy status; however, the number of PGS embryos was small. In
addition, two- and three-pronuclei zygotes displayed threads at the
same frequency as two-pronuclei zygotes, suggesting threads arise
independently of pronuclear status (Table 2).
When conventional microscopy is used to examine the PVS of
human oocytes, it is common to observe an area where no perivitel-
line space exists between the cytoplasmic membrane and zona
pelluicida, termed a ‘cytoplasmic membrane–zona pelluicida contact
point’. Only in oocytes with unusually low cytoplasmic volume or in
hyperosmotic culture conditions does a space exist around the whole
oocyte/zygote. These oocytes are known to result in poor develop-
ment outcomes (Rienzi et al., 2005; Setti et al., 2011; Zhou et al., 2014).
In most embryos, threads were seen in the PVS at the site spe-
cifically associated with prior cytoplasmic membrane–zona pelluicida
contact. It remains to be determined if the cytoplasmic membrane
actually ‘adheres’ to zona pellucida at these sites, if the threads are
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a consequence of this cytoplasmic membrane–zona pelluicida contact,
and whether the threads originate from the plasma membrane, zona
pellucida or granulosa cells. In marsupials, an extracellular matrix
coat within the inner surface of the zona pellucida has been re-
ported to interact with the cytoplasmic membrane during cleavage
(Denker, 2000) but this has not been demonstrated in the human
embryo.
The high proportion of threads observed at the first cleavage furrow
in an organized array within a discrete area, as opposed to ran-
domly within the perivitelline space, may suggest a possible role of
threads in the first cleavage event. Few visual indicators are known
to predict the axis of the first cleavage in the human. Polar body po-
sition in the PVS has been investigated in the mouse, but is not
considered reliable (Hiiragi and Solter, 2004). The maternal spindle
has been suggested as an indicator of meridional cleavage in other
mammals (Cooke et al., 2003; Hosseini et al., 2016). Microtubular
arrays extending from the spindle can be visualized and identified in
a non-invasive way by using polarized light (Wang et al., 2001). Similar
polarized light experiments visualizing the mitotic spindle and the cy-
toplasmic membrane–zona pelluicida contact area would be pertinent
in investigating any relationship between the spindle, the site of threads
from cytoplasmic membrane–zona pelluicida contact area, and cleav-
age plane.
The association with the cleavage furrow could be coincidental,
as a larger PVS is created as the membrane pulls away. Time-lapse
videos, however, have shown that perivitelline threads are visible in
the PVS of zygotes and not only at the site of the cleavage furrow
(Supplementary Videos 2a and 2b). In addition, threads are present
as an organized array in a fan-like arrangement (Supplementary
Videos 3a–d and Figure 1) between the zona pellucida and foci within
the furrow rather than a random arrangement on the larger surface
area of the blastomere membranes or in the entire cleavage furrow.
Embryos that did not display threads at the cleavage furrow or
elsewhere implanted after embryo transfer, suggesting that the
threads are not necessary for cleavage or normal division. Alterna-
tively, they may be present but are not observed owing to the limitations
of time-lapse studies as previously discussed. Pregnancies from zona
free (and presumably thread-free) zygotes have been reported (Stanger
et al., 2001; Vajta et al., 2010).
Threads were observed to be associated with fragments at the two-
cell-stage in most embryos. A causative relationship, however, could
not be established here. Only studies using specific staining tech-
niques for these thread structures could determine if this association
is real or an artefact of two processes occurring simultaneously.
Equally, threads can present at the furrow without the appearance
of fragments in a small number of embryos, and the incidence of frag-
mentation is similar in embryos without threads, which again suggests
that this association could be coincidental.
In conclusion, characterization and functional studies are re-
quired to further our understanding of the significance of these
structures in early embryo development.
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KEY MESSAGE
This is the first study to compare an objective time-lapse algorithm (TLIA) of preimplantation embryo development 
to subjective, conventional blastocyst morphology for embryo transfer and live birth outcome. Detailed analysis of all 
patient covariates indicates that TLIA was superior for selecting embryos for their propensity to generate a live birth.
ABSTRACT
Research question: Does using an objective time-lapse imaging algorithm (TLIA) after IVF relate to conventional morphological 
assessment of human blastocysts as a prognosticator for live birth?
Design: Prospective use of a TLIA to select embryos in multicentre IVF clinics all using the same strictly controlled laboratory protocols. 
Each blastocyst was given a ranking from A to D, with the highest rank preferred for fresh transfer. This ranking was retrospectively 
compared with a given morphological score, which was blinded to the TLIA rank; all embryos were cultured under the same conditions.
Results: Using multiple variable logistic regression models, TLIA embryo rank enabled greater discrimination between cycles 
with and without live births than the conventional morphology grade, even when considered in isolation, and when adjusting for 
covariates related to treatment and patient criteria. Of the 1810 cycles of single blastocyst transfer, 894 (49.4%) resulted in a live 
birth. A Vuong non-nested test including covariates showed strong evidence of the superiority of the embryo rank model compared 
with the transfer grade model (P = 0.0008 [raw], P = 0.0003 [Akaike information criterion – corrected]). From the receiver 
operating characteristic (ROC) curves across all possible thresholds the TLIA rank showed better true positive and true negative 
rates and had a higher area under the curve [AUC] of 67.43% compared with 61.74% for the blastocyst morphology grade. The 
same analysis but excluding covariates demonstrated an AUC of 62.86% versus 54.02%, respectively.
Conclusion: Objective TLIA is superior for selecting embryos for their propensity to generate a live birth over a conventional, 
subjective blastocyst morphology scoring system.
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INTRODUCTION
S ince the introduction of clinical IVF, it is an axiom that not all zygotes have an equal potential for successful development, 
through the cleavage stages up to live 
birth, even in the most favourable 
environment. During the early period 
of IVF this resulted in the transfer 
of multiple embryos, and attempts 
to define viability by morphological 
criteria (Edwards et al., 1984; Fishel 
et al. 1983). Since the routine use of 
advanced culture systems permitting 
optimal development to the blastocyst 
stage, early selection is undertaken to 
eliminate cleavage-arrested embryos 
and other anomalies, permitting higher 
live birth rates with the transfer of single 
blastocysts (Gardner et al., 1998, 2000; 
Marek et al., 1999; Van Royen et al., 
1999). Further refinement of blastocyst 
success rates has been achieved by 
selecting these embryos using defined 
morphological criteria (Alpha Scientists 
in Reproductive Medicine and ESHRE 
Special Interest Group Embryology, 2011; 
Gardner et al., 2000). However, it is also 
acknowledged that morphological criteria 
alone are a crude and subjective tool in 
assessing embryo viability (Hardarson 
et al., 2012) because the blastocyst is a 
dynamic system of changing patterns 
over short periods of time (Campbell 
and Fishel, 2015). Time-lapse incubators 
not only provide the unfettered and 
safe opportunity to observe embryo 
morphology over its total period of in-
vitro culture (Campbell and Fishel, 2015) 
but can also provide objective additional 
data (algorithms, and observational 
dysmorphism) that may provide a more 
accurate assessment of embryo viability 
(Campbell et al., 2013a, 2013c; Meseguer 
et al., 2011, 2012; Pribenszky et al., 2017; 
Rubio et al., 2012; Wong et al., 2010). 
This study compared the use of objective 
time-lapse imaging to conventional, 
subjective morphology criteria for 
embryo selection.
MATERIALS AND METHODS
The 1810 single embryo transfer cycles 
were from the CARE Fertility Group 
clinics at CARE Nottingham, CARE 
Northampton, CARE Manchester, 
CARE Sheffield, Beacon CARE Fertility 
Dublin and CARE London. Patients were 
self-selected and treatment was based 
upon appropriate clinical consultation, 
counselling and decision-making between 
the patient and treating physician; 
but all patients decided to include 
time-lapse imaging in their treatment 
protocol. Detailed embryology and 
clinical methodologies and protocols 
have been previously published (Fishel 
et al., 2017). All embryos were cultured 
in the same time-lapse incubator system 
(EmbryoScope; Vitrolife, Sweden), 
which remained a constant for embryo 
comparison. Embryos at the blastocyst 
stage were assessed both using 
conventional morphological criteria 
and the in-house derived TLI algorithm. 
All protocols for patient treatments 
complied with UK regulations (Human 
Fertilization and Embryology Act, 1990, 
2008) and all UK facilities are regularly 
inspected by the Human Fertilization 
and Embryology Authority (HFEA), which 
includes the use of TLI. The retrospective 
analysis of the data did not require 
ethical or institutional review board 
approval as the clinical and embryology 
protocols were performed according 
to previously validated procedures, and 
practised under licence from the HFEA. 
All patients were fully counselled and 
gave their signed, informed consent to 
their treatment.
Multiple clinical variables were 
categorized for inclusion in the analysis, 
and these (with the final groupings 
applied for each variable) are available 
as Supplementary Table 1. As well as 
considering the raw, continuous patient 
and donor ages in the analysis, patient 
and donor ages were also grouped as 
follows: patient age <33, 33–37, ≥38; 
corresponding to the common grouping 
used. The groupings for categorizing 
body mass index (BMI), anti-Müllerian 
hormone (AMH) and antral follicle count 
(AFC) were chosen to correspond to 
clinically meaningful categories, i.e. to 
reflect what might be considered to be 
above, below or within a normal/healthy 
range.
The following definitions were used: 
(i) BMI: <18.5 (underweight), 18.5–<25 
(healthy weight), 25–<30 (overweight), 
≥30 (obese); (ii) AMH (pmol/l): <6 (low), 
6–<24 (normal), ≥24–<70 (high), 70+ 
(very high); (iii) AFC: <4 (extremely low), 
4–<10 (low), 10–<14 (somewhat low), 
14–<22 (normal), 22–<35 (high), 35+ 
(very high).
The oocyte provider ages (<28, 28–31 
and 32+), gonadotrophin dosing days and 
the total dose were categorized based on 
the quantiles of the observed distribution 
to ensure that sufficient information was 
present in each of the categories for a 
robust analysis.
Ethnicity was also considered and 
categorized according to standard ethnic 
classification into five main groups.
Ovarian stimulation protocols
Pituitary suppression for ovarian 
stimulation and oocyte maturation has 
been described previously (Fishel et al., 
2014).
Oocyte retrieval, denudation and 
intracytoplasmic sperm injection 
(ICSI)
Oocyte retrieval was achieved following 
sedation at approximately 36 h post-
human chorionic gonadotrophin injection 
(10,000 IU; Pregnyl, Organon, UK; or 
Ovitrelle, Merck Serono) or agonist 
trigger (buserelin 0.5 ml subcutaneous; 
Suprefact, Sanofi SA, France); and the 
cumulus-oocyte complexes were cultured 
in Ferticult IVF medium (Fertipro, 
Belgium): all procedures, including IVF 
and, where appropriate, ICSI, have been 
described in detail previously (Fishel 
et al., 2017).
Embryo culture and incubation
Details for TLI: the algorithm used, 
embryo ranking and morphology have 
been previously published (Fishel 
et al., 2017). The morphology scoring 
system, which was not considered by 
the algorithm, was modified from the 
Gardner and Schoolcraft AA/AB/BA, etc. 
annotation of blastocyst trophectoderm 
and inner cell mass morphology 
(Gardner and Schoolcraft, 1999) and 
was replaced by numbers: 1:1/1:2/2:1, 
etc. as per the Istanbul consensus 
recommendation (Alpha Scientists in 
Reproductive Medicine and ESHRE 
Special Interest Group Embryology, 2011). 
The switch to numeric was to distinguish 
from the alphabet-based algorithm 
ranking.
Evaluation of time-lapse images, 
annotation protocols and quality 
control
The evaluation and use of TLI in the 
study system, the timing allowance for 
ICSI, annotation protocols and the strict 
training and adherence criteria for quality 
control have all been detailed previously 
(Fishel et al., 2017, 2018). The algorithm 
did not include morphological criteria 
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extensively validated, the effectiveness of 
an in-house derived algorithm may not 
produce similar results in other settings 
(Freour et al., 2015; Liu et al., 2016; Storr 
et al., 2018), as previously discussed 
(Fishel et al., 2018).
Embryo selection and transfer
Strict user-defined time-lapse algorithms 
as published previously (Fishel et al., 
2017) were used for objective selection 
of embryos. Briefly, for blastocysts, 
these were preferentially selected with 
a tSB (time to the start of blastulation 
in hours after insemination) ≤93.1. If 
this criterion was not met, preference 
was given to embryos where the 
duration of blastulation (dB) = the 
time to blastulation – from ICSI or 
insemination [tB] minus time to the start 
of blastulation [tSB]) was ≤12.5 h. The 
decision to transfer a particular embryo 
was made following annotation, with 
A-ranked embryos given the highest 
priority and a rank of D the lowest. 
Morphology grade, which was not used 
for embryo selection, was scored by an 
experienced embryologist at the time 
of transfer, but blinded to the embryo 
rank by the TLIA. Embryo transfer was 
performed under ultrasound guidance 
using one of several catheters (outlined in 
Supplementary Table 1).
Statistical methods
Separate multiple variable logistic 
regression models were fit to the 
study data to assess the discriminatory 
performance of embryo rank and transfer 
grade on live births. A logistic regression 
model computes the probability of the 
binary outcome as a function of the 
supplied explanatory variables (Agresti, 
2013; Hastie et al., 2009; Pohar Perme 
et al., 2004; Sperandei, 2014). Other 
covariates, aside from embryo rank 
and transfer grade, respectively, were 
considered for inclusion in the models to 
control for potential confounding. These 
covariates aim explicitly to control for 
differences in the patient populations 
between the embryo rank groups and the 
transfer grades, respectively, in the two 
separate models. Morphology assessment 
information (i.e. transfer grade) was not 
considered as a potential confounder in 
the embryo rank model and vice versa.
The variables made available to the 
variable selection procedure and in 
the final models for embryo rank and 
transfer grade, respectively, are given in 
Supplementary Table 1.
The available interactions were limited to 
the following:
- Patient age with an indicator for 
whether the patient was an oocyte 
recipient, to allow for the possibility 
that the patient's age is less (or even 
more) important when they have 
received an egg donation.
- Embryo rank/transfer grade with 
each of patient age, oocyte recipient 
indicator, donor age (where 
applicable), day of embryo transfer, 
ICSI and array comparative genomic 
hybridization. These interactions were 
included to allow for the possibility 
that the sizes and directions of the 
embryo rank/transfer grade effects 
vary for different groups of patients.
- A three-way interaction between 
embryo rank/transfer grade, oocyte 
recipient status and patient age. 
This was included because the 
corresponding two-way interaction 
without embryo rank/transfer grade 
was being included. Consideration 
was also given to the inclusion of 
higher-order effects of patient age, i.e. 
quadratic age terms were considered 
to allow for a non-linear effect of age 
(on the log-odds of live births). Where 
evidence of a quadratic age term was 
found, interactions with this term were 
also considered, consistent with the 
interactions considered for the main 
effect of age.
The models were also run with no 
covariates to explore the predictive 
performance of embryo rank and transfer 
grade in isolation. These models, without 
covariates, demonstrate how well each 
assessment predicts the live births 
outcome without taking account of any 
other information about the cycles.
ROC curves were compared between 
embryo rank and transfer grade, and 
the AUC values achieved by the embryo 
rank and transfer grade models; these 
represent the accuracy of the predictive 
model, where 1 is the best possible value, 
and 0.5 is equivalent to predicting at 
random.
The fitted and final models were also 
used to provide estimates of the 
directions and sizes of the effects of 
interest (presented as odds ratios [OR]), 
and the estimated effect sizes are 
accompanied by confidence intervals 
(CI). Profile likelihood CI are provided, 
which are more reliable than the more 
commonly presented Wald intervals 
(i.e. estimate ± percentile × SE of 
estimate). Likelihood ratio tests (LRT) 
were also calculated to assess the overall 
significance of each variable, across the 
multiple groups of a categorical variable 
(where applicable).
All analyses were performed in the 
statistical software package R version 
3.4.3 (2017-11-30) (R Core Team, 2017). 
The ModelGood package was used to 
implement the ROC curves (and the pscl 
package was used to apply Vuong's test; 
Jackman, 2017).
The variables made available to the 
variable selection procedure and those 
that were selected to be in the final 
models for embryo rank and transfer 
grade, respectively, are not presented but 
can be accessed in the Supplementary 
Materials, along with descriptive statistics 
used to characterize the covariates 
available across the embryo ranks and 
transfer grades.
RESULTS
There were 1810 cycles for analysis, 1373 
cycles of standard (own eggs) patients, 
and 437 cycles of oocyte donation. Of 
these 996 (996/1810; 55.0%) had an 
embryo rank of A, 568 (568/1810; 31.4%) 
of B, 208 (208/1810; 11.5%) of C, and 
38 (38/1810; 2.1%) of D. Whereas 206 
(206/1810; 11.4%) had a transfer grade 
of 1:1, 223 (223/1810; 12.3%) had 1:2, 77 
(77/1810; 4.3%) had 2:1, 1095 (1095/1810; 
60.5%) had 2:2, 149 (149/1810; 8.2%) 
had 2:3, 28 (28/1810; 1.5%) had 3:2, and 
32 (32/1810; 1.8%) had 3:3. Of the 1810 
cycles, 894 (49.4%) resulted in live births. 
These were: 589 (59.1%) for transfers 
with an embryo rank of A, 253 (44.5%) 
for B, 50 (24%) for C and 2 (5.3%) for D. 
In terms of transfer grades: 110 (53.4%) 
for transfers with a transfer grade of 1:1, 
114 (51.1%) for 1:2, 43 (55.8%) for 2:1, 
568 (51.9%) for 2:2, 47 (31.5%) for 2:3, 5 
(17.9%) for 3:2 and 7 (21.9%) for 3:3.
All patients
Supplementary Table 1 shows that 
the variables selected to be included 
in the final models for embryo rank 
were embryo rank, patient age, low 
molecular weight heparin (Clexane®), 
patient type (standard/oocyte recipient), 
gonadotrophin dosing days, embryo 
rank by patient age interaction, embryo 
rank by day of transfer interaction, and 
embryo rank by ICSI interaction; and 
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those included for transfer grade were 
transfer grade, patient age, total previous 
cycles, Clexane®, patient type (standard/
oocyte recipient), gonadotrophin 
dosing days, patient type by patient 
age interaction and transfer grade by 
ICSI interaction. Having accounted for 
these variables, there was no evidence 
of the other, omitted covariates being 
associated with the odds of a live birth.
The embryo rank model results (TABLE 1) 
provide strong evidence of an effect of 
embryo rank (LRT P-value <0.0001), 
presented as OR relative to a rank of A, 
which are the ratios of the odds of a live 
birth with an embryo of rank B, C or D 
to the odds of a live birth with an embryo 
of rank A. For example, the estimated OR 
for an embryo of rank C compared with 
A is 0.0112 with a 95% CI of 0.001–0.152, 
indicating that there is strong evidence 
(Wald P-value 0.0007) that embryos of 
rank C are less likely to result in a live 
birth than embryos of rank A.
The estimated OR associated with the 
other covariates retained in the final 
embryo rank model are also presented 
in TABLE 1. The data suggest, for example, 
that the odds of a live birth are higher 
for oocyte recipients compared with 
standard patients (OR 3.5155; 95% CI 
1.965–6.349).
As the model contains both the 
main effect of embryo rank as well as 
interactions between embryo rank and 
other variables, the LRT for the embryo 
rank variable presented in Supplementary 
Table 14 considers the effect of omitting 
the embryo rank variable having already 
dropped the embryo rank/day of transfer 
interaction, embryo rank/patient age and 
embryo rank/ICSI terms from the model.
The transfer grade model results are 
given in TABLE 2, which provide strong 
evidence of an effect of transfer grade 
(LRT P-value <0.0001). The effect sizes 
are presented as OR relative to a grade 
of 1:1, which are the ratios of the odds of 
a live birth with an embryo of rank 1:2, 
2:1, 2:2, etc. to the odds of a live birth 
with an embryo of grade 1:1. For example, 
the estimated OR for an embryo of grade 
3:2 compared with 1:1 is 0.2757 with a 
95% CI of 0.081–0.811, indicating that 
there is evidence (Wald P-value 0.0261) 
that embryos of grade 3:2 are less likely 
to result in a live birth than embryos of 
grade 1:1. As the model includes both 
quadratic and interaction terms with 
age, the LRT for the associated terms 
consider omitting the individual effects 
having already removed any higher-
order terms with age. Similarly, the 
LRT for transfer grade considers the 
effect of omitting transfer grade having 
already dropped the transfer grade/ICSI 
interaction terms from the model.
A Vuong non-nested test of the final 
models showed strong evidence of 
the superiority of the embryo rank 
model (including covariates) compared 
with the transfer grade model 
(including covariates) (P = 0.0008 
[raw], P = 0.0003 [AIC-corrected]). 
FIGURE 1 shows the ROC curves for 
the final models. Across all possible 
thresholds, the embryo rank model 
showed better true positive and true 
negative rates and had a higher AUC 
of 67.43% compared with 61.74% for 
the transfer grade model, indicating a 
superior predictive accuracy for embryo 
selection by the TLI algorithm.
Excluding all covariates, similar results 
were obtained although a weaker 
performance overall. A Vuong non-
nested test of the models without 
covariates showed strong evidence of the 
superiority of the embryo rank model 
compared with the transfer grade model 
TABLE 1 ESTIMATED COEFFICIENTS AND OR (95% CI) FOR THE LIVE BIRTHS OUTCOME EMBRYO RANK MODEL




– (Intercept) 4.3122 0.708 74.6037 [18.947, 304.259] 6.09 <0.0001 –
Embryo rank Rank B versus A –3.7174 0.945 0.0243 [0.004, 0.155] –3.93 0.0001 <0.0001
Embryo rank Rank C versus A –4.4926 1.326 0.0112 [0.001, 0.152] –3.39 0.0007 <0.0001
Embryo rank Rank D versus A –11.3419 5.807 <0.0001 [<0.0001, 
0.255]
–1.95 0.0508 <0.0001
Embryo rank / day of transfer A: 5–7 versus 2–4 –1.0443 0.294 0.3519 [0.192, 0.611] -3.55 0.0004 0.0009
Embryo rank / day of transfer B: 5–7 versus 2–4 –0.4146 0.382 0.6606 [0.307, 1.391] –1.09 0.2775 0.0009
Embryo rank / day of transfer C/D: 5–7 versus 2–4 0.3101 0.401 1.3636 [0.641, 3.122] 0.77 0.4387 0.0009
Embryo rank / ICSI A: Yes versus No –0.5418 0.154 0.5817 [0.429, 0.785] –3.52 0.0004 0.0045
Embryo rank / ICSI B: Yes versus No 0.0843 0.178 1.0879 [0.767, 1.544] 0.47 0.6363 0.0045
Embryo rank / ICSI C/D: Yes versus No –0.0912 0.336 0.9128 [0.476, 1.784] –0.27 0.7858 0.0045
Patient age (years) Per year: A –0.0973 0.016 0.9073 [0.879, 0.936] –6.09 <0.0001 <0.0001
Patient age (years) / embryo rank Per year: B versus A 0.0599 0.022 1.0618 [1.017, 1.109] 2.72 0.0065 0.0308
Patient age (years) / embryo rank Per year: C versus A 0.0400 0.034 1.0408 [0.972, 1.112] 1.17 0.2413 0.0308
Patient age (years) / embryo rank Per year: D versus A 0.1779 0.147 1.1947 [0.908, 1.689] 1.21 0.2264 0.0308
Clexane Yes versus No –0.2447 0.143 0.7829 [0.591, 1.036] –1.71 0.0872 0.0865
Patient type Oocyte recipient versus standard 1.2572 0.299 3.5155 [1.965, 6.349] 4.21 <0.0001 <0.0001
Gonadotrophin dosing days Per day 0.0783 0.024 1.0815 [1.031, 1.135] 3.21 0.0013 0.0012
z-statistic is the test statistic for a Wald test of the significance of the OR for the corresponding comparison. The LRT tests the significance of the variable across the multiple 
categories, where applicable.
CI = confidence interval; ICSI = intracytoplasmic sperm injection; LRT = likelihood ratio test; OR = odds ratio; SE = standard error.
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(P < 0.0001). FIGURE 2 shows the ROC 
curves for the models without covariates. 
Across all possible thresholds, the 
embryo rank model showed better true 
positive and true negative rates and had 
a higher AUC of 62.86% compared with 
54.02% for the transfer grade model.
Standard patients (non-oocyte 
recipient) only
Of the 1373 cycles for standard patients 
included in the analysis, 679 (49.5%) 
resulted in live births. These were 441 
(60.9%) for transfers with an embryo 
rank of A, 197 (43.4%) for B, 39 (24.1%) 
for C and 2 (6.1%) for D. In terms of 
transfer grades: 78 (49.4%) for transfers 
with a transfer grade of 1:1, 83 (50.6%) 
for 1:2, 30 (60%) for 2:1, 446 (53.3%) for 
2:2, 33 (28.9%) for 2:3, 3 (15%) for 3:2 
and 6 (20%) for 3:3.
The embryo rank model results are given 
in Supplementary Table 14, which provide 
strong evidence of an effect of embryo 
rank (LRT P-value <0.0001). Again, the 
effect sizes are presented as OR relative 
to a rank of A, which are the ratios of the 
odds of a live birth with an embryo of 
rank B, C or D to the odds of a live birth 
with an embryo of rank A. For example, 
the estimated OR for an embryo of rank 
C compared with A is 0.0314 with a 95% 
CI of 0.008–0.107, indicating that there is 
strong evidence (Wald P-value <0.0001) 
that embryos of rank C are less likely 
to result in a live birth than embryos of 
rank A. As the model contains both the 
main effect of embryo rank as well as 
interactions with this variable, the LRT 
for the embryo rank variable (presented 
in Supplementary Table 14) considers 
the effect of omitting the embryo rank 
variable having already dropped the 
embryo rank/day of transfer interaction 
and embryo rank/ICSI terms from the 
model.
The transfer grade model results are 
given in Supplementary Table 15, which 
provide strong evidence of an effect of 
transfer grade (LRT P-value <0.0001). 
The effect sizes are again presented 
as OR relative to a grade of 1:1, which 
are the ratios of the odds of a live birth 
with an embryo of rank 1:2, 2:1, 2:2, 
etc. to the odds of a live birth with an 
embryo of grade 1:1. For example, the 
estimated OR for an embryo of grade 3:2 
compared with 1:1 is 0.1619 with a 95% 
CI of 0.036–0.520, indicating that there 
is strong evidence (Wald P-value 0.0056) 
that embryos of grade 3:2 are less likely 
to result in a live birth than embryos of 
grade 1:1.
A Vuong non-nested test of the final 
models for standard patients showed 
strong evidence of the superiority of the 
embryo rank model (including covariates) 
compared with the transfer grade model 
(including covariates) (P = 0.0005). 
The ROC curves for the final models 
for standard patients only are provided 
in Supplementary Figure 1. Across all 
possible thresholds, the embryo rank 
model showed better true positive and 
true negative rates and had a higher AUC 
TABLE 2 ESTIMATED COEFFICIENTS AND OR (95% CI) FOR THE LIVE BIRTHS OUTCOME TRANSFER GRADE MODEL




– (Intercept) –7.4540 3.001 0.0006 [0.000, 0.201] –2.48 0.0130 –
Total previous cycles Per cycle –0.0609 0.049 0.9410 [0.854, 1.035] –1.24 0.2155 0.2136
Clexane® Yes versus No –0.2636 0.146 0.7682 [0.576, 1.023] –1.80 0.0717 0.0713
Patient type Oocyte recipient versus 
standard
7.9506 5.879 >1000 [0.032, >1000] 1.35 0.1762 0.1716
Transfer grade 1:2 versus 1:1 –0.1627 0.312 0.8499 [0.460, 1.569] –0.52 0.6024 <0.0001
Transfer grade 2:1 versus 1:1 0.0373 0.448 1.0381 [0.435, 2.551] 0.08 0.9335 <0.0001
Transfer grade 2:2 versus 1:1 –0.4512 0.239 0.6368 [0.397, 1.014] –1.89 0.0588 <0.0001
Transfer grade 2:3 versus 1:1 –0.4798 0.384 0.6189 [0.289, 1.312] –1.25 0.2118 <0.0001
Transfer grade 3:2 versus 1:1 –1.2886 0.579 0.2757 [0.081, 0.811] –2.22 0.0261 <0.0001
Transfer grade 3:3 versus 1:1 –0.9500 0.561 0.3867 [0.123, 1.131] –1.69 0.0903 <0.0001
Transfer grade / ICSI 1:1: Yes versus No –0.3666 0.289 0.6931 [0.392, 1.220] –1.27 0.2049 0.0463
Transfer grade / ICSI 1:2: Yes versus No –0.2604 0.289 0.7707 [0.436, 1.356] –0.90 0.3677 0.0463
Transfer grade / ICSI 2:1: Yes versus No –0.4667 0.493 0.6271 [0.234, 1.638] –0.95 0.3442 0.0463
Transfer grade / ICSI 2:2: Yes versus No 0.1358 0.136 1.1455 [0.878, 1.495] 1.00 0.3176 0.0463
Transfer grade / ICSI 2:3/3:2/3:3: Yes versus No –0.9570 0.361 0.3840 [0.189, 0.782] –2.65 0.0080 0.0463
Gonadotrophin dosing days Per day 0.0846 0.025 1.0883 [1.037, 1.143] 3.42 0.0006 0.0006
Patient age (years) Per year: standard 0.5244 0.181 1.6894 [1.188, 2.421] 2.90 0.0037 <0.0001
Patient age (years) / patient type Per year: oocyte recipient 
versus standard
–0.4733 0.314 0.6230 [0.332, 1.145] –1.51 0.1314 0.1151
Patient age (years) – quadratic Per year^2: standard –0.0092 0.003 0.9908 [0.985, 0.996] –3.38 0.0007 0.0041
Patient age (years) – quadratic / patient type Per year^2: oocyte recipient 
versus standard
0.0080 0.004 1.0080 [1.000, 1.017] 1.89 0.0582 0.0561
z-statistic is the test statistic for a Wald test of the significance of the OR for the corresponding comparison. The LRT tests the significance of the variable across the multiple 
categories, where applicable.
CI = confidence interval; ICSI = intracytoplasmic sperm injection; LRT = likelihood ratio test; OR = odds ratio; SE = standard error.
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of 68.86% compared with 63.73% for the 
transfer grade model.
Excluding all covariates, similar but overall 
weaker performing results were obtained. 
A Vuong non-nested test of the models 
without covariates for standard patients 
showed strong evidence of the superiority 
of the embryo rank model compared with 
the transfer grade model (P = 0.0016). 
The ROC curves for the models for 
standard patients without covariates are 
shown in Supplementary Figure 2. Across 
all possible thresholds, the embryo rank 
model showed better true positive and 
true negative rates and had a higher AUC 
of 64.32% compared with 55.52% for the 
transfer grade model.
Oocyte recipients
Of the 437 oocyte recipient cycles, 215 
(49.2%) resulted in live births. These 
were: 148 (54.4%) for transfers with an 
embryo rank of A, 56 (49.1%) for B, 11 
(23.9%) for C and 0 for D. In terms of 
transfer grades: 32 (66.7%) for transfers 
with a transfer grade of 1:1, 31 (52.5%) for 
1:2, 13 (48.1%) for 2:1, 122 (47.3%) for 2:2, 
14 (40%) for 2:3, 2 (25%) for 3:2 and 1 
(50%) for 33.
Excluding all covariates, a Vuong non-
nested test of the models for oocyte 
recipient patients showed weak evidence 
of the superiority of the embryo rank 
model compared with the transfer 
grade model when corrected for the 
number of coefficients included in the 
models (P = 0.1459). The ROC curves 
for the models for oocyte recipient 
patients without covariates are shown 
in Supplementary Figure 3. At the lower 
probability thresholds (towards the 
right-hand side of the figure), the embryo 
rank model showed better true positive 
and true negative rates and had a higher 
overall AUC of 56.70% compared with 
53.13% for the transfer grade model.
DISCUSSION
This is the first study to compare an 
objective TLIA to conventional, subjective 
morphology assessment, and using live 
birth as the endpoint incorporating a 
comprehensive array of potential clinical 
confounders. Comprehensive statistical 
analysis reveals the superior selection 
power of the TLIA over the conventional 
blastocyst morphology scoring system 
(Gardner et al., 2000). However, the study 
confirmed that the Gardner blastocyst 
morphology assessment is in itself a useful 
discriminator for live birth potential – even 
though weaker than the TLIA model. 
An earlier study (Armstrong et al., 2015) 
on TLIA ranking of embryos for their 
propensity for live birth also indicated 
the value of conventional morphology for 
live birth assessment, but highlighted the 
variability and flawed reliance solely on the 
top-ranking grades. In a more recent study 



















Embryo Rank (AUC = 67.43%)
Transfer Grade (AUC = 61.74%)
FIGURE 1 Receiver operating characteristic (ROC) curves (and associated areas under the curve [AUC]) showing the discriminative performance 
between cycles with and without live births for the embryo rank and transfer grade predictive models (including covariates) for all patients. 
Generalization error is estimated via internal bootstrap cross-validation with the grey lines showing the out-of-sample performance estimated 
across 1000 bootstrap samples and the black and red lines the average estimates, respectively.
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2018) blastocyst grade 2:2 morphology 
appeared to have the highest selective 
value. Embryos, especially blastocysts, 
are known to have highly dynamic, 
morphologically changing profiles that 
may vary within a short time-frame, but 
up to now single microscopic assessment 
has been the best system available. 
Selecting an embryo on its morphological 
appearance at a single, short time point in 
a 24 h period gives only a snapshot that 
may change from, for example, a 2:2 to a 
1:1 score, within an hour of assessment, 
notwithstanding the subjective view of 
the embryologist at all times. Time-lapse 
imaging, even without an algorithm 
based on morphokinetics, simply using 
video toggling through its morphological 
vicissitudes, demonstrates this temporal 
variability and, hence, the vagary of clinical 
dependence.
The data in this study provide evidence 
of time-lapse imaging embryo rank 
enabling greater discrimination between 
cycles with and without live births 
compared with using conventional 
transfer grade (morphology) assessment. 
This is evident when the predictive 
performance of embryo rank and transfer 
grade are considered in isolation, but 
more importantly, when adjusting for 
available covariates related to treatment 
and patient histories.
Patient type, i.e. standard or oocyte 
recipients, was controlled for in the 
analysis adjusting for covariates; this 
has been an important omission in 
some recent publications and one of 
the drawbacks to acquiring any positive 
support for TLIA in a recent Cochrane 
Review (Armstrong et al., 2018). As 
an additional sensitivity analysis, the 
assessments were also compared across 
cycles stratified by patient type (standard 
or oocyte recipient patients). The results 
for both standard and oocyte recipient 
patients were consistent with the main 
analysis, i.e. embryo rank provided 
greater discrimination between cycles 
with and without live births than embryo 
morphology assessment.
Since IVF gained acceptance as a 
clinical service in the 1980s, and with 
the introduction of ovarian stimulation 
and the resultant multiple embryos, 
finding discriminators of embryo viability 
became more important (Brison et al., 
2004; Edwards et al., 1984; Fishel et al. 
1983; Fragouli et al., 2010; Katz-Jaffe 
et al., 2009; Seli et al., 2008). But 
attempts to ensure the highest chance 
of a pregnancy resulted (and in many 
clinics still does) in the transfer of 
multiple embryos with the negative 
consequence of high-order multiple 
pregnancies. Since the 1980s it has 
been appreciated that not all embryos 
have the same potential for live birth; 



















Embryo Rank (AUC = 62.86%)
Transfer Grade (AUC = 54.02%)
FIGURE 2 ROC curves (and associated AUC) showing the discriminative performance between cycles with and without live births for the embryo 
rank and transfer grade predictive models (excluding covariates) for all patients. Generalization error is estimated via internal bootstrap cross-
validation with the grey lines showing the out-of-sample performance estimated across 1000 bootstrap samples and the black and grey lines the 
average estimates, respectively.
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aneuploidy was first recognized by 
Angel et al. (1986,1983) and it was well 
established that the implantation and 
live births were materially lower than the 
number of embryos transferred to the 
same uterus. Great strides have been 
made over the last decade to maintain 
or even improve live birth rates by using 
only a single blastocyst transfer and 
various selection tools. However, still the 
most widely used selection protocol is 
a subjective, single point morphological 
assessment of the embryo before 
transfer. More recently, the introduction 
of time-lapse imaging has been 
importantly instructive; objectively 
demonstrating a high incidence 
of morphological dysmorphism 
during cleavage, concomitant with 
reduced implantation and live births, 
providing sophisticated morphokinetic 
computations as a prognosticator for 
embryo viability (Campbell and Fishel, 
2015; Lagalla et al., 2016; Pribenszky 
et al., 2017; Reignier et al., 2018; Viñals 
Gonzalez et al., 2018; Zhan et al., 2016), 
and introducing machine learning to 
evolve independent selective algorithms 
for automated programming (Kohsravi 
et al., 2019; Tran et al., 2019).
The future for IVF is to continue to 
improve live birth rates while eliminating 
the risk of multiple pregnancy, and while 
all protocols and technical procedures 
can be optimized the immutable fact 
of human procreation – that only a 
proportion of embryos have the capacity 
to make a baby, however conceived 
– will ensure the continued drive in 
IVF clinics to discover and automate 
powerful tools for predicting embryo 
viability. This study not only indicates 
that TLIA is an appropriate step in 
that direction, it is also indicative that 
TLIA is unlikely to be binary, as would 
be an accurate assessment of ploidy, 
for example; hence TLIA will rarely be 
used to rule out embryo transfer or 
reduce unnecessary cryopreservation 
of embryos, as would the knowledge 
that the embryo is aneuploid, but will 
act as an objective hierarchical ranking 
system that should reduce the time to 
live birth. Several studies have tried to 
link TLIA to embryo ploidy, with mixed 
uncertain correlation (Campbell et al., 
2013b; Minasi et al., 2016; Rienzi et al., 
2015; Zhang et al., 2017), and although 
it may show cleavage anomaly in gross 
aneuploid embryos it is unlikely to be 
successful in discriminating subtle, but 
devastating, single trisomy.
Some of the OR estimated in this study 
have rather wide CI that contain 1, 
which means in these cases a strong 
conclusion cannot be reached about the 
size or direction of the effect in question. 
Collecting more data to increase the 
sample size would tend to reduce the 
width of the CI, so may help to establish 
whether the estimated effect is real.
By including in the models all the 
covariates that are available (and that 
the data supports), an attempt has been 
made to account for imbalances between 
the embryo rank groups or transfer 
grade groups. However, it is not possible 
to account for any differences not 
contained within the available data, so 
it is also impossible to guarantee that all 
confounding effects have been eliminated 
(e.g. factors that predispose a patient to 
both having a particular embryo rank or 
transfer grade and to having a successful 
outcome). As such, this study cannot be 
used to draw strong conclusions about 
causal links between embryo rank or 
transfer grade and birth outcomes. In 
general, a randomized controlled study 
is required in order to draw strong 
conclusions about causality, but the 
undertaking of a prospective, randomized 
controlled trial using morphology or 
TLIA as the only selection option in 
enough patients that can be controlled 
for all clinical confounders will remain a 
challenge.
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ARTICLE
Time-lapse imaging algorithms rank human 
preimplantation embryos according to the 
probability of live birth
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ABSTRACT
Research question: Can blastocysts leading to live births be ranked according to morphokinetic-based algorithms?
Design: Retrospective analysis of 781 single blastocyst embryo transfers, including all patient clinical factors that might be potential 
confounders for the primary outcome measure of live birth, was weighed using separate multi-variable logistic regression models.
Results: There was strong evidence of effect of embryo rank on odds of live birth. Embryos were classified A, B, C or D according to 
calculated variables; time to start (tSB) and duration (dB{tB – tSB}) of blastulation. Embryos of rank D were less likely to result in live  
birth than embryos of rank A (odds ratio [OR] 0.3046; 95% confidence interval [CI] 0.129, 0.660; P < 0.005). Embryos ranked B were  
less likely to result in live birth than those ranked A (OR 0.7114; 95% Cl 0.505, 1.001; P < 0.01), and embryos ranked C were less likely 
to result in live birth than those ranked A (OR 0.6501, 95% Cl 0.373, 1.118; P < 0.01). Overall, the LRT (Likelihood Ratio Test) p-value for 
embryo rank shows that there is strong evidence that embryo rank is informative as a whole in discriminating between live birth and no live 
birth outcomes (p = 0.0101). The incidence of live birth was 52.5% from rank A, 39.2% from rank B, 31.4% from rank C and 13.2% from 
rank D.
Conclusions: Time-lapse imaging morphokinetic-based algorithms for blastocysts can provide objective hierarchical ranking of embryos for 
predicting live birth and may have greater discriminating power than conventional blastocyst morphology assessment.
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This retrospective study demonstrated for the first time that human blastocyst embryos can be objectively ranked according to their propensity 
to produce a live birth using an in-house derived morphokinetic-based algorithm from time-lapse imaging. This appears to have greater 
discriminating power than subjective, conventional morphology assessment.
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INTRODUCTION
A ssessment of the value of time-lapse imaging (TLI) following its recent introduction into clinical 
IVF practice (Cruz et al., 2011; 
Pribenszky et al., 2010; Wong et al., 
2010) has largely centred on the 
incidence of pregnancy in comparison 
to conventional culture (Rubio et al., 
2014; Wu et al. 2016). Some studies 
have tried to evaluate algorithms 
predictive of blastulation (Cruz 
et al., 2012; Dal Canto et al., 2012; 
Hashimoto et al., 2016; Herrero et al., 
2013; Kirkegaard et al., 2014; Milewski 
et al., 2015; Motato et al., 2016), and 
others have searched for algorithms 
predictive of euploidy or aneuploidy 
(Campbell et al., 2013a,b; Del Carmen 
et al., 2017; Franasiak et al., 2014; 
Kramer et al., 2014; Lagalla et al., 
2017; Minasi et al., 2016; Mumusoglu 
et al., 2017; Rienzi et al., 2015). Of late, 
there have been several reviews  
looking at the use of TLI in all these 
domains (Armstrong et al., 2015; 
Milewski and Ajduk, 2017; Polanski 
et al., 2014; Pribenzsky et al., 2017; 
Racowsky et al. 2015). A large 
retrospective analysis of live births 
comparing TLI to conventional culture 
was recently published, concluding 
that the former can improve the 
incidence of live births by 19% in this 
system (Fishel et al., 2017). There are 
conflicting views on the value of TLI for 
improving IVF outcome, which in part 
is due to what has been  
measured; for instance, assessing TLI 
outcome solely while treating  
the embryo as an independent factor 
(see Kirkegaard et al., 2016); or 
comparing TLI algorithms to  
using a time-lapse incubator as a  
closed incubation system only,  
without considering any algorithms 
(Rubio et al., 2014). Furthermore, 
different days of embryo transfer 
and different culture systems (Ciray 
et al., 2012), and different embryo 
phenotypes (Athayde Wirka et al., 
2014) have been used. Few  
studies have focused on live birth 
outcome.
In this retrospective analysis, treatment 
outcome using single embryo transfer 
at the blastocyst stage was examined; 
all embryos were cultured in the same 
TLI device with an identical culture 
system. All potentially confounding 
clinical factors were evaluated, and  
an assessment was done of  
whether embryos could be objectively 
and successfully ranked for their 
potential to result in a live birth based 
on a simple TLI algorithm.  
The relevance of conventional 
blastocyst morphology in comparison 
to using the TLI algorithm was also 
tested.
MATERIALS AND METHODS
This multicentre study included 843 
transfers for 781 unique patients 
attending CARE fertility centres 
from January 2013 to December 
2015, at CARE Nottingham, CARE 
Northampton, CARE Manchester, 
CARE Sheffield, Beacon CARE Fertility 
Dublin and CARE London. All embryos 
were cultured in the EmbryoScope 
(Vitrolife, Sweden). Only embryos at 
the blastocyst stage were assessed, 
both using conventional morphological 
criteria and the TLI algorithm. All 
protocols for patient treatments 
complied with UK regulation (Human 
Fertilization and Embryology Act, 
1990, 2008) and all UK facilities 
are regularly inspected by the 
Human Fertilization and Embryology 
Authority (HFEA), which includes 
the use of TLI. The retrospective 
analysis of the use of TLI algorithms 
for embryo selection did not require 
ethical or Institutional Review Board 
(IRB) approval, as confirmed by the 
chair of the IRB on 13 January 2017, 
having been performed according 
to previously validated procedures, 
and practised under licence from 
the HFEA. All patients were fully 
counselled and gave their signed 
consent. TLI was undertaken using the 
EmbryoScope with strict adherence 
to annotation protocols. All embryos 
were selected for transfer based on 
their in-house-derived TLI algorithm 
rank for transfer; standard morphology 
of the selected embryos was also 
recorded in the conventional manner 
at embryo transfer. The primary end-
point of this study was a live birth 
event, i.e. the number of patients 
achieving a delivery of a live birth for 
each embryo transfer. Only ‘fresh’ 
single embryo transfer cases were 
included, and all preimplantation 
genetic testing cases were  
excluded.
The following clinical variables 
were categorized for inclusion in 
the analysis: patient age, day of 
embryo transfer, number of embryos 
transferred, donor age (where 
applicable), body mass index (BMI), 
anti-Müllerian hormone (AMH), antral 
follicle count (AFC), gonadotrophin 
type, gonadotrophin dosing days 
and gonadotrophin total dose. The 
groupings applied are presented for 
each variable in TABLE 1. Patient age 
was considered as a binary variable 
in the modelling (<38 and 38+), 
corresponding to the common 
grouping used by HFEA, which is 
familiar to patients. The groupings for 
categorizing BMI, AMH and AFC were 
chosen to correspond with clinically 
meaningful categories, i.e. to reflect 
what might be considered to be above, 
below or within a normal/healthy range. 
The oocyte provider ages (<29, 29–32 
and 33+), gonadotrophin dosing days 
and the total dose were categorized 
based on the quantiles of the observed 
distribution to ensure that sufficient 
information was present in each of the 
categories for a robust analysis.
The following definitions were used for 
the BMI, AMH and AFC categories, relat-
ing to the data presented:
•	 	BMI:	<18.5	(underweight),	18.5–<25	
(healthy weight), 25–<30 (overweight), 
30–<40 (obese), 40+ (extremely 
obese).
•	 	AMH	(pmol/l):	<6	(low),	6–<24	
(normal), 24–<70 (high), 70+ (very 
high).
•	 	AFC:	<4	(extremely	low),	4–<10	
(low), 10–<14 (somewhat low), 14–<22 




Pituitary suppression for ovarian 
stimulation was performed either with 
gonadotrophin-releasing hormone 
agonist (Suprecur; 0.5 ml subcutaneously 
daily; Sanofi Aventis, UK) or antagonist 
(Cetrotide; 0.25 mg daily; Merck 
Serono, UK), and ovarian stimulation 
was achieved using human menopausal 
gonadotrophin (Menopur; Ferring, UK) 
and/or recombinant FSH (Gonal-F; 
Merck Serono), as previously described 
(Campbell et al., 2013b; Fishel et al., 
2016).
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TABLE 1 VARIABLES OFFERED TO THE MODELS DURING THE STEPWISE SELECTION PROCEDURE. FOR EACH OUTCOME 
RESPECTIVELY, THOSE MARKED Y WERE INCLUDED IN THE FINAL MODEL
Variable Included in live  
births model?
Included in  
implantation model?
Included in clinical  
miscarriage model?
Patient age (years) Y Y Y
Embryo rank (A/B/C/D) Y Y N
Total previous cycles Y Y Y
Total previous miscarriages N N Y
Aspirin (Y/N) N N N
Intralipids (Y/N) N N N
Clexane (Y/N) N N N
Prednisolone (Y/N) N N N
BMI N N N
Day 2 FSH N N N
AMH N N N
AFC N N N
Gonadotrophin type Y Y N
Maximum endometrial thickness (mm) N Y N
Ethnicity N N N
Duration of infertility (years) N N N
Gonadotrophin total dose N N N
Gonadotrophin dosing days N N N
MTHFR (Y/N) N N Y
Catheter used N N N
HCG name N N N
Eggs collected N N N
Mature eggs inseminated N Y N
Mature eggs inseminated out of eggs collected ratio N N N
Transfer grade/morphology Y Y N
Patient type (oocyte recipient/standard) Y Y Y
Donor age (years) N N N
Gonadotrophin total dose (IU) N Y N
Oocyte recipient/patient age interaction N N N
Embryo rank/patient age interaction N N N
Embryo rank/oocyte recipient interaction N N N
Embryo rank/donor age interaction  
(where applicable)
N N N
Embryo rank/day of embryo transfer interaction N N N
Embryo rank/patient age/oocyte recipient interaction N N N
Embryo rank/transfer grade interaction N Y N
Embryo rank/transfer stage interaction N N N
Embryo rank/day of embryo transfer and transfer grade 
interaction
N N N
Embryo rank/day of embryo transfer and transfer stage inter-
action
N N N
AFC = antral follicle count; AMH = anti-Müllerian hormone; BMI = body mass index; HCG = human chorionic gonadotrophin.





Female sedation was achieved with 
a combination of propofol (Braun, 
Germany), fentanyl (Auden McKenzie, 
UK) and midazolam (Hamelyn, UK), and 
transvaginal ultrasound-guided oocyte 
retrieval	took	place	approximately	36 h	
post human chorionic gonadotrophin 
injection (10,000 IU; Pregnyl; Organon, 
UK; or Ovitrelle; Merck Serono) 
or agonist trigger (Buserelin 0.5 ml 
subcutaneous; Suprefact, Sanofi SA, 
France), using an aspiration needle 
(Vitrolife, Sweden) connected to a 
vacuum pump (Rocket Medical, UK). 
Oocyte–cumulus complexes were 
recovered from follicular aspirates 
using a stereomicroscope in a class 
II hood with a heated stage, washed 
and cultured in Ferticult IVF medium 
(Fertipro, Belgium) at 5% CO2 in 
air, 37.0°C, and maximum humidity, 
in standard small volume box or 
flatbed incubators (Galaxy 48R, New 
Brunswick, UK; Miri, ESCO, Japan).
Oocytes allocated for intracytoplasmic 
sperm injection (ICSI) were cultured for 
2–4 h before cumulus cell denudation 
with 15–20 IU/ml cumulase (Origio, 
Denmark) in the same medium and 
complete removal of the coronae 
radiatae with a 140 µm pipette (EZ 
Squeeze; Research Instruments, UK). 
Oocytes at the metaphase II stage 
underwent insemination by ICSI within 
2 h of denudation, following which 
they were placed in the EmbryoScope. 
Oocytes allocated for IVF were 
inseminated following sperm preparation 
using SupraSperm density gradient 
(Origio, Denmark) and washing in 
Ferticult IVF medium (Fertipro) at a 
concentration of 0.2 mmol/l, between 3 
and	6 h	post	oocyte	recovery.	Culture	
was performed in standard incubators for 
18 ± 1 h before fertilization was assessed. 
The sperm preparation method was the 
same for IVF and ICSI.
EMBRYO CULTURE AND 
INCUBATION
For TLI, following ICSI or IVF, oocytes 
or zygotes, respectively, were placed 
individually in microwells of EmbryoSlides 
(Vitrolife, Sweden) in 25 µl Global IVF 
medium (LifeGlobal) supplemented with 
10% dextran serum supplement (Irvine 
Scientific); the wells were overlaid with 
1.4 ml mineral oil (Fertipro, Belgium) and 
the slides were placed in the EmbryoScope 
at 37.0°C in 5.5% CO2, 5% O2 and 
89.5% N2	for	up	to	6 days.	EmbryoSlides	
were prepared with medium and oil that 
had equilibrated overnight. The built-in 
microscope was used to acquire images 
of each fertilized oocyte every 10–20 min 
through seven focal planes.
Selection of the embryos was based 
on time-lapse algorithm ranking (A to 
D) and morphological assessment was 
recorded for all transferred blastocysts 
using a scoring system modified from 
the Gardner and Schoolcraft (1999) 
annotation of trophectoderm and inner 
cell mass morphology where scores AA/
AB/BA, etc. were replaced by numbers: 
1:1/1:2/2:1, etc., as per the Istanbul 
consensus recommendation (The 
Istanbul Consensus, 2011).
EVALUATION OF TIME-LAPSE 
IMAGES
Time-lapse images were collected for 
the duration of the culture period, 
until embryo transfer. The images were 
used for the assessment of fertilization 
following ICSI and in vitro embryo 
development. For ICSI, the time of 
insemination was programmed into the 
EmbryoScope as the time-point midway 
through the ICSI procedure. For IVF, 
the time of insemination was recorded 
as the time spermatozoa were added to 
the oocytes. Because of the difference 
in timing of sperm penetration in ICSI 
versus IVF, the designation of time post 
insemination (hpi) was based on pronuclei 
fading (PNf) after carefully controlled 
annotation. For ICSI, the mean time was 
23.23 ± 3.7 h (n = 2547 zygotes); for IVF, 
the	mean	was	25.18 ± 3.6 h	(n = 785). 
Hence ICSI zygote PNf occurred on 
average 1.95 h before IVF embryos. This 
difference in the modelling is accounted 
for as described below.
The EmbryoViewer image analysis 
software (Vitrolife) was used to log 
and display the precise timing of 
developmental events as they were 
annotated by the embryologists 
studying the time-lapse images. The 
morphokinetic variables of interest 
have been described in detail 
previously (Campbell et al., 2013a, 
2013b; Fishel et al. 2017). All times 
were recorded in hpi. Following 
implementation of an in-house-derived 
time-lapse algorithm to rank embryos 
according to likelihood of live birth, 
the algorithm was used prospectively 
for selection of blastocysts for 
transfer. For this study, blastocyst 
ranking depended upon annotating 
for the relative time to the start of 
blastulation (rtSB) and the duration 
of blastulation (dB), with the following 
weighting: rank A = rtSB ≤ 93.1 h; 
B: rtSB > 93.1 h, dB ≤ 12.5 h; C: 
rtSB > 93.1 h, dB > 12.5 h. D was 
scored for those embryos in which 
the start of blastulation could not 
be annotated; this may occur due to 
obscuring fragmentation, presence 
of multiple fluid-filled vacuoles, or 
anomalous kinetics. As the algorithm's 
morphokinetic variable, tSB, is based 
on time from insemination, and as we 
observed a 1.95 h delay for IVF  
embryo development (unpublished 
data) compared with ICSI, the 
algorithm was adjusted for IVF  
embryos as follows in order to 
generate the ranking (A–D): 
RelSBIVF = tSB – 1.95 h.
EMBRYOLOGY ANNOTATION 
PROTOCOLS AND QUALITY 
CONTROL
Following training in annotation and 
competency assessment, CARE 
embryologists participate in regular 
quality assurance (QA) exercises and use 
a centralized annotation QA protocol 
whereby example embryos are annotated 
by each practitioner and their values are 
compared with those of their colleagues. 
Intra correlation coefficients (ICC) 
are calculated for each morphokinetic 
value. Annotation quality is considered 
assured where the ICC is greater than 
0.9, demonstrating close correlation 
between practitioners, and competency 
in annotation.
EMBRYO SELECTION AND 
TRANSFER
Following TLI, embryos were objectively 
selected using user-defined time-
lapse algorithms programmed into 
the ‘Compare and Select’ software 
as described above. All embryos 
were annotated before decision on 
transfer. Rank A was given the highest 
priority while rank D had the lowest. 
Morphology was scored at the time of 
transfer, but for decision on transfer, 
morphology was considered only 
secondary to the morphokinetic 
algorithm.
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Embryo transfer was performed using a 
Wallace (UK) embryo transfer catheter 
under ultrasound guidance.
STATISTICS
The primary outcome measurement was 
live birth, i.e. the delivery of one or more 
babies; and the secondary outcome was 
the incidence of miscarriage (including 
HCG-determined implantation which 
did not result in a clinical pregnancy 
and clinical loss, defined as a loss of 
pregnancy following fetal heart detection 
on ultrasound). Separate multi-variable 
logistic regression models were fitted to the 
study data in order to assess the effects of 
embryo rank on each outcome of interest. 
A logistic regression analysis models the 
probability of the binary outcome as 
a function of the supplied explanatory 
variables. To explicitly control for differences 
in the patient populations between the 
embryo rank groups, potential confounding 
variables from the available clinical data 
were also considered as other explanatory 
variables in the models.
To choose which of the available variables 
to include as covariates in each model, 
a forward–backward stepwise variable 
selection procedure was performed. This 
procedure started with an initial model 
that included just an intercept term and 
new explanatory variables were added (and 
removed) one at a time to look for the 
model that has the best value of the Akaike 
information criterion (AIC) – a measure of 
model fit that has a penalty for the number 
of parameters in the model. TABLE 1 shows 
the variables made available to the variable 
selection procedure and those that were 
selected to be in the final model for each 
outcome.
A number of interactions (‘effect 
modifications’) were made available to 
the variable selection procedure. An 
interaction allows the level of one or more 
variables to change the effect of another 
variable. Any combination of variables 
may interact with each other, resulting 
in an enormous number of potential 
interactions. To make the variable 
selection and model fitting practicable, the 
interactions were limited to the following:
•	 	Patient	age	with	an	indicator	for	
whether the patient was an oocyte re-
cipient, to allow for the possibility that 
the patient's age is less (or even more) 
important when they have received an 
egg donation.
•	 	Embryo	rank	with	each	of	patient	age,	
oocyte recipient indicator, donor age 
(where applicable), day of embryo 
transfer, transfer grade and transfer 
stage (number of cells) and day of em-
bryo transfer and morphology. These 
interactions were included to allow 
for the possibility that the sizes and 
directions of the embryo rank effects 
vary for different groups of patients.
•	 	A	three-way	interaction	between	em-
bryo rank, oocyte recipient status and 
patient age was also made available. 
This was included because the corre-
sponding two-way interaction without 
embryo rank was being included. 
Importantly, these interactions were 
included to allow for the possibility 
that the size and direction of the 
embryo rank effects vary for different 
groups of patients.
Fitted final models were used to provide 
estimates of the directions and sizes 
of the effects of interest (presented as 
odds ratios [OR] which describe the 
relative difference in the odds of a live 
birth or clinical miscarriage between 
different treatment cycles) for each 
outcome (TABLE 2). The estimated 
effect sizes are accompanied by profile 
likelihood confidence intervals (CI), 
which quantify the uncertainty in the 
estimates arising from the sample data. 
Likelihood ratio tests (LRT) are provided 
to assess the overall significance of each 
variable, across the multiple groups of a 
categorical variable. A LRT tests the null 
hypothesis that including the variable in 
question does not improve the model fit 
(as measured by the likelihood).
All analyses were performed using the 
statistical software package R version 3.3.1 
(R Core Team, 2016). The logist package 
was used to implement Firth's penalized 
maximum likelihood logistic regression 
method (Heinze and Ploner, 2016) when 
analysing clinical miscarriage.
RESULTS
A total of 843 single blastocyst transfers 
were examined for LB according 
to their TLI algorithm value of the 
transferred embryos. The mean ages 
of patients were 34.8 (n = 373), 35.4 
(n = 297), 34.8 (n = 93) and 37.1 
(n = 80) for embryos with algorithm 
ranks of A, B, C and D, respectively. 
An assessment of the value of a 
hierarchical ranking of embryos using 
all the available clinical data was 
undertaken, as shown in TABLE 1. A full 
data set was available for 781 transfers, 
included in a detailed analysis; 
summary statistics for each continuous 
or discrete variable were considered in 
the analysis versus embryo rank and are 
shown in TABLE 2. Of the 781 transfers, 




(52.5%) from transfers with an embryo 
ranked A, 107 (39.2%) from rank B, 27 
(31.4%) from rank C, and 9 (13.2%) 
from D-ranked embryos. There was 
strong evidence of an effect of embryo 
rank on the odds of live birth. Embryos 
of rank D were less likely to result in 
a live birth than embryos of rank A 
(OR	0.3046;	95%	CI	0.129,	0.660;	
P < 0.010), and similarly embryos of 
rank D were less likely to result in a 
live birth than embryos of rank B (OR 
0.428;	95%	CI	0.190,	0.963;	P < 0.01). 
Embryos ranked B were less likely to 
result in a live birth than those ranked 
A (OR 0.7114; 95% Cl 0.505, 1.001; 
P = 0.0101), and embryos ranked C 
were less likely to result in a live birth 
than	those	ranked	A	(OR	0.6501,	95%	
Cl 0.373, 1.118; P = 0.0101). Overall, 
the data provide strong evidence of an 
effect of embryo rank on the odds of 
live births (LRT p-value = 0.0101). There 
was no evidence of an independent 
effect of embryo rank on the odds of 
clinical miscarriage.
The role of morphology assessment was 
also examined; in the absence of TLI 
data, this would have been the primary 
factor in deciding which embryo to 
transfer. The highest incidence of live 
birth was achieved with blastocysts 
graded ‘2:2’ when compared with 
other morphology grades (FIGURE 1). 
The comparison showed that selecting 
for an embryo grade 2:2 for transfer is 
associated with an increase in the odds 
of a live birth compared with grades 
1:1/1:2/2:1	(OR	0.6795;	95%	Cl	0.485,	
0.988), or with grades 2:3/3:2/3:3; OR 
0.3181; 95% CI: 0.171, 0.573).
DISCUSSION
In summary, using the EmbryoScope for 
culture to the blastocyst stage, coupled 
with objective embryo selection criteria 
based on a morphokinetic algorithm, 
embryos can be successfully ranked 
based on their chance of achieving 
a live birth. An embryo rank of D is 
estimated	be	associated	with	a	69.5%	
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TABLE 2 SUMMARY STATISTICS FOR EACH CONTINUOUS OR DISCRETE VARIABLE CONSIDERED IN THE ANALYSIS  
VERSUS EMBRYO RANK. THE MEAN (AND SD = STANDARD DEVIATION) AND MEDIAN (AND RANGE), BY RANK
Variable Summary A (n = 354) B (n = 273) C (n = 86) D (n = 68) Total (n = 781)
Patient age (years) Mean (SD) 35.4 (5.11) 36.0	(4.96) 36.2	(5.13) 36.5	(5.20) 35.8 (5.07)
Patient age (years) Median (range) 35.0 (22–48) 35.0 (24–49) 36.0	(25–50) 36.5	(26–47) 35.0 (22–50)
Total previous cycles Mean (SD) 3.2 (2.02) 3.1	(1.62) 3.6	(2.52) 3.9 (2.42) 3.3 (2.00)
Total previous cycles Median (range) 2.0	(2–16) 2.0 (2–12) 3.0 (2–18) 3.0	(2–16) 2.0 (2–18)
Total previous  
miscarriages
Mean (SD) 0.3	(0.61) 0.3	(0.69) 0.4 (0.84) 0.4 (0.77) 0.3	(0.68)
Total previous  
miscarriages
Median (range) 0.0 (0–4) 0.0 (0–5) 0.0 (0–5) 0.0 (0–3) 0.0 (0–5)
Maximum endometrial thick-
ness (mm)
Mean (SD) 10.9	(2.60) 10.6	(2.28) 10.9	(2.62) 10.5	(2.16) 10.8	(2.46)
Maximum endometrial thick-
ness (mm)
Median (range) 10.6	(6–20) 10.2	(6–19) 10.2	(6–17.5) 10.5 (7–19.5) 10.4	(6–20)
Donor age (years) Mean (SD) 29.3 (3.98) 29.6	(3.78) 30.8 (3.75) 30.3 (4.38) 29.6	(3.92)
Donor age (years) Median (range) 30.0	(20–36) 30.0 (21–35) 31.0 (22–37) 29.0 (24–38) 30.0 (20–38)
Duration of infertility (years) Mean (SD) 3.3 (2.47) 3.0 (2.27) 2.9 (2.38) 3.6	(3.10) 3.2	(2.46)
Duration of infertility (years) Median (range) 3.0 (0–12) 3.0	(0–16) 2.0 (0–15) 3.0 (0–21) 3.0 (0–21)
Gonadotrophin total dose 
(IU)
Mean (SD) 2283.1 (981.18) 2294.3 (1112.53) 2439.2 (1075.45) 2862.5	(1199.18) 2356.2	(1069.58)
Gonadotrophin total dose 
(IU)
Median (range) 2250.0 (450–5400) 2250.0	(450–6000) 1800.0	(675–5400) 2700.0 (525–5400) 2250.0 (450–
6000)
Gonadotrophin dosing days Mean (SD) 10.2 (2.42) 9.8 (2.73) 10.3 (2.31) 10.6	(1.72) 10.1 (2.48)
Gonadotrophin dosing days Median (range) 12.0 (3–12) 10.0 (3–12) 12.0 (3–12) 10.5	(6–12) 10.0 (3–12)
Eggs collected Mean (SD) 12.2 (5.72) 11.2 (5.52) 9.8 (5.45) 7.2 (3.71) 11.1	(5.65)
Eggs collected Median (range) 11.0 (1–34) 11.0 (1–30) 9.0	(2–26) 7.0 (1–21) 10.0 (1–34)
Mature eggs inseminated Mean (SD) 9.8 (4.71) 9.2 (5.00) 8.1	(4.68) 5.3	(3.56) 9.0 (4.88)
Mature eggs inseminated Median (range) 9.0 (0–28) 9.0 (0–28) 7.0 (1–25) 4.5 (1–18) 8.0 (0–28)
Mature eggs inseminated  
out of eggs collected ratio
Mean (SD) 0.8 (0.17) 0.8 (0.19) 0.8 (0.18) 0.7 (0.24) 0.8 (0.19)
Mature eggs inseminated  
out of eggs collected ratio
Median (range) 0.9 (0–1) 0.9 (0–1) 0.9 (0.25–1) 0.8 (0.125–1) 0.9 (0–1)
Oocyte recipient patient  
age (years)
Mean (SD) 41.4 (4.01) 41.4 (4.74) 41.6	(5.61) 40.0 (5.41) 41.3 (4.55)
Oocyte recipient patient  
age (years)
Median (range) 42.5 (24–48) 42.0 (27–49) 44.0 (29–50) 40.5	(26–47) 42.0 (24–50)
Non-oocyte recipient  
patient age (years)
Mean (SD) 33.6	(3.88) 34.4 (3.72) 34.6	(3.78) 35.6	(4.79) 34.2 (3.94)
Non-oocyte recipient  
patient age (years)
Median (range) 34.0 (22–43) 34.0	(24–46) 35.0 (25–41) 35.5	(26–45) 34.0	(22–46)
decrease in the odds of a live birth 
compared with an embryo of rank A. 
The 95% CI for this comparison ranges 
from an 87.1% decrease to a 34.0% 
decrease in the odds. The analysis also 
highlighted the weakness of dependence 
on conventional morphology alone as a 
selection tool. For example, a grade 2:2 
blastocyst, which is the equivalent of the 
Gardner and Schoolcraft (1999) ranking 
BB, results in live birth at a significantly 
higher frequency than embryos graded 
1:1/1:2 or 2:1, which contradicts previous 
publications (Gardner and Schoolcraft, 
1999; Gardner et al., 2000; Istanbul 
Consensus, 2011). While TLI algorithms 
are objective and likely to achieve 
greater consistency in embryo selection, 
static morphology assessments remain 
subjective and prone to variability. 
Additionally, morphology grading is likely 
to reflect a limited number of single daily 
time-points when the grade is assigned, 
whereas TLI can provide photographs 
of the embryo at frequent intervals 
throughout culture; this in turn provides 
the opportunity to witness and evaluate 
changes in embryo morphology over time 
and therefore avoid the unreliability of a 
single-moment, subjective morphology 
grading. One of the limitations of most 
TLI studies is the comparison between 
TLI and conventional incubators for 
culturing embryos, irrespective of the use 
of algorithms; this type of comparison 
leaves open the question of whether 
uninterrupted incubation alone is an 
advantage, whether or not morphokinetics 
are considered for embryo selection. This 
study compares embryos cultured only in 
the EmbryoScope from Day 0 (ICSI) or 
Day 1 (IVF) up to Day 5 of development. 
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It also includes single blastocyst transfers 
only, to avoid any ambiguity of the effects 
of more than one embryo transferred. 
The results demonstrate the value of 
an objective algorithm for embryo 
selection. The main limitations of this 
study are, first, that the analysis was 
undertaken to validate the effectiveness 
of an in-house-derived algorithm and this 
algorithm may not produce similar results 
in other settings (Freour et al., 2015; 
Liu et al., 2016). Secondly, the efficacy 
of this ranking system remains to be 
demonstrated prospectively. Further, it is 
not possible to account for any clinical or 
physiological differences not contained 
within the available dataset and therefore 
this investigation may not have eliminated 
all confounding effects in this non-
randomized study.
TLI has been used in clinical practice 
for over 10 years (Hlinka et al., 2012; 
Lemmen et al., 2008) with several 
recent reviews (Armstrong et al., 2015; 
Chen et al., 2017; Kaser & Racowsky, 
2014; Polanski et al., 2014; Racowsky 
et al., 2015). Systematic reviews have 
either considered studies comparing 
TLI incubation to conventional 
incubation, or the overall impact of 
TLI as compared with conventional 
methods, or the potential effect of 
using morphokinetics for embryo 
selection. Van Loendersloot et al. 
(2014) applied a retrospective multi-
variable clinical pregnancy prediction 
model to rank embryos following 
Day 3 transfer, distinguishing those 
embryos with high, moderate or low 
implantation potential. Petersen et al. 
(2016)	also	used	a	morphokinetic	
algorithm for embryos transferred on 
Day 3 to predict blastulation based 
on data from 24 clinics over a 5-year 
period. However, apart from patient 
age, and whether IVF or ICSI was 
performed, embryos were treated as 
independent variables; there is concern 
regarding the validity of such studies 
because cohorts of embryos should 
not be considered independent. When 
associating embryological data with 
clinical outcome, all potential clinical 
confounders must be considered (Fishel 
et al., 2017; Kirkegaard et al., 2016).
Several studies have, however, reported 
on the use of TLI as a potential 
prognosticator in clinical practice 
(Adamson et al., 2016; Chen et al., 2016; 
Kong et al., 2016; Liu et al., 2016; Milewski 
et al., 2015; Mizobe et al., 2016; Rubio 
et al., 2014; VerMilyea et al., 2014; Wu et 
al., 2016; Yang et al., 2014). Other studies 
have disagreed (Freour et al., 2015; Wu 
et al., 2016). Given the complex nature of 
the effects of culture conditions and the 
milieu on preimplantation development, 
in addition to their inherent genetic 
and chromosomal complements, it is 
difficult to pinpoint any single feature 
that may directly impact outcome, 
especially because development of the 
implanting embryo to a live baby depends 
also on the maternal environment. A 
few studies have purported to relate 
discriminating morphokinetics of euploid 
and aneuploid embryos (Campbell 
et al., 2013a, 2013b; Minasi et al., 2016; 






































FIGURE 1 Model estimated odds ratios, comparing the occurrence of live birth between transfer grades. The bars indicate 95% confidence 
intervals.
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this has been disputed (Rienzi et al., 
2015). However, Bronet et al. (2015) 
even found distinctive morphokinetic 
differences between male and female 
embryos. More recently Mumusoglu et al. 
(2017), studying morphokinetics and the 
prediction of ploidy status when patient 
and ovarian stimulation–related factors 
were taken into account, concluded 
that aneuploid embryo development 
appears to be delayed at post-cleavage 
stages, but that the predictive ability 
was ‘low to moderate’. Of previously 
reported cut-off points for various TLM 
parameters, they only noted tSB within 
96.6 h	of	insemination	as	having	significant	
predictive ability (Campbell et al., 2014). 
Kong et al. (2016) reported a relationship 
between early cell division behaviour and 
developmental potential with elongation 
or shortening of the cell cycle affecting 
cell number. This study concluded that 
by excluding such embryos, the incidence 
of implantation and live birth following 
Day 3 transfer of embryos increased 
when cell number was maximal. Recently 
Ottolini et al. (2017), in an important 
study using TLI and genome-wide SNP 
genotyping and meiomapping of both 
polar bodies, analysed tripolar and other 
abnormal mitoses demonstrating that 
failure to coordinate the cell cycle in early 
cleavage and regulation of centrosome 
duplication is a major cause of human 
preimplantation developmental arrest 
in vitro.
Morphological evaluation of the 
embryos at specific time-points has 
been the method of choice for embryo 
selection for decades (Cummins 
et al., 1986; Fishel et al., 1983, 1983), 
although its limitations have later been 
recognized (Fehilly et al., 1985; Guerif 
et al., 2007; Hartshorne et al., 1991; 
Racowsky, 2009). Blastocysts also 
undergo a normal cycle of collapse 
and re-expansion and are often difficult 
to grade reliably. Although they can 
be reassessed at other time-points 
(The Istanbul Consensus, 2011), TLI 
highlights the transient nature of certain 
morphologies and thus a source of 
weakness of morphology-based grading 
as a prognosticator. A number of 
studies have found weak correlation 
between blastocyst morphology and 
chromosomal abnormalities, including 
those incompatible with post-
implantation development (Fragouli 
et al., 2010; Schoolcraft et al., 2010).
In the most recent meta-analysis on 
five randomized controlled trials using 
TLI algorithms, Pribenszky et al. (2017) 
reported a significantly higher incidence 
of ongoing clinical pregnancy and live 
birth, and a significantly lower incidence 
of early pregnancy loss following 
time-lapse incubation and algorithm-
based embryo selection compared 
with conventional culture with embryo 
selection based on single time-point 
morphology. The studies included a 
heterogeneous patient population, days 
of transfer, the way the visual information 
from the time-lapse devices was used 
to support embryo evaluation and 
end-points, and as such the quality of 
the evidence was deemed moderate to 
low owing to inconsistencies across the 
studies. Indeed, the studies in general 
did not include a comprehensive clinical 
confounder analysis. Motato et al. (2016) 
used the timing of expanded blastocyst 
formation (tEB) as the primary variable 
at ≤122.9 h and the synchronicity of the 
third round of cleavage divisions (s3 = 
t8 – t5) as the secondary variable setting 
the	optimal	range	of	≤5.67 h.	Motato 
et al. (2016) used these data to divide 
embryos into four categories (A–D), with 
a decreasing implantation potential (from 
72.2% for A to 39.7% for D). However, 
there are now many different algorithms 
of apparent efficacy, but in some 
laboratories advantages have not been 
proven, as comprehensively reviewed 
recently by Milewski and Ajduk (2017).
In conclusion, this study demonstrates 
the unique live birth capacity of 
individual blastocysts based on an 
algorithm that incorporates time to 
start and duration of blastulation. 
These parameters must be carefully 
annotated by embryologists, with 
tight quality control on annotation 
principles, and within a single 
culture system. This study further 
demonstrates the advantage of 
objective data, which can be 
revisited any time (as TLI images, for 
example) without embryo disruption, 
over the capricious and subjective 
morphological scoring at one or more 
discrete time-points. The study also 
highlights the need to ensure that 
analyses do not treat embryos as 
independent variables because this 
can lead to erroneous conclusions; it 
also argues in favour of inclusion of 
full clinical data in analyses of this type 
before drawing conclusions on clinical 
impact. The data importantly implicate 
a relatively simple algorithm to rank 
and therefore select embryos in clinical 
practice to improve the chance of a 
live birth. Although more high-quality 
evidence, such as large, well-controlled 
prospective randomized studies, are 
needed to definitively demonstrate 
the value of TLI, further research 
into other cellular processes such as 
chromosome segregation, cytoskeleton 
function and energy metabolism are 
required to reduce embryo wastage 
and unnecessary embryo transfers and 
cryopreservation and enable selection 
of only those embryos with the 
capacity to reach full term.
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6.0 Specific aim 5.  
To establish best laboratory practice for time lapse imaging, a) by engaging with the 
scientific community to develop and propose guidelines on the nomenclature and 
annotation of dynamic human embryo monitoring; and b) developing a resource for 
embryologists using time lapse imaging and c) to help develop international IVF laboratory 
performance indicators and IVF culture conditions in general. 
 
Encapsulated in this specific aim are four book chapters, the study proposing standard 
nomenclature and practice for time lapse imaging in human IVF, comprehensive standard 
operating procedures for a group of 11 UK IVF laboratories (CARE Fertility), a published Atlas 
of Time Lapse Embryology  and two consensus documents developing performance indicators 
and guidelines on IVF culture conditions. 
 
Alison Campbell. Time-lapse, the cell cycle, distribution of morphokinetic timings and known 
implantation data. Chapter 3, in Atlas of Time Lapse Embryology, CRC Press 2014 
 
Alison Campbell. Clinical aspects of time lapse embryology. Chapter 2, in Atlas of Time Lapse 
Embryology, CRC Press 2014 
 
Alison Campbell. Noninvasive techniques: Embryo selection by Time-lapse imaging. A 
practical guide to selecting gametes and embryos. Markus Montag (ed.). CRC Press, 2013 
 




Ahlström A, Campbell A, Ingerslev HJ, Kirkegaard K. Prediction of Embryo Viability by 
Morphokinetic Evaluation to Facilitate Single Transfer. In Screening the Single Euploid Embryo 
2015 (pp. 133-145). Springer, Cham. 
 
Ciray HN, Campbell A, Agerholm IE, Aguilar J, Chamayou S, Esbert M, Sayed S. Proposed 
guidelines on the nomenclature and annotation of dynamic human embryo monitoring by a 
time-lapse user group. Human Reproduction. 2014 Oct 24;29(12):2650-60. 
 
 Alison Campbell and Simon Fishel. Altas of Time Lapse Embryology. CRC Press, 2015. This 
book received a ‘Highly Commended’ award in the BMA Medical Book Awards 2016.  
 
ESHRE Special interest Group of Embryology, Alpha Scientists in Reproductive medicine. The 
Vienna Consensus: Report of an expert meeting on the development of ART laboratory 
performance indicators. 
 
There is only one thing that is truly important in an IVF lab: Everything. Cairo Consensus 
guidelines on IVF culture conditions. 2019 in press 
 
Here, my personal contributions were; 
• To author three book chapters pertaining to time lapse and morphokinetic embryo 
selection, and to co author another. 
• To assist in scoping the proposed guidelines project, to write a proportion of the text, 
to edit the manuscript and co-first author this well cited manuscript, with 
international colleagues.  




• To work with the publisher and co editor to scope the Atlas, the first of its kind, as a 
resource for scientists and clinicians working within the field of IVF.  
• To develop a strict standard operating procedure, and quality assurance process to 
provide robust data and clinical results. (See appendix 3) 
• To collaborate with international IVF professionals and professional bodies to 
develop IVF laboratory performance indicators. 
• To collaborate with international IVF professionals to develop guidelines for ART 
laboratory culture conditions. 
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Introduction
Performance indicators (PIs) are objective measures for evaluating
critical healthcare domains (patient safety, effectiveness, equity,
patient-centeredness, timeliness and efficiency) (Kohn et al., 2000).
In the setting of a clinical laboratory, quality indicators are necessary
for systematically monitoring and evaluating the laboratory’s contri-
bution to patient care (ISO15189-2012) and they represent an
important element within the Quality Management System (QMS)
(Mortimer and Mortimer, 2015; ESHRE Guideline Group on Good
Practice in IVF Labs et al., 2016). Currently, there are no estab-
lished PIs for ART laboratories, and there is very little published evi-
dence on the topic.
Any PI should be reliable and robust, and routine data collection for
the indicator should be straightforward. Furthermore, the biological or
technical process to be monitored should be defined, and relevant
qualifiers, confounders and endpoints should be identified. Key PIs
(KPIs) are indicators deemed essential for evaluating the introduction
of a technique or process; establishing minimum standards for profi-
ciency; monitoring ongoing performance within a QMS (for internal
quality control (IQC), external quality assurance (EQA)); benchmark-
ing and quality improvement. In general, the results of a series of KPIs
will provide an adequate overview of the most important steps in the
IVF laboratory process (Salinas et al., 2010).
The aim of the consensus meeting and report was to establish KPIs
for ART laboratories for the use in monitoring ‘fresh’ IVF and ICSI
cycles and provide the basis for several of the quantitative perform-
ance criteria needed to create competency profiles for Clinical
Embryologists. More specifically, the purpose was to achieve an inter-
national consensus regarding: first, a minimum list of IVF laboratory
indicators and KPIs that in the future can be further extended and/or
revised; second, specific definitions for these indicators (including
necessary case inclusion/exclusion criteria; and calculation formulae);
and third, recommended values for each KPI (minimum ‘competency’
limit; and ‘aspirational goal’ benchmark).
Based on the information presented here, each laboratory should
develop its own set of KPIs founded on laboratory organization and
processes, and develop a systematic, transparent and consistent
approach to data collection and analysis and calculation of KPIs (Mayer
et al., 2003; Salinas et al., 2010; Mortimer and Mortimer, 2015; ESHRE
Guideline Group on Good Practice in IVF Labs et al., 2016).
Metholdology
This report is the result of a 2-day consensus meeting of expert profes-
sionals (participants are listed in Table I). As a starting point for the discus-
sion at the meeting, two surveys were organized to collect information on
indicators used in IVF laboratories. The first, the ‘Alpha survey’, was sent
to national and international societies of ART laboratory directors and
........................................................................................
Table I Consensus workshop participants and
contributors.
Name Affiliations
Susanna Apter Fertilitetscentrum Stockholm, Sweden
Basak Balaban American Hospital of Istanbul, Turkey
Alison Campbell* CARE Fertility Group, UK
Jim Catt Optimal IVF, Melbourne, Australia
Giovanni Coticchio Biogenesi, Monza, Italy
Maria José de los
Santos*
IVI Valencia, Valencia, Spain
Sophie Debrock* Leuven University Fertility Centre, Leuven,
Belgium
Thomas Ebner* Kepler University, Linz, Austria
Stephen Harbottle Cambridge IVF, UK
Ciara Hughes Rotunda IVF, Dublin, Ireland
Ronny Janssens Centre for Reproductive Medicine, Brussels,
Belgium
Nathalie Le Clef ESHRE Central Office, Grimbergen, Belgium
Kersti Lundin Sahlgrenska University Hospital, Sweden
Cristina Magli* SISMER, Bologna, Italy
David Mortimer* Oozoa Biomedical, Vancouver, Canada
Sharon Mortimer Oozoa Biomedical, Vancouver, Canada
Zsolt Peter Nagy Reproductive Biology Associates, Atlanta, USA
Johan Smitz* Centre for Reproductive Medicine, Brussels,
Belgium
Arne Sunde St Olav’s University Hospital, Trondheim,
Norway
Nathalie Vermeulen ESHRE Central Office, Grimbergen, Belgium
*Presenters at the consensus workshop.
WHATDOES THIS MEAN FOR PATIENTS?
Performance indicators (PI) are seen as a good way to check that healthcare is working well and within safety guidelines. There are not any
existing PIs set across the board for IVF laboratories. This report looks at PIs for laboratories, and is based on a 2 day professional meeting
and two surveys which aimed to find out more about how IVF laboratories are currently working. The aim was to set up key PI (KPIs) for
IVF laboratories and an expert panel made some recommendations.
The report looked at a number of processes in an IVF laboratory including egg collection, how eggs are evaluated and sperm is assessed, fertil-
ization rates after IVF and ICSI (where the sperm is injected directly into the egg), how well embryos develop, freezing rates and treatment out-
comes. For each of these processes KPIs were defined.
The expert panel concluded that it was important for each laboratory to monitor and check their own performance regularly. The panel out-
lined good practice and suggested a list of 19 PIs for IVF laboratories. The panel also suggested that in the future staff at each laboratory should
select their own indicators based on the way that they worked.
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Clinical Embryologists, and to the members of the ESHRE committee of
national representatives. Eighteen responses (with opinions from Australia,
Austria, Belgium, Bulgaria, Canada, Croatia, France, Germany, Ireland,
Italy, Japan, Slovenia, Sweden, South Africa, Turkey, UK and USA) out of
34 sent were received, and its results informed the expert panel on min-
imum expected, or competence, values (i.e. values that any laboratory
should be able to achieve), and aspirational, or benchmark, values (i.e.
values that can be employed as a best practice goal), for a range of quality
indicators. Where possible, responses were based on standardized informa-
tion (national collected data, or large data sets), but in most countries such
data are not available. Another survey, the ‘ESHRE survey’, provided informa-
tion on current practice (how many KPIs are measured, frequency of meas-
urement, characteristics of a reference population for KPIs) and the degree of
importance of some indicators. This survey was sent to 2413 members of the
ESHRE Special Interest Group (SIG) of Embryology, and 384 responses were
received. In addition, where relevant, published data were collected from a lit-
erature search and summarized, although for most indicators, especially in
ART, there is a general lack of evidence to support their importance, scientific
soundness and usefulness (Shahangian and Snyder, 2009).
During the consensus meeting, the results of the surveys, scientific evi-
dence and personal clinical experience were integrated into presentations
by experts on specific topics. For each indicator, information was presented
in a fixed format: definition, rationale, qualifiers, formula, data sources, KPI
strengths and weaknesses, frequency of data collection and reference values
for minimum expected and target value based on 50 and 75 percentile
values, respectively. After the presentation for the topic, each proposed
indicator was discussed until consensus was reached within the group.
After the meeting, a report was prepared describing the presentations
(workshop report) and the consensus points. After approval of the report
by the meeting participants, the national and international societies that
contributed to the questionnaires were invited to review the report and
submit comments. The final version of the manuscript was approved by
the Executive Committees of ESHRE and Alpha before publication.
This paper is divided into two parts: the workshop report and the
recommendations of the expert panel.
Results (Workshop report)
Effects of ovarian stimulation on embryology
parameters
The methods of ovarian stimulation have been evolving since the earli-
est days of clinical IVF, in the search for the best stimulation protocol.
With that goal in mind, there has been an enormous effort to develop
the best pharmaceuticals and protocols, but in practice, economic fac-
tors as well as prevailing opinion can influence treatment decisions
beyond consideration of the patient’s endocrine background.
Despite the thousands of smaller studies on this subject in the litera-
ture, there are very few large multicentre RCTs beyond those orga-
nized by pharmaceutical companies, and these do not consider ‘non-
standard’ groups of patients. Furthermore, the meta-analyses that
have been conducted are often unclear about their inclusion criteria.
As a result, the prevailing approach is to use what works within each
clinic, and is often uncorrected for the patients’ weight, BMI or endo-
crine background. Some clinics also do not monitor cycles, for financial
reasons, which can have an influence on the cycle outcome.
In general, a ‘good’ stimulation is one that produces a homogeneous
cohort of mature oocytes, with the least inconvenience and risk to the
patient, and results in the birth of a healthy singleton. From the Clinical
Embryologist’s perspective, a good stimulation results in the retrieval
of well-expanded cumulus-oocyte complexes (COCs), as is expected
from each follicle >14 mm in diameter, with a high proportion of meta-
phase II (MII) oocytes (Scott et al., 1989; Ectors et al., 1997; Nogueira
et al., 2006). On the other hand, a poor stimulation, caused for
example by sub-optimal decisions regarding timing or stimulation
dose, is one that may result in a high rate of abnormal COC morph-
ology observed at the time of oocyte retrieval, possibly resulting in an
increased rate of abnormal fertilization (e.g. one pronucleus [PN],
3PN, etc.) and/or decreased rate of normal fertilization and an
increased aneuploidy rate (Soares et al., 2003).
Aggressive ovarian stimulation has effects on the patient’s well-
being, by increasing the risk of ovarian hyperstimulation syndrome,
(Delvigne, 2009; Rizk, 2009) as well as on the endometrium and the
ovaries. There are studies showing an increased likelihood of embryo
aneuploidy in connection with aggressive ovarian stimulation, even in
patients younger than 35 years, including post zygotic segregation
errors and maternal segregation errors (Baart et al., 2007; Haaf et al.,
2009), as well as having a negative impact on the maintenance of gen-
omic imprints during early embryogenesis (Fauque et al., 2007;
Denomme and Mann, 2012; Saenz-de-Juano et al., 2016). It has been
shown that in patients belonging to either high or low strata of
antimüllerian hormone levels an inverse correlation exists between the
daily dose of recombinant human FSH used in the stimulation and the
proportion of blastocyst formation (Arce et al., 2014).
To determine whether there is a stimulation method that could
yield a higher number of competent oocytes, one first needs to
consider the effects of LH and FSH as the principal drivers of ovar-
ian stimulation, and their pharmacodynamics. In a natural cycle,
FSH receptor expression peaks during the early follicular phase
then declines, while LH receptor expression increases from mid-
follicular phase, indicating that LH is likely to be involved in follicu-
lar development (Jeppesen et al., 2012). This could explain, at least
in part, why follicular recruitment is compromised in women with
profound pituitary downregulation (Ferraretti et al., 2004). The
role of the theca cells in ovarian responsiveness to FSH is also illu-
strated by compromised follicular recruitment in women older
than 35 years (Piltonen et al., 2003; Humaidan et al., 2004; Hugues
et al., 2010), particularly those with reduced ovarian sensitivity to
FSH (Davison et al., 2005) and reduced ovarian capacity to secrete
androgens under basal LH conditions (Spencer et al., 2007). In add-
ition, it has been shown that LH induces epidermal growth factor-
like factors in the mural granulosa. Amphiregulin, one of these
factors, has been correlated with good oocyte quality (Zamah
et al., 2010; Sugimura et al., 2015).
The time of oocyte retrieval relative to the time of the ovulation trig-
ger is typically in the range of 34–38 h. In a meta-analysis including five
RCTS with a total of 895 women, it was found that a time of oocyte
retrieval relative to the time of the ovulation trigger of >36 h com-
pared to <36 h resulted in a higher oocyte maturation rate, but no dif-
ference in fertilization rate, implantation rate or pregnancy rate (Wang
et al., 2011). Deviations from the locally established protocol should
be documented and taken into consideration.
In conclusion, to optimize outcomes, there is a need for individualiza-
tion of the treatment protocol. As stimulation can affect a range of sys-
tems, closely monitoring the patient’s response could reduce many of the
risks associated with ovarian stimulation, as stimulation can affect a range
of systems, which will also have an impact on the success of treatment.
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Because of the interlinked effects of ovarian stimulation on oocyte qual-
ity and developmental competence, it is logical that the most successful
clinics are those in which the embryologists and clinicians speak with each
other and communicate regularly and effectively about outcomes related
to stimulation (and other procedures) (Van Voorhis et al., 2010).
Oocytes
Not all oocytes collected from a patient following ovarian stimulation
for ART will have the same developmental competence, which is illu-
strated by the observation that only 5% of oocytes collected eventually
result in a live birth (Lemmen et al., 2016). Intrinsic oocyte compe-
tence is derived not only from the degree of nuclear maturity of the
oocytes, but also from their cytoplasmic maturity (Patrizio and Sakkas,
2009; Garrido et al., 2011; Lemmen et al., 2016). Furthermore, oocyte
developmental competence is affected by a range of intrinsic patient-
related and external factors. These patient-related factors include age,
BMI, lifestyle factors and type of infertility. The external factors include
ovarian stimulation, laboratory procedures (such as oocyte retrieval,
denudation, cryopreservation, preparation for ICSI), culture conditions
(temperature, pH, pO2), environmental conditions (light, air quality,
humidity) and culture medium.
Against that background, the question is whether any laboratory
indicator can provide a measure of the intrinsic oocyte competence at
the time of oocyte retrieval, as all of the subsequent events could be
influenced by laboratory procedures, and/or by the genetic contribu-
tion of the spermatozoon. In other words, is quality measurable for
oocytes, or perhaps more pertinently, is there any measure that could
pinpoint where a dysfunction occurred during the long process of
oocyte development?
There are a number of possible markers for oocyte competence,
but these are largely research-based, and have not found widespread
application in clinical service. These include assessment of biochemical
markers in follicular fluid, gene expression studies of follicular cells and
oxygen uptake assessments (Nagy et al., 2009; Nel-Themaat and
Nagy, 2011). Other markers, such as assessment of oocyte morph-
ology, spindle imaging, and polar body (PB) biopsy, can be incorpo-
rated into clinical service, but this is not a universal approach (Patrizio
et al., 2007; Rienzi et al., 2011; Braga et al., 2013).
When the results of the Alpha and ESHRE surveys were combined,
respondents identified oocyte recovery rate and oocyte maturity rate as
the most important indicators for oocytes. Although, strictly speaking,
they do not provide an indication of laboratory performance, they do
provide an estimate of response to stimulation, and therefore a general
estimation of the likely developmental competence of the oocytes.
In the Alpha survey, oocyte recovery rate was defined as the likeli-
hood of aspirating a COC from each follicle over a certain size as mea-
sured on the day of triggering. The rationale for this is the expectation
that those follicles that have achieved a certain size, with a good
response to FSH and a sufficient number of LH receptors in follicular
cells, will respond appropriately to the ovulation signaling cascade,
resulting in the release of the COC into the follicular fluid, thereby
facilitating its aspiration. A concern with this potential indicator was its
reliance on the accuracy of follicular scanning, and the need for a con-
sistent time interval between ovulation trigger and oocyte retrieval.
However, while a range of follicle sizes was identified in the survey as
the ‘ideal’ size for triggering, the expected recovery rates were
remarkably similar, generally ranging from 70 to 80% as the compe-
tence level, and 85–100% as the benchmark value.
Oocyte maturity rate is generally related to nuclear maturity, being
defined as the proportion of oocytes at MII stage. Its potential value is
as a marker of the efficiency of ovarian stimulation and triggering. Of
the Alpha survey respondents, 80% indicated that their laboratory
determined the MII rate, with median competence and benchmark
values of 75 and 90%, respectively. It was noted that the timing of this
assessment is an important factor, as it is not possible to assess oocyte
maturity at the time of oocyte retrieval in the case of insemination by
routine IVF. Since this assessment requires the removal of the cumulus
and corona cells, it can be performed at the time of denudation of the
oocytes prior to ICSI, but for a universal competence and benchmark
value to be established, a consistent time interval between the time of
trigger and the time of cumulus cell removal would be required (e.g.
40 ± 1 h post ovulation triggering).
A third potential indicator, oocyte grade, was defined as the propor-
tion of COCs with expanded cumulus at the time of oocyte retrieval.
As ovulation triggers cumulus expansion by mediating the synthesis of
hyaluronic acid and the organization of a stable cellular matrix (Russell
and Salustri, 2006), this indicator provides an assessment of the quality
of communication between the oocyte and its cumulus cells. The
potential problems associated with the use of this indicator are a lack
of objective criteria for making this assessment, and a concern that
there is not always a good correlation between nuclear maturity and
cumulus cell expansion (Balaban and Urman, 2006).
Other indicators that were proposed but not considered valuable
or reliable by the survey respondents were: rate of degenerated (or
empty) zonae pellucidae; rate of germinal vesicle oocyte recovery; def-
inition of the minimum number of follicles to justify flushing; and oocyte
degeneration rate at the time of oocyte retrieval. Oocyte degeneration
rate after removal of cumulus cells is discussed in the section on ICSI.
Overall, the responses to the surveys highlighted the lack of consist-
ent data for the evaluation of oocyte quality and competence, and
identified an opportunity for national and international registries to
promote the collection of this information.
Sperm KPIs
Proposed andrology laboratory PIs were sperm recovery rate, and
sperm motility post-wash. In addition, sperm parameters were dis-
cussed in relation to the decision for IUI, IVF or ICSI.
Survey responses revealed such wide ranges in perceived semen
analysis minima for suitability for IUI, IVF or ICSI, as well as expected
sperm recovery post-wash, as to make it impossible to determine
robust recommendations for competency and benchmark values for
any of these criteria.
With regard to sperm preparation, it is possible that respondents
were confused when reporting the ‘recovery rate’, and the substantial
variability in terms of the expected/required number of spermatozoa
in the final preparation likely included confusion between percentage
recovery (‘yield’) values and the actual number of spermatozoa (mil-
lions); hence these data were considered unreliable. However, the
expected proportion of motile spermatozoa in the final washed prep-
aration showed coherence across the respondents, with both median
and mode values of 90% for competency and 95% for the benchmark.
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A major issue when considering semen analysis data is that many
ART laboratories do not employ methods that meet the minimum
standards required by either the World Health Organization (WHO)
or the ESHRE SIG Andrology (Björndahl et al., 2010; World Health
Organization, 2010). Therefore, reported values for sperm concentra-
tion and motility must be understood to have high uncertainty of
measurement, and hence need to be considered as inaccurate and
unreliable (Sanchez-Pozo et al., 2013; Björndahl et al., 2016). As a con-
sequence, any association between semen analysis characteristics,
yield and fertility potential will remain unclear if based on studies using
inappropriate semen analysis techniques. From a best practice stand-
point, any clinical laboratory providing semen analysis or post-
preparation values that are to be used for diagnostic or treatment
management purposes should participate in an EQA programme which
provides a comparison between the participating laboratories’ results
and established reference (‘correct answer’) values so as to permit qual-
ity improvement in laboratory work (Björndahl et al., 2010).
Moreover, there is a general concern that semen analysis reference
values have little or no value for ART procedures (Björndahl, 2011). In
particular, the WHO reference values for sperm concentration, motil-
ity and vitality were derived from populations of men who had
achieved in vivo conceptions (Cooper et al., 2010), and therefore these
cut-off values have no a priori relevance in regard to ART patients, and
hence the need or suitability for any form of ART treatment should
not be decided based on these reference values.
The Tygerberg Strict Criteria for normal sperm morphology were
derived in regard to ART success (Kruger et al., 1988; Coetzee et al.,
1998), so these cut-offs might be pertinent in differentiating between
the need for IUI, IVF or ICSI—although concern regarding measure-
ment uncertainty cannot be ignored (Menkveld et al., 2011). While a
cut-off of 4% normal forms might help to define sub-populations of
patients with differing prognoses, at the level of individual patients a
result of 4% based on 200 spermatozoa evaluated is not very inform-
ative since the result has a statistical expectation ranging from 2 to 8%
(Björndahl et al., 2010), and to be able to differentiate between 3 and
5% with statistical robustness would require the assessment to have
been made by evaluating over 1500 spermatozoa.
Because of the limitations of semen analysis cut-off values, a decision
on the suitability of IUI or routine IVF for a couple should be made
based on post-preparation sperm numbers/concentration and their
motility, ideally assessed during a pre-treatment ‘trial wash’ (while still
taking into account the uncertainty of measurement). In case of ICSI,
there should not be any cut-off based on semen analysis characteris-
tics, the only logical criterion would be having sufficient (in comparison
with the expected number of oocytes) spermatozoa that are, ideally,
viable, and preferably motile or positive in the hypo-osmotic swelling
(HOS) test (Nagy et al., 1995). As a general principle, laboratories
should develop and apply their own criteria for deciding on IUI, IVF or
ICSI, based on the couple’s clinical situation and reproductive history
rather than semen analysis.
Regarding andrology laboratory PIs, results from the Alpha survey
indicated that only post-preparation sperm motility would be a valu-
able indicator, as it monitors the effectiveness of the sperm washing
procedure. Therefore, post-wash sperm motility should be monitored
for fresh ejaculate specimens that show normozoospermia as per the
WHO5 guidelines (World Health Organization, 2010), but still taking
into account the poor reliability of sperm motility data, non-robust
classification of semen samples based on the high uncertainty of semen
analysis data, and variability in sperm preparation methods.
Sperm recovery rate, defined as the percentage recovery of progres-
sively motile sperm after washing as compared to pre-washing (Björndahl
et al., 2010), can be used as a laboratory KPI, providing useful information
for inter-operator comparison and proficiency testing. However, given
the high uncertainty in counting and the different protocols for sperm
preparation (notably with density gradient washing resulting in higher
recovery rates as compared to direct swim-up from semen), no compe-
tence values can be provided. Laboratories should develop their own
standards according to their own clinical and laboratory practice.
Fertilization after insemination by ICSI
Although several potential KPIs have been identified in ICSI, the pres-
entation focused on the four most pertinent, i.e. normal fertilization
rate, oocyte degeneration rate, poor fertilization rate and failed fertil-
ization rate.
The definition used most often for the ICSI normal fertilization rate
is the proportion of injected oocytes with 2PN the day after injection,
except for the Spanish Registry and the Istanbul Consensus which
include the observation of two PBs in the definition (Alpha Scientists in
Reproductive Medicine and ESHRE Special Interest Group of
Embryology, 2011). The suggested competence and benchmark values
for this indicator were consistent among respondents ranging from 60
to 80%, and 70 to 100%, respectively. The UK’s Association of Clinical
Embryologists proposed benchmark for the 2PN rate is >65% includ-
ing only patients below 40 years of age with at least three oocytes col-
lected (Hughes and Association of Clinical Embryologists, 2012). From
the literature, it was found that ICSI results in an average fertilization
rate of 70% (Heindryckx et al., 2005; Kashir et al., 2010), which was
similar to 68.7% based on over 20 000 unselected MII oocytes at the
CARE Fertility laboratory, UK (personal communication Alison
Campbell). ICSI fertilization rate is a commonly reported and effective
indicator that is informative of gamete quality and operator compe-
tence. ICSI 2PN rate does depend on the various criteria used for per-
forming ICSI, which can be considered a weakness of the indicator.
The ICSI damage rate or oocyte degeneration rate was ranked as
important. In the Alpha survey, the minimum expected value and tar-
get value ranged from 3 to 30% and 0 to 10%, respectively. Oocyte
damage can be observed at three time points during the ICSI process:
from the start at stripping, during ICSI, or at the fertilization assess-
ment on Day 1. Oocyte damage probably occurs most frequently during
injection, but without immediate signs of damage, this is not detected until
the fertilization check. In addition, as both the damage detected at injection
and at fertilization check reflect damage from the ICSI process, these
should not be recorded and calculated separately. Damage at denuda-
tion/stripping can be monitored separately as it mainly reflects operator’s
competency, but it has a very low frequency. ICSI damage rate is therefore
defined as the number of oocytes damaged during ICSI, and/or observed
at fertilization check over the number of injected oocytes. It is useful to
monitor this indicator for operator competence, oocyte quality, and
laboratory performance. The damage rate can also be indicative of tech-
nical problems (e.g. cumulus cell removal stress, vibration). Alternatively,
the term ICSI oocyte survival rate can be used.
Poor fertilization rate is defined as the proportion of cycles in which
<25% of the injected oocytes are fertilized. The responses from the
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survey are much divided, ranging from 5 to 20% for the competence
and from 0 to 15% for the benchmark value. Poor fertilization rate can
give an indication of operator competence and reflect gamete quality.
Failed fertilization rate scored relatively low on importance in the
surveys. Failed fertilization rate is defined as the proportion of cycles in
which none of the injected oocytes are fertilized. The indicator can be
informative of gamete quality/function and/or operator skill. A defi-
ciency in the mechanism of oocyte activation is regarded as the princi-
pal cause of ICSI fertilization failure or abnormally low fertilization.
Complete (‘or virtually complete’) fertilization failure with ICSI occurs
in 1–5% of cycles (Liu et al., 1995; Flaherty et al., 1998; Mahutte and
Arici, 2003; Yanagida, 2004; Kashir et al., 2010). From the Alpha sur-
vey there was a wide range in the competence values for this indicator
ranging from 2 to 15% (median 5%), with a benchmark of <1%.
For these and other KPIs, a reference population could be relevant.
With regard to ICSI fertilization rate, it could be relevant to exclude
cases where reduced fertilization rates are anticipated, including in vitro
matured metaphase I oocytes (although inconclusive data), artificially
activated oocytes, the use of testicular sperm, and cases of globozoos-
permia and asthenozoospermia (Rubino et al., 2016). However, owing
to the low prevalence, including these cases may not significantly affect
the indicators in most clinics.
In conclusion, from the surveys and collected evidence, ICSI damage
rate and ICSI normal fertilization rate are considered relevant and
important KPIs, while the value of ICSI low/failed fertilization rate as a
KPI is less clear. Oocyte maturity rate and 1PN/3PN rate were not
specifically discussed for ICSI. The ICSI rate, defined as the proportion
of cycles that use ICSI, was not commonly recorded by the survey
respondents, judging this as a less relevant PI.
Fertilization after (routine) IVF insemination
This section deals with normal fertilization rate, polyspermy rate, poor
fertilization rate and zygote morphology after routine IVF insemination.
Pronuclear formation occurs 1.5–2.0 h earlier in oocytes insemi-
nated by ICSI compared with those inseminated by conventional IVF
(Nagy et al., 1998; Montag et al., 2001). This should be taken into con-
sideration when setting the time for fertilization check, relative to the
time elapsed since insemination (recommended as 17 ± 1 h) (Alpha
Scientists in Reproductive Medicine and ESHRE Special Interest Group
of Embryology, 2011). A normally fertilized oocyte should have 2PN
of similar size that are closely apposed and centrally located (Alpha
Scientists in Reproductive Medicine and ESHRE Special Interest Group
of Embryology, 2011). Although the provenance of micronuclei
remains unclear, their presence could be considered to be abnormal,
as could the presence of pronuclei of different sizes. From the litera-
ture, the normal fertilization rate (i.e. the proportion of inseminated
oocytes with 2PN at the time of the fertilization check on Day 1) is
expected to be around 67%, with a range of reported values of
53–81%. This range was reflected in the Alpha survey results, where
the median value for competency was 61% of inseminated oocytes,
with a median benchmark value of 77%.
The presence of three or more pronuclei is indicative of an abnor-
mal fertilization, arising from either nondisjunction (failure to extrude
the second PB) or polyspermy. Polyspermy may be the result of either
oocyte immaturity (causing failure of the cortical reaction), oocyte
overmaturity and/or an extremely high concentration of motile
spermatozoa in the insemination volume (Wang et al., 2003). From
the literature, the incidence of ≥3PN is 4–7% in IVF (Joergensen et al.,
2015). This agrees well with the median values from the Alpha survey
of <9% for competence, and <4.5% as a benchmark.
The calculation of the total fertilization rate following IVF includes all
fertilized oocytes with ≥2PN. Although, as already stated, oocytes
with >2PN are abnormally fertilized, this parameter provides an indi-
cation of the ability of the culture system to support sperm capacita-
tion and sperm-oocyte interaction in IVF cycles. Of the published
studies that included >100 oocytes, the median total fertilization rate
was 76% (range 69–87%) in selected patient populations. This is similar
to the Alpha survey results, which suggested a competency level of at
least 63% and a benchmark of at least 84%.
Oocytes with a single pronucleus after insemination by IVF, which
occurs in 1–5% of cases, can be indicative of fertilization and syngamy,
asynchronous appearance of pronuclei (an extremely rare event, as
evidenced by the use of time-lapse microscopy), or parthenogenetic
activation (Levron et al., 1995). The incidence of diploidy in 1PN
oocytes following conventional IVF has been reported to be in the
range of 45–50% (Sultan et al., 1995; Staessen and Van Steirteghem,
1997; Kai et al., 2015). In contrast, 1PN oocytes arising after ICSI have
a reported diploidy rate of only 7–14%, with genetic abnormalities in
the subsequent embryos (Mateo et al., 2013).
The incidence of poor fertilization (<25% of inseminated COCs with
2PN) or total failure of fertilization (no oocytes with signs of fertilization)
could be indicative of a problem with sperm function, too few motile
spermatozoa during insemination, or failure of oocyte activation (Ebner
et al., 2015). There is very little evidence in the literature regarding the
expected incidence of either poor or failed fertilization. However, the
Alpha survey results suggested competency and benchmark levels for
poor and failed fertilization of 14 and 6%, and 8 and 4%, respectively.
Although the Istanbul Consensus made recommendations about
grading zygote morphology (Alpha Scientists in Reproductive Medicine
and ESHRE Special Interest Group of Embryology, 2011), the question
remains as to whether indicators referring to zygote morphology are
useful, especially as differences in pronuclear pattern could be related
to the insemination method and timing of the observation (Montag
et al., 2001; Ebner et al., 2003).
Cleavage-stage embryos
Proposed indicators for cleavage-stage embryos are early cleavage
rate, cleavage rate, embryo development rates, embryo fragmentation
rate, and rate of good quality embryos (embryo score or grade).
Early cleavage rate is defined as the proportion of cleaved zygotes at
the early cleavage check on Day 1 (26 ± 1 h post-ICSI or 28 ± 1 h post-
IVF) (Alpha Scientists in Reproductive Medicine and ESHRE Special
Interest Group of Embryology, 2011), but other time-intervals after
insemination have been used for assessing early cleavage. This indicator
reflects the ability of the culture system to support early cleavage of ferti-
lized oocytes and the viability and quality of the embryos (Shoukir et al.,
1997). There are conflicting results on the importance of early cleavage.
Studies have shown that early cleavage, together with other factors, can
be used as an embryo selection method (Lundqvist et al., 2001; Ciray
et al., 2005). Early cleavage rate has also been shown to correlate with
blastocyst implantation and pregnancy rates (Shoukir et al., 1997; Balaban
and Urman, 2003) and it is a better independent marker of implantation
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potential than zygote morphology (Brezinova et al., 2009). In contrast,
early cleavage was not found to be an independent predictor of implant-
ation in IVF patients with good prognosis (Thurin et al., 2005). In addition,
premature occurrence of early cleavage can be negatively, instead of posi-
tively, associated with embryo implantation potential (Meseguer et al.,
2011). Furthermore, it was not a reliable predictor for embryo implant-
ation rate when good quality embryos are transferred (Sundstrom and
Saldeen, 2008; de los Santos et al., 2014), or when using a GnRH antag-
onist protocol (Yang et al., 2015). In the Alpha survey, competence and
benchmark values ranged from 10 to 50% and 15 to 60%, respectively.
Cleavage rate reflects the ability of the culture system to support cellular
division of fertilized oocytes. It is an indicator of embryo viability and has
the ability to detect culture media contaminants. The presence of non-
cleaved embryos or arrested zygotes on Day 3 is associated with a
decrease in quality of the remaining cohort, but without a negative impact
on clinical outcome (Machtinger et al., 2015). Cleavage rate is considered
important and is widely monitored, and defined as the proportion of
zygotes which cleave to become embryos on Day 2 at 44 ± 1 h post-
insemination (Alpha Scientists in Reproductive Medicine and ESHRE Special
Interest Group of Embryology, 2011). Cleavage rate should be calculated
not only in the total population, but also in reference groups (IVF versus
ICSI, female age, ejaculated versus surgically retrieved sperm), and con-
trolled for confounders (the timing of observation and oocyte maturity).
Also, the presence of a refractile body in the oocyte is associated with
reduced cleavage rates and impaired embryo development, while the cyto-
plasmic granularity did not seem to have an effect on embryo development
(Fancsovits et al., 2012). Cleavage rate should be calculated frequently in a
laboratory (at least once per month). In the Alpha survey, the competence
values ranged from 80 to 95%, with a benchmark of 90 to 100%.
Embryo development rate is defined as the proportion of 4-cell
embryos on Day 2 among the 2PN zygotes (measured at 44 ± 1 h
post-insemination), the proportion of 8-cell embryos on Day 3 (mea-
sured at 68 ± 1 h post-insemination), and the proportion of morula-
stage embryos on Day 4 (92 ± 2 h post-insemination) (Alpha Scientists
in Reproductive Medicine and ESHRE Special Interest Group of
Embryology, 2011). This indicator reflects the ability of the culture sys-
tem to support cleavage according to the expected developmental
stages and the quality and viability of embryos, especially for Day 2 or
3 transfer, while less important for blastocyst transfer. Possible con-
founders are the timing of laboratory observations and the type of cul-
ture media used. Although dependent on iatrogenic factors such as the
culture conditions, embryo development rate is an important indica-
tor; in well-defined categories of patients, it reflects the overall labora-
tory performance. It was stated that sufficient numbers of embryos or
longer data collection are necessary, as this indicator is influenced by
short-term variations. Calculation of a sliding mean can be helpful for
detecting long-term variations. The value and practicability of the mor-
ula check on Day 4 was questioned as centers performing Day 5
embryo transfer often do not assess the embryo development at Day
4. Also, instead of assessing the number of 4-cell embryos on Day 2,
or 8-cell embryos on Day 3, a combination of 4-cell and 8-cell
embryos on Days 2 and 3 can be used. This was analyzed in a study by
van Royen, who thereby characterized a top quality embryo as having
4- to 5-cells on Day 2 and ≥ 7 cells on Day 3 (Van Royen et al., 1999).
In larger centers, assessing the embryos at the specified time points
can be difficult, and counting 4- and 5-cell embryos on Day 2, and 7-,
8- and 9-cell embryos on Day 3 may be more relevant.
The rate of good quality embryos is defined as the proportion of
Days 2 and 3 embryos with high score or grade. Many different scoring
systems exist, based on different variables, including cell number, frag-
mentation, cell size and multinucleation (Alpha Scientists in Reproductive
Medicine and ESHRE Special Interest Group of Embryology, 2011) and
blastomere nuclear status (Fauque et al., 2013). A recent study evaluating
which set of embryo variables is most predictive for live birth rate (LBR)
reported that blastomere number, proportion of mononucleated blasto-
meres, degree of fragmentation and variation in blastomere size were sig-
nificantly associated with LBR in univariate analysis, while symmetry of the
embryo was not (Rhenman et al., 2015). Furthermore, the grading sys-
tems are not robust, but can be used as internal quality assessment para-
meters. The importance of this parameter is also affected by the limited
significance of the fragmentation rate.
Embryo fragmentation rate, defined as the proportion of Days 2 and
3 embryos with <10% fragmentation, reflects the quality and viability
of embryos. From the Alpha survey, the competence value for this
parameter ranged from 20 to 90% (median 50%) and the benchmark
from 30 to 90% (median 70%). These large ranges underline the diffi-
culties with this parameter: embryo fragmentation rate is reported to
be a subjective parameter and difficult to evaluate as one has to differ-
entiate between a cell and a fragment and then estimate the relative
proportion of fragments (Paternot et al., 2011).
Embryo utilization rate is defined as the number of embryos utilized
(transferred or cryopreserved) per number of 2PN zygotes in the
same cycle. This parameter is often presented in studies, but compe-
tence and benchmark values cannot be calculated because of its
dependence on strategies for embryo transfer and cryopreservation,
as well as patient request.
In conclusion, embryo cleavage rate and embryo development rate
are extremely important indicators, while early cleavage rate, rate of
good quality embryos and embryo fragmentation rate are less import-
ant as quality indicators.
Blastocyst development
In the case of blastocyst-stage embryo transfer, several parameters
were suggested as indicators: blastocyst development rate, good
blastocyst development rate, the proportion of good quality blastocyst
and Day 5 embryo transfer rate.
The blastocyst development rate, defined as the proportion of 2PN
zygotes (not just of cleaved zygotes) which are at the blastocyst-stage
at Day 5 (116 ± 2 h post-insemination) (Alpha Scientists in
Reproductive Medicine and ESHRE Special Interest Group of
Embryology, 2011), was rated important because it reflects the effi-
ciency of the whole culture system. Blastocyst development rates can
be calculated on Day 5, 6 or Days 5/6 combined. Assessment and cal-
culation on Day 5, consistent with previous consensus, is preferred
based on limited numbers of embryos available on Day 6. The compe-
tence and benchmark values for blastocyst development rate on Day 5
ranged from 25 to 60%and 44 to 80%, respectively. The blastocyst
development rate is an objective parameter, but dependent on the
assessment of blastocyst morphology, which is straightforward in case
of good quality blastocysts, but can be challenging for embryos show-
ing an attempt of cavitation. Confounders can be the timing of labora-
tory observation, the culture medium and the culture conditions (in
particular the pO2 concentration).
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A good blastocyst development rate is defined as the proportion of
2PN zygotes which are good quality blastocysts on Day 5 (116 ± 2 h
post-insemination) (Alpha Scientists in Reproductive Medicine and
ESHRE Special Interest Group of Embryology, 2011). Similar to blasto-
cyst development rate, measuring this as an indicator only on Day 5
could make the indicator more robust. Blastocyst quality should be
based on three factors, namely blastocoele expansion, appearance of
trophectoderm (TE) and appearance of inner cell mass (ICM).
Although all three parameters have been shown to be significantly cor-
related to pregnancy and LBR (Van den Abbeel et al., 2013), only TE
was found to be a statistically significant independent predictor of live
birth outcome after adjustment for known confounders (Ahlstrom et al.,
2011). Even though the ICM is important, a strong TE layer is essential
at this stage of embryo development, allowing successful hatching and
implantation (Ahlstrom et al., 2011). In the Alpha survey, the compe-
tence and benchmark values for good blastocyst development rate on
Day 5 ranged from 15 to 45% and 25 to 80%, respectively.
The proportion of good quality blastocysts can be calculated from
the blastocyst development rates and good blastocyst development
rates. There is no evidence pertaining to the significance of this param-
eter in the literature, and no data from the Alpha survey.
Day 5 embryo transfer rate was defined as the proportion of cycles
with ≥1 2PN zygotes on Day 1 that had ≥1 blastocyst for transfer on
Day 5. From the Alpha survey there was a large variation in the values
for competence and benchmarks (ranging from 25 to 90% and 40 to
100%, respectively), which is assumed to be related to differences in
the time of blastocyst assessment, and different grade of expansion. In
addition, this parameter depends on different policies for transfer in
different settings. PGD/PGS (globally indicated as preimplantation
genetic testing—PGT—that includes PGD for single gene disorders or
for chromosome structural abnormalities, and PGS for aneuploidy)
cycles should be excluded from this calculation. Some possible con-
founders are the timing of laboratory observation (ideally at 116 ± 2 h
post-insemination), but in some laboratories the time of observation
depends on the timing of embryo transfer (physician availability), the
culture medium and other culture conditions (e.g. pO2 concentration),
and the grade of blastocyst expansion.
Fresh cleavage or fresh blastocyst transfer?
Recently, a Cochrane review summarized evidence from RCTs com-
paring the reproductive outcomes after fresh cleavage-stage versus
fresh blastocyst-stage embryo transfer (Glujovsky et al., 2016). Based
on low-quality evidence, they concluded that the LBR following fresh
transfer was higher in the blastocyst transfer group as compared to the
cleavage-stage transfer group [odds ratio (OR) 1.48, 95% CI
1.20–1.82; 13 RCTs, 1630 women, I2 = 45%]. This is translated in a
LBR of 29% after fresh cleavage-stage transfer, and between 32 and
42% after fresh blastocyst-stage transfer. The five RCTs that reported
cumulative pregnancy rates after fresh and frozen transfers, showed
no significant difference after one round of oocyte retrieval (based on
very low-quality evidence). The main limitation was serious risk of
bias, associated with failure to describe acceptable methods of ran-
domization, and unclear or high risk of attrition bias (Glujovsky et al.,
2016). Another review reported that blastocyst (Day 5/6) transfer in
a fresh IVF/ICSI treatment cycle significantly increased LBR (OR 1.77;
95% CI 1.32–2.37), clinical pregnancy rate, implantation rate, and
ongoing pregnancy rate, and reduced first trimester miscarriage rate,
in comparison with cleavage-stage (Day 2/3) embryos transfer based
on seven RCTs and 1446 cases (Wang and Sun, 2014).
Implantation rate and LBR
Implantation rate is judged an important indicator that reflects the
overall performance of the laboratory and an overall low implantation
rate is a serious alert. Implantation rate is defined as the number of
gestational sacs observed divided by the number of embryos (cleav-
age-stage or blastocysts) transferred (Zegers-Hochschild et al., 2009),
or as the proportion of fetal hearts relative to the number of embryos
transferred (Alpha Scientists In Reproductive Medicine, 2012).
Implantation rate reflects the efficiency of the whole culture system,
but it can be influenced by uterine receptivity, and by different policies
for embryo transfer in different centers.
LBR may be considered as the ultimate KPI for checking IVF clinic
performance and defined as the likelihood of a baby to be born per
embryo transferred. LBR is largely affected by a series of clinical mater-
nal factors pertaining to post-implantation development, rather than
reflecting laboratory performance. This parameter can be calculated
annually, but it is often difficult to collect the data.
PGT: PGD/PGS
The indicators proposed for PGD/PGS (PGT) were successful biopsy
rate/tubing rate, rate of no biopsy, proportion of samples submitted
to analysis where no results were available (no DNA was detected),
and embryos not found on warming. Other indicators suggested in the
survey were ‘survival after warming’, embryo transfer per PGT cycle,
and miscarriage rate, but there were very few responses for these vari-
ables in the Alpha survey.
A successful biopsy rate is defined as the proportion of biopsied and
tubed/fixed samples where DNA is detected. It was suggested to use
this parameter combining the tubing rate (the proportion of embryos
where cells were tubed) and the proportion of samples submitted to
analysis where no DNA was detected, as the tubing of the cells can
often not be inspected visually and will only be detected by the pres-
ence of DNA after amplification. A benchmark for the tubing rate of
95% was reported in the Alpha survey. Confounders for the successful
biopsy rate are embryo quality, and the criteria for biopsy (for Day
three embryos: presence of a visible nucleus; for Day 5/6: grade of
hatching, TE quality). In the data of the ESHRE PGD Consortium, of
254 820 samples that were biopsied, 91.3% were diagnosed (De
Rycke et al., 2015). It is important to underline that, as already men-
tioned, these data mainly refer to Day 3 biopsies and that in the case
of PGT for aneuploidy (generally known as PGS) the analysis of biop-
sies was mainly by fluorescence in situ hybridization (FISH), a technique
requiring cells to be fixed on a glass slide. FISH is now being replaced
by other methods providing 24-chromosome testing, which require
tubing of cell biopsies.
The rate of no biopsy is defined as the proportion of intended
PGD/PGS (PGT) cases where there were no embryos available to
biopsy. This parameter was rated important, but it reflects patient-
related factors and the ability of the culture system to support cleav-
age/blastocyst formation, rather than the performance ability of the
laboratory to perform a PGD/PGS (PGT) treatment/analysis.
Furthermore, the parameter is different whether biopsy is performed
at the cleavage or blastocyst-stage, and depends on the timing of the
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laboratory observation, culture medium and culture conditions (e.g.
pO2 concentration), criteria for biopsy, the time point of assisted
hatching (Day 3 or 5), and patient selection. The parameter should
also be calculated for PGD and PGS separately, based on the differ-
ence in patient populations. From the Alpha survey, the median com-
petence value and benchmark were 20 and 10%, respectively. In the
last data collection of the ESHRE PGD Consortium, out of 45163
reported cycles, 2.8% were canceled before biopsy (De Rycke et al.,
2015). However, as this data collection covers cycles performed up to
2010, this figure refers to Day 3 biopsies, implying that possibly a high-
er value could be expected for Day 5 biopsies.
For a number of samples, no results are available after amplification.
Results can be inconclusive even with a strong DNA amplification
band in the agarose gel, which can be due to early fragmentation of
DNA. In single gene analysis, results can be inconclusive if information
is found only on a reduced number of markers, or the gene of interest
failed to amplify. Although this indicator is not strictly related to the
performance of the laboratory, it is relevant to inform clinicians on the
total number of embryos where PGD/PGS (PGT) results are available.
The number of samples where no results are available after amplifica-
tion was reported in the Alpha survey with a benchmark of <5%,
which corresponds with the converse of the tubing rate.
Nowadays, the majority of PGT cycles are based on blastocyst
biopsy and cryopreservation. The proportion of embryos not found
on warming and embryos degenerated after warming mainly reflects
operator skills. In the Alpha survey, the median competence values
were 3 and 10% for not found and degenerated embryos, respectively.
These indicators can also be reported as one combined indicator. It
was mentioned that clinicians should be aware that although laborator-
ies strive for 100%, not all embryos submitted to PGD/PGS (PGT) will
be recovered after warming.
Reference values for implantation rate and LBR after PGT can be
derived from the data from the ESHRE PGD Consortium. The implant-
ation rate was 26% for PGD and 22% in PGS, with delivery rates (per
oocyte retrieval) of 21 and 14%, respectively (De Rycke et al., 2015).
Indicators for cryopreservation: addition
to the previous consensus
Blastocyst re-expansion rate is defined as the proportion of warmed
blastocysts that show re-expansion within a defined time period (e.g.
2 h) (Alpha scientists in reproductive medicine, 2012). Recent evi-
dence shows an impact on the performance results depending on the
quality/expansion of the blastocysts which are cryopreserved (Cobo
et al., 2012). Also, in blastocyst fresh transfer, from multivariate ana-
lysis it was shown that the odds of live birth increased by 36% for each
grade of expansion (P = 0.0061) and decreased by 29% for blastocysts
with grade B TE compared with Grade A TE (P = 0.0099).
Furthermore, after thawing, the odds of live birth increased by 39%
(P = 0.0042) for each 10% increase in degree of re-expansion.
Therefore, blastocoel expansion and TE grade were selected as the
most significant pre-freeze morphological predictors of live birth and
degree of re-expansion was selected as the best post-thaw parameter
for prediction of live birth (Ahlstrom et al., 2013). Confounding factors
are time of observation, female age and fertilization method. These
observations do not include embryos that had been biopsied on Day 3
as they have a different hatching dynamic (Lopes et al., 2015).
Recommendations of the expert
panel
General comments
(1) Regarding frequency of data collection for indicators, it was the
consensus opinion that this should be done, ideally, on a monthly
basis. However, it was recognized that this is not always practical,
based on caseload, and therefore either a longer timeframe or a
specific predetermined number of cases might be used instead.
The minimum number will depend on the stability of the indicator
and will need to be developed by the laboratory, although an initial
dataset of 30 cases could be used as a guideline. Nonetheless
laboratories should remain vigilant and respond promptly to unex-
pected fluctuations.
(2) The discussions identified three different types of indicators: refer-
ence indicators (RIs), PIs and KPIs.
– RIs were related to the oocytes coming into the laboratory, and
so were proxy indicators of the response to ovarian stimulation.
– PIs were those for which data should be documented and stored,
even if they are not routinely reported in a control chart.
– KPIs were those related to the ‘core business’ of the ART
laboratory.
(3) The values for indicators are presented as competency and bench-
mark values, as was done for the cryopreservation consensus
(Alpha Scientists In Reproductive Medicine, 2012). The gap
between the competency and the benchmark values is the ‘desir-
able range’.
(4) It was the opinion of the expert panel that ovarian stimulation can
have an impact on the overall treatment cycle but is less likely to
have an impact on any single laboratory PI.
(5) To apply the recommended values:
– The time of oocyte retrieval relative to the time of the ovulation
trigger is typically in the range of 34–38 h (mostly 36 h).
Deviations from the locally established protocol should be docu-
mented and taken into consideration.
– The timing of all observations should be made as recommended in
the Istanbul consensus (Alpha Scientists in Reproductive Medicine
and ESHRE Special Interest Group of Embryology, 2011).
(6) Individual clinics should decide whether it is more practical to sub-
divide their results into specific patient groups for KPI and PI deter-
minations, based on their clinical practice. The indicator values
presented here were derived relative to cycles that met the cri-
teria for a ‘reference population’. With the exception of indicators
with specific qualifiers identified, these criteria were:
– Female patients <40 years old;
– own fresh oocytes;
– ejaculated spermatozoa (fresh or frozen);
– no PGD/PGS (PGT);
– all insemination methods (i.e. routine IVF and ICSI).
(7) It was the opinion of the panel that national and international regis-
tries should be encouraged to gather data that can be used for the
derivation of KPI standard values.
(8) Any selection procedure in addition to embryo morphology, for
example PGD/PGS (PGT) or time-lapse imaging, is not expected
to increase the cumulative pregnancy/LBR, but in the case of PGS
it may result in reduced time to pregnancy/live birth.
Indicators
The results of the discussions have been summarized for the majority
of the indicators. The values for indicators have also been presented in
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Tables II–IV, but these should be read in association with the summary
for each indicator.
Proportion of oocytes recovered
The proportion of oocytes recovered RI (Table II) is defined as the
number of oocytes retrieved as a function of the number of ovarian
follicles seen at ultrasound assessment. It is useful as a measure of
whether the quantity of oocytes is maximized. The values are not influ-
enced by laboratory practice, and so cannot be held to be laboratory
PIs, but values outside the expected range could prompt an investiga-
tion of any changes in stimulation practice. Having this information is
an important factor in troubleshooting. The expected range is 80–95%
of follicles measured in stimulated cycles.
Proportion of MII oocytes at ICSI
The proportion of MII oocytes at ICSI RI (Table II) is defined as the
proportion of oocytes that have nuclear maturity at the time of injec-
tion, and so acts as a proxy indication of the effectiveness of ovarian
stimulation. It is not a laboratory PI, as values are not influenced by
laboratory practice, but rather reflects factors that influence the com-
petence of oocytes coming into the laboratory. The expected range is
75–90% at 40 ± 1 h post-trigger for all COCs retrieved. Values outside
this range could prompt a review of any changes in ovarian stimulation,
triggering or follicle aspiration practice, as changes in the proportion of
MII oocytes could be a factor in changes in fertilization rates and/or
embryo development. Instability in this value could indicate changes in
the stimulation, resulting in a higher proportion of either immature or
post-mature oocytes.
Notes:
– Since this value is expected to be stable, laboratories may choose
‘reporting by exception’—only reporting on it when it falls outside
the expected range.
– It should be noted that nuclear maturity does not necessarily indicate
cytoplasmic maturity of the oocyte (Sundstrom and Nilsson, 1988;
Eppig, 1996; Coticchio et al., 2012).
– Clinics should consider whether they should sub-divide their assess-
ment of this indicator based on patient demographics.
– Good communication between laboratory and clinic (cycle planning
and cycle review) were cited as being vital to excellent outcomes in
IVF programmes (Van Voorhis et al., 2010).
Semen analysis characteristics
Sperm concentration, motility and vitality. Unless semen analyses are
performed employing analytical methods as per the ESHRE SIG
Andrology (Björndahl et al., 2010) or WHO5 (World Health
Organization, 2010) the results for sperm concentration, motility and
vitality will be subject to unacceptably high uncertainty of measure-
ment (Sanchez-Pozo et al., 2013; Björndahl et al., 2016).
Sperm morphology. Sperm morphology assessment is subjective
and so is dependent on consistent training. Since the Tygerberg
Strict Criteria cut-off of 4% normal forms was derived in relation
to IVF success, it could be pertinent in differentiating between the
need for IUI, IVF or ICSI (Mortimer and Menkveld, 2001;
Menkveld, 2010). However, the current visual evaluation of 200
or 400 spermatozoa used in the vast majority of laboratories to
assess ‘percentage normal forms’ has such a large uncertainty of
.............................................................................................................................................................................................
Table II RIs for identifying performance of the ART laboratory.
RI Calculation Benchmark ialue
Proportion of oocytes recovered (stimulated cycles) ×
no. oocytes retrieved
no. follicles on day of trigger
100 80–95% of follicles measured
Proportion of MII oocytes at ICSI ×
no. MII oocytes at ICSI
no. COCs retrieved
100 75–90%
MII, metaphase II; RI, reference indicators; COC, cumulus-oocyte complex.
.............................................................................................................................................................................................
Table III PIs for the ART laboratory.
PI Calculation Competency value (%) Benchmark value (%)







no. fertilized oocytes with 2PN
no. COCs inseminated
100 <6




1 PN rate (ICSI) ×
no. 1PN oocytes
no. MII oocytes injected
100 <3
Good blastocyst development rate ×
no. good quality blastocysts on Day 5
no. 2PN/2PB oocytes on Day 1
100 ≥30 ≥40
PN, pronucleus; PI, performance indicator; PB, polar body.
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measurement that it cannot be considered a reliable predictor for
IVF success/failure for individual men (Kvist and Bjorndahl, 2002;
Björndahl et al.). Unless determined using a more robust method-
ology, sperm normal forms should not be used to direct ART
treatment options.
Sperm motility post-preparation
The sperm motility post-preparation PI is defined as the proportion of
progressively motile spermatozoa in the sperm preparation for insem-
ination, and includes only fresh normozoospermic ejaculate specimens.
Sperm motility after washing should be very high, and low values would
indicate problems with the sperm preparation procedure. In this case,
progressive motility is defined as spermatozoa that are moving with
net space gain of the head, and so includes hyperactivated spermato-
zoa. Although there was excellent agreement among the survey
responses, potential weaknesses of this PI include: possible poor reli-
ability of sperm percentage motility data; non-robust classification of
cases based on uncertainty of semen analysis data; variability in sperm
preparation method used; and abnormal response of the sperm to the
preparation method used. The reference values were competence
90% and benchmark ≥95%.
Notes:
– There is no sperm recovery rate KPI recommended because this is
so heavily dependent on the processing method.
– Recommendations for IUI or IVF treatment:
It was the recommendation of the expert panel that decisions
regarding a man’s suitability or need for an appropriate ART treat-
ment modality (IUI, IVF or ICSI) should be based on sperm numbers
and motility assessments determined in a pre-treatment ‘trial prep-
aration’. The competency threshold value was agreed as at least
90% progressive motility post-wash with a benchmark of at least
95% progressive motility.
– Recommendations for ICSI treatment:
There was no cut-off value recommended for ICSI treatment,
beyond the spermatozoa ideally being alive. In this case, the best evi-
dence of vitality is motility, while the second-best evidence, in the
absence of motility, is HOS-test positive (Björndahl et al.), although
other methodologies exist.
ICSI damage rate
The ICSI Damage Rate KPI (Table IV) is defined as the proportion of
oocytes that is damaged during the ICSI injection, or have degenerated
by the time of fertilization assessment on Day 1. It is informative of
gamete quality and/or operator skill, and excludes damage from
oocyte stripping, which should be very rare. The results can be skewed
by the patient mix or the stimulation protocols used, so all cycles
should be included, to reduce the relative impact of these variables.
The Alpha survey gave similar median and mode values for each level.
These values were agreed by the expert panel in relation to those
.............................................................................................................................................................................................
Table IV KPIs for the ART laboratory.
KPI Calculation Competency value (%) Benchmark value (%)
ICSI damage rate ×
no. damaged or degenerated
all oocytes injected
100 ≤10 ≤5
ICSI normal fertilization rate ×
no. oocytes with 2PN and 2PB
no. MII oocytes injected
100 ≥65 ≥80
IVF normal fertilization rate ×
no. oocytes with 2PN and 2PB
no. COCs inseminated
100 ≥60 ≥75
Failed fertilization rate (IVF) ×
no. cycles with no evidence of fertilization
no. of stimulated IVF cycles
100 <5
Cleavage rate ×
no. cleaved embryos Day 2
no. 2PN/2PB oocytes on Day 1
100 ≥95 ≥99
Day 2 Embryo development rate ×
no. 4-cell embryos on Day 2




Day 3 Embryo development rate ×
no. eight cell embryos on Day 3




Blastocyst development rate ×
no. blastocysts Day 5




Successful biopsy rate ×no. biopsies with DNA detected
no. biopsies performed
100 ≥90 ≥95
Blastocyst cryosurvival rate ×
no. blastocysts appearing intact
no. blastocysts warmed
100 ≥90 ≥99










aDefined as oocytes with 2PN and 2PB on Day 1.
bBased on total number of embryos transferred to all patients in the reference group, not just those for whom an implantation occurred.
cDefinition reached after discussion, as some felt that no. fetal hearts / no. embryos transferred was a more meaningful indicator.
KPI, key performance indicator.
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recommended by the Association of Clinical Embryologists (Hughes
and Association of Clinical Embryologists, 2012). The reference values
for ICSI damage rate are: competence ≤10%; benchmark ≤5%.
ICSI normal fertilization rate
The ICSI Normal Fertilization Rate KPI (Table IV) is defined as the
number of fertilized oocytes on Day 1 (presence of 2PN and 2PB
assessed at 17 ± 1 h post-injection) (Alpha Scientists in Reproductive
Medicine and ESHRE Special Interest Group of Embryology, 2011), as
a function of all MII oocytes injected. This is a common, broad, effect-
ive indicator of good laboratory practice, as it is informative of gamete
quality and/or operator skill. This KPI includes ejaculated spermatozoa
only (fresh or frozen) as results may be lower with surgically retrieved
spermatozoa, and excludes in vitro matured oocytes, as well as
thawed/warmed oocytes (this was dealt with in the cryopreservation
consensus) (Alpha Scientists In Reproductive Medicine, 2012).
Reference values were agreed by the expert panel: competence ≥
65%; benchmark ≥ 80%.
Notes:
– Total ICSI failed fertilization rate: It was the consensus of the expert
panel that complete failure to achieve normal fertilization in an ICSI
cycle did not need to be a PI, but should be reported by exception,
meaning that ‘every case’ should be investigated. This includes only
stimulated cycles, as natural cycles are expected to have only one
oocyte.
– Poor ICSI fertilization rate: Although opinion regarding the expected
incidence of cycles with ICSI fertilization rates <25% was sought in
the Alpha survey, the consensus of the expert panel was to exclude
this indicator, as it did not add to the information already collected.
– Giant oocytes should not be injected due to published evidence of
chromosomal abnormality (Balakier et al., 2002; Rosenbusch et al.,
2002; Lehner et al., 2015).
– Regarding smooth endoplasmic reticulum (SER) positive oocytes,
more recent publications of outcomes suggest that the Istanbul
Consensus recommendation not to inject/inseminate these oocytes
may need to be revisited (Mateizel et al., 2013). It was the opinion
of the expert panel that in the meantime, the decision to inject SER
positive oocytes should be reviewed by the clinical team on a case-
by-case basis. Follow-up of results, including pregnancy outcome
and babies born, in case of insemination and transfer of the resulting
embryos should be performed.
Normal IVF fertilization rate
The Normal IVF Fertilization Rate KPI (Table IV) is defined as the num-
ber of fertilized oocytes on Day 1 (presence of 2PN and 2PB assessed
at 17 ± 1 h post-insemination (Alpha Scientists in Reproductive
Medicine and ESHRE Special Interest Group of Embryology, 2011)), as
a function of all COCs inseminated. IVF normal fertilization rate is an
important indicator of laboratory performance, as it relies upon effect-
ive gamete handling and culture, and so is a measure of the whole IVF
system. The reference values are: competency ≥60%; benchmark
≥75%. It should be noted that the benchmark value was determined
based on a rounding of the product of the benchmark rates for MII
oocytes (90%) and fertilization rate of MII oocytes (80%).
IVF polyspermy rate
IVF Polyspermy Rate PI (Table III) is defined as the proportion of inse-
minated oocytes with more than two pronuclei on Day 1 (17 ± 1 h
post-insemination) and is needed to provide the information to inter-
pret any observed variations in the normal fertilization rate. It was the
consensus that polyspermy rate should be <6%. Observed values
above this rate should be reported and investigated.
1PN rate following IVF or ICSI
The 1PN Rate Following IVF or ICSI PI (Table III) is defined as the pro-
portion of inseminated oocytes with one pronucleus on Day 1 (17 ±
1 h post-insemination). It can provide a marker of a problem in gamete
handling or culture conditions and so should be low under normal con-
ditions. It was the consensus that the 1PN rate should be <5% for IVF
cycles, and <3% for ICSI cycles. The difference between IVF and ICSI
is related to the pre-selection of oocytes prior to ICSI injection.
Observed values above this rate should be reported and investigated.
Failed fertilization rate (IVF cycles)
The failed fertilization rate (IVF cycles) KPI (Table IV) is defined as the
proportion of IVF cycles (excludes ICSI cycles) with no evidence of fer-
tilization (i.e. 0 oocytes with ≥2PN) on Day 1 (17 ± 1 h post-insemin-
ation). It can provide a marker of a problem in gamete quality (sperm
function, oocyte activation, gamete receptors), sperm processing, or
in the number of spermatozoa used for insemination. It should be low,
under normal conditions. Based on the Alpha survey, and on the
values recommended by the Association of Clinical Embryologists
(Hughes and Association of Clinical Embryologists, 2012), it was the
consensus that the IVF failed fertilization rate should be <5% for stimu-
lated cycles. Observed values above this rate should be reported and
investigated.
Zygote grade (IVF cycles)
Zygote grade is an evaluation of the quality of the fertilized oocyte,
conducted 17 ± 1 h post-insemination. It was the consensus that there
were not enough data to recommend indicator values for this meas-
ure. In the discussion related to micronuclei, it was agreed that while
micronuclei are abnormal, there is no evidence to confirm the identity
of these dynamic manifestations.
Early cleavage rate
Early cleavage rate is the proportion of fertilized oocytes that have
undergone the first round of cleavage by 26 ± 1 h post-insemination
by ICSI or 28 ± 1 h post-insemination by IVF. There is evidence that
early cleavage, together with other factors, can be used as embryo
selection method as it has been correlated with implantation rate
(Shoukir et al., 1997; Lundqvist et al., 2001; Balaban and Urman, 2003;
Ciray et al., 2005; Brezinova et al., 2009). However, as it is not rou-
tinely calculated, it was the consensus that while this indicator can be
useful for troubleshooting purposes, there were no recommendations
for expected values.
Cleavage rate
The cleavage rate KPI (Table IV) is defined as the proportion of
zygotes that cleave to become embryos on Day 2 (44 ± 1 h post-
insemination) (Alpha Scientists in Reproductive Medicine and ESHRE
Special Interest Group of Embryology, 2011). It provides an indication
of the ability of the culture system to support cleavage of fertilized
oocytes (i.e. with occurrence of cellular division), and of embryo viabil-
ity, so a low cleavage rate could be a warning that the culture system
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has been impacted by an extrinsic factor. Furthermore, there is evi-
dence that the presence of at least one non-cleaved embryo is predict-
ive of reduced embryo quality for the remaining cohort (Machtinger
et al., 2015). The reference values are: competency > 95%; bench-
mark > 99%.
Embryo development rate
The KPI embryo development rate (Table IV) is defined as the propor-
tion of cleaved embryos at the 4-cell stage on Day 2 (44 ± 1 h post-
insemination) or at the 8-cell stage on Day 3 (68 ± 1 h post-insemin-
ation) per normally fertilized oocyte. This is an indicator of the ability
of the culture system to support cleavage according to the expected
stages, as well as providing an indication of the viability and quality of
embryos. This KPI just considers the developmental stage of the
embryo, regardless of grade, because developmental stage has been
reported to give the highest degree of predictive power, and has the
advantage of being an objective measure. It was acknowledged that
not all clinics consider the specific cell stages defined here, and that the
culture system used can affect the kinetics of embryo development.
The reference values, based on the median and maximum results
from the participants’ laboratories are: Day 2, competency ≥ 50% and
benchmark ≥ 80%; and Day 3, competency ≥ 45% and benchmark ≥
70%.
Notes:
– It was the decision of the expert panel not to consider Day 4 embryo
development rate.
– The Embryo Development Rate KPI is most relevant to clinics that
transfer embryos on Day 2 or 3.
Embryo and blastocyst utilization rates
These potential indicators were defined as the number of embryos (or
blastocysts) suitable for transfer or cryopreservation as a function of
the number of normally fertilized (2PN) oocytes observed on Day 1.
Although it was agreed that these indicators could be of value for
internal laboratory comparison, the consensus opinion was that
because there are so many differences in laboratory and clinical prac-
tice, it was not practical to suggest any values for these indicators.
Blastocyst development rate
The KPI blastocyst development rate (Table IV) is defined as the pro-
portion of blastocysts observed at 116 ± 2 h post-insemination as a
function of the number of normally fertilized oocytes. It estimates the
ability of the culture system to support blastocyst formation from ferti-
lized oocytes (i.e. with formation of ICM, TE and a blastocoele cavity),
and provides an indication of embryo viability. It should be noted that
this definition only considers blastocyst formation, with no consider-
ation of blastocyst-stage or blastocyst quality.
The reference values are: competency ≥ 40%; benchmark ≥ 60%
(Day 5). A possible additional PI might be the development of an add-
itional 10–15% blastocysts by 140± 2 h post-insemination (i.e. by Day 6).
Good blastocyst development rate
The good blastocyst development rate PI (Table III) is defined as the
number of good quality blastocysts as a function of the number of nor-
mally fertilized oocytes. Blastocyst quality is as defined in the Istanbul
consensus (Alpha Scientists in Reproductive Medicine and ESHRE
Special Interest Group of Embryology, 2011). This indicator estimates
the ability of the culture system to support the formation of high-grade
blastocysts from fertilized oocytes (i.e. with formation of ICM, TE and
a blastocoele cavity), and an indication of embryo viability. The refer-
ence values are: competency ≥ 30%; benchmark ≥ 40% (Day 5). A
possible additional PI might be the development of an additional
5–15% blastocysts by 140 ± 2 h post-insemination (i.e. by Day 6)
(depending upon the culture system).
Proportion of good blastocysts
This PI is defined as the proportion of blastocysts with a grade of
‘good’ or higher. There was no discussion of reference values for this
indicator, as they can be inferred from the preceding two Indicators.
Day 5 embryo transfer rate
This PI is defined as the proportion of cycles with at least one utilizable
blastocyst on Day 5 relative to the presence of at least one 2PN
oocyte on Day 1, to allow for the inclusion of cycles in which the deci-
sion has been made to cryopreserve all embryos. This indicator
reflects the efficiency of the whole culture system, but is only relevant
for those clinics that have a blanket strategy of Day 5 transfers. It was
the consensus opinion that as there are too many clinic-specific vari-
ables, including different embryo transfer policies in different centers,
clinics should develop their own expectations for this indicator,
depending on when the decision to go to Day 5 transfer is made (e.g.
Day 0 vs Day 3).
Implantation rate
For this consensus, the implantation rate KPI (Table IV) is defined as
the number of gestational sacs divided by the total number of embryos
transferred, irrespective of whether a pregnancy was established
(Zegers-Hochschild et al., 2009). There was some dissent about the
use of sacs, rather than fetal hearts—which was felt to be a more
meaningful indicator of implantation rate—however sacs are used by
most national/international registries. Following discussion, it was
agreed to use sacs for the purpose of this consensus, but that the use
of fetal heart as the numerator should be revisited in the future.
Implantation rate provides an indication of the overall performance
of the laboratory so an overall low implantation rate is a serious sign of
a systemic problem. Values would be expected to be lower for Days 2
and 3 transfers than for blastocyst transfers. In addition, results will be
influenced by clinical factors (e.g. uterine receptivity) and the existence
of different policies in different centers for deciding the day of embryo
transfer.
Reference values for implantation rates
Planned transfers of cleavage-stage embryos (Day 2 or 3): competency ≥
25%, benchmark ≥ 35%.
Blastocyst transfers: competency ≥ 35%, benchmark ≥ 60% (the panel
was divided between 55% and 60%, but agreed that 60% was an aspir-
ational goal).
Note: These values could be affected if there are a large number of
patients in the cohort who have had a large number of previous,
unsuccessful cycles or significant clinical adverse factors. In addition,
individual clinics may wish to further stratify their results based on
patient age groups.
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Live birth rate
It was the consensus that there are too many other variables to sup-
port the use of LBR as a laboratory indicator for either cleavage-stage
or blastocyst-stage embryo transfers.
Successful biopsy rate
The KPI successful biopsy rate (Table IV) is defined as the proportion
of biopsied and tubed/fixed samples where DNA is detected. It is a
measure of the ability of embryologists to transfer the biopsied sam-
ples to test tubes, as proven by positive DNA amplification.
Based on data from the surveys and the PGD Consortium, which
reported a 91% diagnosis rate in 254,820 biopsies (De Rycke et al.,
2015), the reference values were: competency ≥ 90%; benchmark ≥
95% (Table IV).
No biopsy
This indicator was defined as the proportion of treatment cycles that
had no embryos available for biopsy. It was the consensus that not
having good quality blastocysts for biopsy is not an indication of the
quality of the PGD/PGS service. It is an expression of blastocyst devel-
opment rates, and so no further values were developed for this
indicator.
No embryos found on warming/degenerated on warming
Nowadays, the majority of PGT cycles are based on blastocyst biopsy
and cryopreservation. It was agreed that no embryos found on warm-
ing/degenerated on warming should be a KPI, as it provides a reflec-
tion of operator skills, and/or the device used. However, since not
finding the embryo is a rare event, the panel was unable to estimate a
competency value, as the value would be very low.
Owing to greater experience with blastocyst vitrification, the rate of
degeneration on warming should now be lower than that estimated in
the previous cryopreservation consensus (Alpha Scientists In
Reproductive Medicine, 2012). Similarly, it was the consensus that re-
expansion does not differ between (warmed) biopsied and non-
biopsied blastocysts.
Notwithstanding some device differences, the reference rates for
blastocyst cryosurvival could now reasonably be expected to be: com-
petency ≥ 90%, benchmark ≥ 99% (Table IV).
Implantation rate of biopsied embryos
It was the consensus that the implantation rate for blastocysts biopsied
for PGS should exceed that expected for the age-matched patient
population in the same clinic. From the literature, a meta-analysis
reported an improvement of 30% sustained implantation rate after the
transfer of PGS-selected blastocysts relative to controls (Scott et al.,
2013; Dahdouh et al., 2015).
Time-lapse imaging
Despite the increasing number of IVF cycles incorporating time-lapse
imaging for embryo assessment and selection, the panel considered it
premature to propose time-lapse related PIs for the IVF laboratory,
owing to the limited and varied data associating precise timings of
human embryo development with viability or good laboratory practice.
It was accepted, however, that because of the detailed morphological
and kinetic information collected per embryo, time-lapse imaging may
prove to be a future early warning tool for compromised culture con-
ditions, providing a (intra-)laboratory PI, specifically if a change in mean
timings for embryos to reach developmental milestones may be
detected more readily and rapidly than with standard assessment
methods.
A time-lapse assay of mouse embryo development linked specific
morphokinetic changes to toxicity of mineral oil. This demonstrates
the sensitivity of mouse embryo cleavage timings to the quality of the
culture environment, and the potential value of time-lapse in detecting
such changes (Wolff et al., 2013). To date, no studies of this type have
been performed on human embryos.
The current recommendation, therefore, was that clinics may
wish to establish time-lapse KPIs and benchmarks based on their
own experience. It was suggested that the frequency of anomalous
cleavage events, such as trichotomous mitosis (direct cleavage to
three cells), which is known to be relatively common (6–8%) and
associated with reduced implantation potential, could be moni-
tored for future use as a KPI (Rubio et al., 2012; Athayde Wirka
et al., 2014). In addition, it was considered that clinics using valid-
ated time-lapse algorithms for embryo selection may develop
benchmarks associated with the proportion of embryos which
ranked highest using morphokinetic modeling. Large-scale popula-
tion studies are, however, required in order to identify which, if
any, morphokinetic markers can be developed into universal and
useful laboratory KPIs. It is also important to point out that mor-
phokinetic embryo performance is believed to be highly associated
with clinical and laboratory practices, and may, therefore, be diffi-
cult to compare between laboratories.
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Clinical Aspects of Time Lapse Imaging
Alison Campbell
Introduction
Morphological assessment of the preimplantation human 
embryo is the single and most commonly used method employed 
for embryo selection following IVF, and the correlation between 
embryo morphology and implantation potential has been exten-
sively demonstrated and documented.
Typically, this morphological evaluation consists of up to six 
single, daily, conveniently scheduled observations during in 
vitro development to the blastocyst stage. Although, as stated, 
selection of the embryo(s) for transfer tends to be weighted 
toward the morphology of the embryo just prior to embryo trans-
fer, other factors play a significant role. Assessing cell number at 
a particular time of development and the amount of fragmenta-
tion have led to simple embryo grading schemes, such as that 
utilized within the United Kingdom.1 Other schemes include a 
more graduated approach to embryo scoring that takes into 
account several other variables such as pronuclear morphology.2 
More recently, the Istanbul consensus workshop on embryo 
assessment aimed to define common terminology and the mini-
mum criteria for oocyte and embryo morphology assessment to 
allow effective comparisons and standardized reporting.
This published evidence-based grading scheme relies on 
morphological parameters as well as developmental stages 
being reached, each of which have been proven to be associated 
with embryo viability.3,4
Failure to select a viable embryo from a cohort will inevitably 
limit the chance of a positive outcome. The unwitting selection 
of a nonviable embryo, and the cryopreservation of viable 
alternative(s) within a cohort, will also delay the desired out-
come. There is rapidly growing evidence to support that more 
emphasis should be given to the selection of embryos displaying 
optimal morphokinetic characteristics; however, assessment of 
morphokinetics (the morphology and dynamic behavior of the 
embryo, studied over time) is not possible when using standard 
incubation accompanied by static microscopical methods. The 
limited observations employed to minimize environmental 
stress to the embryos using this traditional ‘snapshot’ approach 
provide comparatively limited information on developmental 
rates or patterns.
The introduction of time-lapse microscopy as a clinical tool 
in IVF has resulted in several reports of improved embryo 
selection based on the analysis of sequential time-lapse images 
of embryo development. Time-lapse devices, now commer-
cially available for the IVF laboratory, allow the capture of 
images of the embryos developing in vitro at regular intervals 
throughout the culture period. This provides continuous and 
uninterrupted monitoring that furnishes embryologists with a 
more sophisticated and promising tool for the study and selec-
tion of the human preimplantation embryo beyond conven-
tional daily microscopy. The EmbryoScope was the first 
instrument to provide stable, uninterrupted incubation com-
bined with internal microscopy. Meseguer et al., using this sys-
tem, observed a 20 per cent increase in pregnancy rate compared 
to standard incubation and attributed this improvement to the 
EmbryoScope’s stable culture conditions and use of morphoki-
netic variables for embryo selection.5 Time-lapse technology 
also allows the identification of aberrant embryo cleavage that 
would not be observable using static traditional methods. An 
example of aberrant cleavage, which is reportedly common, is 
the phenomenon of a direct, or rapid, cleavage to three cells—
in less than 5 hours.6 This study demonstrated the ability of 
time lapse to identify aberrant cleavage divisions and high-
lights the reduced implantation potential when such embryos 
were transferred compared with embryos that did not exhibit 
this behavior. In a cohort of 1,659 transferred embryos, the 
incidence of this ‘direct division’ was 13.7 percent, and the 
known implantation rate of these embryos was markedly and 
statistically significantly lower than for embryos with a normal 
cleavage pattern (1.2 versus 20.2 percent, respectively). 
Importantly, this aberrant, but relatively common and clini-
cally significant, cleavage had not been identifiable prior to 
time lapse being available.
There are multiple applications for time-lapse monitoring 
within the IVF laboratory. These include validation of conven-
tional static assessment methodologies, prediction of embryo 
viability and outcome, comparison of the potential impact of 
variables such as culture media or drug regimens on morpho-
kinetics, observation of transient or aberrant morphological 
phenomena, quality control, and improvement of flexibility 
and working patterns. This chapter considers practical aspects 
of time-lapse imaging, considers the use of morphokinetic data 
to develop embryo selection algorithms, and discusses how 
time lapse can be incorporated into the IVF laboratory in order 
to increase flexibility, information, and outcome for IVF 
patients.
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Selection and Deselection Morphokinetic Criteria
Time-lapse monitoring of the dynamics of embryo develop-
ment, in addition to traditional qualitative morphological obser-
vations, provides morphokinetic information on individual 
embryos. These data, generated by the manual or automatic 
recording (annotation) of the images, collected over precise 
time points, can be retrospectively analyzed against outcome 
variables, such as blastulation implantation, ploidy, or live birth. 
This type of analysis may allow practitioners to identify pro-
spective and preferential selection criteria for embryo transfer 
or cryopreservation.
It is also effective in identifying exclusion, or ‘deselection’ 
criteria. For example, if a morphokinetic variable or event is 
shown to be associated with very poor clinical outcome, or even 
preclude implantation, embryos exhibiting this can be dese-
lected for transfer, irrespective of their traditional morphologi-
cal score.
Data Handling
Morphokinetic data from time-lapse monitoring systems should 
be precisely grouped according to known outcome following 
embryo transfer, for comparison and statistical analysis. 
Specific attention is required to exclude data following multiple 
embryo transfer that resulted in a lower number of fetal hearts 
or babies born than the number of embryos transferred. 
Additionally, inclusion of double embryo transfer morphoki-
netic data where two implantations resulted may be problematic 
without the use of genetic fingerprinting to ascertain the chori-
onicity or zygoticity of the pregnancies. Due to the ranges 
observed for each morphokinetic variable, it is recommended 
that median values be used for comparison between successful 
and unsuccessful groups of embryos as opposed to means in 
order to avoid skewing the results. Once key significant vari-
ables have been identified, depending on the power of the data 
set available, they can be ranked according to their association 
with outcome and simple embryo selection algorithms, or mod-
els, developed.
Embryo Selection Algorithms
IVF clinics already use evidence-based biomarkers of embryo 
quality to aid their decision as to which embryo should be trans-
ferred or cryopreserved (e.g., early cleavage to two cells, pres-
ence of smooth endoplasmic reticulum aggregates), but this 
practice has limitations based on the static nature of the obser-
vation and often transient nature of the markers. Nevertheless, 
the embryologist may elect to use these existing selection or 
deselection criteria while building experience and data with a 
newly introduced time-lapse system, and while their individual, 
specific criterion is fine-tuned over time. For example, rather 
than using the current consensus value of 25 ± 1 hour, postin-
semination, for early cleavage observation on day 1, as defined 
by the embryo grading and assessment guidelines, a more pre-
cise time point for this event, perhaps incorporating the insemi-
nation method, or patient factors, will in time be established for 
that setting which relates to outcome.3,4 It may then be incorpo-
rated into an embryo selection model.
The first morphokinetic-based model, which used specific 
timings to predict embryos most likely to develop to the blasto-
cyst stage, was reported by Wong and colleagues in 2010.7 Since 
then, prediction of blastulation, as a measure of embryo quality, 
or viability, has now been superseded by more robust clinical 
outcome measures such as ploidy, implantation, and live 
birth.8-14
Meseguer and colleagues used a hierarchical approach to 
modeling such that embryos received a classification based pri-
marily on developmental milestones and relative timings asso-
ciated with them. In a retrospective analysis of over 500 
transferred embryos, where specific implantation data were 
available for 247, they found significant differences between 
implanted and not implanted embryos for six early morphoki-
netic variables, the most significant for implantation prediction 
being the time the embryo reached the five-cell stage (t5) and 
the duration of the second cell cycle (cc2). Their published 
model included three exclusion criteria based on their negative 
association with implantation. These were direct cleavage from 
one to three blastomeres, uneven blastomeres, and multinucle-
ation at the four-cell stage.8 More recently, Campbell and col-
leagues considered whether there was a difference in the 
morphokinetics of euploid and aneuploid embryos using data 
from blastocysts that had undergone biopsy and preimplanta-
tion genetic screening (PGS).9 The only significant variables 
identified, from more than 20 variables compared, were the 
time to start blastulation (tSB) and the time to reach the full 
blastocyst stage (tB) defined according to their annotation sys-
tem. From this, using recursive partitioning, they presented a 
risk classification model for aneuploidy.9 More recently, Basile 
and coworkers have proposed a logistic regression–based 
model to improve the chance of selecting a euploid embryo 
from a cohort, based on morphokinetic data from embryos that 
underwent blastomere biopsy and PGS. They reported that 
chromosomally normal and abnormal embryos have different 
kinetic behavior and based the model on the significant mor-
phokinetic variables t5-t2 and cell cycle three (cc3 = t5-t3).15 
Even though euploidy is crucial for optimum live birth out-
come, there are clearly many more factors required within the 
embryo itself, and maternally, in order to ensure viability. For 
this reason, healthy live birth, rather than ploidy, is the ultimate 
outcome measure. Live birth was used as an outcome measure 
in a multiplicative model for early cleavage embryo selection. 
In this model, key variables and timings or intervals were 
weighted in order to create a ranking of embryos based on their 
predicted live birth potential. When morphokinetic profiles 
were compared between embryos that resulted in live birth and 
those that did not, the significant morphokinetic variables iden-
tified related to the first cleavage and early cell cycle lengths. 
Although a small study, this model is promising and was dem-
onstrated to be very predictive of live birth as measured by the 
area under the receiver operating characteristic (ROC) curve 
(value was 0.8).14
Despite a number of morphokinetic embryo selection models 
now being published, it should be noted that such models may 
not be directly transferrable to another clinical setting. Inability 
of a model to be effectively reproduced in an alternative setting 
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may be due to confounding factors, such as culture environ-
ment. For example, partial pressures of incubation gases or 
media used have been reported to influence morphokinetics, as 
have patient factors such as age and body mass.16-18 It was 
recently demonstrated that the multivariate hierarchical selec-
tion model described above was not transferable from one clini-
cal setting to another without modifications.19 Conversely, the 
aneuploidy risk classification model, also referred to above, was 
effectively tested on large and independent data in relation to 
implantation outcome.20 Whether pre-embryonic genome acti-
vation events, such as cleavage morphokinetics prior to the 
eight-cell stage, or later morphokinetic information represent-
ing the activated embryonic genome will give the most reliable 
selection criteria needs further study. Most published work to 
date has focused on events up to the five-cell stage, and as a 
prognosticator for blastulation, or implantation, rather than live 
birth.7,8 While it is recognized that maternal effects may miti-
gate against the survival of the viable embryo, in any event—
and not least because aneuploidy is the largest single cause of 
failure—live birth outcome, in relation to morphokinetics as a 
selection tool, should be the gold standard measure. While 
arguably easier, and consequently more objectively interpreted 
for annotation, they may not be as reliably representative of 
onward embryo development and potential following activation 
of the embryonic genome.
Need for Consensus
Consensus guidelines for professionals working with time-lapse 
monitoring in IVF do not exist currently, although with training 
workshops and forums often facilitated by device suppliers, 
there are opportunities for embryologists and researchers to 
compare and debate best practice. With an inevitably increasing 
proportion of IVF cycles now being conducted using time-lapse 
imaging, the need for professional guidelines for definition, 
interpretation, and annotation of images becomes a priority. 
Annotations are the records of morphological and dynamic 
events that provide the basis on which individual embryos can 
be evaluated and selected using defined criteria. Consistency in 
annotation, within the clinic, and the field will allow alignment 
of effective morphokinetic embryo evaluation.
The process of reaching proposed consensus for morphoki-
netic embryo selection, and acceptance of it, will be challenging 
due to the already existent heterogeneity within the published 
time-lapse studies and the lack of prospective randomized con-
trolled trials to fully support the concepts. Many clinics experi-
ence difficulty in recruiting patients into these studies; this 
classical measure of ‘evidence-based’ data may delay consensus 
for morphokinetic embryo selection. However, these would be 
facilitated hugely by consensus guidelines for the annotation of 
time-lapse images and the definitions used to describe morpho-
kinetic variables.
Second Opinions and Training
One of the key advantages of time-lapse systems in the IVF 
laboratory is the facility to allow clinical embryologists to 
rewind, pause, and review photographic frames in order to con-
sider the detail and context of embryo development with practi-
cal flexibility without interruption of embryo culture. The 
storage of images also allows them to be reviewed retrospec-
tively in order to reannotate further detail and perhaps consider 
novel events that went unrecorded previously (as noted in this 
atlas). It may be particularly worthwhile to annotate additional 
variables, for example, for embryos with known outcomes only. 
This would provide clinical relevance and possibility in the 
search for morphokinetic biomarkers for live birth outcome.
Quality Control and Assurance
As with many aspects of the embryologist’s role, there are prac-
tical and efficiency benefits if multiple individuals are trained 
and competent in routine daily tasks. Time-lapse annotation is 
no exception, and once introduced into the laboratory, review, 
annotation, and interpretation of time-lapse images is currently 
considered a daily task. Where there are multiple practitioners 
involved, the risk of subjectivity and inconsistency is highest, 
although intrapractitioner annotation variation may also exist. 
Ensuring the most accurate and objective record of dynamic, 
often anomalous, embryo development brings challenges 
whether using automatic detection software or solo or collective 
manual methods. In order to minimize subjectivity, it is recom-
mended that key variables for annotation be defined within the 
standard operating procedure (SOP) and that these be routinely 
recorded. With the current lack of consensus, policy should be 
set in house, adhered to, monitored, and refined where required. 
Core morphokinetic variables should be identified and anno-
tated following rigorous training and competency assessment. 
Some morphokinetic variables are more at risk of subjective 
interpretation than others (e.g., the appearance of pronuclei). 
The use of reference images may be beneficial in assuring anno-
tation quality.
The most commonly recorded morphokinetic variables fol-
low the basic principles of embryology and mitosis and include 
timing of pronuclear appearance and fading, increasing cell 
numbers (time to two, three, four, five, six cells, etc.), and times 
of embryo differentiation to the morula and blastocyst stages. 
Durations of mitotic cycles and synchronicity can then be cal-
culated from these. In addition, specific anomalies or phenom-
ena associated can be annotated, depending on the 
customizability of the time-lapse system available.
Once established, a regular audit of annotation completion 
and quality and adherence to SOP is essential in order to main-
tain high-quality data to allow analysis and opportunity for 
identification of significant selection or deselection morphoki-
netic criteria.
Early indications are that many of the morphokinetic events 
are recorded objectively, but it is critical that regular review and 
assessment exercises should be undertaken to assure quality. A 
study by Sundvall and colleagues considered inter- and intra-
practitioner variation in annotation, using the intraclass correla-
tion coefficient.21 Their study demonstrated a close correlation 
between both experienced and new time-lapse users for most 
morphokinetic variables but highlighted that some ‘static mor-
phologic parameters’ such as multinucleation and blastomere 
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evenness remained at risk of subjectivity. With ongoing assess-
ment and clear definitions and SOP, this can be minimized. 
Another report also found close correlation between annotators 
but highlighted how one misannotation could skew the data out-
put.22 In summary, until we know the potential impact of subtle 
deviations from protocol, culture dishes or slides should be pre-
pared in a standard and precise fashion, and annotation of time-
lapse images, where performed manually, performed with 
objectivity by all practitioners.
Flexibility and Opportunity
Due to the great interest in time-lapse technology by profession-
als in the field of IVF, the promising clinical results, opportuni-
ties to broaden knowledge of the preimplantation embryo’s 
development, and its visual nature which appeals to clinic staff 
and patients, swift advances in the technology and the applica-
tion of it are inevitable.
Computer servers, rather than stand-alone devices, will allow 
the support of new applications such as patient interface, 
improved data collection, storage, sharing, and remote access.
The Zoi server (FertiliTech, Denmark) is such a platform that 
supports secure data sharing within and between clinics using 
EmbryoScope. Patient data can be collected from multiple con-
nected incubators and centralized in a common storage loca-
tion. This enables IVF practitioners to view, annotate, and select 
embryos remotely which opens up new opportunities for pro-
ductivity and flexibility. Before too long, time-lapse users may 
also expect statistical software packages for quality assurance 
and detailed analysis of data with associated embryo selection 
model building.
Summary
Within this rapidly progressing and promising area of reproduc-
tive medicine, practitioners now have an additional and increas-
ingly reliable tool for improving embryo selection. It is yet 
unclear as to which patients may benefit most from this new 
approach, and reported significant uplifts in pregnancy and live 
birth rates by the use of this technology are still to be proven in 
large, randomized, controlled trials. However, it makes sense to 
observe and interpret the dynamic process of preimplantation 
embryo development, using technology that allows the dynamics 
to be studied, rather than a rigid and static, snapshot method, not 
least for the anomalies that can be excluded. The more we inter-
rogate the collated images and data output, the more we can 
understand whether an optimal morphokinetic profile exists. 
The technology has the potential to provide embryo selection 
algorithms such that numerous criteria will be defined for a 
range of varying circumstances, from individual patient criteria 
to generalized laboratory conditions. In time, the optimal ranges 
for defined dynamic events such as those directly associated 
with the ‘normal’ cell cycle may be fine-tuned and further novel 
morphokinetic markers of embryo viability identified.
Time-lapse monitoring is a tool that not only dramatically 
increases flexibility in the IVF clinic but also has the potential 
to train, educate, and most importantly enhance clinical 
outcome.
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Time Lapse, the Cell Cycle, Distribution of Morphokinetic Timings, 
and Known Implantation Data
Alison Campbell
Cell Cycles and Time Lapse Monitoring
A cell cycle is a series of complex events involving cellular and 
nuclear processes through particular phases that ensure the 
cell’s division into two daughter cells. Mitosis consists of nuclear 
division and cytokinesis and consists of several phases: pro-
phase, prometaphase, metaphase, anaphase, and telophase. 
These are preceded by interphase which encompasses stages 
GAP-1 (G1), Synthesis (S), and GAP-2 (G2) of what is known as 
the cell cycle. The duration of cell cycles in the human preim-
plantation embryo appears to be related to embryo viability.1 
Prolonged or rapid cell cycles could be associated with DNA 
repair, cellular rearrangements, or failure of an embryo to 
undergo cell cycle checkpoints. Both cycles could potentially 
compromise embryo development.2
The first cell cycle following fertilization has recently been 
described in detail following a large time-lapse study by Aguilar 
and colleagues.3 In their study, they described initiation of the 
first cell cycle as the time from the completion of the second 
polar-body extrusion. The length of the S-phase (DNA replica-
tion) was defined as the time from appearance to the fading of 
two pronuclei. In this study, embryos with prolonged S-phase 
demonstrated significantly reduced implantation rates compared 
with embryos with S-phases ranging from 5.7 to 13.8 hours. 
Completion of the first cell cycle can be defined as the time point 
at which the embryo reaches the two-cell stage, such that the two 
daughter cells are discrete from each other.
Postinterphase cleavages of corresponding sister blastomeres 
rarely occur at precisely the same time, and so time-lapse users 
may also consider the synchronization of cell divisions within a 
round of mitosis, particularly as this has been reported to be cor-
related to embryo viability. The optimal value for this being 
reported is less than 0.76 hours.4 This can be calculated by the 
synchrony of sister cell divisions. For example, synchrony of the 
second cell cycle would be defined as the duration of the transi-
tion of an embryo from two cells to four cells and is calculated by 
subtracting the time the embryo reached the three-cell stage (t3) 
from the time it reached the four-cell stage (t4). With frequent 
time-lapse image acquisition (such as every minute), the duration 
of each cytokinesis can also be measured from the time a cleav-
age furrow is first visible to the time that the daughter blasto-
meres are discrete from each other.5
Cell cycle duration is calculated using time-lapse annotation 
either according to a single cell division or as a round of mitosis 
whereby the number of blastomeres doubles. For the first cell 
cycle, as development begins with the single cell, these are the 
same. However, the second cell cycle begins with two cells, both 
of which should subsequently divide, forming two daughter cells 
each. There are therefore two individual blastomere cell cycles 
but a single embryo cell cycle, and this results in the doubling 
from two to four cells.
Figure 3.1 provides a schematic to represent the blastomere cell 
cycles (cc) and the rounds of divisions herein defined as embryo cell 
cycles (ECCs), resulting in the doubling from two to four and from 
four to eight cells. The cell cycle for blastomere a, is calculated as 
t3-t2 and documented as cc2a, and for blastomere b as t4-t2 and 
documented as cc2b. The cell cycle whereby the embryo reaches 
four cells from two cells (ECC2) is also calculated as t4-t2. The 
time that the last cleaving blastomere takes to cleave (from t2 to t4) 
equates to the duration of the ECC: All individual blastomeres 
cleave within this time frame. The same applies for the third cell 
cycle. The duration of the embryo’s third cycle (ECC3) is the time 
it takes the embryo to develop from four to eight cells and includes 
four blastomere/cell cycles: a, b, c, and d. The cycle cc3a is t5-t4, 
cc3b is t6-t4, cc3c is t7-t4, and cc3d is t8-t4. Cycle ECC3 is t8-t4. 
The synchronization for ECC3 (S3) is calculated as t8-t5 as the 
period begins once the first of the four cells cleaves (Figure 3.1). 
Video 3.1 shows an oocyte post ICSI as it undergoes fertilization 
and cell division to a hatching blastocyst. The video pauses at the 
described morphokinetic time points; t0 is normally considered as 
the time at insemination (ICSI). The video can be viewed online: 
http://goo.gl/U6TN1n.
Morphokinetic markers depicted in Figure 3.1 and Video 3.1 
are defined as follows, and unless otherwise stated, are considered 
as time post insemination (t0), generally recorded in hours; time to 
pronuclear fading (tPNf); time to two cells (t2), three cells (t3), 
four cells (t4), five cells (t5), and so forth; morula (tM); start of 
blastulation (tSB); and full blastocyst (tB).
Known Implantation Data (KID)
The precise timings or durations of an embryo’s development, its 
pattern and movement (kinetics), alongside its morphology have 
14 Atlas of Time Lapse Embryology
been referred to as its morphokinetics.6 The morphokinetic data 
of a specific and transferred embryo which has a known out-
come is commonly referred to as known implantation data 
(KID). The known outcome may be a pregnancy test result 
(positive or negative), a gestational sac or fetal heart on ultra-
sound scan, a pregnancy loss, or a live birth. Morphokinetic 
data can be compared between embryos giving positive or nega-
tive implantation data (KID+ or KID−), depending on the out-
come measure used. All data can be utilized following a single 
embryo transfer, or a double embryo transfer with a negative 
outcome as the fate of these embryos is known. Using data, fol-
lowing multiple embryo transfer that has resulted in the same 
number of fetal hearts or babies born, may be problematic with-
out the use of genetic fingerprinting to ascertain the chorionic-
ity or zygoticity. However, in time, the level of monozygotic 
twinning can be established and factored to assess its signifi-
cance and thereby the need for DNA fingerprinting.
Due to the ranges observed for each morphokinetic variable, 
it is recommended that median values are used as opposed to 
means. This way, extreme high or low values outliers do not 
introduce a skew.
 The KID positive rates (or ratios) can be calculated for each 
morphokinetic variable in order to consider their impact and 
potential use in embryo selection models. Varied mathematical 
approaches, including recursive partitioning, have then been 
used in model development in order to ascertain significant and 
optimal time values, or ranges, for building embryo selection 
algorithms.7
Figure 3.2 shows a schematic representation of KID.
Distribution of Timings of Cleavages
These data represent over 9000 embryos (in vitro fertilization 
[IVF] and intracytoplasmic sperm injection [ICSI]) that under-
went time-lapse monitoring at the CARE Fertility Group, 
United Kingdom, using EmbryoScope (FertiliTech, Denmark) 
technology. The blue bars represent the numbers and morpho-
kinetic timings for each variable of embryos which implanted, 
defined by the presence of a fetal heart on ultrasound scan (7 ± 
1 week gestation). Timings are given in hours post insemina-
tion (hpi). Embryo culture was performed in microwells of 25 
µL Global IVF medium (LifeGlobal®) supplemented with 10 
percent Dextran serum supplement (Irvine Scientific), overlaid 
with 1.4 mL mineral oil (Fertipro, Belgium). Embryo culture 
took place at 37°C in 5.5 percent CO2, 5 percent O2, and 89.5 
percent N2. It is important to note that ranges of morphokinetic 
variables may vary according to gas tension, culture media, or 
patient factors, and clinics should consider their own data to 
establish expected ranges within their clinical practices.
The morphokinetic variables used in this evaluation are 
described within the text and in Figure 3.3. Durations of a dis-
tinct cell stage (or series of cell stages) can be obtained by sub-
tracting one cleavage time from a later one (e.g., t7-t6 = duration 
of the six-cell stage).
Figure  3.3 shows a schematic representation of commonly 
used morphokinetic variables and calculated durations.
Time to Two Cells (t2)
The distribution of timings for the morphokinetic variable t2 
in all embryos and in KID-positive embryos is shown in 
Figure 3.4.
Figure 3.4 supports the consensus based on static methodol-
ogy that late t2 is associated with reduced implantation poten-
tial.8 The upper limit for t2 in KID-positive embryos is 31 hpi; 
however, the majority of the embryos here were not transferred. 
Figure 3.4 also shows that first cleavage prior to 21 hpi is rela-
tively uncommon at 1.2 percent of t2 data (n = 9,391) and that 
embryos that undergo this first cleavage prior to 21 hpi may 
have a lower incidence of known implantation compared to 
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Figure 3.1 Three embryo cell cycles (ECC1, ECC2, and ECC3).
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Figure  3.4 shows a distinct range of t2 for preferential 
embryo selection and demonstrates how dynamic assessment 
of t2, as an example, provides practitioners with a tool that 
may allow the deselection, or exclusion, of embryos with t2 
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(for live birth)
For implantation (fetal heart activity conrmed) or live birth,
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Figure 3.2 Schematic KID. (Modified from Alison Campbell, Non-invasive techniques: embryo selection by time-lapse imaging. 






























Figure 3.3 Morphokinetic variables.
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Time to Three (t3) and Four (t4) Cells
The non-Gaussian distributions of timings for the morphoki-
netic variables t3 and t4 are shown in Figure  3.5. Optimal 
ranges for t3 and t4 are observed where the highest proportions 
of KID-positive embryos are present. These correspond, how-
ever, to the mode value for embryos overall.
Time to Five (t5) and Eight (t8) Cells
The non-Gaussian distribution of timings for the morphokinetic 
variables t5 and t8 are shown in Figure 3.6. The ranges for KID-
positive embryos at t5 and t8 are broad, and the pattern of dis-
tribution, compared to embryos overall differs from those 
observed in Figure 3.5 for t3 and t4.
Time to Start Blastulation (tSB) and Time to 
Full Blastocyst Stage (tB)
The non-Gaussian distributions of timings for the morphoki-
netic variables tSB and tB are shown in Figure 3.7. For these 
variables, in contrast to the chronologically earlier variables 
discussed, the median values for tSB and tB in the KID-
positive cohorts are earlier than the median values for the over-
all cohorts. These two morphokinetic variables were 
demonstrated to be delayed in preimplantation genetic screen-
ing (PGS)–confirmed aneuploid embryos compared with their 
euploid counterparts and have therefore been identified as 
potential morphokinetic variables for blastocyst selection 
models.7



































Figure 3.6 (a) Distribution of timings for the morphokinetic 
variable t5. (b) Distribution of timings for the morphokinetic 
variable t8.














Figure 3.4 Distribution of timings for the morphokinetic vari-
able t2 in all embryos and in KID-positive embryos.


































Figure 3.5 (a) Distribution of timings for the morphokinetic 
variable t3. (b) Distribution of timings for the morphokinetic 
variable t4.
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Second Cell Cycle (cc2)
Time-lapse studies of rapid cleavage events to the three-cells 
stage (in less than 5 hours) have demonstrated this to be a mor-
phokinetic criterion significantly associated with reduced 
implantation rates. Embryos displaying this irregular division 
pattern, described as direct cleavage, gave rise to implantation 
rates of 1.2 percent compared with 20.2 percent for embryos not 
displaying this division pattern.8
Analyses of the duration of the second cell cycle, in over 
9000 embryos, at the CARE Fertility Group show a bimodal 
distribution with differing variance; the direct division from 
one to three cells (trichotomous mitosis), associated with the 
first peak, was less frequent than the division pattern when 
two cells were reached as an intermediate stage (Figure 3.8). 
The irregular division pattern in this cohort, represented by 
the first peak, is also associated with significantly reduced 
implantation.
This large analysis demonstrates that 26.3 percent of embryos 
undergo irregular cleavage, either directly (or rapidly) from one 
to three cells in less than 5 hours. Such events are not observ-
able using static conventional assessment.
A peak for optimal cc2 range is observed where the highest 
number of KID-positive embryos are present (Figure 3.8).
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Figure 3.7 (a) Distribution of timings for the morphokinetic 
variable tSB. (b) Distribution of timings for the morphokinetic 
variable tB.
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Prediction of Embryo Viability 
by Morphokinetic Evaluation to Facilitate 
Single Transfer 
Aisling Ahlström , Alison Campbell , Hans Jakob Ingerslev , 
and Kirstine Kirkegaard 
Introduction 
Optimal culture conditions and reliable embryo selection constitute two major 
challenges for successful IVF treatment. Embryo quality is typically assessed by the 
use of grading systems based on morphological evaluation under a microscope at 
certain, distinct time points. This methodology has several limitations. The inability 
to accurately assess embryo quality constitutes a hindrance for evaluating the impact 
of culture conditions and for estimating the reproductive potential of an embryo. 
The recent development of clinical time-lapse instruments has enabled continuous 
monitoring of human embryos, hereafter referred to as time-lapse imaging (TLI). 
TLI, where consecutive images are obtained during embryo culture by using a 
microscope and a camera, allows for a refi ned evaluation of known morphological 
parameters and represents a new method of evaluating embryo viability. Several 
retrospective studies have demonstrated a correlation between timing of key events 
and developmental or implantation potential, which suggests time-lapse imaging as 
a promising method for a more reliable embryo selection than morphology alone. 
However, as we expand our knowledge of pre-implantation embryo development, it 
becomes increasingly clear that timing is infl uenced by several patient- and 
treatment- related factors. This may complicate the establishment of a prediction 
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model for optimal embryo development that may be applied under a variety of 
conditions across heterogeneous patient groups. This chapter addresses the use of 
TLI in the evaluation of pre-implantation embryo development and pregnancy 
potential in an effort to provide an overview of the feasibility and potential use of 
TLI in IVF treatment. 
Scoring of Static vs. Dynamic Parameters 
Traditionally, the quality and viability of pre-implantation embryos are evaluated by 
a microscopic inspection at a few, well-defi ned discrete time points. There is a welldocumented 
close correlation between morphological appearance and developmental 
stage of the embryo at given time points and developmental competence (as reviewed 
by ALPHA and ESHRE [ 1 ]). Due to the simplicity and cost-effectiveness of static 
morphological grading and lack of documentation for existing alternative methods, 
traditional morphological evaluation therefore remains the choice method for embryo 
evaluation. Nevertheless, this approach has several recognized limitations. Firstly, the 
information obtained with a few, discrete time point provides an incomplete picture 
of the inherent dynamic process of embryo development, as illustrated by the observation 
that embryo score may change markedly within a few hours [ 2 ]. This limitation 
is obviously overcome with continuous monitoring. Furthermore, morphological 
scoring of embryos has shown substantial inter- as well as intra-observer variation, 
which in turn has implications for the decision to transfer, cryopreserve, or discard 
the embryos [ 3 – 5 ]. A probable cause for this variation is that assessment in categories 
tends to be rather imprecise. In contrast, the assessment of time-lapse parameters 
appears to have a high degree of intra- and interobserver agreement [ 6 ]. Theoretically, 
this agreement will depend on the instrument used, in particular the resolution, the 
number of focal planes, and the intervals between the photographic recordings. Any 
variation in clinical decision-making remains to be assessed, as no model has presently 
been prospectively validated, as discussed in detail below. TLI necessitates periodical 
light exposure, use of moving devices, and magnetic fi elds that constitute 
potential risks to the embryos. The safety of TLI for IVF has been documented in two 
trials conducted with the same instrument. Embryo development was the primary 
endpoint in both trials [ 7 , 8 ]. As for any new method introduced in the ART laboratory, 
a suffi ciently powered study using pregnancy rate or live birth rate with pediatric 
follow-up would be preferable before any defi nitive conclusions are drawn. Likewise, 
it must be noted that both trials were conducted using the same TLI instrument and 
that the conclusions may not necessarily extend to include other systems. 
Introduction to Time-Lapse Parameters 
While time-lapse monitoring is a rather novel method in the ART lab, the method 
has been used for nearly a century to study embryo development for research purposes 
[ 9 ]. Prior to the introduction of clinical instruments, research was conducted 
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on embryos from various animal species or more seldom, surplus human embryos. 
Initially, the studies were aimed at describing the process of development, but as IVF 
was introduced, the attention was directed toward the potential use of time- lapse 
imaging to characterize division patterns and dynamic parameters that potentially 
would identify embryos that are viable beyond the time of observation. The following 
section describes typical in vitro development of a pre-implantation human 
embryo and the events that are visible and thus recordable in a time-lapse analysis. 
Development of a human embryo begins with fertilization. The spermatozoon 
penetrates the extracellular multilayer glycoprotein coat, zona pellucida (ZP) [ 10 ], 
and the spermatozoon membrane fuses with the oocyte membrane [ 10 ]. The associated 
formation of the male pronucleus can be visualized with time-lapse monitoring. 
During normal fertilization the fusion of the two membranes initiates oocyte 
activation, leading to the completion of the second meiotic division of the oocyte. 
This stage is visualized by the extrusion of the second polar body 3–7 h after fertilization 
[ 11 ] followed by the visible formation of the male and female pronuclei. The 
male and female pronuclei ( pn ) start replicating their DNA as they migrate toward 
each other in the zygote. This process can be visualized morphologically as syngamy/ 
abuttal of pn [ 12 ]. After DNA replication, the two nuclear envelopes break 
down, and the 2 pn are no longer visible. The zygote subsequently enters the fi rst 
mitotic division and cleaves and two embryonic cells, or blastomeres, are formed. 
The process from formation of the cleavage furrow until complete separation of the 
two daughter cells is denoted fi rst cytokinesis [ 13 , 14 ]. The fi rst cleavage cycle is 
completed with the fi rst division early on “day 2,” 24–29 h after fertilization 
[ 15 – 17 ]. The two embryonic cells divide during the second cleavage cycle, forming 
a 4-cell embryo on day 2. 
The third cleavage cycle results in the formation of an 8-cell embryo on day 3, 
followed by a fi nal round of cell divisions, before compaction occurs, visualized as 
obscured intercellular boundaries, and the embryo develops into a morula on day 4. 
Shortly after the morula stage a fl uid-fi lled cavity develops. This appearance of this 
cavity, the blastocoel, defi nes the beginning of the early blastocyst stage [ 10 ]. This 
cavity expands until it fi lls most of the embryo (full blastocyst stage). Continued 
expansion leads to a progressive thinning and, eventually, focal rupture of the surrounding 
zona pellucida (ZP). Escape of the mammalian embryo from the ZP, 
referred to as hatching, is initiated on day 5–6 in vitro. 
Deviations from the above description of a normal in vitro development are often 
observed and are of particular interest as they presumably represent underlying 
abnormalities. An extreme short duration of the fi rst division cycle (the 2-cell stage), 
referred to as a direct cleavage from one to three cells, is often observed in 
tri- pronuclear embryos presumably as a result of an excess centriole [ 18 ]. Direct 
cleavage from one to three cells is however also observed in embryos with a presumed 
normal chromosomal content where the deviation is associated with a signifi 
cantly lower implantation rate compared to embryos with a normal cleavage 
pattern [ 19 , 20 ]. Likewise, an aberrant fi rst cytokinesis has been correlated to 
decreased developmental potential [ 14 ]. These studies illustrate the potential benefi 
ts of characterizing not only optimal division patterns but also deviations from the 
normal pattern as a single embryo is selected for transfer. 




First to demonstrate the potential of morphokinetic-based predictive models, Wong 
and colleagues [ 14 ] predicted the developmental fate of 4-cell embryos with exceptional 
sensitivity (93 %) and specifi city (94 %). In this model, a combination of 
three morphokinetic parameters (duration of fi rst cytokinesis, interval between fi rst 
and second mitosis, and interval between second and third mitosis) was used successfully 
to predict blastocyst formation or developmental arrest. More recently, 
Conaghan and colleagues chose to reevaluate solely these parameters during development 
of a morphokinetic model for prediction of usable blastocysts (blastocysts 
selected for transfer or frozen storage on day 5) [ 13 ]. In this large study, morphokinetic 
data from fi ve clinical sites were collected from embryos cultured to blastocyst. 
No patient and treatment selection criteria were used or restrictions to culture 
conditions enforced [ 13 ]. Notably, the resulting predictive algorithm did not achieve 
the same sensitivity as Wong et al., but when validated on a large independent dataset 
it was much better at identifying embryos that were less capable of developing 
to usable blastocysts than those that did (specifi city of 84.7 %, sensitivity of 38.0 %, 
PPV 54.7 %, and NPV 73.7 %). 
Although blastocyst formation and quality has been used as a measure of embryo 
viability in a number of morphokinetic studies and confers a number of practical 
advantages when researching and validating new technologies [ 21 , 22 ], the information 
generated only becomes useful when translated into pregnancy and live birth 
outcome. Only a few studies have investigated the compatibility between morphokinetic 
prediction of blastocyst formation and quality and prediction of pregnancy 
outcome and these studies have demonstrated confl icting results. The aforementioned 
blastocyst prediction model [ 13 ] was subsequently tested on a large combined 
set of transferred embryos with known clinical outcome [ 23 ]. This study demonstrated 
that the model was somewhat effective with a relative increase of 30 % for 
implantation in the model-selected group of embryos, but it fell short, as there was a 
concomitant large rejection of embryos from the test cohort, which actually resulted 
in pregnancy. This highlights the limitations of predicting blastulation only. 
Hlinka et al. [ 24 ] showed that only 26.4 % of timely blastocysts resulted in a successful 
implantation, not surpassing current IVF success rates [ 24 ]. Moreover, both 
Kirkegaard et al. [ 25 ] and Chamoyou et al. [ 26 ] identifi ed several morphokinetic 
parameters as signifi cant predictors of high-quality blastocyst development, but 
these same parameters were unable to discriminate between implanted and unimplanted 
embryos [ 25 , 26 ]. In dramatic contrast, Dal Canto et al. [ 16 ] showed that 
signifi cantly shorter cleavage times from the 2-cell to 8-cell stage were predictive of 
embryos that develop to blastocysts, expand, and implant [ 16 ]. In another study, 
optimal cleavage stage timings proposed for implantation success have also been 
successfully shown to identify a large proportion of embryos that develop to blastocysts 
with good morphology [ 15 ]. It would seem that further studies are needed to 
elucidate the interpretation of these discrepancies and determine if predictive algorithms 
trained to predict blastocyst development could be used to predict 
implantation. 
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The fi rst group to construct a morphokinetic-based model to predict implantation 
potential developed a hierarchical model that uses both morphological observations 
and kinetic timings to rank embryos in 10 different categories of descending implantation 
potential [ 17 ]. First, embryos are discarded by a set of exclusion criteria 
including poor morphology, direct cleavage from 1 to 3 cells, uneven blastomere 
size at 2-cell stage, and multinucleation at 4-cell stage. Then timings of three morphokinetic 
parameters were ordered according to predictive strength: time to 5-cell 
stage, time interval between second and third mitosis, and time interval between 
fi rst and second mitosis are used to characterize embryos depending on timings 
lying in or out of acceptable ranges. These optimal time ranges were defi ned by the 
timings of 247 implanting and non-implanting embryos that were fi rst subdivided 
into quartiles and the two consecutive quartiles with the highest number of implanting 
embryos were then selected as in-range values. Embryos that did not develop 
within these time intervals were considered out of range. This group suggested that 
categorization of embryos from high to low implantation potential according to this 
model was improved when compared to using morphology alone (AUC 0.72 vs. 
0.64). Nevertheless no statistical difference in implantation rate was found between 
embryos in the highest scoring category compared to embryos of highest morphological 
grade [ 17 ]. Subsequently, the same group tested the application of this model 
to data collected from 10 clinical sites in a larger retrospective study and suggested 
that a relative improvement to the clinical pregnancy rate of 20.1 % per embryo 
transfer could be achieved compared to a control group of embryos cultured in conventional 
incubators and selected solely by static morphological grade [ 27 ]. 
However, this study was not randomized and the improved clinical pregnancy rate 
could also be explained by better culture conditions supplied in a time-lapse incubator 
compared with the traditional incubator or selection bias. So far no prospective 
controlled trial has been published to determine if embryo selection using this timelapse 
model can improve IVF success rates. The IVI group has recently completed 
a randomized study. Yet unpublished results report signifi cantly improved ongoing 
pregnancy rate (51.4 % vs. 41.7 %; p = 0.01) and implantation rate (44.9 % vs. 
37.1 %; p = 0.02) for embryos selected using time-lapse criteria compared with 
selection by standard morphological criteria (Rubio et al. [ 20 ]). It has been demonstrated, 
though, that the tested selection model was not transferable from one clinical 
setting to another without modifi cations [ 28 ], thus underlining the diffi culties in 
determining universal criteria for optimal division patterns. 
Since these studies were published, similar hierarchical models to predict 
implantation have been described and again quartiles yielding highest number of 
implanting embryos were used to defi ne optimal time ranges and embryos developing 
in range have been shown to have higher implantation rates than those embryos 
developing out of range [ 29 , 30 ]. Additionally, several investigators have confi rmed 
that shorter durations of cell cycles and synchronous divisions of sister blastomeres 
are strongly predictive of implantation and that prolonged durations in one or more 
cell cleavage cycles and aberrant cleavage behavior are characteristics of nonimplanting 
embryos [ 16 , 20 , 24 , 30 ]. Most strikingly, abrupt cleavage from one to 
three cells, defi ned by a short 2-cell duration of <5 h, has been shown in a number 
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of studies to be a strong negative marker of implantation [ 17 , 20 , 25 ]. This abnormal 
cleavage pattern has largely been unnoticed in static routine observations before the 
introduction of TLI monitoring. It may be argued that the superior ability of morphokinetic 
models to identify less viable embryos rather than identify embryos of 
highest reproductive potential may create the basis for a strategy of time-lapse based 
embryo selection that will translate into improved clinical outcome. Such an 
approach will have particular relevance in the setting of single embryo transfer. 
Recently, the correlation between timing of kinetic parameters and embryonic 
aneuploidy, has been the focus of several morphokinetic studies [ 19 , 29 , 31 – 33 ]. 
In the past, morphology and sequential embryo scoring systems have had limited 
success at identifying aneuploid embryos [ 34 – 37 ] and static observation of multinucleation 
on days 2 and 3 has been shown to have a positive association with 
aneuploidy and used routinely to deselect embryos [ 38 , 39 ]. However, a number 
of preliminary studies suggest that morphokinetic behavior can be used to increase 
the probability of selecting euploid embryos without invasive genetic screening. 
A number of small studies report possible correlations between timings of early 
mitotic divisions and embryonic aneuploidy [ 33 , 40 – 42 ]. One of these studies 
suggests that delayed fi rst and second cleavage divisions and a prolonged transition 
from the 2- to 4-cell stage were signifi cantly correlated to aneuploidy, in 
particular multiple aneuploidies [ 40 ]. This study also confi rmed that embryos 
undergoing abrupt cleavage from 1- to 3-cells and 2- to 5-cells are predominately 
aneuploid. Chavez et al. [ 33 ] observed cell cycle parameters for 45 embryos up to 
the 4-cell stage and found that euploid embryos displayed tightly clustered timings 
when compared to aneuploid embryos, which had more widely distributed 
comparative timings. In this study, only 30 % of aneuploid embryos displayed 
normal timings and these normal timings were determined to predict embryonic 
euploidy with 100 % sensitivity and 66 % specifi city [ 33 ]. Most recently, a much 
larger study analyzing the chromosomal content of 504 embryos by blastomere 
biopsy on day 3 and array CGH created a hierarchical model to subdivide embryos 
into four categories (A–D) according to expected risk of aneuploidy [ 29 ]. The two 
morphokinetic variables used in this algorithm included time interval between 2 
and 5 cells (>20.5 h) and duration of the third cleavage cycle (t5–t3) (11–18 h). 
Embryos categorized according to in- or out of range timings suggested by 
this model showed a signifi cant decrease in the percentage of normal embryos 
for each decreasing category (A, 35.9 %, B, 26.4 %, C, 12.1 %, and D 9.8 %; 
p < 0.001). Interestingly, this algorithm was better at predicting blastocyst formation, 
which was interpreted by the authors as strengthening their fi ndings. The 
area under the curve was 0.634. 
A similar number of time-lapse studies have not identifi ed an association between 
early cleavage timings and blastocyst aneuploidy as determined by trophectoderm 
biopsy and 24-chromosome analysis [ 19 , 43 – 45 ]. In contrast, one of these studies 
suggested a simple classifi cation model using timing of initiation of blastulation and 
timing of full blastulation to classify embryos into high-, medium-, or low-risk categories, 
with an area under the curve of 0.72 [ 19 ]. An assumption that TLI parameters 
correlate with aneuploidy is hardly justifi ed if the same parameters are not 
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predictive to implantation potential. When this model was tested on a group of 
transferred blastocysts ( n = 88) from un-selected non-PGS IVF patients and related 
to implantation and live birth outcome, the risk classifi cation was shown to correlate 
to clinical outcome. Interestingly, the relation was consistent, even when accounting 
for an important confounding parameter, such as age [ 31 , 32 ]. The other signifi cant 
variable identifi ed to differ, between embryos with multiple aneuploidies only and 
euploid embryos in the Campbell study, was the time to the start of compaction 
(tSC) [ 19 ]. Several other small studies considering ploidy and morphokinetics have 
reported peri-compaction and cavitation delays in aneuploid embryos diagnosed by 
comprehensive chromosome screening methods of trophectoderm biopsies. 
Montgomery et al. reported that where the duration of compaction was <22 h, fragmented 
embryos were signifi cantly more likely to produce a euploid blastocyst 
( p = 0.009) compared with embryos with longer compaction periods [ 46 ]. Melzer 
also reported longer duration of compaction in aneuploidy blastocysts compared 
with euploid, using TLI and blastocyst biopsy techniques ( p < 0.004) [ 47 ]. Delays in 
later developmental stages were also described by Hong et al. [ 48 ]. This group 
reported longer duration to the start of cavitation in aneuploid embryos. The two 
signifi cant variables providing some discrimination of aneuploidy risk were the 
time from fi rst cytokinesis ( p = 0.02) or from the 5-cell stage ( p = 0.01) to the onset 
of cavitation ( p = 0.01)—when the data were considered in quartiles. Ultimately, 
morphokinetic-based embryo selection models should focus on healthy euploid live 
birth as the outcome measure. A promising study of over 200 embryos with known 
implantation outcome data, which did this, presented an early cleavage algorithm 
with an area under the curve of 0.8 [ 49 ]. 
Limitations for Model Building: Sensitivity, Specifi city, 
and Confounders 
In summary, a large number of publications confi rm that timing of development 
does indeed differ between viable and nonviable embryos. The challenge is that 
most studies show divergent results and that no consensus therefore exists on which 
parameters are the most predictive. Only a few publications have offered clinically 
applicable models of embryo selection [ 13 , 17 , 31 ] and these models remain to be 
validated in randomized trials. 
Developing valid time-lapse models applicable to heterogeneous patient populations 
and in different clinical settings is diffi cult, as multivariate hierarchical selection 
models [ 17 ] have been shown not to be transferable from one clinical setting to 
another without modifi cations [ 28 ]. Similarly, in a hypothetical experiment, where 
a blastocyst prediction model [ 13 ] was applied retrospectively on a large set of 
transferred embryos, a theoretical increase of 30.0 % in implantation rate for 
embryos grouped as usable compared with the entire test cohort was demonstrated. 
Notably, 50.6 % of embryos that were categorized as having a low chance of forming 
usable blastocyst nevertheless resulted in fetal heart beat [ 23 ]. While a part of 
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the explanation may be found in heterogeneous patient populations and different 
clinical settings, it also emphasizes one of the crucial dilemmas in developing diagnostic 
tests in general—the balance between sensitivity and specifi city. The study 
very nicely illustrates the risks of defi ning too narrow time intervals for optimal 
division in order to achieve a high specifi city at the expense of a low sensitivity. It 
thus underlines the importance of carefully considering that a model must not only 
provide a substantial increase in implantation, but equally important, that a low 
rejection rate of viable embryos is secured. 
Other plausible explanations for the diverging conclusions on which parameters 
are most predictive are most likely to be found in the distinct differences in the population 
of embryos studied, the parameters evaluated, the endpoints chosen, and the 
differences in treatment-related factors and culture conditions between the studies. 
Embryos from fertile oocyte donors have been shown to proceed faster through 
the fi rst cellular divisions compared to embryos from infertile patients [ 50 ]. 
However, it remains unanswered whether the signifi cant differences in age may 
explain that particular fi nding. In mice, culture in 20 % oxygen signifi cantly delays 
all stages of embryonic development compared to culture in 5 % oxygen [ 51 ] as 
well as infl uences the embryonic metabolism [ 52 ]. In humans, culture in high oxygen 
appears to delay pre-compaction development [ 53 ]. ICSI-fertilized embryos 
have been reported to display an earlier fi rst cleavage than IVF-fertilized embryos 
[ 16 , 54 – 56 ]. The observed difference most likely originates from a difference in the 
starting time of registration or oocyte activation [ 57 ], and can therefore be overcome 
by normalization to an early event or durations of events. The difference does, however, 
complicate the comparison of absolute time points between IVF and ICSI 
populations which is overcome by using intervals between events. 
The choice of medium has been shown to infl uence the cleavage rates for human 
embryos [ 58 – 62 ]. Surprisingly, a recent study did not report any correlation [ 63 ], 
which indicates that the impact may depend on the type of medium and perhaps a 
combination with other factors as well. Factors relating to the infertility treatment, 
such as gonadotrophin doses, have been reported to affect timing, with embryos 
from oocyte donors receiving higher doses of gonadotrophin reaching advanced 
developmental stages later than those receiving lower doses [ 64 ]. Since gonadotrophin 
doses were presumably administered according to the treatment response of 
the patient, it could be argued that the fi nding might be correlated with patientrelated 
factors, such as age and ovarian response which are both interrelated—and 
correlated to prevalence of aneuploidy—rather than the differences in stimulation 
per se. Finally, studies on time lapse have been conducted using different time-lapse 
systems. A difference in technology could potentially infl uence the assessment of 
the embryo and limit the comparability between studies. 
These confounding factors become even more important if the time intervals of 
optimal division are defi ned too narrowly, as small displacement in timing may result 
in viable embryos being declared nonviable. Arguably, low sensitivity may be attributed 
to the infl uence of many of these confounding factors demonstrated to affect 
embryo kinetics and viability, in particular maternal age, oxygen tension, fertilization 
method, and culture media, which are rarely considered in the predictive models. 
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Albeit even controlling for these confounders during collection of morphokinetic 
data, moderate predictive values were still attained by some predictive models [ 25 ]. 
Future Directions 
An increasing number of studies demonstrate that timing of development differs 
between viable and nonviable embryos, evaluated by blastocyst development, clinical 
pregnancy, or euploidy. The future challenge is to translate this knowledge into 
clinically useful models that will improve pregnancy rates after single embryo 
transfer. 
A major challenge is that timing not only refl ects viability but is also infl uenced 
by patient and treatment-related characteristics, which must be considered when 
predictive models are developed. How much of the variation in timing that is 
explained by viability and culture conditions remains to be clarifi ed. The diffi culties 
in transferring a model from one clinic to another may, however, indicate that one 
model does not fi t all. Furthermore, concern must be taken for both sensitivity and 
specifi city. 
Several studies have reported that shorter durations of cell cycles and synchronous 
divisions of sister blastomeres are strongly predictive of implantation while 
prolonged durations in one or more cell cleavage cycles and aberrant cleavage 
behavior are characteristic of non-implanting embryos. The superior ability of morphokinetic 
models to identify less viable embryos by deviations from the normal 
division pattern, rather than to identify embryos of highest reproductive potential by 
defi ning optimal division patterns, may indicate that the true potential for TLI lies 
in de-selection of embryos. The association between poor viability, aneuploidy, and 
certain TLI patterns supports this. Likewise, attention could profi tably be directed 
toward identifying normal and abnormal patterns in embryos from the individual 
patient combined with a traditional evaluation of morphology, rather than focusing 
exclusively on defi ning time points for optimal division, which most likely vary 
depending on external factors. This might be combined with broad intervals for timing 
with suffi cient respect for sensitivity and specifi city, in particular perhaps at the 
later stages of development. 
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study question: Can the approach to, and terminology for, time-lapse monitoring of preimplantation embryo development be uniformly
defined in order to improve the utilization and impact of this novel technology?
summaryanswer: The adoption of the proposed guidelines for defining annotation practice and universal nomenclature would help unify
time-lapse monitoring practice, allow validation of published embryo selection algorithms and facilitate progress in this field.
what is known already: An increasing quantity of publications and communications relating to time-lapse imaging of in vitro embryo
development have demonstrated the added clinical value of morphokinetic data for embryo selection. Several articles have identified similar
embryo selection or de-selection variables but have termed them differently. An evidence-based consensus document exists for static embryo
grading and selection but, to date, no such reference document is available for time-lapse methodology or dynamic embryo grading and selection.
study design, size and duration: A series of meetings were held between September 2011 and May 2014 involving time-lapse
users from seven different European centres. The group reached consensus on commonly identified and novel time-lapse variables.
participants/materials, setting, methods: Definitions, calculated variables and additional annotations for the dynamic
monitoring of human preimplantation development were all documented.
main results and the role of chance: Guidelines are proposed for a standard methodology and terminology for the of use
time-lapse monitoring of preimplantation embryo development.
limitations, reasons for caution: The time-lapse variables considered by this group may not be exhaustive. This is a relatively
new clinical technology and it is likely that new variables will be introduced in time, requiring revised guidelines. A different group of users from
those participating in this process may have yielded subtly different terms or definitions for some of the morphokinetic variables discussed. Due to
the technical processes involved in time-lapse monitoring, and acquisition of images at varied intervals through limited focal planes, this technology
does not currently allow continuous monitoring such that the entire process of preimplantation embryo development may be visualized.
wider implications: This is the first time that a group of experienced time-lapse users has systematically evaluated current evidence and
theoretical aspects of morphokinetic monitoring to propose guidelines for a standard methodology and terminology of its use and study, and its
clinical application in IVF. The adoption of a more uniform approach to the terminology and definitions of morphokinetic variables within this
developing field of clinical embryology would allow practitioners to benefit from improved interpretation of data and the sharing of best practice
and experience, which could impact positively and more swiftly on patient treatment outcome.
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Introduction
Preimplantation embryo development is a dynamic event. Assessment of
embryo viability, on the other hand, is commonly based on observations
of morphology at pre-defined intervals (ALPHA Scientists in Reproduct-
ive Medicine and ESHRE Special Interest Group of Embryology,
2011a,b). The introduction of time-lapse technology enables almost
continuous monitoring of embryo development through frequent mul-
tiple image acquisitions without potentially compromising viability due
to the interruption of culture conditions (Wright et al., 1990; Oh et al.,
2007). This technology generates comprehensive information regarding
morphologyand kinetics of embryo development and facilitates observa-
tion of dynamic, and often transient, events occurring between static ob-
servation periods. Together, these have been defined as ‘morphokinetic’
variables (Meseguer et al., 2011).
The potential impact of several confounding factors on morphokinetic
variables, such as age (Leibenthron et al., 2012; Hampl and Stěpán,
2013), ploidy (Chavez et al., 2012; Campbell et al., 2013a,b), ovarian
reserve (Fréour et al., 2012), infertility indication (Wissing et al., 2012),
ovarian response to stimulation (Muñoz et al., 2013), gas composition
during in vitro culture (Meseguer et al., 2012), culture media (Ciray
et al., 2012; Basile et al., 2013), embryo biopsy (Terada et al., 2009; Kir-
kegaard et al., 2012; Kroener et al., 2012), fertilization method (Lemmen
et al., 2008; Cruz et al., 2013), cryopreservation of sperm (Garcia et al.,
2012), female body mass index (Bellver et al., 2013) and female smoking
habits (Fréour et al., 2013), have been assessed. Strong correlations
between embryo kinetics and embryo viability have been demonstrated
in various studies (Pribenszky et al., 2010; Wong et al., 2010; Cruz et al.,
2011; Meseguer et al., 2011; Azzarello et al., 2012; Campbell et al.,
2013b; Chamayou et al., 2013; Herrero et al., 2013; Aguilar et al.,
2014). These studies have been challenged by a recent publication,
reporting live births following the transfer of blastocysts with ‘deviant’
morphokinetic profiles (Stecher et al., 2014), which has highlighted the
need for IVF clinics to proceed with caution when applying embryo ex-
clusion or selection criteria based on time-lapse literature, mainly due
to the fact that, to date, all the studies relating to embryo selection para-
meters have been retrospective, and randomized control trials are
required to establish and confirm morphokinetics parameters which
enhance selection of the embryo with greatest implantation potential.
In order to allow the comparison of these morphokinetic variables of
embryos within a cohort, between patients and most importantly
according to their outcome, such as implantation and live birth, measure-
ments associated with embryo development can be recorded or anno-
tated (automatically or by the embryologist) to allow retrospective
analysis. Correct annotation is key in order to exploit reliable information
from time-lapse systems and ‘almost perfect agreement within and
between observers has been reported in a clinic utilizing this technology
(Sundvall et al., 2013). Such data can be utilized to build models, or
algorithms, which aid prospective embryo selection by distinguishing
between the morphokinetic parameters of embryos with known
outcomes. For this, standardization of the nomenclature and time of
annotations is a prerequisite.
Several clinical time-lapse devices with automatic image capture and
software are currently available for IVF practice. The systems vary in
several ways including device design (modular within a standard incuba-
tor or integrated incubation-camera system), type of microscopy and
image acquisition utilized (bright or dark field, single or multiple focal
planes and frequency of image collection), culture method (single or
group embryo culture) and annotation (automatic, semi-automatic or
manual) and in the style of embryo selection software tools available
(fixed universal algorithm or customisable software) (Campbell, 2014).
Whilst this document aims to provide generic guidelines, some of the
parameters, such as those associated with pronuclear morphology and
dynamics, described within this document may not be clearly observable
with a dark field time-lapse system. Additionally, the ability to record or
annotate each parameter defined may be restricted by the device or
software available.
The aim of this document is to propose guidelines on the nomencla-
ture of morphokinetic parameters and how and when they should be
annotated uniformly. The morphological characteristics of static obser-
vations established by ALPHA and ESHRE consortiums were used as ref-
erence criteria (ALPHA Scientists in Reproductive Medicine and ESHRE
Special Interest Group of Embryology, 2011a,b) and time-lapse publica-
tions and abstracts were used as a resource. These parameters trace the
development of embryos produced from fresh, or cryopreserved then
warmed/thawed oocytes, and follow their development until in vitro
culture is completed (up to the blastocyst stage). It is recognized that
users with specialist interests may choose to annotate in greater detail
during particular periods of embryo development and that, for practical






In the following definitions, ‘t’ represents time and references to ‘frames’
refer to images generated by time-lapse photography during in vitro
culture (Fig. 1, Supplementary data, Video S1 and Table I). Appearance
and fading, of a described variable, are represented by ‘a’ or ‘f’ respect-
ively and cell, or episode, number are represented by ‘n’.
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It is recommended that, during manual assessment, time-lapse images
are rewound in order to ensure that the correct time point has been
selected for the annotation of each variable. In addition, at the outset,
users are advised to decide whether non-recording of a variable will
indicate its absence or that all variables within the clinic’s standard
operating procedure will be recorded as absent or present.
t0: The time at which insemination occurs in conventional IVF. For
ICSI/IMSI, where the time-lapse monitoring system and practice
allows, the time of the sperm injection may be recorded, per oocyte
but otherwise, it is the mid-time point from when injection begins and
ends for that patient’s cohort of oocytes. This time point is used as a
start time for the variables below which are measured in hours post in-
semination/injection, unless otherwise stated.
tPB2: The time at which the second polar body (PB2) is extruded. This
is annotated at the first frame in which PB2 appears completely detached
from the oolemma. The extrusion of the second polar body can be
obscured depending on the position of the oocyte in the well or by
cumulus cells in routine IVF insemination.
tPN: The time at which fertilization status is confirmed. It is recom-
mended to annotate fertilization immediately before fading of pronuclei
(tPNf) hence coinciding to tZ (time of pronuclear scoring), since no
further observational dynamic changes are expected to occur. Appear-
ance of individual pronuclei may be further annotated as tPNna (‘n’ for in-
dividual pronuclei in the order of appearance: ‘a’): e.g. tPN1a, tPN2a,
tPN3a the initial time at which the first, second, third, etc. pronuclei
become visible.
tPNf: The time when both (or the last) PN disappear. This annotation
is made at the first frame whereby the embryo is still at the 1-cell stage but
pronuclei can no longer be visualized. Pronuclear fading may be further
recorded according to individual pronuclei, tPN1f, tPN2f, etc. to
........................................................................................
........................................................................................
Table I Summary of Morphokinetic variables and
proposed definitions.
Timings
Time Definitions of expected events
t0 Time of IVF or mid-time of micro/injection (ICSI/IMSI)
tPB2 The second polar body is completely detached from the
oolemma
tPN Fertilization status is confirmed
tPNa Appearance of individual pronuclei; tPN1a, tPN2a; tPN3a..
tPNf Time of pronuclei disappearance ; tPN1f; tPN2f. . .
tZ Time of PN scoring
t2 to t9 Two to nine discrete cells
tSC First evidence of compaction
tMf/p End of compaction process (last frame before cavity formation)
‘f’ corresponds to fully compacted;
‘p’ corresponds to partial compaction
tSB Initiation of blastulation.
tByz Full blastocyst (last frame before zona starts to thin)
‘y’ corresponds to morphology of inner cell mass;
‘z’ corresponds to morphology of trophectoderm cells
tEyz Initiation of expansion; first frame of zona thinning
tHNyz Herniation; end of expansion phase and initiation of hatching
process
tHDyz Fully hatched blastocyst
Each timing defines the first time lapse frame in which the expected phenomenon is
observed or detected.
Figure 1 Definitions for the dynamic monitoring of human preimplantation embryo development.
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denote the time at which the first, second or additional pronuclei fade
(i.e. similar to annotation of their appearances).
tZ: The time of time-lapse PN assessment. PN aredynamic structures;
they move and their morphology can change between tPNa and tPNf
(Azzarello et al., 2012). It has recently been reported that the movement
of the pronuclei within the cytoplasm and fading of nuclear membranes
may be indicative of subsequent blastocyst development potential and
hence a novel parameter providing an early indication of the embryo’s
developmental potential (Wirka et al., 2013). Changes in pronuclear
appearance and position may coincide with movement of the nucleolar
precursor bodies (NPBs) inside pronuclei, allowing differential PN
scoring to be deduced. The time-lapse user group recommends annota-
tion of PN scoring, if required, at the last frame before the pronuclei
disappear (i.e. tPNf) because the alteration in pronuclear morphology
has been completed.
t2: The time of the first cell cleavage, or mitosis. t2 is the first frame at
which the two blastomeres are completely separated by individual cell
membranes.
t3: The first observation of three discrete cells. The three cells stage
marks initiation of the second round of cleavage.
tn: The first time these numbers of discrete cells are observed (until
compaction of blastomeres prevents visualization of individual cells).
tSC: The first frame in which evidence of compaction is present; the
initial frame that any (two) cells start to compact is observed. The
precise timing of initiation of compaction may be difficult to observe due
to the increased number of cells and the type of compaction (partial or
complete; as described below).
tMf/p: This marks the end of the compaction process; when observ-
able compaction is complete. The morula may be fully or partially com-
pacted, where f is full and p is partial; the morula has excluded material.
The degree and time of compaction has been reported to be associated
with blastocyst formation and quality (Ivec et al., 2011).
Dynamic developmental stages of blastocyst formation cannot easily
be scoredusing existing static grading schemes (Gardnerand Schoolcraft,
1999), for example the time when the blastocoel constitutes less than
half the volume of the embryo (early blastocyst) maynot be differentiated
with certainty from when it is greater than or equal to half of the volume
of the embryo (blastocyst). Therefore the time-lapse user group re-
commends employment of a novel scoring system for depicting the
developmental stage of blastocysts, while it is recommended that
the morphology of the inner cell mass (y) and trophectoderm (z) are
graded in agreement with the static parameters within the time frame
described for dynamic developmental stages, at fixed time points. This
group acknowledges that blastomere biopsy may alter the dynamics of
embryo development and blastocyst expansion thereby confounding
morphokinetic comparisons with non-biopsied embryos (Kirkegaard
et al., 2012). However, facilitative laser breaching of the zona pellucida,
at the early cleavage stage, to facilitate herniation of trophectoderm
for biopsy, has been reported not to impact downstream develop-
ment to the full blastocyst stage, compared with unbreached controls
(Campbell et al., 2013a).
tSB ¼ initiation/start of blastulation. The first frame when initiation of a
cavity formation is observed.
tByz ¼ full blastocyst. The last frame before the zona pellucida starts
to thin.
tEyz ¼ initiation of expansion. The first frame when the zona pellucida
starts to thin.
tHNyz ¼ herniation. The first frame where extrusion of cell(s) from the
zona is observed. This marks the end of the expansion phase and the
initiation of the hatching process.
tHDyz ¼ hatched blastocyst. The first frame where the embryo is
detached from the zona as a whole.




Calculated variables refer to durations of either events to occur or par-
ticular morphologies to become visible and they comprise the period in
between initiation and termination or appearance and disappearance,
respectively (Table II).
Duration of events related to dynamics of early
preimplantation period
PN duration (VP: visible pronuclei)
VP is the time period in which the pronuclei are visible. It is calculated as
VP ¼ tPNf 2 tPNa. If pronuclei are annotated individually, the duration
for each can be calculated (e.g. tPN1f 2 tPN1a).
Duration of cell cycles
The cell cycle is an orderly sequence of events in which a cell duplicates its
contents and then divides into two (Fig. 2). The duration of the cytoplas-
mic cleavage and subsequent rearrangements of the individual blasto-
meres appears to be highly indicative of subsequent viability of embryos
(Ramsing and Callesen, 2006). Prolonged cell cycles can be due to
DNA repair or cellular rearrangement prior to cleavage (Ramos and de
Boer, 2011).
Cell cycle duration is calculated using time-lapse annotation either
according to a single cell division or as a round of mitosis whereby the
number of blastomeres doubles. For the first cell cycle, as development
begins with the single cell, these are the same. However, the second cell
cycle begins with two cells, both of which should subsequently divide,
forming two daughter cells each. There are therefore two individual
blastomere cell cycles but a single embryo cell cycle, which results in
the doubling from two to four cells.
Figure 2 provides a schematic to represent the blastomere cell cycles
(cc) and the rounds of divisions herein defined as embryo cell cycles
(ECC), resulting in the doubling from two to four, and from four to
eight, cells. The cell cycle for blastomere ‘a’ is calculated as t3 2 t2
and documented as cc2a, and for blastomereb as t4 2 t2, and documen-
ted as cc2b. The cell cycle whereby the embryo reaches four cells from
two cells (ECC2) is also calculated (t4 2 t2). So, the time that the last
cleaving blastomere takes to cleave (from t2 to t4) equates to the dur-
ation of the ECC; all individual blastomeres cleave within this time
frame. The same applies for the third cell cycle. The duration of the
embryo’s third cycle (ECC3) is the time it takes the embryo to
develop from four to eight cells, and includes four blastomere/cell
cycles; a, b, c and d. cc3a is t5 2 t4; cc3b is t6 2 t4; cc3c is t7 2 t4
and cc3d is t8 2 t4. ECC3 is t8 2 t4 (Fig. 3).
An alternative annotation termed ‘synchronization’, as defined below,
is recommended as a simpler alternative:
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Earlyembryo development followsa geometric sequence cleavage pattern
{1 cell, 2 cells, 4 cells, 8 cells....} as mentioned above, and therefore syn-
chronization can be measured as the time sister cells take to divide into
two new cells, reaching the next step in the geometric sequence.
s2 ¼ The synchronicity of the two blastomere divisions within the
second cell cycle, calculated as t4 2 t3.
s3 ¼ The synchronicity of the four blastomere divisions within the third
cell cycle, calculated as t8 2 t5.
Duration of cytokinesis (dck)
The duration of each cytokinesis may also be calculated (related to speed
of the event and image capture capacity) from the first frame where a
cleavage furrow is observed and the time point when cytokinesis is com-
pleted.
Duration of events related to dynamics of late
preimplantation period
Duration of compaction (dcom)
This is the time period from initiation to cessation of compaction. For
full compaction (dcom) ¼ tMf-tSC. For partial compaction (dcom) ¼
tMp-tSC.
Duration of blastulation (dB)
This is the time period from initiation of blastulation to full blastocyst
formation (tB-tSB).
Duration of blastocyst expansion (dexp)
This is the time period from initiation of expansion to herniation
(tHN-tE).
Duration of blastocyst collapse/re-expansion (dcol/dre-exp)
Regular cycles of expansion and collapse are physiological during blasto-
cyst development (Hardarson et al., 2012). For collapse, these are
Figure 2 Schematic representation of the blastomere cell cycles (cc)
and the rounds of divisions herein defined as embryo cell cycles (ECC),
resulting in the doubling from two to four, and from four to eight, cells.
The cell cycle for blastomere ‘a’, is calculated as t3 2 t2 and documen-
ted as cc2a, and for blastomere b as t4 2 t2, and documented as cc2b.
The cell cycle whereby the embryo reaches four cells from two cells
(ECC2) is also calculated (t4 2 t2).
............................................................................................................................................................
.............................................................................................................................................................................................
Table II Summary of calculated variables of dynamic monitoring of human preimplantation embryo development.
Timings
Annotations Calculated duration of
events
Dynamic event
VP tPNf-tPNa PN Duration
ECC1 t2 2 tPB2 Duration of first cell cycle
ECC2 t4 2 t2 cc2a ¼ t3 2 t2
cc2b ¼ t4 2 t2
Duration of second embryo cell cycle Duration of single blastomere cell cycle
ECC3 t8 2 t4 cc3a ¼ t5 2 t4
cc3b ¼ t6 2 t4
cc3c ¼ t7 2 t4
cc3d ¼ t8 2 t4
Duration of third embryo cell cycle Duration of single blastomere cell cycle
s2 t4 2 t3 Synchronization of cell divisions
s3 t8 2 t5 Synchronization of cleavage pattern
dcom tMf-tSC (full compaction)
tMp-tSC (partial compaction)
Duration of compaction
dB tB-tSB Duration of blastulation
dexp tHN-tE Duration of blastocyst expansion
dcol tBCend(n)-tBCi(n) Duration of blastocyst collapse;
‘n’ is number of episodes of collapse and re-expansion
dre-exp tre-exp end(n)-tre-expi(n) Duration of re-expansion
dHN tHN-tHD Duration of herniation
It comprises calculation of events related to dynamics of early and late preimplantation period.
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defined as tBCi(n) and tBCend(n), for initiation and completion of the
episode, respectively, where ‘n’ corresponds to the subsequent epi-
sodes (for example, tBCi1 ¼ first expansion of blastocyst cavity which
follows tBCend1 ¼ first collapse of the blastocoel). The duration of
each phase of expansion-contraction cycle can be calculated; the initi-
ation of collapse is annotated according to the first frame in which the
blastocoel volume visibly decreased when compared with the volume
(diameter) on the previous frame. The final frame prior to the initiation
of re-expansion (tBCend) marks the end of the collapse episode.
The period in between is the ‘duration of collapse (dcol)’ and is
tBCend(n) 2 tBCi(n). The initiation of re-expansion is annotated accord-
ing to the first frame in which the blastocoel volume visibly increased com-
pared with the volume (diameter) on the previous frame. The duration
of re-expansion (dre-exp) is tre-expend(n) 2 tre-expi(n).
Duration of herniation (dHN)
This is the time period from initiation of herniation to hatching
(tHN-tHD).
Additional annotations
The proposed annotation for initiation or cessation of the appearance of
these events is described below. From these, the duration, or visible
period for the event may be calculated as follows: d(event) ¼
t(event)(end) 2 t(event)(i) (Table III).
Smooth endoplasmic reticulum clusters
Aggregation of smooth endoplasmic reticulum (SER) in oocytes has been
associated with suboptimal outcome in some patients (Ebner et al.,
2008) (Supplementary data, Video S2). Presence of SER should be anno-
tated as the time points for the appearance, tSER(i) and disappearance,
tSER(end).
Fragmentation
To annotate stage-specific fragmentation, x%ftn should be used, where x
is the percentage of fragmentation and tn is the last cell division that was
completed. The time-lapse user group suggests the annotation of
embryo fragmentation associated with blastomere number, at the final
frame prior to the subsequent round of cleavage, because, as develop-
ment proceeds, embryonic fragments may remain as separate units, or
alternatively, may be reabsorbed by the same blastomere from which
they were produced or fuse with a neighbouring blastomere (Hardarson
et al., 2001; Chavez et al., 2012). For example: ‘10%ft2’ means presence
of 10% fragmentation during the final frame ‘t’ at the 2-cell stage.
Annotation of nuclear morphology
nMONO (mononucleated) where ‘n’ represents the number of blasto-
meres in which a unique nucleus is seen.
nBI (binucleated) number of blastomeres in which two nuclei per cell
are visible.
nMULTI (multinucleated) number of blastomeres in which more than
two nuclei are visible. This definition includes micronuclei.
Any cytoplasmic structurewithout any visible nucleus during the entire
cell cycle should be considered as fragments regardless of their sizes.
The time of appearance (‘a’) and fading (‘f’) of nuclei can be annotated
among individual blastomeres enabling calculation of duration of nuclear
visibility. For example, ‘t4MONO1(a)’ depicts the time when the single
(mono) nucleus becomes visible in the ‘first blastomere’ (chosen arbi-
trarily) of a 4-cell embryo, while t4mono3(f) depicts the fading time of
the single nucleus in the third blastomere of the 4-cell embryo.
Blastomere (a)symmetry
Asymmetry of blastomeres is physiological in certain periods of mitotic
cycles (e.g. those excluding 2, 4 and 8-cell stages) and such patterns con-
tribute positively to overall embryo selection parameters (Sela et al.,
Figure 3 Schematic representation of the third cell cycle. The duration of the embryo’s third cycle (ECC3) is the time it takes the embryo to develop from
four to eight cells, and includes four blastomere/cell cycles; a, b, c and d. cc3a is t5 2 t4; cc3b is t6 2 t4; cc3c is t7 2 t4 and cc3d is t8 2 t4. ECC3 is t8 2 t4.
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2012). Therefore it is recommended that blastomere (a)symmetry is
annotated at the end of 2-, 4- and 8-cell stages, during which symmetry
of blastomeres is considered optimal morphology. The degree of devi-
ation (i.e. uneven/severe uneven) from normal should be considered
as a compromise from embryo viability potentially accompanied with an-
euploidy (Hardarson et al., 2001). Cells are described uneven (at the 2-,
4-, 8-cell stages) if blastomeres are more than one third different from
sibling cells in size (Puissant et al., 1987). The time-lapse user group
encourages annotating alterations in the evenness of blastomeres at
these cell stages at the beginning to the end of a particular blastomere div-
ision, which may have an impact on subsequent embryo viability.
Irregular cleavage events
Rapid cleavage
Rapid cleavage is a novel dynamic event, which was first described and
defined by Rubio et al. (2011) as a ‘direct cleavage from two to three
cells occurring in ,5 h’. They have been reported to occur in around
14% of all embryos and they were demonstrated to be one of the
most conclusive embryo de-selection parameters, since they comprom-
ise implantation capacity (Rubio et al., 2011, 2012).
The time-lapse user group consider that this phenomenon described
by Rubio and colleagues is more accurately defined as ‘rapid cleavage’.
Rapid cleavage describes cleavage of a single cell to two daughter cells
occurring faster than the ‘normal’ duration, which is yet to be defined
specific to each cell cycle. This phenomenon may be related to errors
in cell cycle mechanisms, which result in this premature cytokinesis.
Such irregular cleavage patterns can occur at any cell stage but are
most readily identified during early cleavage embryo stage development.
As the optimal or normal duration of early cleavage events has not been
defined, rapid cleavage cannot yet be annotated as present or not, unless
an arbitrary value is introduced. Rather, the durations associated with
cleavages can be calculated from the annotation of the embryo reaching
sequential cell stages and if and when the normal cell cycle duration is
defined, precocious or rapid cleavage can then be identified against
normal limits and based on clinical evidence.
Trichotomous mitosis
The first demonstration of, what this proposal is referring to as, trichot-
omous mitosis was performed and reported by Kola et al. (1987) who,
employing time-lapse cinematography, described it as an event occurring
at the first cleavage of tripronucleated oocytes in order to prevent them
developing into triploid embryos (Supplementary data, Video S3). Kola’s
group considered the spindle forming at the first cleavage in such zygotes,
to be tripolar. A year earlier, Angell et al. (1986) introduced the concept
of direct cleavage and a rapid second division, although they were unable
to distinguish between the two irregular phenomena as time-lapse
imaging was not employed.
This irregular cleavage event, an aberrant cleavage from a single cell
directly to three daughter cells (irrespective of the number of pronuclei),
defined as trichotomous mitosis is observable using time-lapse imaging.
As in rapid cleavage, this type of irregular division may also occur at any
stage of development. Trichotomous mitoses and rapid cleavages can be
distinguished from each other as different developmental patterns, pos-
sibly associated with differing biological events. Trichotomous mitosis
may be associated with errors in spindle apparatus (e.g. tripolar). Trich-
otomous mitosis, as defined above, can be calculated, for example if t3 2
t2 ¼ 0, when the embryo did not, at least observably within the acquired
images, exist at the 2-cell stage as it cleaved directly to three cells or in a
general formula if t(n) 2 t(n 2 1) ¼ 0. This may be annotated on obser-
vation as tTM.
Cell fusion (independent of compaction)
This is defined as a reduction in the number of cells of an embryo during
its development due to the merging, or fusion, of cells giving the appear-
ance of a reversed cleavage event (Supplementary data, Video S4). This
phenomenon must be distinguished from fragment internalization or re-
absorption through identification of a nucleus within the cells involved,
prior to occurrence of this event. It is also distinguishable from the
merging of cells during compaction preceding morula formation. In an
observational study of 1698 zygotes, this phenomenon was observed
in 10% of all embryos (Hickman et al., 2012). Although this study demon-
strated that cell fusion did not impair embryo development to the blasto-
cyst stage, and was not associated with embryo ploidy, further research is
needed to determine the clinical significance of embryos exhibiting such
cell fusion, and the mechanisms that cause embryos to undergo this
process. When observed, this should be annotated as tFu.
Planar arrangement. Cleavage planes of a 4-cell-stage embryo are con-
sidered as normal when they are perpendicularly orientated and
blastomeres are tetrahedrally arranged. Some embryos may display
........................................................................................
........................................................................................
Table III Summary of additional dynamics annotations.
Additional annotations
Time Definitions of special annotations
devent Duration of event ¼ t(end)-t(i)
tSER(i) Appearance of SER
tSER(end) Disappearance of SER
x%ftn Stage-specific fragmentation
‘x’ is percentage of fragmentation
‘tn’ is last cell division that was completed
nMONO ‘n’ is number of mononucleated blastomeres
nBI ‘n’ is number of binucleated blastomeres
nMULTI ‘n’ is number of multinucleated blastomeres
Even/Uneven
cells
Symmetry of blastomere sizes
tTM Trichotomous mitosis
tFu Time of cell fusion
tPA Time of planar blastomere arrangement
tRoll Time of embryo rolling without divisions
tRoll (i) Initiation of embryo rolling
tRoll(end) End of embryo rolling
tCW Timing of cytoplasmic waves
tCS Timing of cytoplasmic strings
tV S/M Presence of vacuoles
‘S’ represents single vacuole; ‘M’ represents multiple
vacuoles
tG Appearance of granularity of the cytoplasm
Each timing defines the first time lapse frame in which the expected phenomenon is
observed or detected.
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parallel-orientated cleavage axes and are non-tetrahedral or planar pos-
sibly due to the disruption of the mitotic spindle (Ebner et al., 2012).
The reported incidence of planar embryos ranges between 3% (Ebner
et al., 2012) and 21% (Cauffman et al., 2014). While some associated
them with poor implantation capacity (Ebner et al., 2012, Paternot
et al., 2014), others reported similar clinical outcomes to tetrahedral
embryos (Cauffman et al., 2014). When observed, this may be annotated
on observation, tPA.
Embryo rolling. Time-lapse monitoring allows the visualization of embryo
rolling; the blastomeres move on themselves without dividing. Prolonged
periods of cellular rearrangements following a cell division event can be
indicators of poor embryo viability and poor developmental competence
as well as poor implantation potential (Ramsing et al., 2007; Cruz et al.,
2012). When observed, its beginning and termination should be anno-
tated as tRoll(i) and tRoll(end), respectively.
Cytoplasmic waves. Mouse studies have shown a correlation between
rhythmic cytoplasmic movements in oocytes and subsequent develop-
ment to the blastocyst stage (Ajduk et al., 2011). These movements
are caused by contractions of the actomyosin cytoskeleton triggered
by calcium oscillations induced by fertilization. Similar waves have been
identified in human oocytes; however, they were not correlated with
embryo development (Swann et al., 2012). When observed, the waves
may be annotated tCW(i) and tCW(end), for their beginning and termin-
ation, respectively.
Cytoplasmic strings. Cytoplasmic strings can often be observed in the
blastocyst traversing the blastocoel (Supplementary data, Video S5).
They are commonly present in early blastocysts and may withdraw as
the blastocyst expands. Their persistence in the expanded blastocyst
has been associated with poor embryo quality, poor media conditions
or a breakdown in polarization (Scott, 2000; Hardarson et al., 2012).
More recently, and using time-lapse data from transferred blastocysts,
the presence of cytoplasmic strings was observed not to compromise
viability (unpublished data).
Time-lapse annotation of the presence or absence of cytoplasmic
strings is recommended in order to retrospectively assess their potential
value in assessment of embryo viability. When observed, the proposed
recommendation for annotation is tCS.
Zona pellucida. The time-lapse user group accepts possible effects on
patient or cycle specific basis and proposes annotating exceptional
observations regarding the morphology of the zona pellucida. As the ap-
pearance of the zona pellucida remains the same throughout the pre-
expansion stages, its annotation does not require to be related to time.
Vacuoles. The time-lapse user group proposes the annotation of the pres-
ence of vacuoles and the time and duration of appearance. When
observed, the proposed guideline for annotation is tV S/M (i) and tV
(end), where S refers to a single vacuole; M to multiple vacuoles. As
used for other annotations, ‘I’ and ‘end’ should be used to annotate
the first appearance of vacuoles (i) and when they are no longer visible
(end). Measurement of their dimensions may be possible with time-lapse
device software tools.
Granularity. Cytoplasmic granularity is poorly defined and its impact on
embryo development and viability is not clearly understood. It may be
persistent or transitional and should be annotated at the time it is
observed and, if applicable, ends. When observed, the proposed guide-
line for annotation is tG (i) and tG (end).
Discussion
In recent years, the number of studies relating to dynamic development
of the preimplantation human embryo development under in vitro condi-
tions has increased rapidly and this trend is expected to continue. This
paper proposes definitions and annotations for events occurring and
observed during dynamic development of the preimplantation human
embryo development. During the preparation of this paper, a review
paper, incorporating a proposal to standardize nomenclature for time-
lapse embryo imaging has been published (Kaser and Racowsky,
2014). While some nomenclature is common, these dedicated guide-
lines describe and define the dynamic events of preimplantation
embryo development more comprehensively, with supporting informa-
tion and resources. Furthermore, with regard to the important objective
of defining clear guidelines in order to maximize its utilization, the current
proposal lacks some definitions used by Kaser and Racowsky (e.g. ‘for-
mation of expanding blastocyst’) since they have been considered too
subjective and finite, by this group, for dynamic monitoring as is discussed
within. However, others have been highlighted within this document,
omitted by Kaser and Racowsky, which have been reported to have clin-
ical significance (e.g. irregular cleavage events).
The major challenge in proposing guidelines for time-lapse technology
in IVF arises from the natureand variability of observable events; that they
are dynamic. Dynamic events are more difficult to define compared with
static observations since the additional dimension of time comes into
play. A specific dynamic event may be regarded to occur at its initiation,
i.e. the first frame of observation, its end, i.e. that it has been completed,
or anytime in between while the event progresses, for example the time
when the defined morphology according to static assessments is
observed. Examples of such confusions appear as the literature, sur-
rounding morphokinetics of human embryo development, accumulates:
pronuclear fading (PNf) as described by this time-lapse user group has
been previously defined as the last frame (recorded as tC) where both
pronuclei were observed (Chamayou et al., 2013), with a difference of
one consecutive frame and as pronuclear disappearance (Lemmen
et al., 2008) or pronuclear breakdown (Azzarello et al., 2012). The im-
portance of consensus is enhanced in situations where reference
point(s) are established. As an example, time of insemination during
ICSI has been defined as ‘midway through ICSI’ (Campbell et al.,
2013a), where other previous studies refer to the time where the pro-
cedure has been completed (generally referred as ‘t0’ as in Chamayou
et al., 2013). It is of utmost importance that future studies refer to a con-
sented terminology in order to minimize the negative impact of dynamics
of these events, and instead provide a benefit gained through this novel
technology.
During dynamic monitoring of preimplantation embryo development,
some events are easier to observe and define than others. Cleavage-
stage cell cycles are such examples since the beginning or termination
of dividing blastomeres can clearly be observed through distinct cell
membranes unless there is extensive fragmentation. Due to the relative
objectivity, ease of study and annotation, early morphokinetic events
have been most studied and consequently they feature more frequently,
than later events, in algorithms assessing developmental competence
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and/or implantation prediction. For example, time between division
from two to three cells and from three to four cells have been found pre-
dictive in two different algorithms; those described by Wong et al. (2010)
and Meseguer et al. (2011) and referred to as P2 and P3 by the former or
cc2 and s2 by the latter groups, respectively. In addition to these para-
meters, Wong et al. (2010) suggested P1, which referred to the duration
of first cytokinesis and Meseguer et al. (2011), t5 as being the duration for
the embryo to reach the 5-cell stage, as an adjunct. In the currently pro-
posed terminology, descriptions suggested in earlier publications have
been used as much as possible; however, some have been modified
with the intention of simplification and/or clarification. For example, ter-
minology regarding definition of cell cycles has been changed in this pro-
posal; the second cell cycle, as the time the embryo takes to cleavage
from two to three cells, is now collectively called CC2, additionally,
the time the embryo requires to cleave from three to five cells is called
the CC3 (Wong et al., 2010; Meseguer et al., 2011; Herrero et al.,
2013; Basile et al., 2014). CC3 was demonstrated as a key parameter
associated with greater implantation rates compared with other down-
stream parameters (Herrero et al., 2013). In this document, the term
ECC2 has been proposed, which spans the period where the embryo
develops from two to four cells and is divided to CC2a and CC2b, as divi-
sions from two to three and to four cells, respectively. Likewise, the third
embryo cell cycle refers (ECC3) to cleavage from four to eight cells and
now proposed to be subdivided to CC3a-d in accordance to consecutive
blastomere divisions. Because cell cycle terminology and subsequent cal-
culations may be confusing to future investigators, use of terminology
regarding synchronization is encouraged. Nevertheless, findings and cal-
culations previously reported, which show a relationship between the
duration of blastomeres cell cycles are not invalidated by this proposed
terminology.
It is expected that uptake of proposed guidelines for time-lapse ter-
minology will enable utilization of events occurring at later stages of
embryo development. Without consensus in terminology and annota-
tion, morula and blastocysts stages of development may be more difficult
to track and evaluate, as events are more complex, transitional, overlap-
ping and optically restricted due to the increased number of cellular and
a-cellular structures. There are few studies assessing morphokinetics of
later development stages yet diversity among terminology and annota-
tions are nevertheless evident. Time of full blastocyst formation has
been annotated as tB and described as ‘blastocoel filling the embryo
with ,10% increase in diameter’ and time of expanded blastocyst as
‘blastocyst increased in diameter by .30% in diameter concomitant to
initiation of zona thinning’ (Campbell et al., 2013a,b); however, tB has
also been defined as the frame in which ‘a crescent-shaped area began
to emerge from the morula’ in the study by Chamayou et al. (2013)
and the successive frame was the time of expanded blastocyst (tEB), con-
sistent with the ‘increase of the overall volume of the embryo and expan-
sion of the blastocoel cavity’. Many of these discrepancies may refer to
concepts that are easily understandable. However, the rapid increase
in the number of publications concerning time-lapse technology may
trigger an endless list of definitions based on the researchers point of
view unless a consensus between time-lapse users is not reached.
Through introduction of this novel technology, many events, which
had remained obscure with static observation, have come to light.
Some examples of such events are abnormal cleavage patterns like trich-
otomous and reverse cleavages, and rolling of the embryo. Terminology
regarding description of these novel events may cause more confusion.
For example ‘irregular divisions’ have been collectively referred to as
those from one to three and/or two to five cells in ,5 h (Campbell
et al., 2013a,b); the former has also been defined as abrupt division
(Meseguer et al., 2011), direct (Rubio et al., 2012), tri-polar cleavage
(Wong et al., 2010) or very recently as abnormal cleavage (Wirka
et al., 2014). A round of mitosis, in the early human preimplanta-
tion embryo has been documented to occur ‘normally’ 10 to 12 h
(Cummins et al., 1986). It is yet to be established how much viability
may be compromised in those embryos cleaving between 5 and 10 h.
It should be noted that the time-lapse user group does not propose it
being necessary to annotate all the parameters listed in this proposal. It is
also likely that once the technology becomes available to a wider popu-
lation of professionals, events that may have escaped current attention
will also be described. An update of this current paper will then
become a necessity. As stated earlier, the ultimate goal for successful in-
tegration of morphokinetic parameters into clinical practise should
include: (i) their statistical and biological significance and reproducibility,
(ii) their validation through prospective clinical studies proving safety, ef-
ficacy and practical utility and (iii) development of reliable technology to
measure and quantify such markers (Wong et al., 2013).
Within this rapidly progressing and promising area of reproductive
medicine, practitioners now have an additional and increasingly reliable
tool for improving embryo selection. The more time-lapse images are
interrogated and annotated, and data output is standardized, the more
we may understand whether an optimal morphokinetic profile exists.
With this, will come the possibility to develop new, and fine tune existing,
morphokinetic embryo selection criteria. Time-lapse monitoring is a tool
which provides precise information on embryo development, but also
has the potential to train, educate and most importantly enhance clinical
outcome.
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Hampl R, Stěpán M. Variability in timing of human embryos cleavage
monitored by time-lapse system in relation to patient age. Ceska Gynekol
2013;78:531–536.
Hardarson T, Hansen C, Sjogren A, Lundin K. Human embryos with unevenly
sized blastomeres have lower pregnancy and implantation rates: indications
for aneuploidy and multinucleation. Hum Reprod 2001;16:313–318.
Hardarson T, Van Landuyt L, Jones G. The blastocyst. Hum Reprod 2012;
27(Suppl 1):i72– i91.
Herrero J, Tejera A, Albert C, Vidal C, de los Santos MJ, Meseguer M. A time
to look back: analysis of morphokinetic characteristics of human embryo
development. Fertil Steril 2013;100:1602–1609.
Hickman CFL, Campbell A, Duffy S, Fishel S. ‘Reverse Cleavage’: its
significance with regards to human embryo morphokinetics, ploidy and
stimulation protocol. Hum Reprod 2012;27(Suppl. 2):ii103–ii105.
Ivec M, Kovacic B, Vlaisavljevic V. Prediction of human blastocyst
development from morulas with delayed and/or incomplete
compaction. Fertil Steril 2011;96:1473–1478.
Kaser DJ, Racowsky C. Clinical outcomes following selection of human
preimplantation embryos with time-lapse monitoring: a systemic review.
Hum Reprod Update 2014;20:617–631.
Kirkegaard K, Hindkjaer JJ, Ingerslev HJ. Human embryonic development
after blastomere removal: a time-lapse analysis. Hum Reprod 2012;
27:97–105.
10 Ciray et al.








Kola I, Trounson A, Dawson G, Rogers P. Tripronuclear human oocytes:
altered cleavage patterns and subsequent karyotypic analysis of embryos.
Biol Reprod 1987;37:395–401.
Kroener L, Ambartsumyan GG, Briton-Jones CC, Dumesic DD, Surrey MM,
Munne SS, Hill DD. The effect of timing of embryonic progression on
chromosomal abnormality. Fertil Steril 2012;98:876–880.
Leibenthron J, Montag M, Koster M, Toth B, Reinsberg J, Van der Ven H.
Influence of age and AMH on early embryo development realised by
time-lapse imaging. Hum Reprod 2012;27(Suppl 2):ii162–ii205.
Lemmen JG, Agerholm I, Ziebe S. Kinetic markers of human embryo quality
using time-lapse recordings of IVF/ICSI-fertilized oocytes. Reprod Biomed
Online 2008;17:385–391.
Meseguer M, Herrero J, Tejera A, Hilligsøe KM, Ramsing NB, Remohı́ J. The
use of morphokinetics as a predictor of embryo implantation. Hum Reprod
2011;26:2658–2671.
Meseguer M, Rubio I, Cruz M, Basile N, Marcos J, Requena A. Embryo
incubation and selection in a time-lapse monitoring system improves
pregnancy outcome compared with a standard incubator: a
retrospective cohort study. Fertil Steril 2012;98:1481–1489.
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The ability to acquire sequential, photographic, time-lapse images of the developing preimplantation human 
embryo in vitro has recently provided clinical embryologists with a powerful noninvasive embryo monitor-
ing and selection tool. Time-lapse imaging was used to study fertilization and early human embryo kinetics 
more than 15 years ago, but this technology is now available for the routine clinical in vitro fertilization (IVF) 
 setting [1]. The rst live birth after time-lapse imaging of embryos was reported by Pribenszky and colleagues in 
2010, and since then time-lapse imaging of embryos has rapidly become a key topic and area of research in the 
eld of human fertility [2]. This chapter focuses on practical aspects of time-lapse imaging for embryo selection. 
It covers some of the key ndings that have been reported to date and considers the potential impact this exciting 
technology may have on our understanding of embryo development and on clinical IVF outcome.
Standard versus Time-Lapse Methodology in the Embryology Laboratory
Currently, embryo selection methods rely primarily on morphological evaluation of the embryo based on ve or 
six single, conveniently scheduled observations during their in vitro development. Although these daily observa-
tions are recorded and considered, selection of the embryo(s) for transfer, or cryopreservation, tends to be weighted 
toward the morphology of the embryo just before embryo transfer, focusing on cell number and amount of frag-
mentation. Selection is often based on a simple embryo grading scheme or a graduated embryo scoring scheme that 
may also take into account several other variables such as static pronuclear morphology [3,4]. These observations 
are, in general, not photographic but are recorded by a scribed entry onto a laboratory worksheet, as a database 
entry, or both. Although this methodology is evidence based, and now guided by a consensus document, time-lapse 
technology has highlighted the limitations of this rather subjective approach to a crucial clinical decision [5,6].
It is logical that a static snap-shot method to accurately study a dynamic process, such as embryo develop-
ment, may not be optimal; however, to date, IVF practitioners have worked within these limitations to study and 
improve embryo selection in the interest of their patients.
A static snap-shot method is not accurate to study a dynamic process such as embryo development.
Conventional light microscopical observations, unlike time-lapse imaging, cannot allow the precise timings of 
mitoses, or the observation of anomalous cleavage events of the in vitro preimplantation embryo, to be recorded. 
Furthermore, without time lapse, transient characteristics such as multinucleation can easily be missed when 
embryos are limited to a single daily observation. Many studies have demonstrated the detrimental effect of 
multinucleation on embryo implantation, pregnancy, and birth rates [7]. Time-lapse imaging and analysis ensure 
that such phenomena are observed and recorded, allowing embryo deselection, where appropriate.
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Having thousands of time-lapse images available, compared with the usual four to six records of a static obser-
vation with conventional methods, may initially seem daunting to the embryologist responsible for embryo selec-
tion, but, with robust training and quality assurance, condence and skills develop quickly and the  inquiring 
mind of the embryologist is opened to this exciting approach.
The wealth of detail that can be observed and information gleaned from such time-lapse images is remark-
able. As an example, even before the rst cleavage, and within hours of insemination, polar body extrusion can 
be visualized, providing rapid reassurance that fertilization is likely underway. The dynamics and nature of the 
proceeding pronuclear formation and morphology now question the extent to which traditional pronuclear grad-
ing can assist in embryo selection.
Throughout the preimplantation embryo’s development, from insemination to uterine transfer, new phenom-
ena, observed using time-lapse imaging and analysis devices, are being dened and observed as the study of 
human preimplantation embryology takes on a new direction.
Essential Tools: The Time-Lapse Device
Several clinical time-lapse devices with automatic image capture and software for data collection and analysis 
are commercially available for IVF practice. Some use the standard incubator (e.g., Primo Vision, Vitrolife, 
Sweden and Eeva, Auxogyn, United States). Such systems use a single microscope objective within a unit placed 
inside the incubator chamber to capture images within one culture dish. These systems allow group culture 
conditions due to the design of the dishes provided with the devices. Each is modular, allowing multiple devices 
to be tted within one incubator, with the number depending on the size of the incubator. Primo Vision uses 
Hoffman contrast integrated optics with green light-emitting diode (LED) (550 nm) illumination and can collect 
images through 11 focal planes. The Eeva system uses dark-eld image capture, in a single focal plane, and auto-
matic cell division tracking and uses software to analyze early embryo development, providing evidence-based 
quantitative data on each embryo’s developmental potential to the blastocyst stage [8]. The Primo Vision system 
allows user-dened programming of the software to record morphokinetic variables. It also allows published 
or in-house–developed embryo selection algorithms to be used to rank embryos accordingly. Although widely 
available, these two systems are not yet cleared for clinical use in the United States.
Selection of a time-lapse system for clinical use is likely to be a task that all IVF centers will be 
faced with over the next few years to provide the optimum clinical outcome for their patients.
The most widely used integrated device available and in use worldwide is the EmbryoScope (FertiliTech, 
Denmark). Rather than using a conventional incubator, this device in itself is a nonhumidied incubator with inter-
nal circulation of ultraviolet (UV)-light sterilized air through a high-efciency particulate air (HEPA) and volatile 
organic compound ltration system. The EmbryoScope has an in-built red LED (635 nm) illumination camera sys-
tem that arguably allows the most stable and uninterrupted time-lapse imaging and culture. The EmbryoScope can 
image up to 72 embryos, through a maximum of nine equidistant focal planes. This system includes embryo selection 
modeling software and provides tools for knowledge building through retrospective analysis of embryo developmen-
tal data. A more recently developed device by ESCO Medical (Singapore) is an alternative time-lapse incubation 
system with capacity for up to 84 embryos from six patients. This system consists of six individually controlled and 
monitored culture compartments and also requires manual annotation of the acquired time-lapse images.
Selection of a time-lapse system for clinical use is likely to be a task that all IVF centers will be faced with over 
the next few years to provide the optimum clinical outcome for their patients. It is also likely to be a long-term invest-
ment. When deciding which system, or systems, to introduce, consideration should be given to potential impact of 
clinical outcome, opportunities for development and continuous improvement, device specication, focal planes, 
image quality and capacity, user friendliness, degree of validation conducted by the supplier and required in-house, 
certication and licensing (where required), limitations, space, and cost. Customer support, servicing, and training 
should also be taken into account because accessibility to these may be limited by clinic or supplier location.
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Identification and Annotation of Dynamic Embryo Development
When using time lapse, the frequency of image acquisition can take place at variable time intervals set by the 
individual laboratory. At present 5, 10, 15, or 20 min intervals are most commonly used. As the technology 
advances, these time intervals may be moved closer, to acquire more detailed information, or even varied during 
the course of preimplantation embryo development to access more information during certain periods and less 
during periods of quiescence or where there is evidence of image capture being of lesser clinical impact.
Time-lapse images played, rewound, and paused sequentially as a video can be assessed automatically or 
semiautomatically by software, or manually. Embryologists and researchers can now study the movement (kinet-
ics) and durations of developmental events alongside embryo morphology. The embryo’s developmental patterns 
and appearance have been referred to as morphokinetics [9]. To date, several specic morphokinetic variables 
have been correlated to embryo viability, and the outcome measures considered have been blastocyst develop-
ment, implantation, and live birth. As data from embryos transferred with a known outcome amasses, the most 
predictive morphokinetic variables for viable embryo selection can be identied. It should be noted, of course, 
that embryo quality and selection is just one of the several factors inuencing IVF treatment success. Factors 
such as clinical history, embryo transfer procedure, and endometrial receptivity are also of great importance.
Unless the selected time-lapse system has fully automated image capture and analysis tools, some degree 
of user denability, in terms of morphokinetic variables to be recorded, may be required when establishing 
a  clinical time-lapse service or research program.
Because there may be multiple practitioners in the laboratory involved with the assessment of time-lapse 
images, it is recommended that key variables for annotation are dened within the standard operating procedure 
and that these variables are routinely recorded. It is crucial that an early decision is made as to whether variables 
or morphological features that are not seen in a particular embryo (e.g., compaction or vacuolation) should be 
reported as “not seen” or whether not reporting them is sufcient to suggest that they were not observed.
Additional or novel variables can be added at a later date once the practitioners have gained familiarity and 
are able to annotate more swiftly. Annotation is the process of interpreting and recording morphokinetic events 
on visualizing the time-lapse images and entering this information into the time-lapse device software, where 
applicable. The introduction of time lapse should not been seen as a burden but rather as a tool that not only dra-
matically increases exibility in the embryologists’ working day but also has the potential to train, educate, and 
most importantly enhance clinical outcome. Because time-lapse images viewed as a video can be retrospectively 
studied and annotated, colleagues can work together to ensure the quality of annotation, discuss queries, and 
even go back to historical images to annotate new variables at a later date.
Guidelines and consensus are required for standard time-lapse imaging, and to date, without this agreement, 
several alternative denitions have already been used for the same variable and the approach and standard prac-
tice varied from clinic to clinic.
The most commonly used morphokinetic variables are established based on the basic principles of embryol-
ogy and mitosis and include timing of pronuclear appearance and fading, increasing cell numbers (time to two, 
three, four, ve, six cells, etc.) and times of embryo differentiation to the morula and blastocyst stages. Durations 
of mitotic cycles and synchronicity, as used in some of the published dynamic embryo selection algorithms, can 
then be calculated from these variables.
Annotation is the process of interpreting and recording morphokinetic events on visualizing 
the time-lapse images and entering this information into the time-lapse device software.
If there is a specic research interest, additional “user-dened” variables can be recorded. An example may 
be surrounding multinucleation. If the number, size, degree, appearance, fading, and dynamics of nuclei are of 
particular interest during embryo development, this information can be recorded. To facilitate downstream data 
analysis, it is important that strictly dened terms or phrases are used for these phenomena. An accepted con-
sensus document dening such criteria would assist scientists in data sharing.
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Table 12.1 summarizes the commonly used morphokinetic variables and provides basic descriptions and abbre-
viations for them. The abbreviations in bold may be considered core variables, several of which have been referred 
to in time-lapse–related clinical publications to date. It is recommended that they are routinely recorded when 
using time lapse in a clinical setting. This table is not exhaustive and is included as a guideline for users of time 
lapse. It has been adapted from a document, in preparation, by a team of time-lapse experts aiming to encourage 
users of time-lapse technologies in IVF to standardize practice for data to be amassed, experiences shared, and 
best practice reached. Anomalous and non-time-lapse–dependent variables have not been included but may be 
annotated at the embryologist’s discretion and in line with standard operating procedure.
Assurance of Annotation Quality
Ensuring an accurate and objective record of dynamic, and often anomalous, embryo development can be chal-
lenging, whether using automatic detection software, the human eye, or even by committee. To amass data of 
high quality and a resource for embryo selection algorithm development to enhance clinical outcome, a  quality 
assurance system should be introduced early on to ensure that embryologists’ or practitioners’ interpretations 
and annotations are objective and consistent. This exercise may be developed in-house or provided by the 
time-lapse device supplier. Even where there is a sole annotator, data should be compared over time to ensure 
that consistency and objectivity remain.
Several morphokinetic variables are at risk of subjective interpretation. The appearance of pronuclei and 
 initiation of compaction are just two examples. Thorough training and the use of reference images and audit 
should be used to ensure annotation quality.
The Challenges of Annotation
Many of the morphokinetic variables within Table 12.1 (see also Figures 12.1 through 12.4) can readily be iden-
tied on studying the embryo’s time-lapse images, whereas others can cause great discussion and debate. The 
current lack of an industry standard makes comparing practice and data difcult. An example of one annotation 
challenge may be fragmentation.
Fragmentation is a poorly understood but a very common and dynamic feature of human preimplantation 
IVF embryos that has been linked to aneuploidy [10,11]. Time lapse provides an opportunity for the dynamics 
of fragmentation to be studied in greater detail and has recently been used in a study by Chavez et al. [12] that 
suggested that most fragmented early cleavage-stage embryos were aneuploid. More recently, a preliminary 
study by Montgomery et al. [13] has shown an association between the timing and completion of compaction in 
fragmented embryos, and blastocyst ploidy.
Fragmented embryos with extended periods of compaction were signicantly more likely to give rise to aneu-
ploid blastocysts than embryos that completed compaction within 22 hrs of ICSI. Conventionally, fragmentation 
has been reported by an estimation of the proportion of the embryo affected, and ranges are used rather than 
specic values [5,6]. To share data and experience with other time-lapse practitioners, surrounding this common 
feature of human embryos, when annotating fragmentation, it is recommended that a percentage value and the 
number of cells at the time point of recording are used. There is currently no recommendation for the denition 
or standard recording of patterning or dynamic movement of fragmentation within the embryo, but there is a 
desire for such guidelines to be developed.
Outcome Measures
Successful live birth is the ultimate outcome after IVF treatment, and despite the limitations of any outcome 
measure, including live birth, this should be the primary outcome measure when considering the potential of a 
developing embryo.
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TABLE 12.1




t0 IVF or midtime of ICSI/IMSI
tPB2 The second polar body is completely detached from the ooplasm
tnPN Fertilization status is conrmed
(tPN1a) The rst pronucleus is rst visible
(tPN2a) The second pronucleus is rst visible
tPNf All pronuclei have faded (see Figure 12.1)
t2-t9 Two (see Figure 12.2) to nine sequential, distinguished cells are present
tSC The rst two cells merge; initiation of compaction observed (see Figure 12.3)
tMx/w Morula is formed or compaction goes no further; “x” corresponds to fully compacted, and “w” corresponds 
to partially compacted or cells excluded
tSB The rst sign of a cavity is observed as blastulation begins (see Figure 12.4)
tByz Full blastocyst stage is reached; the last frame before the zona pellucida starts to thin; “y” corresponds to 
morphology of inner cell mass cells, and “z” corresponds to trophectoderm cells (see Figure 12.4)
tEyz Initiation of expansion is conrmed; the zona pellucida starts to thin
tHNyz Extrusion of cells from the zona pellucida is present
tHDyz Blastocyst is fully hatched from the zona pellucida
Calculated Variables
VP tPNf-tPN1a (period of visible pronuclei)
Cell Cycle
CC1 t2-tPB2
The end of the second meiosis to the formation of two discrete cells
CC2 The time for a two-cell embryo to form a four-cell embryo
The two blastomeres (a and b) can be considered individually
CC2a = t3-t2
CC2b = t4-t2
CC3 The time for a four-cell embryo to form an eight-cell embryo






S2 The duration of the transition from two sister cells, each dividing to reach the four-cell stage
t4-t3
S3 As above, but from four to eight cells
t8-t5




tHN-tSB Duration of blastulation
Note: Each time point denes the time-lapse frame in which the phenomena described are rst observed or recorded.
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FIGURE 12.1 Sequential time lapse images of fading pronuclei. Image (c) is tPNf.
FIGURE 12.2  Sequential time lapse image of the rst mitosis. Image (c) shows t2.
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FIGURE 12.3 Initiation of compaction (tSC). More clearly seen with multiple focal planes. Image (c) shows tSC.
FIGURE 12.4 Initiation of blastulation (tSB). Images (b) and (c) show the increasing cavity and image (d) shows tB.
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Due to the relatively recent introduction of time-lapse technology for IVF, the length of the gestational period, 
and the time required to acquire and collate obstetric outcome data from patients, alternative and less robust 
 outcome measures have been used in published time-lapse studies. Blastulation, although of great scientic 
 interest, has limited clinical value due to the high incidence of blastocysts that fail to implant or are  aneuploid [8]. 
Clinical pregnancy, dened by the presence of a fetal heart on ultrasound scan, has also been used, but due to the 
early nature of these reported pregnancies, some pregnancies may be lost before term [14]. The difculty remains 
that failed pregnancies or even failed implantations cannot necessarily always be attributed to the embryo; 
however, in terms of outcome measure, live birth arguably remains the most reliable indicator of the viability 
potential of the preimplantation embryo for IVF and time-lapse practitioners [15].
KID refers to transferred embryos with a known outcome.
What is commonly referred to as “known implantation data,” or KID, are the morphokinetic data of a specic 
and transferred embryo that has a known outcome, with the outcome being either a negative pregnancy test, 




1 × KID 
Positive
One embryo 
1 × KID 
Negative
Two embryos 
2 × KID 
Negative
Two embryos  





 loss × 2 
Pregnancy  
loss × 1 
One live birth  
1 × KID(LB) 
Positive
Two live birth  
2 × KID(LB) 
Positive
No live birth 
1 × KID(LB) 
Negative
No live birth 
No KID(LB) 
No live birth 





FIGURE 12.5 Known implantation data (KID). KID is the morphokinetic data of a specic, transferred embryo that has a known 
outcome. *Zygoticity of a twin pregnancy, following double embryo transfer, cannot be ascertained without genetic ngerprinting. 
Due to relatively low incidence of dizygotic twinning, practitioners, accepting this limitation, may include these data in KID analy-
ses. **As implantation data cannot be deduced or used following a double embryo transfer resulting in a single implantation or birth, 
the KID ratio, or rate, is lower than the implantation rate per embryo transferred, commonly used for IVF data analyses.
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how morphokinetic data may be used for analysis after embryo transfer. Data can be compared between embryos 
giving positive or negative implantation data (KID+ or KID–, respectively). All data can be used after a single 
embryo transfer, or a double embryo transfer with a negative outcome. Using data after multiple embryo transfer 
that has resulted in the same number of fetal hearts or babies born may be problematic without the use of genetic 
ngerprinting to ascertain the chrorionicity or zygoticity of the pregnancies. However, due to the very low inci-
dence of monozygotic twinning, most analyses could justify the inclusion of these data.
Data Collection and Analysis
Data can be exported from the time-lapse devices for assessment and analysis, or they can be processed using 
integrated software tools. Provided the data are quality assured and complete, meaning that all relevant mor-
phokinetic variables have been recorded according to standard policy, where they occurred, and that outcome 
of transferred embryos has been updated, there exists a powerful tool for retrospective analysis. The data should 
be carefully divided into groups for comparison and statistical analysis. Due to the ranges observed for each 
morphokinetic variable, it is recommended that median values are used as opposed to means. This way, extreme 
high or low outliers do not introduce a skew.
KID rates (or ratios) can be calculated for each signicant variable for exclusion (deselection) and selection 
criteria to be identied and then used to develop embryo selection algorithms or models.
KID rates are calculated using the following formula: KID+/KID+ plus KID– × 100%.
Regular data review is recommended to continually improve embryo selection algorithms.
Selection and Deselection Criteria and Algorithms for Embryo Selection
Several time-lapse studies have linked kinetic markers to embryo viability. In a retrospective analysis of 
EmbryoScope-acquired time-lapse human embryo data, a signicant association was previously demonstrated 
between the timing of pronuclear fading and the rst three cleavage events, and successful implantation [16]. 
Another study, looking at early embryo development, showed an inverse relationship between the ability of 
embryos to develop to the blastocyst stage and the length of time for zygote division [17].
Time lapse identifies aberrant cleavage patterns.
More recently, a study by Rubio and colleagues [18] focused on the phenomenon of direct, or rapid, cleavage 
from a single cell to three cells in <5 hr. This study demonstrated the ability of time lapse to identify aberrant 
cleavage divisions and the reduced implantation potential when such embryos were transferred compared with 
embryos that did not exhibit this behavior. In a cohort of 1659 transferred embryos, the incidence of this “direct 
division” was 13.7%, and the known implantation rate of these embryos was statistically signicantly lower than 
for embryos with a normal cleavage pattern (1.2% vs. 20.2%, respectively). Figure 12.6 shows a series of time-
lapse images demonstrating this phenomenon within 0.5 hr.
This consecutive series of four time-lapse images, taken at about 10 min intervals, demonstrates the phe-
nomenon of direct cleavage from one to three cells and would not be observed without time lapse and has been 
reported to be associated with reduced implantation potential [18].
Several embryo selection models, or algorithms, indicating the added value of using morphokinetic information 
when selecting embryos have now been published. The rst by Wong and colleagues [8] identied three signicant 
morphokinetic variables associated with the likelihood of blastulation. These variables and values (in parentheses) 
were P1, the duration of the rst cytokinesis (within 33 min); P2, the interval between the rst and the second cyto-
kineses, that is, the total length of time at the two-cell stage (7.8–14.3 hr); and P3, the time between the second and 
third mitoses, that is, the total length of time at the three-cell stage or the synchrony of cleavage of the rst two cells 
(within 5.8 hr). This work was used to develop the Eeva test (early embryo viability assessment) (Auxogyn).
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The work of Meseguer et al. [9] used the EmbryoScope and looked beyond blastulation to implantation and 
pregnancy rates. By studying 247 transferred embryos with known implantation outcome, optimal ranges for 
specic morphokinetic variables were dened. By analyzing multiple preimplantation embryo developmen-
tal milestones and durations, a hierarchical model to classify embryos, according to the most signicant 
morphokinetic variables, was developed. The timing of the cleavage to ve cells (t5) in this study showed the 
highest correlation with positive implantation. This model rst introduced exclusion criteria. These exclusion 
criteria were uneven blastomeres after the rst cytokinesis, rapid or direct cleavage from one to three cells, 
and multinucleation at the four-cell stage. After the exclusion of embryos fullling these criteria, embryos 
were classied according to the timings of similar variables proposed by Wong et al. (P2 and P3 above), 
referred to as cc2 (within 11.9 hr) and S2 (within 0.76 hr), as well as t5 (48.8–56.6 hr post-intracytoplasmic 
sperm injection [ICSI]). Despite there being some similarities in the morphokinetic variables used within 
these published models, the timings differ and caution should be exercised when considering applying such 
models, developed in a different research or clinical setting, before robust validation is performed 
(as  discussed below). It has been demonstrated that a published embryo selection model from one setting may 
not always effectively be transferred to another setting, but it may be useful with some modication, and 
after a validation process [19].
More recently, an aneuploidy risk classication model has been published [20]. Also, using the EmbryoScope, 
20 morphokinetic variables and durations were recorded for blastocysts that then underwent trophectoderm 
biopsy and preimplantation genetic screening (PGS) for all chromosomes using array-comparative genomic 
Time-lapse–based embryo selection models indicate the value of applied morphokinetics, but care 
has to be taken while transferring models from one clinical setting to another.
FIGURE 12.6 Rapid or direct cleavage from one to three cells.
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hybridization (CGH) or single-nucleotide polymorphism (SNP) array. Two variables signicantly correlated with 
embryo ploidy were used to develop an algorithm for embryo selection that classied embryos as having a low, 
medium, or high risk of aneuploidy. These variables were the start of blastulation (tSB) and the time to reach 
the full blastocyst stage (tB). Risk classications were dened according to the time an embryo reached these 
two developmental milestones. Table 12.2 shows the probability of aneuploidy when embryos were partitioned 
according to their morphokinetic values for the two signicant variables.
This model was later tested retrospectively, by the same researchers, on transferred blastocysts with known 
clinical outcome that had not undergone biopsy and PGS. Signicant relative increases in positive fetal heart 
and live birth rates were demonstrated when an embryo retrospectively classied as low risk was transferred, 
compared with the overall rates after blastocyst transfer, indicating the potential clinical applicability of this 
noninvasive time-lapse algorithm for embryo selection.
Practitioners working with selection models where embryos are deselected or excluded should consider the 
supporting data to help with the decision process regarding the fate of such embryos. Considerations should be 
made as to whether the morphokinetic phenomena or timings observed during a particular embryo’s develop-
ment, deeming it deselected for transfer, preclude implantation entirely or are associated with reduced viability 
or potential. An embryo identied as having a high risk of aneuploidy or low potential to blastulate by a model, 
for example, may be the highest ranking embryo within a cohort and still give the patient a chance of a positive 
outcome, albeit small.
Transferability of Embryo Selection Algorithms
Whether such embryo selection algorithms can be directly transferrable between clinics remains to be demon-
strated but based on reports that rates of embryo development can differ according to intrinsic or extrinsic factors, 
it is likely that they may not. Either way, it should be preferable for clinics to develop their own models for their 
specic patient populations, stimulation regimens, culture conditions, and according to their interpretation of 
time-lapse images.
Clinics introducing time-lapse methodologies are advised to do so with strict and standard practice through-
out the process. Until we know the potential impact of subtle deviations from protocol, culture dishes or slides 
should be prepared in a standard and precise manner, and time-lapse images, where performed manually, should 
be assessed objectively and observations recorded (annotated) in the same way by all practitioners. Only this 
will allow centers to collate robust and complete data to develop in-house embryo selection models that can be 
ne-tuned as experience and data amasses.
Confounding Factors
There have been several reports on the impact, on embryo morphokinetics, of compounding factors that may be 
patient or clinic specic. Examples are gas composition during in vitro culture, age, female body mass index, 
and culture media [14,21–23].
TABLE 12.2
Time-Lapse–Derived Model for Classication of Ploidy with Associated Probabilities 
of Aneuploidy
Aneuploidy Risk Class Model n Probability of Aneuploidy (%)
Low tB < 122.9 hr and tSB < 96.2 hr 36 37
Medium tB < 122.9 hr and tSB ≥ 96.2 hr 49 69
High tB ≥ 122.9 hr 12 97
All 97 61
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A recent study, however, reported that morphokinetic parameters used for embryo selection were not affected 
between two different culture media analyzed [24]. Over the next few years, such questions surrounding confounding 
factors and those crucially asking whether algorithms for embryo selection are transferable will likely be a key focus 
for time-lapse study in the eld of IVF. To make the most effective progress in this eld, embryologists are urged to 
work together, sharing best and common practice to enable this shift in practice to take place most effectively.
Change Control
Due to the possible impact of intrinsic and extrinsic factors on morphokinetic timings, great care should be taken 
when a change to practice is being considered or made when using time-lapse systems. The impact of a control-
lable factor such as a change in media or plasticware, for example, on the precise timings of embryo develop-
ment, should be understood and validated before full implementation, particularly if embryo selection models 
have been developed under specic conditions. As with all changes made in IVF laboratories, these changes 
should be justied, controlled, validated, and evaluated but now with the additional consideration of potential 
impact on morphokinetics, when using time-lapse imaging.
A Tool or a Rule? The Role of the Embryologist
As a clinical treatment, we are still in the relatively early stages of clinical implementation of time-lapse 
 technology. We remain unclear as to whether published algorithms, developed using particular incubation 
 conditions (such as gas mix and culture media), can be directly transferred between centers using not only 
alternative incubation but also potentially differing denitions and operating procedures for recording dynamic 
observations of embryo development. Although the expectation is that, eventually, agreement will be reached as 
to the most signicant indicators of an embryo’s potential to develop through to live birth, the specic timings 
may differ according to the variation in, for example, patient history, age, or incubation conditions, and this could 
result in clinics having numerous algorithms that can be applied for the purpose of embryo selection, according 
to these factors. In time, and with increasing data and experience, the optimal ranges for dened dynamic events 
such as the interval between the rst and second cytokineses may be further ne-tuned, and additional novel 
morphokinetic markers of embryo viability will be identied.
The role of the embryologist remains key, despite the most sophisticated algorithm.
The role of the embryologist remains key. Even with sophisticated morphokinetic selection algorithms, the 
embryologist may need to overrule the algorithm should an embryo reaching all of the milestones within the 
optimal time ranges also have features considered detrimental, such as smooth endoplasmic reticulum clusters, 
large areas of cellular degeneration, or late-onset developmental arrest. The use of bright-eld time-lapse devices 
provides embryologists with images already familiar to them and allows this facilitative interaction between the 
digital and the human eye.
Acknowledgments
I am grateful for permission to use and adapt the table of proposed denitions, currently being drafted for sub-
mission by The Embryo Morphokinetic Consensus Group; Inge Agerholm, Jesus Aguilar, Sandrine Chamayou, 
Nadir Ciray, Marga Esbert, Shabana Sayed, and Alison Campbell.
I thank Louise Kellam for assistance with image preparation for this chapter and my CARE Fertility 
colleagues.
Embryo Selection by Time-Lapse Imaging 189
REFERENCES
 1. Payne D, Flaherty SP, Barry MF, et al. Preliminary observations on polar body extrusion and pronuclear forma-
tion in human oocytes using time-lapse video cinematography. Hum Reprod 1997; 12: 532–541.
 2. Pribenszky C, Matyas S, Kovacs P, et al. Pregnancy achieved by transfer of a single blastocyst selected by time-
lapse monitoring. Reprod Biomed Online 2010; 21: 533–536.
 3. Cutting R, Morroll D, Roberts SA, et al. Elective single embryo transfer guidelines for practice British Fertility 
Society and Association of Clinical Embryologists. Hum Fertil 2008; 11: 131–146.
 4. Fisch J, Rodriguez H, Ross R, et al. The graduated embryo score predicts blastocyst formation and pregnancy rate 
from cleavage stage embryos. Hum Reprod 2001; 16: 1970–1975.
 5. Alpha Scientists in Reproductive Medicine, ESHRE Special Interest Group of Embryology. The Istanbul consen-
sus workshop on embryo assessment: Proceedings of an expert meeting. Hum Reprod 2011; 26: 1270–1283.
 6. Alpha Scientists in Reproductive Medicine, ESHRE Special Interest Group of Embryology. The Istanbul con-
sensus workshop on embryo assessment: Proceedings of an expert meeting. Reprod Biomed Online 2011; 22: 
632–646.
 7. Van Royen E, Magelschots K, Vercruyssen M, et al. Multinucleation in cleavage stage embryos. Hum Reprod 
2003; 18(5): 1062–1069.
 8. Wong CC, Loewke KE, Bossert NL, et al. Non-invasive imaging of human embryos before embryonic genome 
activation predicts development to the blastocyst stage. Nat Biotechnol 2010; 28(10): 1115–1121.
 9. Meseguer M, Herrero J, Tejera A, et al. The use of morphokinetics as a predictor of embryo implantation. Hum 
Reprod 2011; 26(10): 2658–2671.
 10. Munne S, Cohen J. Chromosome abnormalities in human embryos. Hum Reprod Update 1998; 4: 842–855.
 11. Alikani M, Calderon G, Tomkin G, et al. Cleavage anomalies in early human embryos and survival after pro-
longed culture in vitro. Hum Reprod 2000; 15: 2634–2643.
 12. Chavez SL, Loewke KE, Han J, et al. Dynamic blastomere behaviour reects human embryo ploidy by the four-
cell stage. Nat Commun 2012; 3: 1251.
 13. Montgomery S, Duffy S, Bowman N, et al. Does the duration of compaction differ in fragmented cleavage stage 
embryos that ultimately become euploid or aneuploidy blastocysts? Is this reected in the timing of blastulation? 
ESHRE, London. Hum Reprod 2013; 28(Suppl 1): i1–i4.
 14. Meseguer M, Rubio I, Cruz M, et  al. Embryo Incubation and selection in a time-lapse monitoring system 
improves pregnancy outcome compared with a standard incubator: A retrospective cohort study. Fertil Steril 
2012; 98: 1481–1489.
 15. Campbell A, Fishel S, Bowman N, et al. Retrospective analysis of outcomes after IVF using an aneuploidy risk 
model derived from time-lapse imaging without PGS. Reprod Biomed Online 2013; 27: 140–146.
 16. Herrero J, Alberto T, Ramsing NB, et al. Linking successful implantation with the exact timing of cell division 
events obtained by time-lapse system in the EmbryoScope. Fertil Steril 2010; 94(4): S149.
 17. Cruz M, Perez-Cano I, Gadea B, et al. Time-lapse video analysis provides a correlation between early embryo 
division kinetics and subsequent blastocyst formation and quality. Hum Reprod 2011; 26: P-115.
 18. Rubio I, Kuhlmann R, Agerholm I, et al. Limited implantation success of direct-cleaved human zygotes: A time-
lapse study. Fertil Steril 2012; 98: 1458–1463.
 19. Best L, Campbell A, Duffy S, et al. Session 57: Does one model t all? Testing a published embryo selection 
algorithm on independent time-lapse data. Hum Reprod 2013; 28: i87–i90.
 20. Campbell A, Fishel S, Bowman N, et al. Modelling a risk classication of aneuploidy in human embryos using 
non-invasive morphokinetics. Reprod Biomed Online 2013; 26: 477–485.
 21. Liebenthron J, Montag M, Koster M, et al. Inuence of age and AMH on early embryo development realised by 
time-lapse imaging. Hum Reprod 2012; 27: P-135.
 22. Bellver J, Mifsud A, Grau N, et al. Similar morphokinetic patterns in embryos derived from obese and normo-
weight infertile women: A time-lapse study. Hum Reprod 2013; 28: 794–800.
 23. Ciray HN, Aksoy T, Goktas C, et  al. Time-lapse evaluation of human embryo development in single versus 
sequential culture media-a sibling oocyte study. J Assist Reprod Genet 2012; 29: 891–900.
 24. Basile N, Morbeck D, García-Velasco J, et al. Type of culture media does not affect embryo kinetics: A time-lapse 
analysis of sibling oocytes. Hum Reprod 2013; 28: 634–641.
1 RBMO  VOLUME 00  ISSUE 0  2019
ART Institute of Washington, USA
© 2019 The Author. Published by Elsevier Ltd on behalf of Reproductive Healthcare Ltd. This is an open access article 
under the CC BY-NC-ND license. (http://creativecommons.org/licenses/by-nc-nd/4.0/)
*Corresponding author. E-mail addresses: jc@embryos.net, JacquesC7@gmail.com (J Cohen). https://doi.org/10.1016/j.
rbmo.2019.10.003 1472-6483/© 2019 The Author. Published by Elsevier Ltd on behalf of Reproductive Healthcare Ltd. This 









‘There is only one thing that is truly 
important in an IVF laboratory: everything’ 
Cairo Consensus Guidelines on IVF Culture 
Conditions
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This report presents outcomes from an international expert meeting to establish consensus guidelines on 
IVF culture. Topics reviewed were: embryo culture; temperature; humidity; gas control, pH; workstations; 
incubators; micromanipulation; handling and assessment; stasis, composition, supplementation, type of culture 
and storage; equipment and monitoring. More than 50 consensus guideline points were established.
ABSTRACT
This proceedings report presents the outcomes from an international expert meeting to establish consensus 
guidelines on IVF culture conditions. Topics reviewed and discussed were: embryo culture – basic principles and 
interactions; temperature in the IVF laboratory; humidity in culture; carbon dioxide control and medium pH; 
oxygen tension for embryo culture; workstations – design and engineering; incubators – maintaining the culture 
environment; micromanipulation – maintaining a steady physcochemical environment; handling practices; assessment 
practices; culture media – buffering and pH, general composition and protein supplementation, sequential or single-
step media for human embryo culture; use and management – cold chain and storage; test equipment – calibration 
and certification; and laboratory equipment and real-time monitoring. More than 50 consensus guideline points were 
established under these general headings.
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INTRODUCTION
C linical IVF has had a relatively unrestricted development over the past 40 years, with the result that there is now 
a plethora of permutations of laboratory 
culture systems. Some laboratories have 
retained aspects from the mid-1980s, 
while others are more likely to embrace 
change and adopt novel aspects of IVF 
culture as they are introduced.
Against this background, it is a 
challenge to identify and define what 
might constitute ‘best practice’ in 
the IVF laboratory. However, there 
are key physcochemical factors that 
affect oocytes and embryos in every 
IVF laboratory: temperature control, 
maintaining osmolarity and pH, and 
protection from oxidative stress and 
toxic substances, such as volatile organic 
compounds (VOC) (Mortimer et al., 
2018). The purpose of this consensus 
workshop, held at the UEARS 2018 
conference (17–18 February 2018, Cairo, 
Egypt) was to define the technical 
and procedural requirements for an 
IVF laboratory’s culture system while 
taking these factors into account. The 
overarching goal of the workshop was 
to identify how best to operate within a 
framework of quality and excellence to 
achieve best practice and to optimize 
the developmental competency of all 
gametes received and embryos obtained.
The aim was to develop an international 
expert (TABLE 1) consensus opinion 
regarding the strengths and weaknesses 
of various options currently available 
for equipment and procedures and the 
criteria by which users can determine 
fitness for purpose within their own 
laboratories and operating environments, 
and to identify areas for priority research 
to fill knowledge gaps or resolve unknown 
optimization parameters. It was not the 
goal to define exactly what should – or 
should not – be done in the IVF laboratory, 
as these decisions must be taken in 
connection with local regulatory and 
licensing requirements, as well as local 
availability of products and services.
The structure of the meeting was 
presentations on the current state-of-
the-art aspects of the IVF laboratory 
culture system, followed by facilitated 
discussions and the development of a set 
of guidelines and recommendations for 
each topic.
WORKSHOP REPORTS
Embryo culture – basic principles and 
interactions
It is often said that the goal of embryo 
culture is to replicate the conditions 
of the maternal reproductive tract. 
While it is true that the oviduct and 
uterus provide the best possible culture 
environment, the reproductive system 
is extremely complex and is the result 
of aeons of evolution. Given this 
complexity, it is unrealistic to suppose 
that all the diverse interactions between 
the embryo and the maternal tract will 
be understood in the near future, and 
even less realistic to suppose that they 
can be replicated perfectly in vitro. The 
goal of in-vitro embryo culture is to 
provide conditions that will lead to the 
production of embryos that have the 
same developmental potential as the 
embryos that develop in vivo.
That said, there are at least two facets 
of the maternal tract that are well 
recognized and can – and should – be 
replicated in vitro. The first is oxygen 
tension. Although the exact oxygen 
tension in the normal human female 
reproductive tract is not known, it is 
certain to be well below the ∼21% found 
in ambient air. This has been borne 
out by the results of perhaps hundreds 
of studies of the effect of low (5–10%) 
versus high (ambient) oxygen tension on 
the development of embryos of every 
mammalian species studied, including 
humans. To date, no studies have shown 
a positive effect of high O2 on the 
preimplantation development of human 
embryos, compared with many that have 
shown a deleterious effect (see Gardner, 
2016). Consequently, placing human 
embryos in a high O2 environment 
constitutes exposure to a known 
embryo toxin, which may be considered 
unethical.
The second area of concern is the 
exposure of the embryo to in-vitro 
conditions with the potential for adverse 
effects. For instance, it is possible that 
environmental pollutants, particularly 
VOCs, may play a role. Although the 
embryo is not completely protected 
from VOCs in the maternal tract, the 
mother’s lungs, liver and kidneys do 
provide considerable filtration and 
detoxification of VOCs, thus reducing the 
exposure of the embryo. Conversely, the 
embryo in vitro has no such protective 
mechanisms, and therefore steps must 
be taken to actively reduce VOCs in 
the general laboratory air and within 
the incubator in particular (discussed in 
Mortimer et al., 2018).
Early approaches to culturing human 
embryos involved the use of culture 
media designed for the culture of 
somatic cells. Many of the components 
of those media were inappropriate and/
or at the wrong concentrations for 
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embryo culture. Since then, large strides 
have been made in the formulations of 
embryo culture media, beginning with 
the development of Quinn’s Advantage 
Fertilization (HTF) Medium for culture to 
the cleavage stages, and then media for 
culture through to the blastocyst stage. 
The inclusion of all 20 amino acids has 
proved to be particularly important, with 
glutamine being provided via dipeptides 
with alanine or glycine. Commercial 
mass-produced and distributed media 
are manufactured under much more 
stringent and controlled conditions 
than could ever be possible in an IVF 
laboratory, and are subject to rigorous 
testing and regulatory oversight.
It is, however, important to recognize 
that the embryo culture medium is 
but one among perhaps hundreds of 
factors in the IVF laboratory that might 
affect the outcome of any given cycle 
(Poole et al., 2012). This includes every 
pipette tip, holding tube and culture 
dish that is in contact with any of several 
media. Laboratory apparatus, gases 
and procedures could all have effects 
independent of the culture medium: 
the fact that a developmental anomaly 
or failure appears while the embryo is 
in a culture medium does not mean 
that the medium is responsible for it. 
For example, the presence of vacuoles 
in the sperm head has been shown to 
have no effect on development through 
the cleavage stages, but to significantly 
decrease the rate of development to the 
blastocyst stage (Gardner and Kelley, 
2017; Vanderzwalmen et al., 2008). There 
is only one thing that is truly important in 
an IVF laboratory: everything.
Some consideration must also be given 
to the measures of success of embryo 
culture. Although in-vitro evaluation 
of development can be informative, 
the evaluation must ultimately include 
measures of in-vivo development after 
transfer. Traditionally, this has centred on 
pregnancy, clinical pregnancy, ongoing 
pregnancy, miscarriage, birth and live 
birth rates. None of these are valid 
measures of embryo viability, because 
none of them account for the number 
of embryos transferred. For example, if 
two embryos are transferred, and one 
embryo fails to implant in each recipient, 
it would have absolutely no effect on 
the clinical pregnancy rate. Clearly, any 
measure that cannot distinguish between 
0% and 50% embryonic loss is of no 
use in evaluating embryo viability. The 
use of cumulative pregnancy rate is 
also inappropriate, because it does not 
account for the number of transfers. In 
effect, transfers of viable embryos could 
be interspersed with the transfer of 
degenerate embryos, aneuploid embryos, 
grains of sand, air bubbles, or nothing 
at all, and it would have absolutely no 
effect on the cumulative pregnancy rate. 
Conversely, implantation rate, sustained 
implantation rate, fetal loss rate, and 
babies born per embryo transferred all 
account for the number of embryos 
transferred. It has been suggested that 
implantation rate is statistically biased 
(Griesinger, 2016), but this is easily 
circumvented by doing only single 
embryo transfer.
Without question, the trend in ART 
is towards embryo transfer at the 
blastocyst stage (Days 5–7), and rapidly 
diminishing transfer at the cleavage 
stage (Days 2–3). The transfer of 
cleavage-stage embryos to the uterus 
is non-physiological, particularly in the 
presence of elevated oestrogen levels 
following ovarian stimulation. In addition, 
culture to the blastocyst stage provides 
the opportunity for more and better 
evaluations of development, including 
morphological, morphokinetic, metabolic 
and cytogenetic aspects. As a result, the 
implantation rate for blastocyst transfer 
is significantly greater than for cleavage-
stage transfer for all maternal age groups 
(SART National Summary, 2015–2017). 
Blastocyst transfer provides better 
synchrony between the embryo and 
uterus than does cleavage-stage transfer, 
so it would seem difficult to justify the 
transfer of cleavage-stage embryos. In 
clinics where the current blastocyst 
development rate might not support this 
approach, there should be a focus on 
improving this outcome measure.
However, even with blastocyst transfer, 
the high concentrations of oestrogen 
and progesterone resulting from ovarian 
stimulation produce a less than optimal 
uterine environment. The logical 
approach to eliminating this problem 
is to freeze all of the blastocysts and 
then transfer them (singly) in one or 
more subsequent unstimulated cycles 
(1985c). The implantation rate for the 
transfer of frozen–thawed blastocysts is 
significantly greater than for the transfer 
of fresh blastocysts for all maternal age 
groups (SART National Summary, 2016 
and 2017). Moreover, the incidence of 
small for gestational age (SGA) babies 
is significantly decreased with frozen 
embryo transfer, while the incidence of 
large for gestational age (LGA) babies 
is significantly increased (Luke et al., 
2017; Wennerholm et al., 2013). It is 
important to note that SGA is associated 
with increased overall rates of neonatal, 
infant and later death but there is no 
association between LGA and overall 
rates of neonatal, infant or later death 
(Wennerström et al., 2015; Xu et al., 
2010).
The incidence of aneuploidy is high, 
even among morphologically high-quality 
blastocysts. Such aneuploid embryos 
have a greatly reduced chance of 
implanting or of resulting in a live birth. 
The implantation rate for the transfer 
of blastocysts identified as euploid by 
preimplantation genetic testing for 
aneuploidy (PGT-A) is significantly greater 
than that for untested blastocysts, for 
all maternal age groups (SART National 
Summary, 2016). Clinically, the use of 
PGT-A may be a better standard of 
care, although accepted evidence is still 
missing. In terms of experimental design, 
the presence of aneuploid embryos is a 
significant source of experimental noise 
and markedly increases the number of 
transfers, time to pregnancy, patient 
distress and cost of hypothesis testing for 
other aspects of ART.
In conclusion, the basic requirements for 
embryo culture seem to be:
– complete culture medium (all 20 amino 
acids);
– attention to all laboratory and clinical 
factors;
– low O2 environment;
– low/no VOC environment;
– culture to Day 5(+);
– blastocyst vitrification (freeze-all); and
– optional transfer of single frozen–
thawed (euploid) blastocysts.
Temperature in the IVF laboratory
Using and maintaining the appropriate 
temperature during cell handling and 
culture is a critical component of 
optimizing an IVF culture system because 
improper temperatures can compromise 
cell function and development and hence 
reduce IVF outcomes. However, the ideal 
temperature to use in vitro remains an 
area of debate.
While recreating in vitro the conditions 
that exist in vivo to accommodate the 
embryo’s physiological needs is a logical 
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approach (Gardner and Leese, 1990; 
Gardner et al., 1996, 2002; Lane and 
Gardner, 2000a), there is a risk of 
errors in the in-vivo measurements (Ng 
et al., 2018). Additionally, the in-vitro 
environment might necessitate unique 
considerations and require departure 
from in-vivo parameters to ensure 
optimal gamete handling and embryo 
development in vitro.
A core body temperature in humans of 
37°C is widely accepted but this value 
might not be entirely accurate because 
body temperature is actually a range 
(Dewdney, 1993; Elert, 2015; Mackowiak 
et al., 1992; Sund-Levander et al., 
2002), and can be affected by how the 
measurement is taken (oral versus axillary 
versus rectal versus tympanic), the time 
of day, the individual being measured, 
and their sex (Elert, 2015; Sund-Levander 
et al., 2002). Hence this could bring 
into question whether the current IVF 
laboratory standard of 37.0°C is optimal.
Testicular temperature of most mammals, 
including man, is 2–4°C lower than core 
body temperature, and is necessary 
for normal spermatogenesis and 
spermiogenesis (Durairajanayagam 
et al., 2015). Similarly, the temperature of 
the female reproductive tract might also 
be lower than core body temperature: a 
temperature gradient exists in the oviduct 
of pigs and rabbits, with the isthmus 
being 0.2–1.6°C cooler than the ampulla 
(Hunter, 2012; Hunter and Nichol, 1986; 
Hunter et al., 2006). Mature follicles 
in rabbit, pigs and cows are 1.3–1.7°C 
cooler than the ovarian stroma (Grinsted 
et al., 1980; Hunter, 2012; Hunter and 
Einer-Jensen, 2005; Hunter et al., 1997, 
2000, 2006) and ∼2.3°C cooler than 
stroma in human ovaries (Grinsted et al., 
1985). Such observations, as well as a lack 
of reliable information on the uterine 
temperature at the time of implantation, 
have led to the proposition that human 
embryo development might benefit from 
a temperature lower than core body 
temperature (Leese et al., 2008).
Interestingly, apparent detrimental 
effects of short periods of reduced 
temperature on the oocyte has led to 
most practices in the IVF laboratory 
being performed at a strict 37°C. Prior 
studies, often using compromised 
starting material, have shown that: 
(i) cooling mouse oocytes to near 4°C 
resulted in zona hardening, probably as 
a result of premature cortical granule 
exocytosis; (ii) transient cooling of human 
oocytes to room temperature caused 
disorganized spindles, with some oocytes 
showing displaced chromosomes, and 
only some of the oocytes showing 
reorganization of the meiotic spindle 
upon rewarming; and (iii) the severity of 
defects increased with lower temperature 
and longer time (Johnson et al., 1988; 
Pickering and Johnson, 1987; Pickering 
et al., 1990). Reassembly of the human 
oocyte meiotic spindle observed using 
polarized light microscopy was retarded 
at room temperatures but was not 
different between 33°C or 37°C (Wang 
et al., 2001). Additionally, performing 
intracytoplasmic sperm injection (ICSI) 
at 37°C, rather than at 33°C or 34°C, 
resulted in a significantly higher number 
of oocytes with a visible meiotic spindle, 
as well as significantly higher fertilization 
and pregnancy rates (Wang et al., 2002).
It should be noted, however, that 
not all temperature excursions below 
37°C are necessarily harmful to the 
oocyte. One report indicated that it 
was not necessary to perform ICSI at 
37°C for successful outcomes to be 
achieved (Atiee et al., 1995), but did not 
address the achievement of optimum 
clinical outcomes. Many successful 
cryopreservation protocols require 
equilibration in cryoprotectant solutions 
at room temperature for several minutes 
– but these are special circumstances 
and are associated with careful thawing 
and warming protocols.
Temperature sensitivity of 
preimplantation embryos is less well 
studied. While one study on incubator 
performance reported an increased 
pregnancy rate from incubators with 
a temperature of 36.96 ± 0.13°C 
compared with those with a temperature 
of 37.03 ± 0.13°C (Higdon et al., 2008), 
another that reported slight temperature 
gradients of up to 0.3°C between shelves 
in culture incubators found no significant 
impact on clinical outcomes (Walker 
et al., 2013). Of importance, accuracy of 
these minor temperature variances is less 
than the uncertainty of measurement 
of most thermometers. However, a 
prospective randomized controlled trial 
(RCT) using patient zygotes cultured 
for 5–6 days at either 37°C or 36°C 
demonstrated that culture at 37°C 
yielded higher average cell numbers on 
Day 3 and higher blastocyst formation 
and more useable blastocysts compared 
with 36°C (Hong et al., 2014). Similarly, 
another prospective study also suggested 
37°C was superior for extended embryo 
culture compared with 36.5°C (Fawzy 
et al., 2018). Thus, prolonged differences 
in culture temperature appear to impact 
embryo development.
Current IVF culture media have been 
formulated for use at ∼37°C and it is 
perceived that alteration of culture 
temperature could affect cell metabolism 
as well as medium pH, especially in 
media containing HEPES or MOPS 
(Jeyendran and Graham, 1982; Swain, 
2010, 2011, 2012a,b; Will et al., 2011). 
However, it should be noted that 
ΔpH/Δ°C is only –0.0096 for 25 mmol/l 
bicarbonate, hence medium pH 
barely differs between 36°C and 38°C. 
Nonetheless, a general change in culture 
temperature could necessitate medium 
formulation changes and adjustments to 
the culture atmosphere.
Although the optimal temperature 
for culturing embryos might not be 
established unequivocally, it is critical 
that a narrow acceptable temperature 
range be strictly adhered to in order 
to reduce culture system variability. 
Therefore, the laboratory should be kept 
at a temperature that is comfortable 
for the staff, and equipment set-points 
should meet the temperature needs of 
gametes and embryos. This requires 
the use of calibrated thermometers 
and proper measurements, i.e. of the 
culture medium surrounding the oocytes 
or embryos rather than the surface 
temperature of equipment (Cooke et al., 
2002; Lane et al., 2008). Regardless, the 
embryo may experience temperature 
variations during location changes. 
Measurements should be performed 
on a daily basis at a minimum, usually 
taken in the morning prior to equipment 
use. Temperature dataloggers are useful 
in identifying temperature fluctuations 
during the day and during equipment 
use. In practical terms, a tightly 
controlled temperature range is required 
for each piece of warmed laboratory 
equipment, although a slightly lower 
temperature might be safer than a higher 
temperature.
Humidity in culture
Preimplantation embryos require 
consistent culture conditions to reduce 
environmental stress and optimize their 
development. These conditions include 
the culture medium and its osmolality 
and pH (which also depends on the 
 RBMO  VOLUME 00  ISSUE 0  2019 5
gas phase composition), temperature, 
humidity and air quality, all of which are 
crucial (Pool et al., 2012). While there are 
recommended values or ranges for most 
of these conditions (Wale and Gardner, 
2016), the optimum level of incubator 
humidity has yet to be determined.
Originally, CO2 regulation in incubators 
was mediated using thermal conductivity 
sensors that relied on a humidified 
atmosphere for correct operation, 
but the more recent shift to infrared 
sensors has removed this requirement 
(Swain, 2014). Further, concerns have 
been expressed that humidity could 
increase the likelihood of microorganism 
overgrowth in the incubator, negatively 
impacting embryo development 
(Geraghty et al., 2014), and it has been 
postulated that the use of an oil overlay 
in the culture dishes would prevent 
evaporation from the culture medium in 
dry culture, thereby protecting against 
the risk of increased osmolality. Together, 
these points have encouraged a shift 
towards embryo culture in a non-
humidified environment.
Two recent studies have demonstrated 
that an oil overlay is not sufficient to 
protect against osmolality changes during 
dry incubation. Fawzy et al. (2017a) 
reported that introducing humidity 
into a normally dry incubator resulted 
in improved embryo development 
and ongoing pregnancy rates. Albert 
et al. (2018) used time-lapse imaging 
to evaluate the effect of removing 
humidification from a normally 
humidified incubator on embryo 
development, and also reported better 
outcomes with humidification. It must 
also be noted that ‘humid’ versus ‘dry’ 
is not a binary condition, and aspects of 
relative volumes and both surface and 
interface areas are likely to influence 
the precise relationship between a 
humidified incubator and the actual 
culture environment experienced by 
the embryos, and vice versa. Effects on 
osmolarity in non-humidified culture may 
be less deleterious in culture systems 
with regular medium renewal (every 48 h) 
as the shift in osmolality accumulates with 
time (Fawzy et al., 2017a; Swain, 2018, 
Swain et al., 2016). The central question 
is why might evaporation occur and 
osmolarity increase during dry incubation 
in oil-based culture? Room humidity may 
also play a role. Considering satisfactory 
development and outcomes reported 
in a host of papers after culture in 
the EmbryoScope™, which is used in 
a dry environment without medium 
changeover, one difference may be 
the large surface area of microdroplets 
under oil in flat dishes compared with 
the vertical tube-like culture in first-
generation EmbryoScope™ slides. 
Mouse embryos cultured in non-
humidified EmbryoScope™ slides 
developed as well or better than those 
cultured in microdroplets under oil in 
a humidified incubator using the same 
media (Kelley and Gardner, 2017). Until 
there is clarity regarding the reasons 
involved in promoting or inhibiting 
evaporation through oil, embryologists 
should consider humidification as an 
obvious choice for culture, but only if 
incubator manufacturers recommend the 
use of humidification.
Carbon dioxide control and medium 
pH
Carbon dioxide control is paramount for 
culture media to maintain a physiological 
pH, but it is not as simple as just adding 
sodium bicarbonate. The pH of a 
medium is complex, with interactions 
between amino acids and other 
zwitterions and proteins (because of 
their amino acid composition and bound 
caprylate). Generally, concentrations of 
CO2 between 5 and 6% (at sea level) 
should result in the correct physiological 
pHe of 7.2–7.4 (Swain, 2012b), where 
pHe is the extracellular pH of the culture 
medium (Bavister, 1995).
But pHe is not the parameter of real 
biological significance; that is pHi, 
the intracellular pH of the cytoplasm, 
which should be about 0.1 pH units 
below the pHe because the bovine 
embryo utilizes this gradient to drive 
transport mechanisms and offset internal 
acidification from metabolic processes 
(Lane et al., 1999). The pHi of human 
oocytes and embryos varies slightly 
during development but is usually 
accepted to be 7.12, which means the 
pHe should be 7.2–7.3 (Phillips et al., 
2000). This pH is achieved by culturing 
in an environment where the partial 
pressure of (pCO2) is titrated to give the 
correct pH.
In principle, medium pH should be easy 
to measure, but in practice it is not. 
There are three main ways to measure 
the pH of culture media, each with their 
own pros and cons. A pH meter must 
have a three-point calibration, ideally 
inside the incubator. The glass electrode 
must be kept clean because protein 
in media will adsorb onto the glass 
affecting measurement; despite regular 
cleaning the electrode will still need to be 
replaced frequently. Blood gas analysers, 
whether static or portable, can measure 
pH as well as pCO2 and pO2. The results 
can be accurate but one must be very 
careful to ensure that the concentration 
of CO2 and O2 is maintained in the gas 
phase before the measurement is made. 
But pH meters and blood gas analysers 
only give a ‘snapshot’ of the pH, which 
might change over time.
A new technology uses fluoroscopy to 
measure pH continuously. It employs 
immobilized fluorescent dyes that 
change colour or intensity with the pH. 
The sensors with standard solutions 
are placed inside an incubator and give 
a continual pH readout. The problem 
with these sensors is that they rely on a 
standard that might not reflect the pH of 
the culture medium.
Control of pH is complex, and CO2 
measurement alone is not a good proxy 
for pHe in a complex culture medium, 
where pH should be measured directly. 
Different types and makes of incubators 
should be thoroughly validated before 
use, to ensure that the culture medium is 
maintained at the desired pHe.
Oxygen tension for embryo culture
Another variable important for embryo 
development and assisted reproductive 
outcomes is oxygen tension used within 
the culture incubators. Two alternate 
levels of O2 are commonly used in vitro: 
ambient atmospheric O2 (nearly 21% 
at sea level) and 5%, the proposed 
physiological level (review: Nielsen and 
Ali, 2010). Although O2 levels in the 
reproductive tract are reported to be 
between 2 and 8% (Fischer and Bavister, 
1993; Kaufman and Mitchell, 1994; 
Kigawa, 1981; Mastroianni and Jones, 
1965; Yedwab et al., 1976), questions have 
been raised about the methods used in 
these studies, prompting a suggestion 
that they be re-evaluated (Ng et al., 
2018).
Numerous studies have demonstrated 
superiority of 5% O2 compared with 
ambient O2 for human embryo culture. 
For example, better embryo cleavage 
and blastocyst development in vitro 
under a 5% O2 atmosphere have been 
reported, and these culture conditions 
led to the first IVF live birth (Edwards 
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et al., 1970; Steptoe et al., 1971; Steptoe 
and Edwards, 1978). Other studies of 
human embryo culture have reported 
that 20% O2 was inferior to 5% O2 in 
terms of clinical pregnancy, live birth 
and implantation (Bontekoe et al., 2012; 
Meintjes et al., 2009a; Nastri et al., 
2016), but recommended further studies 
with more stringent design and culture 
protocols. Time-lapse studies of mouse 
and human embryo culture have shown 
a detrimental effect of short exposure to 
atmospheric O2 (Kirkegaard et al., 2013; 
Wale and Gardner, 2010).
Oxygen is considered a secondary 
stressor in embryo culture as it works 
with ammonium to disrupt the pathway 
of glutamine and alanine transamination, 
leading to abnormal fetal development 
(Wale and Gardner, 2016). Embryo 
culture under ambient O2 has also been 
reported to increase the production 
of reactive oxygen species (ROS), 
which can affect embryonic growth 
and the resulting offspring (Bedaiwy 
et al., 2004, 2010; Yang et al., 1998). 
It can also disturb the transcriptome, 
proteome, carbohydrate and amino 
acid metabolism, embryo homeostasis, 
and the epigenome, including inducing 
premature X-chromosome inactivation, 
and differentially affects male and female 
embryos (Gardner and Lane, 2005; 
Katz-Jaffe et al., 2005; Lengner et al., 
2010; Li et al., 2016; Rinaudo et al., 
2006; Wale and Gardner, 2012, 2013).
It has been suggested that culture under 
an even lower O2 level (2%) from the 
morula stage onwards might result in 
the development of healthier embryos, 
as the uterine O2 tension is speculated 
to be lower than that of the oviduct 
(Ng et al., 2018), and aerobic glycolysis is 
more important after genomic activation, 
increasing the risk of ROS production in 
an O2-rich environment (Morin, 2017). 
Studies directly addressing the question of 
using lower O2 levels for human embryo 
culture, by Kaser et al. (2016) and Yang 
et al. (2016), have been underpowered, 
although Fawzy et al. (2017b) cultured 
human embryos continuously from Day 0 
to Day 5 or 6 in either 3.5% or 5.0% O2 
concentration and found that while 3.5% 
O2 was associated with significantly higher 
fertilization and cleavage rates it gave 
significantly lower blastocyst formation 
and clinical outcomes parameters.
The optimum O2 level(s) for embryo 
culture remains to be determined, 
with the question of whether embryos 
need stage-specific O2 levels remaining 
unclear. For the present, 5% remains 
the recommended O2 tension for 
human embryo culture in vitro. One 
of the surprising facts has been the 
reluctance of some laboratories to 
reinvest in reduced O2 incubators and 
to add the extra nitrogen gas phase, also 
associated with increased costs. Financial 
considerations are a central issue when 
suggesting guidelines, but the evidence 
for improved success after introducing 
reduced O2 is apparent and must be the 
prime consideration.
Workstations – design and engineering
The entire IVF process is governed by 
the biology of the gametes and embryos 
and it is expected that the laboratory, 
its design, equipment and operational 
systems will provide optimal conditions 
for them. It is incumbent on the 
laboratory to protect the gametes and 
embryos from physiological stress (while 
embryos are highly adaptable, adaptation 
costs energy and hence equates to 
metabolic stress) as well as from adverse 
external factors. Hence, we must select 
equipment that has been designed and 
engineered to maintain the correct 
biophysical and biochemical conditions 
for each step of the IVF process, 
and then calibrate and maintain the 
equipment to ensure it is fit for purpose. 
Various types of workstation are required 
in the IVF laboratory so that key tasks 
can be performed under the appropriate 
physcochemical conditions: handling 
and assessing oocytes and embryos; 
micromanipulation workstations (see 
next section); processing oocytes and 
embryos during cryopreservation and 
thawing/warming; and preparing dishes.
Handling and assessing oocytes and 
embryos
Although many IVF laboratories use 
vertical laminar air flow (VLAF) cabinet-
based workstations for many or all 
aspects of oocyte and embryo handling 
(horizontal LAF cabinets do not provide 
any protection to the operator), a 
critical analysis of their ability to support 
and maintain the key physcochemical 
factors that affect oocytes and embryos 
compared with ‘IVF chamber’ type 
workstations reveals substantial weaknesses 
(see Mortimer and Mortimer, 2015).
Optimizing the use of VLAF cabinets 
as IVF workstations includes 
accommodating the following challenges:
– While a VLAF-based workstation has 
very clean air (up to ISO Class 5), it 
 operates at ambient temperature and 
the high air flow across the work sur-
face causes a substantial cooling effect. 
The air flow may also enhance evapora-
tion and hence increase osmolality.
– Integral stereozoom microscopes are 
set into a heated working surface, 
which must be calibrated to main-
tain dish contents or drops at 37°C. 
This can be tricky because although 
the  observation area (glass plate) is 
surrounded by a heated metal work 
surface the glass plate is usually heated 
only by conduction from the sides, 
and so is cooler.
– Work surface temperature needs to be 
calibrated for each type of dish that 
is to be used because different sized 
dishes have different air gaps that 
introduce differential insulation.
– When performing dish temperature 
calibration should the dish lid be on 
or off, and should the LAF cabinet be 
running or not? Many laboratories still 
turn off the air flow when handling 
open dishes (especially during an egg 
search procedure), but if the air flow is 
off then there is no advantage to using 
a LAF cabinet. Also note that with 
the lid off (and no oil, e.g. during egg 
search) the evaporative cooling effect 
increases as a function of the square 
of the dish diameter.
Some IVF laboratories use Class II 
biohazard hoods for oocyte and embryo 
handling and assessment. While the 
rationale for this is clear when working 
with infectious cases (e.g. HIV and 
hepatitis), the vast majority of laboratories 
continue to use VLAF cabinets because 
they work on pre-screened patients.
It has been established that for culture 
dishes comprising 50 µl droplets of 
medium under oil, re-gassing (pH re-
equilibration) takes ∼20 × longer than 
de-gassing, which is very fast even with 
oil in that the pH will be >7.4 in <2 min 
(Debbie Blake, 1999 unpublished data, 
see Mortimer and Mortimer, 2016). 
Hence it is recommended that a culture 
dish be exposed to air for <2 min. Based 
on these timings, the use of a gas ‘hood’ 
(e.g. a glass funnel through which pre-
mixed gas is delivered around the dish) 
can only minimally extend this working 
time: medium pH will rise, and embryos 
may be stressed, when the ‘out’ time 
exceeds ∼2 min, even with rigorous use 
of a gas hood.
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‘IVF chamber’ workstations have been 
used since the earliest days of IVF, 
when they were built using converted 
neonatal isolettes with a built-in 
microscope (Testart et al., 1982). The 
internal atmosphere is room air with 
temperature, CO2 and humidity control, 
with contemporary custom-built models 
including HEPA filtration and even 
photocatalytic VOC removal. Some 
manufacturer’s chambers have variants 
that can enclose an entire ICSI rig, and 
a very recent model has a dual optical 
system that combines both a stereozoom 
microscope and a digital inverted 
microscope with Hoffman-type optics.
How stable could the culture and 
handling systems be in an ergonomically 
designed laboratory based on ‘IVF 
chamber’ workstations with humidified 
bench-top incubators? The process 
would operate as:
– dish removed from bench-top incuba-
tor with lid on, so gas environment is 
maintained;
– dish transferred immediately (5 s) to 
the workstation;
– lid removed, same pCO2 inside the 
workstation;
– lid replaced when finished, enclosing 
the controlled pCO2 atmosphere;
– dish transferred (5 s) back into bench-
top incubator; and
– bench-top incubator re-equilibrates its 
internal gas in 30 s.
In all practical terms this would be 
effectively ‘undisturbed culture’. 
Achieving this using VLAF cabinets will 
require high operator skills and speed as 
well as enhanced workstation calibration 
and quality control (QC). Such cabinets 
may be recommended as a backup when 
central HVAC units are out of service.
Processing oocytes and embryos 
during cryopreservation
Cryopreservation media for both slow 
freezing and vitrification techniques are 
usually zwitterion buffered, and hence will 
be pH stable under an air atmosphere. 
Processing usually takes place at ambient 
temperature, although many protocols 
start or end at 37°C, which can be easily 
achieved using a heated surface or stage, 
and by having a ‘holding’ bench-top 
incubator nearby (with pre-mixed gas if 
necessary).
Typically slow freezing and thawing 
processing was performed in VLAF 
cabinet-type workstations, but because 
of the complications of needing liquid 
nitrogen immediately adjacent to 
the microscope, and avoiding cold 
nitrogen vapour accidentally cooling 
the solutions in the processing dishes, 
many embryologists perform vitrification 
and warming procedures on the open 
bench using a combination of large 
area (heated) stages on the stereozoom 
microscope, warming plates, and having 
a ‘holding’ bench-top incubator nearby 
(with pre-mixed gas if necessary).
Dish preparation
This needs to be performed in a VLAF 
cabinet to maintain sterility of the dishes, 
culture media and oil during handling, 
labelling and preparation of the culture 
dishes. Even though these tasks are all 
performed at ambient temperature, 
speed is of the essence to avoid 
evaporation from microdrops between 
them being dispensed and overlaid with 
oil (Swain et al., 2012).
Incubators – maintaining the culture 
environment
The maintenance of incubator 
performance for each variable within 
predetermined acceptable limits is, 
perhaps, the single most important 
aspect of running an IVF laboratory. 
Acceptable performance is established 
through identification of set-points 
and tolerances. These benchmarks 
are met after an incubator is turned 
on for the first time and stabilized, 
and then are maintained by constant 
surveillance of performance through 
a quality management programme. 
For all variables impacting incubator 
operation, including temperature as 
discussed above, gas phase, pH, humidity 
and air quality, any correction after 
disturbance in the environment entails an 
equilibration phase prior to reaching the 
set-point, and then stabilization within 
an acceptable range of tolerance (Swain, 
2010).
Factors influencing stability of the 
culture environment
There is a variety of factors that influence 
stability of the culture environment, 
not the least of which is the frequency 
of opening/closing the incubator door 
(if box incubator) or lid (in the case of 
bench-top incubators). These openings/
closings can be kept to a minimum by 
ensuring there is an adequate number 
of culture incubators for a programme’s 
caseload, and by having ‘holding’ 
incubators dedicated to non-culture 
activities such as dish equilibrations, 
sperm preparations, etc. Importantly, 
only one patient’s gametes/embryos 
should be cultured in any one incubator 
compartment (whether this is a box 
incubator with a split door per shelf, or 
a bench-top incubator). Such a principle 
not only reduces door opening/closing 
but also reduces the likelihood of sample 
mix-up. Beyond physical perturbation 
of the incubator environment, other 
factors influencing stability of the culture 
environment include the type of culture 
dish, whether a lid is used over the dish, 
the type and volume of medium used 
and the protein supplementation, as well 
as the presence/absence of an oil overlay. 
Multiple dishes should be prepared in 
series and not all at once.
Box versus bench-top/top-load 
incubators offer varying advantages and 
disadvantages regarding temperature 
control and measurement and control 
of humidity (reviewed in Swain, 2014). 
Moreover, the critical requirement for 
a stable and pure gaseous environment 
requires consideration of both the supply 
and control of gases. There are both 
advantages and disadvantages to using 
either pre-mixed gas or a gas that is 
regulated by the incubator. Regardless 
of which gas supply is used, in-line 
filters are recommended for removal 
of various known toxins including VOC, 
dust, bacteria, etc., and backup gas 
supplies should be available for use. 
Individual incubator outcomes should 
be monitored using key performance 
indicators such as blastocyst 
development and pregnancy rates.
Principles for incubator management
There are two broad principles for 
incubator management:
1. Preventative maintenance, which 
should be performed at least annually. 
The machine should be shut down 
and, if not an incubator that is steriliza-
ble by elevated dry heat, the chamber 
must be disassembled according to 
the manufacturer’s recommenda-
tions. All components, as well as the 
interior chamber, should be thorough-
ly cleaned with a diluted mild soap 
from IVF-specialized manufacturers, 
although trace residues may be found 
even after thorough rinsing with deion-
ized water and sterilization with hy-
drogen peroxide (Fawzy, unpublished 
data). Hydrogen peroxide can be used 
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instead of mild soap as it removes 
protein and other residues. Successful 
sterilization can be achieved using 
both diluted mild soap cleaning and 
sterilization cycles or hydrogen per-
oxide by itself. Cleaning of time-lapse 
chambers needs to be performed 
with great care and manufacturer’s in-
structions must be followed. Chamber 
ventilation is recommended before 
the machine is turned back on for 
recalibration. Aside from cleaning, the 
gas sensors should be checked against 
certified standards and the tempera-
ture calibrated against a certified NIST 
thermometer (USA) or performed by 
an ISO17025 accredited company. A 
NIST thermometer should be certified 
within 1 year of use.
2. Daily operation, which should entail 
implementation of a robust and 
verified QC programme (see below), 
minimization of door/lid openings 
and electrical stability. The latter is 
particularly important for time-lapse 
incubators. All incubators should 
be connected to generator-protect-
ed electrical outlets and/or battery 
operated backup units as well as an 
alarm system that is regularly tested 
for functionality and that sends alarms 
through a telephone tree of personnel 
to enable quick response.
General rules for incubator QC
Optimum set-points and tolerances 
should be established for each culture 
system because different systems 
probably have different system-specific 
requirements. These values should 
be determined using independent 
calibrated external NIST devices and 
not be obtained from digital readouts. 
Each laboratory should determine the 
minimum frequency for measuring each 
variable although it is recommended 
that critical variables discussed 
previously, such as temperature, CO2 
and O2, are measured daily, with pH 
measurements read a minimum of 
weekly. Recordings should be captured 
on P-charts (performance charts) or 
electronically real-time with dataloggers 
and performance reviewed daily to verify 
acceptable performance with corrections 
made as indicated.
Micromanipulation – maintaining a 
steady physcochemical environment
Micromanipulation includes all 
procedures requiring technology-
mediated distance-controlled robotic 
manipulation of gametes or embryos. 
In short, the systems are designed to 
eliminate tremor and allow precise 
manipulation of cells, even at high 
magnification. Micromanipulation rigs 
are routinely used in all IVF laboratories 
during ICSI to improve the chances of 
fertilization, zona opening for enhancing 
or facilitating hatching and for biopsy of 
the trophectoderm, and for blastocoel 
collapse prior to vitrification. Maintaining 
stable environmental conditions 
for gametes and embryos during 
micromanipulation requires the following 
considerations:
– maintenance of a steady, optimal 
 temperature, similar to culture 
 conditions as described above;
– limitation of exposure to light;
– vibration reduction to reduce 
 damage to cells and enhance ease of 
handling;
– maintenance of osmolality similar to 
controlled culture conditions; and
– maintenance of pH similar to 
 controlled culture conditions.
Despite hundreds of papers on work 
involving micromanipulation, literature on 
the rationale and technical requirements 
for achieving steady conditions 
during micromanipulation is sparse. 
Consequently, our understanding of 
optimization, and even the necessity of 
steady-state conditions, is rudimentary.
Among the most important criteria 
for maintaining a steady state during 
excursions of gametes and embryos 
outside the incubator is the need 
to avoid potential problems such as 
unexpected temperature changes or 
drifts in osmolality. Diligence and risk 
management should always remain a 
central focus of an embryology laboratory 
(see Mortimer and Mortimer, 2015, 
Chapter 9), even when optimization of 
conditions is relatively unknown.
Intracytoplasmic sperm injection 
(ICSI)
Sperm preparation methodologies 
dramatically changed during the first 15 
years of clinical IVF. The basic purpose 
is to remove all traces of seminal plasma 
and debris and select a subpopulation 
of highly motile spermatozoa, all in an 
affordable manner that is fast and with 
the least trauma to the viable cells. It 
is known that maintaining physiological 
pH, temperature and buffering is 
less critical for spermatozoa than for 
unfertilized oocytes (Fleming and King, 
2003), but there are time constraints 
in terms of exposure to seminal plasma 
and body temperature (Cohen et al., 
1985a). Handling techniques should 
follow general tissue culture techniques 
and include an appreciation of potential 
materials toxicity, sperm survival 
tests, protein supplementation, use of 
antibiotics, optimal osmolality (250–
290 mOsm/kg) and aseptic technique.
Sperm preparation aspects are covered 
under ‘Handling practices’ (below). 
Commercial products include density 
gradient kits, motility enhancers and 
hypo-osmotic swelling solutions, and are 
subject to sterility, pH, endotoxin and 
osmolarity quality testing. Product QC 
by the mouse embryo assay (MEA) test 
is considered essential by some, but its 
relevance is debatable and some holding 
products are not MEA tested.
Oocytes are much more sensitive to 
changes in pH and temperature, and 
possibly osmolality, than spermatozoa. 
A deviation from acceptable standards 
might not affect fertilization but might 
influence later development. Denudation 
by hyaluronidase and narrow-bored 
pipettes or strippers might have long-
term effects, but clinical studies are 
lacking. In 1998, Van de Velde concluded 
that cytoplasmic maturation must be 
complete during or shortly after egg 
retrieval based on an RCT that showed 
that eggs denuded after 1–2 h had 
similar outcomes to those denuded at 
a 4–6 h interval (Van de Velde et al., 
1998), and this information is used by 
many practitioners as the basis for ICSI 
timing – although this will also depend 
on the interval between ovulation trigger 
and egg collection. Recently, Pujol 
et al. (2018), in a large retrospective 
multivariate analysis, reported that 
increasing oocyte retrieval to ICSI time 
increased the fertilization rate, and that 
each 1 h increase in this interval reduced 
the likelihood of biochemical pregnancy 
by 7.3%, and of clinical pregnancy 
by 7.7% after fresh embryo transfer, 
although there was no effect on either 
the ongoing pregnancy or live birth rates. 
Another large retrospective analysis by 
Naji et al. (2018) reported that retrieval 
to denudation time intervals of <2 h 
and 2–5 h did not affect outcomes, but 
the analysis did not consider the actual 
trigger-to-stripping interval, and the 
overall fertilization, implantation and 
pregnancy rates were modest (68%, 
26–27% and 37–38%, respectively).
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However, these recent papers contrast 
with a number of studies published 
over the last 20 years that generally 
support the principle that a delay of 
more than 2 h before oocyte denudation 
gives improved oocyte maturity, 
fertilization rate, embryo quality and/or 
ICSI outcome (Dozortsev et al., 2004; 
Ho et al., 2003; Isiklar et al., 2004; 
Patrat et al., 2012; Rienzi et al., 1998). 
In addition, another study reported 
better outcomes by delaying stripping 
until 4 h post-oocyte retrieval and then 
performing ICSI promptly, compared 
with either stripping and injecting 
immediately after oocyte retrieval or 
stripping immediately and delaying 
injection for 4 h (Hassan, 2001).
Although clinical information is sparse, 
prolonged exposure to hyaluronidase 
could affect oocytes. In the mouse, the 
duration of hyaluronidase exposure might 
reduce fertilization and adversely affect 
subsequent developmental steps (Ishizuka 
et al., 2014). Short co-incubation of 
spermatozoa and eggs during standard 
IVF seems to be beneficial according to a 
Cochrane Review on eight RCT (Huang 
et al., 2013) but the quality of evidence 
was considered low.
Oocyte handling during 
micromanipulation
Oocyte handling during regular 
observations does not involve a change 
from the standard bicarbonate-buffered 
conditions, but manipulations such 
as preparation for ICSI or vitrification 
could require a change to the external 
conditions outside the incubator. There is 
a wide variation in commercially available 
products for handling oocytes outside 
incubators: the choice of handling 
medium is usually HEPES-buffered, less 
frequently phosphate-buffered saline, 
while some laboratories still use regular 
bicarbonate-buffered culture media. 
MOPS is also used in a number of 
handling media now. There are heparin-
free media as well as antibiotic-free 
variants for use when patients have 
allergies. Hyaluronidase is occasionally 
replaced by other enzymatic products 
such as recombinant coronase. Sourcing 
and testing of these products rarely 
involve studies on fertilization effects or 
long-term outcomes.
Mechanical stress during 
micromanipulation
It has been shown that shear stress, 
similar to the force that occurs during 
pipetting, has a negative effect on mouse 
embryos, up-regulating the stress gene 
for phosphorylated MAPK8/9, formerly 
known as stress-activated protein 
kinase/jun kinase/SAPK/JNK (Xie et al., 
2007); the effects were similar at nearly 
all stages and enhanced in zona-free 
embryos. This work is under-appreciated 
among practitioners and relatively rough 
handling of gametes and embryos is 
common in IVF laboratories.
Culture system configurations during 
micromanipulation
The preferred incubation system during 
micromanipulation is microdroplets 
under oil (closed system). Advantages 
of an oil overlay include: reduced 
microbial contamination; providing 
a higher heat capacity and stability 
than air; controlled separation of fluid 
droplets; limiting evaporation; and 
providing a limited VOC sink. ICSI 
results are probably enhanced when the 
procedure is performed quickly with a 
limited number of eggs per dish. There 
is no recommended maximum egg 
range per dish, whereas the number of 
spermatozoa in a pipette should probably 
be limited. Before starting the procedure, 
it is recommended to optimize 
visualization of spermatozoa, egg, pipette 
tips, alignment of all objects, and perform 
a quick check of suction devices. The 
literature is not helpful when defining 
laser alignment and validation. The use 
of the blade or laser knife is probably 
permissible for rapid zona opening, but 
probably less advantageous when cutting 
the trophectoderm for biopsy as it might 
increase cell lysis.
In the mouse, the optimal handling 
temperature is room temperature and 
mouse zygotes and embryos are more 
tolerant to a reduction in temperature 
during incubation than an increase 
over 38°C. For human material 37°C 
is recommended for unfertilized eggs 
and embryos, and any time at room 
temperature is a possible confounder. 
QC assessment of the stage warmer or 
heating system should be performed 
periodically, watching for cold and hot 
spots, drifts and fluctuations.
Polyvinylpyrrolidone (PVP) has been used 
for half a century in cell culture. For ICSI, 
PVP (average 10 kDa molecular weight) 
or an alternative like hyaluronate is used 
to increase the medium’s viscosity so as 
to decrease sperm motility and reduce 
fluid movement in micro-pipettes. PVP 
has been associated with ultrastructural 
sperm damage and sperm membrane 
effects, and can delay calcium oscillations 
and decondensation and remain in the 
oocyte for an extended time (Kato and 
Nagao, 2012). Half-life time for PVP 
differs between brands of media (Kato 
and Nagao, 2009).
Handling practices
The use of time-lapse incubators can 
negate the need to remove embryos 
from incubators from Day 1 (or Day 
0 for ICSI) until the time of embryo 
transfer. This enables more consistent 
and possibly better outcomes (Chen 
et al., 2017; Racowsky et al., 2015). 
Unfortunately, there are up to six 
procedures that must take place during 
IVF (five for ICSI) before zygotes are put 
into culture, and up to three procedures 
at the termination of culture. Care 
must be taken during these procedures 
to avoid stressing both gametes and 
embryos.
General practices
Procedures outside of the incubator 
usually involve pipetting and microscopic 
observation. Unless one uses a controlled 
environmental chamber to conduct 
these procedures then great care must 
be exercised to control both temperature 
and pH. The central importance of 
these environmental aspects has been 
described above.
Mathematical modelling and actual 
measurements of temperature changes 
during pipetting have shown that a 
pipette tip quickly loses heat – up to 
5°C in 5 s in a glass pipette (Blomfield, 
2011). Preheating the pipette makes no 
difference: even though the pipette body 
retains heat the tip does not. Similarly, 
keeping embryo transfer catheters in 
a warm oven does nothing and may 
increase the VOC concentration inside 
the catheter, and the catheter tip will be 
at ambient temperature within seconds. 
Realization of this rapid loss of heat 
should govern how embryologists work 
outside of a controlled environment, 
and any procedure that is conducted 
at ambient temperature (e.g. oocyte 
recovery) should be simulated and a 
datalogging probe used to determine 
where any heat losses occur, so they can 
be minimized.
Most embryologists have been using 
warm stages for years without fully 
understanding the basic principles by 
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which they work. Again, mathematical 
modelling and actual measurement have 
shown that, depending on the culture 
dish and contents, a warm stage takes 
at least 3 min to start to warm a dish 
because of the air trapped between the 
dish bottom and the warm stage. This 
is exacerbated using metal warm stages 
with a hole in them.
When one considers that pH changes 
will show similarities to the temperature 
changes, then the argument for 
controlled environment ‘IVF chambers’ 
becomes compelling.
Oocyte recovery
A heated tube holder is essential, but 
precautions should also be taken to 
minimize heat loss that could occur in 
either the oocyte retrieval needle or the 
tubing from the needle to the collection 
tube (Yeung et al., 2004). Simulation 
measurements (Mortimer and Mortimer, 
unpublished data) show that the main 
heat loss is in the oocyte retrieval needle 
itself and not in the Teflon tubing from 
the needle to the tube, probably due to 
Teflon being a much better insulator than 
stainless steel. The heat loss is variable, 
being dependent on the flow rate of 
the fluid, and is minimized when the 
flow rate is maximal – although flow rate 
should be restricted to approximately 
20 ml/min to avoid damage to the 
cumulus–oocyte complex (COC). While 
aspiration of the follicles as quickly as 
possible is recommended to minimize 
heat loss, even in a continuous flow 
model the temperature of the initial part 
of the aspirate still falls by about 2°C as 
it enters the collection tube. A possible 
solution to this problem is to prime the 
collection tubes with 2 ml of warm buffer 
to restore the aspirate to 37°C as quickly 
as possible.
If an environmental chamber is not 
used, then pipetting during the egg 
search should be performed as quickly 
as possible and putative COC should 
not be held in the pipette while 
searching for others. Trimming of COC 
is recommended if blood has infiltrated 
as this may affect embryo development 
(Ebner et al., 2008). An effect of 
reducing cumulus size in the absence 
of blood clots on development has not 
been shown Ebner et al., 2017.
Sperm preparation
Seminal plasma contains one or more 
factors, prolonged exposure to which 
adversely affects sperm function, 
including the ability to penetrate 
cervical mucus, undergo the acrosome 
reaction in vitro and the fertilization 
process generally (Björndahl et al., 
2010; Mortimer, 2000; Yanagimachi, 
1994). Exposure to seminal plasma for 
more than 30 min after ejaculation 
permanently diminishes the fertilizing 
capacity of human spermatozoa in vitro 
(Rogers et al., 1983), and contamination 
of prepared sperm populations with only 
trace amounts of seminal plasma (0.01% 
v/v = 1 in 10,000) can decrease their 
fertilizing capacity (Kanwar et al., 1979).
Variables to control during sperm 
preparation are the choice of method, 
type of medium and temperature. 
Currently there are three main methods 
of sperm preparation: swim-up, 
microfluidics and density gradients. The 
first two methods are usually conducted 
in bicarbonate-buffered ‘medium’ inside 
an incubator. Density gradients usually 
employ a HEPES- or MOPS-based 
medium (‘buffer’) for use under air in 
the centrifuge. The advantage of using 
‘medium’ is that spermatozoa have a 
requirement for bicarbonate for normal 
functionality (Boatman and Robbins, 
1991) and the bicarbonate concentration 
is reduced in buffer formulations. A 
‘buffer’ is easier to use than a ‘medium’ 
because pH control is not a problem.
Temperature control is relatively easy 
to achieve, but there is some question 
about what temperature to use. Swim-
ups and microfluidic devices are usually 
inside an incubator so 37°C is the 
norm, but density gradients are variable 
depending on the time in the centrifuge, 
although heated centrifuges are available. 
Consideration has to be given to these 
variables and each laboratory will have 
to define its own protocols to ensure a 
consistent approach is used. The most 
common sperm separation techniques 
have been well described with detailed 
standardized protocols (e.g. Björndahl 
et al., 2010).
IVF insemination, hyaluronidase use, ICSI 
and embryo transfer are procedures 
where pH and temperature can be 
controlled with an environmental 
chamber or judicious use of a warm 
stage and speed. The importance of 
these aspects was discussed above. To 
predict the range of temperatures that 
will occur, each procedure should be 
simulated, and temperatures checked at 
key stages using calibrated datalogging 
temperature probes. Although there will 
always be a temperature drop during 
embryo transfer, this can be minimized 
with care and speed.
Vitrification/warming
There is a plethora of methods 
and associated commercial media 
and devices for effective embryo 
cryopreservation. The most important 
steps are the initial movement of the 
embryo from the incubator to the 
holding buffer, and from the final 
warming solution to the incubator, 
because the embryo is more susceptible 
to temperature changes at these points 
than in the vitrification solutions, when 
embryonic metabolism is dramatically 
slowed. It is suggested that at the first 
step in vitrification the embryo(s) be 
removed from culture into the holding 
buffer at 37°C and allowed to cool to 
ambient temperature before vitrifying. It 
is also suggested that if the final warming 
solution is at ambient temperature then 
it should be warmed to 37°C before 
returning the embryos to culture.
Assessment practices
The need to assess
Assessment of gametes and embryos is 
a necessary, routine aspect of the IVF 
process, which is primarily morphology 
based. Gamete assessment aids decision-
making, alongside patient clinical factors, 
regarding the type of fertility treatment 
required. The frequency and timing of 
assessment must be specified within a 
laboratory’s SOP and allow sufficient 
and timely observations to aid effective 
embryo assessment and selection 
practice.
Assessment of semen should include, 
as a minimum, volume, motility, count 
and morphology of a liquefied sample, 
following standardized timely procedures 
and ensuring appropriate temperature 
control (Björndahl et al., 2010; World 
Health Organization, 2010).
Assessment of oocytes can be subjective 
due to variable morphologies, and the 
appearance of the cumulus–corona 
complex or denuded oocyte can 
be discordant with oocyte maturity 
or viability. The literature relating 
oocyte quality and clinical outcome is 
inconsistent (Rienzi et al., 2011). Cumulus 
removal and oocyte assessment is 
necessary prior to ICSI, although care 
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should be taken to ensure this is not 
performed too soon after oocyte retrieval 
(as already noted), and the presence of a 
polar body is the standard requirement 
to proceed with sperm injection.
Embryo assessment is performed to 
select the embryo with the highest 
potential for implantation (Alpha 
Scientists in Reproductive Medicine 
and ESHRE Special Interest Group of 
Embryology, 2011) and is considered in 
more detail below. Gamete and embryo 
assessments allow preferential selection 
to optimize clinical outcome and are 
used by embryologists to inform and 
set expectations for patients, and for 
monitoring the quality of laboratory 
performance against relevant key 
performance indicators (KPI). Laboratory 
KPI such as fertilization, cleavage, 
blastulation and embryo utilization rates 
are considered broad and beneficial 
indicators of IVF laboratory performance 
(ESHRE Special Interest Group of 
Embryology and Alpha Scientists in 
Reproductive Medicine, 2017).
Optimizing assessment conditions
Control and maintenance of 
physcochemical conditions are essential 
to minimize stress to the gametes and 
embryos during assessment. During 
assessments the laboratory environment, 
equipment and consumables used 
for handling, as well as the actual 
manipulations, should be reduced to 
essential steps only and risks and benefits 
must be considered when defining 
related practices. All consumables 
should be traceable and, where possible, 
designed and certified for IVF use. 
Equipment should be preventatively 
maintained and specified for use. High 
magnification microscopy should be 
available (generally 200–400 ×) with 
Hoffman modulation contrast, or similar, 
optics being recommended for the 
detailed examination in plasticware of 
low-contrast specimens such as oocytes 
and embryos (ESHRE Guideline Group 
on Good Practice in IVF Laboratories, 
2016).
Without time-lapse or video monitoring, 
assessment of embryos necessitates 
their removal from the optimized and 
stable incubator environment. Dedicated 
or compartmentalized incubators, 
and models with rapid CO2 recovery 
(infrared CO2 sensors) reduce the 
possible detrimental impact of inevitable 
fluctuations in conditions caused 
by door openings. Oil overlays are 
recommended to minimize evaporation, 
gaseous exchange and temperature-
induced changes in culture conditions 
during assessment. As described above, 
temperature, pH, osmolarity and air 
quality should be optimized, validated, 
monitored and standardized across 
devices and work areas to protect 
gametes and embryos. Optimal working 
ranges for these variables should be 
established and validated for the culture 
system being utilized. Regular tracking 
and monitoring of these limits is required 
for optimized IVF laboratory practice.
The impact of atmospheric or ambient 
conditions on culture media, and hence 
the gametes and embryos, must be 
considered if humidity and gas levels 
differ between the incubator and the 
heated assessment area or workstation. 
General aspects of temperature and 
humidity during IVF and embryo 
development were discussed above. 
With an appropriate heated workstation, 
the use of zwitterion-buffered media for 
pH maintenance during very brief visual 
assessments (<2 min) is not considered 
justified, although when denuding 
oocytes and assessing their maturity 
prior to ICSI such media can be used to 
provide a stable environment (Koustas 
and Sjoblom, 2011). Medical-grade 
compressed gases with in-line VOC 
filters help to ensure high air quality in 
incubators and workstations, and protect 
against particulates, VOC and other 
contaminants. Profiling of pH changes 
to assess culture media stability limits in 
the assessment environment is advisable 
if an isolette/humidicrib-style or similar 
controlled environment workstation is 
not available. Exposure to ambient pCO2 
must be controlled and minimized so as 
to avoid significant changes in medium 
pH (Lane et al., 2000). If sequential 
culture media are used, then assessments 
should be aligned with the medium 
changeover to minimize time outside 
of stable incubation. For cumulative or 
sequential embryo assessments over a 
number of days, single embryo culture 
or the use of specified microwell culture 
plates is required to allow robust tracking 
of individual embryos over time.
The wavelength of light from all 
sources within the laboratory should 
be considered if exposure can occur 
during assessment, and adverse, 
shorter wavelengths avoided (Ottosen 
et al., 2007). Literature on the relative 
impact of different wavelengths on 
human gametes and embryos is sparse, 
but many IVF laboratories take the 
precautionary approach of minimizing 
light exposure and use ultraviolet 
light filters. The positioning of critical 
equipment used for assessments is 
an important consideration during 
laboratory design: close proximity 
between the incubators and microscopes 
helps reduce exposure to ambient 
laboratory conditions.
Assessment practice and guidelines
Assessment of oocytes and embryos 
must be performed by properly trained 
and qualified personnel. Embryologists 
should be competency-assessed and 
participate in internal and external quality 
assurance schemes (ESHRE Guideline 
Group on Good Practice in IVF 
Laboratories, 2016). Assessments should 
be performed as swiftly and accurately as 
possible, for maintenance of intracellular 
homeostasis, and records of each 
embryo assessment collected, ideally 
using live data entry or contemporaneous 
scribing rather than retrospective 
recollection. If time-lapse image capture 
is available, more time is available for 
the study and assessment of images 
because the embryos remain within the 
incubation environment.
Consensus guidelines derived from 
evidence and experience, and 
standardized by time of insemination, 
still provide the most robust foundation 
for non-invasive gamete and embryo 
assessment. There are several published 
grading schemes, offering either 
formulated or cumulative scoring, or 
ranking, as well as assessment guidelines 
from professional organizations (Alpha 
Scientists in Reproductive Medicine 
and ESHRE Special Interest Group 
of Embryology, 2011; Cutting et al., 
2008; Machtinger and Racowsky, 
2013; Racowsky et al., 2010, 2011). 
However, despite the availability of 
several guidelines the assessment and 
selection of embryos is not standardized 
across the IVF field. Practice varies 
from single to sequential assessments, 
to computer-assisted and time-lapse 
evaluation (Paternot et al., 2011; 
Racowsky et al., 2009). Most of the 
guidelines recommend that cleavage-
stage embryo assessment include cell 
number, size and symmetry, percentage 
of fragmentation, granulation, vacuoles 
and nuclear status. Blastocyst stage 
assessment recommendations include 
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assessment of expansion, blastocoel 
cavity size and morphology of the inner 
cell mass and trophectoderm. Blastocyst 
grading is most commonly performed 
using criteria adapted from the scheme 
published by Gardner and Schoolcraft 
(1999a,b). Laboratories performing 
blastocyst culture may use sequential or 
one-step culture media, the latter with 
or without continuous culture. Some 
laboratories use time-lapse observations, 
others static observations each day 
or only once or twice. All of these 
approaches seem to be compatible with 
acceptable outcomes. The advantages 
and disadvantages of each of these 
alternatives are complex and the optimal 
approach is unknown.
Time-lapse multi-plane imaging provides 
the opportunity for more detailed and 
protected assessment, and is generally 
considered safe practice (Nakahara 
et al., 2010), although oocytes or 
embryos might need to be removed 
from this environment to change their 
orientation or to observe at higher 
magnification. Time-lapse assessment 
permits precise logging of cleavage 
events and developmental milestones; 
standardized annotation of images is 
recommended (Ciray et al., 2014). 
Although several time-lapse embryo 
selection models have been proposed, 
and while there are similarities between 
them, they have not been demonstrated 
to be widely transferable between 
laboratories (Barrie et al., 2017; Pedersen 
et al., 2016).
A recent meta-analysis of five RCT 
reported an association between 
morphokinetic embryo selection and 
significantly higher pregnancy and 
birth rates compared with standard 
methodological assessment of embryos 
cultured in ‘big box’ incubators, as well 
as significantly lower early pregnancy loss 
(Pribenszky et al., 2017), while another 
reported no benefit (Racowsky and 
Martins, 2017). Clearly, further RCT are 
still needed, as the meta-analyses are of 
necessity limited by the heterogeneity of 
the trials included.
Culture media – buffering and pH
Stabilization of pH during IVF is critical 
to avoid environmental stress that can 
compromise embryo development. The 
pH of culture medium, or the external 
pH (pHe), is normally determined by the 
balance between CO2 levels provided 
in the incubator and, primarily, the 
sodium bicarbonate concentration in 
the culture medium, although other 
factors can impact the final pHe. Periodic 
fluctuations in culture conditions, such 
as pHe, can be harmful as these can be 
transduced into deleterious intracellular 
perturbations (Phillips et al., 2000). 
Improper intracellular pH (pHi) can 
impede sperm function (Babcock and 
Pfeiffer, 1987; Babcock et al., 1983; 
Hamamah and Gatti, 1998; Marquez 
and Suarez, 2007), impairs embryo 
metabolism (Edwards et al., 1998; Lane 
et al., 2000), alters organelle localization 
(Squirrell et al., 2001), and is detrimental 
to embryo development (Lane and 
Bavister, 1999; Lane et al., 1999; Leclerc 
et al., 1994; Zhao and Baltz, 1996; Zhao 
et al., 1995), and even retards subsequent 
fetal growth (Zander-Fox et al., 2008). 
This is more apparent in cell types like 
the denuded mature oocyte (FitzHarris 
and Baltz, 2006; FitzHarris et al., 2007; 
Lane et al., 1999; Phillips and Baltz, 
1999), or cryopreserved/thawed embryos 
(Lane et al., 2000), which lack robust 
pHi regulatory mechanisms, making them 
especially susceptible to deviations in 
pHe. Optimizing embryo handling and 
culture systems must therefore include 
careful selection of buffers to stabilize 
pHe.
Buffers are selected based on their 
optimal pH buffering capacity (the 
ability to resist pH change) or pKa 
value, which needs to be matched to 
the application because many biological 
processes only function over a narrow 
range of pHe. Buffers can impact cell 
development and function independently 
of pH, and different cell types display 
different growth rates dependent on 
the type, as well as concentration, of 
buffer used (Eagle, 1971; Ferguson 
et al., 1980; Good and Izawa, 1972; 
Good et al., 1966). Different buffers 
can also differentially impact various 
cellular processes, including electron 
transport, photophosphorylation and 
mitochondrial oxidation (Ferguson et al., 
1980; Good et al., 1966). Unfortunately, 
very few comparative studies have 
been performed to assess the impact 
of various biological buffers on oocyte 
and embryo development, but evidence 
reviewed elsewhere has shown that 
many concerns regarding the use 
of buffers other than bicarbonate in 
human ART are unfounded, being based 
on misinterpretation of studies with 
faulty experimental design and invalid 
conclusions (Swain and Pool, 2009; Will 
et al., 2011). From these extensive reviews 
it can be concluded that:
– Concern over the use of buffers during 
ICSI on the oocyte’s pHi is unwarranted.
– Concerns regarding zwitterionic buffers 
and IVF are based on studies that were 
confounded by simultaneous altera-
tions in other media components that 
impacted embryo development, such 
as the reduction in bicarbonate levels 
and the consequent need for less CO2.
– HEPES [4-(2-hydroxyethyl)-1-pipera-
zineethanesulfonic acid], a modified 
taurine molecule, is an extensively 
studied zwitterionic organic buffer, the 
efficacy of which with spermatozoa 
is widely accepted; yet its safety with 
oocytes and embryos remains con-
troversial. This is in spite of numerous 
studies actually indicating HEPES can 
efficiently support oocyte maturation 
(Byrd et al., 1997; Downs and Mastropo-
lo, 1997), fertilization (Bhattacharyya and 
Yanagimachi, 1988; Behr et al., 1990; 
Hagen et al., 1991) and embryo develop-
ment (Ali et al., 1993; Hagen et al., 1991; 
Mahadevan et al., 1986; Ozawa et al., 
2006). In particular, HEPES supports 
embryo development in the presence of 
bicarbonate, but not when bicarbonate 
is absent (Mahadevan et al., 1986). Bi-
carbonate levels influence blastocyst de-
velopment, possibly through activity of 
various HCO3–-dependent transporters, 
and the CO2 of the incubator atmos-
phere is utilized by embryos as a carbon 
source (Graves and Biggers, 1970; 
Quinn and Wales, 1971, 1974). Indeed, af-
ter accounting for CO2 and bicarbonate 
levels as co-variables, medium with up to 
50 mmol/l HEPES gave similar rates of 
blastocyst development and cell number 
compared with medium without HEPES 
(Swain and Pool, 2009).
– MOPS buffer can be used at 25 or 
even 50 mmol/l to culture mouse zy-
gotes to blastocysts with no significant 
differences in rates of development or 
cell number compared with control 
medium (Swain and Pool, 2009).
– Gene expression profiling of environ-
mentally sensitive genes in bovine 
embryos indicated that expression 
levels of embryos handled in MOPS or 
HEPES-buffered media were most sim-
ilar to embryos derived in vivo (Palasz 
et al., 2008).
– MOPS is now included in commercial 
handling media and used successfully 
for human ART procedures, ranging 
from sperm washing to oocyte and 
embryo handling and vitrification. 
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MOPS has been reported to be supe-
rior to HEPES for vitrification, although 
the exact reason for this remains 
unclear (El-Danasouri et al., 2004).
– Phosphate buffers tend to precipi-
tate polyvalent cations (e.g. Ca2+), 
while also acting as a metabolite or 
inhibitor in various systems. Although 
phosphate-buffered saline (PBS) has 
an appropriate pKa, elevated levels 
of phosphate can damage cellular 
function, compromise gamete and 
embryo metabolic activity (perhaps 
via the Crabtree effect), disrupt 
organelle distribution, and interfere 
with intracellular ionic homeostasis, 
including pHi.
The simultaneous use of multiple different 
buffers allows for adjustment of pKa 
values to the desired range, while also 
permitting a reduction in individual buffer 
concentrations and potentially alleviating 
concerns for toxicity. Recent attention has 
focused on use of combination buffers in 
handling media for IVF to further refine 
the current mono-buffered systems 
(Swain and Pool, 2009).
Culture media – general composition 
and protein supplementation
Little has changed since the statement 
‘It remains true in 2011 that there is 
no culture medium available that is 
truly optimized for human embryo 
development’ (Harper et al., 2012). 
Consequently, attempting to define 
consensus is limited by our relative 
uncertainty of what is optimal for human 
embryo development.
There are only a few concepts that have 
reached consensus status for medium 
composition. Because most culture 
media contain over 40 components, 
at different concentrations and ratios 
relative to each other, the number 
of possible combinations is limitless. 
As osmolality and pH are reviewed 
elsewhere in this document, the 
discussion here will be limited to the 
presence, form and concentration 
of nutrients. The following areas of 
general consensus are based on years, 
often decades, of evidence supporting 
their central role in metabolism and 
development of preimplantation 
mammalian embryos.
Antibiotics, mostly in the form of 
gentamicin, are a ubiquitous component 
of human embryo culture media. Although 
not required, the benefits outweigh the 
risks, making inclusion of antibiotics a 
standard practice in the industry (Kastrop 
et al., 2007; Swain, 2015).
Carbohydrate needs are met via 
pyruvate, lactate and glucose, with 
pre-compaction embryos preferring 
pyruvate followed by a shift to glucose 
for compaction and blastocyst formation 
(Leese, 2012). Most culture media 
provide pyruvate at concentrations 
between 0.2 and 0.5 mmol/l (Morbeck 
et al., 2014a, 2017), reflecting both the 
concentration as measured in fallopian 
tubes (Dickens et al., 1995; Gardner 
et al., 1996; Lopata et al., 1976; Tay 
et al., 1997), and the concentrations 
derived via simplex optimization (Lawitts 
and Biggers, 1991). Results from the 
latter study suggest that pyruvate 
concentrations higher than 0.5 mmol/l 
may be detrimental. Perhaps not 
surprising, all but one now-discontinued 
medium provided pyruvate at 
≤0.5 mmol/l (Morbeck et al., 2017).
Glucose, while not required for pre-
compaction embryo development, and 
at one point considered detrimental to 
early cleavage divisions (Quinn et al., 
1995), is now included as a standard 
component of all complex culture media 
on the market. Amino acids and EDTA are 
important contributors to the metabolic 
environment that limits the utilization 
of glucose during the pre-compaction 
stage (Biggers and McGinnis, 2001; 
Houghton, 2012; Lane and Gardner, 
1997). Post-compaction, glucose becomes 
the preferred energy source and is 
supplied at ostensibly physiological levels 
of ∼3 mmol/l in blastocyst-stage media 
(Gardner et al., 1996; Morbeck et al., 
2014a) versus 0.2–1.0 mmol/l for ‘single-
step’ or cleavage-stage media (Morbeck 
et al., 2017). The lack of consensus on 
glucose concentration probably reflects 
the embryo’s ability to obtain its energy 
and carbon from diverse sources, 
including pyruvate, lactate and amino 
acids. It is worth noting that EDTA, an 
additive that was believed to be necessary 
to chelate potentially toxic metals, is used 
in all media at varying concentrations as it 
may be involved with glucose metabolism, 
limiting the availability of magnesium as 
a cofactor for glucose metabolism (Lane 
and Gardner, 2001).
Amino acids are ubiquitously present in 
culture media and in at least one protein 
supplement (Morbeck et al., 2014a, 
2014b, 2017). Early iterations of culture 
media for human embryos were mostly 
amino acid free, e.g. Earle’s medium 
(Cohen et al., 1985b) and Quinn’s HTF 
(Quinn et al., 1985), although Ham’s 
F-10 (Leung et al., 1984) and Menezo’s 
B2 and B3 media (Menezo et al., 1984) 
contained amino acids based on Eagle’s 
formulation (Eagle, 1959). While all 
amino acids were included in Gardner’s 
blastocyst-stage media, only non-essential 
amino acids were included in cleavage-
stage sequential media (Gardner and 
Lane, 1998) due to the possibility of 
reduced development of cleavage-stage 
embryos exposed to essential amino 
acids – at least when used at MEM 
(minimal essential medium) levels (Lane 
and Gardner, 1997). In contrast, the 
single-step media include most or all 
of the 20 amino acids (Morbeck et al., 
2017). Amino acids play numerous 
roles in cellular function, including but 
not limited to acting as metabolites, 
antioxidants, osmolytes and buffers. Thus, 
there is a consensus that complex media 
should contain a robust complement of 
essential and non-essential amino acids. 
The selective efficiency of non-essential 
and essential amino acids in early stages 
needs further clinical research, but 
there seems to be consensus that both 
groups are needed for post-compaction 
development.
l-glutamine, an amino acid with many 
roles during embryo growth and thus 
considered an essential component 
of culture medium, breaks down 
spontaneously with ammonium as a by-
product (Kleijkers et al., 2016a). There 
are concerns regarding the relative 
amount and impact of ammonium 
accumulation in culture media (Biggers 
et al., 2004), but the effect is magnified 
in 20% O2 (Wale and Gardner, 2016). A 
simple solution has been the introduction 
of glutamine in a stable dipeptide form 
(Lane and Gardner, 2003). The use of 
dipeptide glutamine is now standard 
practice for all versions of complex ART 
culture media.
Protein is an important component 
of culture medium that is provided 
in several forms and, by consensus, 
should be included in all embryo culture 
media. Albumin is the most abundant 
protein in the oviduct (Leese, 1988) and 
thus the most common protein used 
in culture media. Albumin serves many 
functions, most notably as an antioxidant 
(Bavister, 1995; Morbeck, 2015). Lot-to-
lot variations exist with human serum 
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albumin (HSA) (Swain, 2015), particularly 
with respect to the stabilizer octanoic 
acid (Fredrickson et al., 2015; Leonard 
et al., 2013). Human albumin is also 
available in a recombinant form (recHSA; 
Bungum et al., 2002), although exclusivity 
rights restrict its availability, mostly as 
a supplement for end-users to add to 
non-supplemented media. Even the 
sole supplier does not offer media pre-
supplemented with recHSA, probably 
due to issues with cost of the product. 
So, while recHSA might offer theoretical 
advantages over HSA in terms of safety 
and product consistency, its routine use 
is unlikely while commercial exclusivity 
remains in place.
Complex protein supplements are 
common and have a strong market 
presence, particularly in the Americas. 
There are two classes of complex protein 
supplements: HSA solutions containing 
alpha and beta globulins or dextran. 
The latter is a surfactant and volume 
stabilizer, although there is little evidence 
for the benefit of using a polysaccharide 
along with albumin (Campbell et al., 
2013). In contrast to dextran, alpha and 
beta globulins carry potential benefits 
that can yield improved live birth rates 
(Meintjes et al., 2009b). There are two 
formulations of protein supplements 
containing globulins: one where USP (US 
Pharmacopeial Convention) grade alpha 
and beta globulins are mixed with HSA 
and one that is a less pure fraction of 
human serum that contains both albumin 
and alpha and beta globulins. Both 
empirical observations and regulatory 
barriers limit the widespread use of 
these complex protein supplements 
globally. Globulin-containing products 
are poorly defined, can contain high 
levels of pro-oxidant metals (Morbeck 
et al., 2014b), and suffer from significant 
lot-to-lot variation (Meintjes, 2012). For 
these reasons, and with limited evidence 
for benefit, the proposed consensus is 
that industry should move to protein 
supplements that are the most defined, 
and, at some point, not a human 
product. The proposed consensus is that 
recHSA is theoretically safer and more 
consistent than HSA, which is safer and 
more consistent than globulin-containing 
formulations.
Human serum, the predominant form 
of protein supplement used during the 
early years of clinical IVF (Edwards and 
Steptoe, 1983), is inherently variable 
and can carry risks to the health of 
the offspring. Thus, the field reached 
consensus in the 1990s that serum was 
no longer suitable as a supplement for 
human embryo culture.
Phenol red is included in many culture 
media as a QC measure to monitor 
medium pH, rather than it having any 
role in embryo development (Swain, 
2015). However, phenol red addition 
carries some hypothetical risks, based 
on its oestrogenic activity (Moreno-
Cuevas and Sirbasku, 2000) or as a 
source of ROS (Nakayama et al., 1994), 
thus making it a component for which 
risks outweigh benefits. In this era of 
microdrop culture, where volumes of 
media are <100 µl, a colour indicator is 
neither necessary nor beneficial because 
visual assessment of colour changes 
in such small volumes is very hard to 
standardize.
However, in other areas, consensus is 
lacking, as described below.
Lactate concentrations vary widely. 
An important partner with pyruvate 
during the first few days of embryo 
development, lactate is intimately 
involved in pyruvate uptake and 
metabolism (Lane and Gardner, 
2000b) and production of NADH and 
thus REDOX potential in blastomeres 
(Dumollard et al., 2007, 2008). Nearly 
all studies of reproductive fluids report 
lactate concentrations of 5–10 mmol/l 
(Dickens et al., 1995; Gardner et al., 
1996; Lopata et al., 1976; Tay et al., 
1997) and the concentration chosen, at 
least for single-step media, is within this 
range to give a lactate:pyruvate ratio of 
approximately 20 (Morbeck et al., 2017). 
Lactate concentrations at 2 mmol/l, 
which result in lactate to pyruvate ratios 
of 2 to 5, have been introduced by 
some designers (Morbeck et al., 2014a), 
although these low lactate concentrations 
and lactate:pyruvate ratios have not been 
rigorously studied in animal models and 
thus lack consensus.
Calcium and magnesium, in terms 
of their absolute and relative 
concentrations, also vary widely with a 
nearly 10-fold difference in magnesium 
concentrations (0.2–1.8 mmol/l) that 
result in a 10-fold difference in the 
ratio of calcium to magnesium (0.6–7.1; 
Morbeck et al., 2017). The significance 
of the difference in Ca:Mg ratios is 
unknown, although calcium signalling 
after fertilization is a likely target, and 
differences in this ratio could affect 
developmental potential (Lu et al., 2018). 
Thus, absolute concentrations of Ca2+ 
and Mg2+ and their ratio lacks consensus.
Hyaluronan, a glycosaminoglycan, and 
taurine/hypotaurine, an aminosulfonic 
acid, are added to some but not all 
culture media. Benefits of hyaluronan 
have been described for embryo transfer 
media (Bontekoe et al., 2010), but there 
is a limited clinical evidence base for 
benefits in embryo culture (Gardner 
et al., 1999). Recent work in bovines and 
sheep, particularly after cryopreservation, 
has shown outcome improvement 
(Dattena et al., 2007; Palasz et al., 
2008). In contrast, taurine is used in 
culture media for domestic animals with 
proposed antioxidant and osmolytic 
benefits (Devreker and Hardy, 1997; 
Dumoulin et al., 1997).
There are numerous micronutrients 
present in some culture media, 
components with minimal evidence 
basis and thus lack of consensus among 
media manufacturers. These factors 
include antioxidants, such as lipoic acid, 
essential nutrients like choline, and 
vitamins, including but not limited to the 
B vitamins, vitamin C and vitamin E.
Insulin has been included in a minority 
of embryo culture media, possibly as a 
reflection of the common inclusion of 
insulin, transferrin and selenium in cell 
culture media (Shamsuddin et al., 1994). 
A recent study showed that insulin added 
to a single-step human embryo culture 
medium improved embryo development 
and ongoing pregnancy rates (Fawzy 
et al., 2017c), although further studies are 
warranted to validate these findings.
Growth factor or cytokine 
supplementation of commercial human 
embryo culture media is currently 
limited to granulocyte-macrophage 
colony-stimulating factor (GM-CSF), a 
multifunctional cytokine present within 
the oviduct and uterine epithelium during 
the peri-implantation period (Robertson, 
2011). A large RCT showed a benefit of 
GM-CSF in select patient populations 
(Ziebe et al., 2013), but only when the 
level of HSA was reduced. In the control 
group the lower level of HSA (2 mg/ml) 
had lower outcomes than the standard 
5 mg/ml. Similar to recHSA, manufacturer 
exclusivity limits the availability of 
recGM-CSF to one culture medium. This 
commercial exclusivity limits the broad 
 RBMO  VOLUME 00  ISSUE 0  2019 15
application and clinical assessment of 
GM-CSF, making it premature to establish 
consensus on its use.
In conclusion, reaching a consensus 
on the composition of human embryo 
culture medium is difficult due to the fact 
that individual components have not – 
and cannot – be optimized in patients, 
notwithstanding the possibility that one 
culture medium might not be suitable 
for all patients. Hence the conclusions 
summarized here are actually an expert 
opinion based on industry practices. 
There are several components that 
can be considered standardized and 
several others that merit consideration 
for consensus. These two groups of 
components comprise a small minority 
of the total constituents of culture media 
on the market, making most of the 
composition not standard.
– Carbohydrates – pyruvate, lactate 
and glucose – are universally added 
to culture media, as are most if not all 
common amino acids.
– Glucose and pyruvate concentrations 
fall within a relatively narrow range.
– Amino acid concentrations vary con-
siderably; glutamine is notable given its 
lability and hence its routine inclusion 
as a stable dipeptide.
– Inclusion of the antibiotic gentamicin 
is standard.
– Serum-free culture is standard.
– Protein supplementation has con-
siderable variation and presents an 
opportunity for standardization. Com-
plex protein supplements may bring 
benefits, yet are poorly defined and 
variable from lot to lot. Moving to the 
most defined protein available, and 
preferably not from human sourc-
es, is warranted. Ideally, protein is 
added to the culture medium by the 
 manufacturer.
– Inclusion of phenol red remains var-
iable and is generally unnecessary in 
media used for extended culture.
In practice the ART field is faced with the 
challenge of improving the composition 
of culture media while acknowledging 
that there is no suitable model in 
which to prove the principles first. 
Harper and colleagues, when providing 
recommendations for how to bring new 
culture media to market, stated: ‘If we 
aim to change the design of culture 
media in significant ways, we must 
carefully assess the risk of those changes, 
as well as the potential benefits.’ Yet new 
single-step media with significant changes 
in design were recently introduced 
with no published animal studies and 
little clinical oversight (Hardarson 
et al., 2015; Sfontouris et al., 2017). The 
composition of new culture media, such 
as a new single-step medium with low 
lactate, are shrouded in mystery, leaving 
practitioners, and thus patients, with little 
evidence or assurance of safety (Sunde 
et al., 2016). An area where we most lack 
consensus is how to continue to make 
improvements to culture media in a safe 
yet effective manner.
Culture media – sequential or ‘single-
step’ media for human embryo culture
Two different approaches to developing 
embryo culture media have been 
proposed, more than a century after 
the first cell tissue culture system 
(simple salt solution) was described by 
Ringer and Ludwig. Aiming to mimic 
the reproductive environment (the 
so-called ‘back to nature’ principle), 
experimental embryologists in the 1970s 
tailored culture medium composition 
to closely match the chemistry of the 
female reproductive tract. An example 
of the back to nature principle is the 
sequential embryo culture system. The 
second group of media was designed to 
optimize growth in vitro, having embryo 
development as an endpoint to optimize 
composition, to some extent ignoring 
existing formulations and principles. 
These ‘simplex optimization’, or SOM, 
media were described by scientists 
supported by the National Institutes of 
Health in the USA during the 1990s, in a 
team effort that was colloquially referred 
to as ‘The Culture Club’. To formulate 
SOM media the performance of each 
ingredient is evaluated separately using 
the ‘simplex optimization’ process – a 
mathematical system developed first 
for the mouse in the laboratory of John 
Biggers at Harvard University 25 years 
ago. The advantage of this approach over 
the sequential system is that there is no 
consideration of fallopian and uterine 
conditions, and that embryos can be 
left alone without altering conditions for 
5 days or longer. The core question is 
whether this perceived advantage comes 
at a cost.
Gardner and Lane (1997) were the first 
to suggest that ‘in order to optimize 
mammalian embryo development in 
culture, sequential media are required, 
each designed to meet the changing 
requirements of the developing embryo’. 
The need for sequential changes 
in their culture media was a logical 
conclusion of their experiments. This 
compelling principle and the ‘back to 
nature’ approach in general have been 
challenged in part because the approach 
is reliant on the analysis of oviductal and 
uterine components, and such analyses 
may have shortcomings (Biggers, 2002; 
Cohen and Rieger, 2012).
The suggestion that either the single-step 
SOM approach or sequential culture 
is better is not based on scientific 
arguments and cannot be decided after 
evaluation of the literature. More than a 
thousand papers and abstracts have been 
written about culture media systems 
and a considerable number of thorough 
reviews have been published comparing 
the two approaches (Dieamant et al., 
2017; Sfontouris et al., 2016; Youssef 
et al., 2015). Analyses like this are 
unfortunately compromised by the 
quality of the original comparative studies 
and a multitude of confounders affecting 
laboratory results. Common confounders 
such as support media for gamete 
handling, protein supplementation and 
details of incubator QC aspects are 
often ignored by authors, and are hence 
unavailable to reviewers.
The recent systematic reviews plead for 
additional studies (including repeat trials), 
larger investigations and improved quality 
of evidence. There are five important 
aspects known to affect the reliability of 
RCT: (i) appropriate randomization; (ii) 
allocation concealment; (iii) blinding; 
(iv) limiting technological bias (such 
as rigorously applying manufacturer’s 
instructions and reducing the effect 
of known confounders); and (v) 
independent statistical evaluation. Trials 
evaluating the two culture systems are 
often lacking in most of these areas. The 
debate over evidence-based practice has 
been long and tedious in reproductive 
medicine and particularly the use of 
the RCT as the sole argument to prove 
or disprove a hypothesis has been 
questioned (Cohen and Alikani, 2013; 
Harper et al., 2012).
Harper and coworkers (2012) suggested 
not just paying attention to RCT studies 
and the typical evidence base when 
evaluating new and existing clinical 
embryology technologies. This model 
of medicine and evidence by itself was 
not new, but the context was refreshing. 
They considered seven premises: (i) Is 
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the technology based on an appropriate 
hypothesis? (ii) Were studies in animals 
performed? (iii) Were spare gametes 
and embryos evaluated? (iv) Was the 
technology validated in small series 
studies? (v) Were RCT performed? (vi) Is 
the technology relevant from a routine 
application point of view? (vii) Is the 
technology economically sensible?
It is suggested that the ‘Harper model’ 
be considered seriously, as there is 
sufficient merit to each of the ‘common 
sense’ premises. If each technology is 
evaluated for these seven themes, and 
one aspect is not considered more 
important that any of the others, the lack 
of RCT might be considered acceptable 
(in some cases), and technologies can 
be evaluated (and compared) according 
to their Harper model score. Using 
this model, a score can be derived 
within a few years after the introduction 
of the technology, rather than the 
evidence-based approach, which can 
drag out over decades, often causing 
considerable debate and confusion. 
This was illustrated by the work of David 
Gardner and colleagues describing 
the first sequential culture medium 
system G1 and G2, nearly 20 years 
ago (reviewed in Niederberger et al., 
2018). Those studies fulfilled the Harper 
model criteria in short order, although 
later RCT comparing sequential media 
against single-step KSOM-derived 
culture in systematic reviews did not 
show differences (Dieamant et al., 2017; 
Sfontouris et al., 2016).
Use and management – cold chain and 
storage
Manufacturers provide specific guidelines 
regarding transport and storage of 
human IVF culture media products, with 
little real difference between suppliers. 
Guidelines for storage and handling are 
based on manufacturers’ experience, 
professional organization directives, 
and an example set by the associated 
field of cell tissue culture. General 
recommendations are:
– Culture media products must be 
stored at refrigerated temperatures 
according to the manufacturer’s in-
structions (2–8°C) and kept away from 
light, particularly sunlight.
– Storage conditions and expiry date 
should be clearly shown on labels and 
product inserts.
– Products should be used in order of 
batch or lot numbers.
– Products should never be used after 
expiration of the shelf life indicated on 
the product or inserts.
– Bottles of ready-to-use culture medium 
should not be opened once, closed 
and reopened again for use later.
Culture media effects for ART do not 
just start during egg retrieval, but are 
a function of transportation as culture 
media may go out of their specified 
tolerance range during transport and 
storage. Culture medium is produced at 
room temperature and may be kept for 
a while at ambient environments before 
final packaging and refrigerated storage. 
It is obviously safe to assume that culture 
medium tolerates some changes in 
temperature, but potential detrimental 
effects, if any, are a function of exposure 
changes, duration and frequency of 
temperature fluctuations. There are 
two extreme events that may occur in 
cold chain failure: freezing or becoming 
overheated.
Effect of freezing
When the ambient temperature drops 
below 0°C it may take a while before a 
medium freezes, due to the shipping box 
and its thermal mass, which reduce the 
impact of temperature excursions. The 
general composition of culture media is 
such that they will not freeze immediately 
but will first super-cool, without inducing 
ice crystallization. Recommended 
storage conditions are +2°C to +8°C, 
indicating that manufacturers rely on a 
safety margin. Once a culture medium 
freezes, it will have to be discarded 
because the freezing can cause the 
liquid part to become non-homogeneous 
and subsequently the medium might 
not reconstitute properly. If the culture 
medium is protein supplemented, there 
is an increased risk of denaturation, 
as the liquid portion might have a 
sub-optimal osmolality and pH. Low 
temperatures do not have much effect 
on mineral oil.
Effect of elevated temperature
The cold chain might be broken due 
to transportation delays or temporary 
storage at elevated temperatures. A 
slightly elevated temperature between 
refrigeration and room temperature for 
up to a week might not be detrimental. 
The main effect of elevated temperature 
exposure is oxidation and a reduction in 
the concentration of active components. 
Through deamination amino acids and 
proteins might slowly release ammonium 
ions that have been shown to have a 
negative impact on the embryo; an effect 
that is worse when the monopeptide 
version of glutamine is used (as opposed 
to the more stable alanyl-glutamine or 
glycyl-glutamine dipeptide forms) or in 
protein-supplemented culture media. 
The process is slow, but effects may be 
noticeable after several days, and occurs 
even when samples are held at stable 
refrigerator temperatures: protein-free 
culture media do not have any marked 
ammonium ion build-up in vitro at 37°C 
or during 6 weeks in the refrigerator, but 
undiluted protein supplements showed 
considerable deamination after just a 
few days at 37°C (Kleijkers et al., 2016a). 
The actual levels of ammonium ions and 
specific effects at very low concentrations 
are unknown and effects could be brand-
dependent. The reactions are O2- and 
temperature-dependent and degradation 
can be calculated. A similar problem 
can occur in the event of a laboratory 
refrigerator malfunctioning.
Logging thermometers are sometimes 
sent in shipments. From their data, the 
mean kinetic temperature (MKT) can 
be calculated, a measure routinely used 
in the pharmacological industry as a 
simplified way of expressing the overall 
effect of temperature fluctuations during 
storage or transit of perishable goods.
There are no known international 
recommendations for storing IVF culture 
media. Regular residential refrigerators 
and freezers, which have very poor 
temperature stability, are still seen in IVF 
laboratories. Appropriate refrigeration 
can only be achieved with clinical 
grade (‘pharmacy’) refrigerators, which 
generally reduce fluctuations and failures. 
These units have wire shelves and 
compartments for improved circulation, 
and the doors do not have any shelves 
for storing samples. Combined side-by-
side refrigerator/freezer units should not 
be used. Storage efficiency is dependent 
on load, so that empty and completely 
full refrigerators under-perform. A built-in 
unit should have a fan in the front.
Monitoring refrigerators and freezers 
using an external/secondary method is 
highly advisable and typically required 
by accreditation bodies. Monitoring 
should be periodic (at least daily). 
The Centers for Disease Control and 
Prevention (CDC) recommends NIST-
calibrated certified thermometers 
using a glycol-filled bottle in addition to 
 RBMO  VOLUME 00  ISSUE 0  2019 17
display temperature. Dataloggers may be 
helpful. An audible alert is useful, as are 
self-closing doors, open door alerts and 
keyed locks.
Effect of light
Visible light is non-existent in the 
reproductive tract, but during laboratory 
exposure both gametes and embryos, 
as well as the products used for embryo 
culture, are exposed to visible light of 
various intensities (review by Pomeroy 
and Reed, 2013). The sources of light in 
ART laboratories are ceiling lights and 
microscopes (Pomeroy and Reed, 2013) 
and Ottosen et al. (2007) have shown 
that illuminance (lux) and irradiance 
are greater from microscopes than 
ambient light by a factor of 10–20 × . 
Harmful light-mediated effects have been 
described in invertebrates, hamsters, 
mice and cattle, but the direct effect 
of light on human embryos is basically 
unknown (Ottosen et al., 2007). Blue 
and ultraviolet light are found to be the 
most harmful and the effects can be 
suppressed by use of red and green 
filters on microscopes. Important indirect 
peroxidation effects of light on mineral 
and silicone oil have been documented 
(Otsuki et al., 2007). Indirect effects of 
light via hydrogen peroxide have also 
been found in HEPES-buffered media 
and culture media including essential 
amino acids like tryptophan and tyrosine. 
The intensity of the exposure (irradiance) 
is an important aspect to consider, as 
well as the duration of exposure and 
actual wavelength. Photo-oxidation (also 
known as peroxidation) of oil can occur 
when exposed to ultraviolet. Other 
compounds affected by light exposure 
are hydrocarbons, nitrogen and sulphur.
Test equipment – calibration and 
certification
Laboratory environment
VOC and air contaminant monitoring: 
Equipment with the proper sensitivity 
must be used (Hall et al., 1998). 
Meaningful VOC values are measured 
as ppb and not ppm. Sensitized photo-
ionization detection (PID) devices are 
used for screening with sensitivities 
not lower than 100 ppb. Frequent 
calibration (at least semi-annually is 
recommended) is typically performed 
at the factory with a reference gas such 
as isobutylene. Heated metal oxide 
sensors (HMOS) are not recommended 
as their sensitivity is not acceptable. 
For the continuous measuring of ppb, a 
photoelectric absorptiometric principle 
is used, applying a sensor cartridge 
(150–1000 tests).
Particulates: Particle size to be measured 
should be defined. Most particle 
counters are certified and calibrated by 
the manufacturer using NIST-traceable 
particles; typically, in-house calibrations 
are not required. For ISO-certified 
clean rooms, particle counts should be 
performed according to ISO 14644, 
although a recent consensus on IVF 
laboratory air quality recommends a 
more practical approach (Mortimer et al., 
2018).
Temperature: Temperature 
measurements should be tailored to the 
purpose and acceptable tolerance for the 
equipment being tested. Temperature 
measuring devices for working surfaces 
can be accepted with an accuracy of 
±0.05°C. Thermometers should be 
calibrated at regular intervals, at least 
annually to conform to ISO 15189:2012.
Humidity: Control of room humidity is 
strongly recommended to minimize the 
risk of fungal growth and contamination, 
for staff comfort, and to minimize 
evaporation during the open handling 
(no oil overlay) of gametes and embryos. 
Inexpensive measurement devices can 
be used successfully, but typically last 
only for months. Continuous and/or 
wireless humidity sensors are calibrated 
at installation and should be recalibrated 
at least twice per year.
Culture environment
Temperature: When measuring the 
temperatures of incubators or other 
highly sensitive environments, a 
tolerance limit of no more than ±0.1°C 
is recommended. Thermometers should 
be calibrated against a NIST-traceable 
reference device at least twice per year. 
pH: Monitoring of pH is commonly 
used as a means of validating culture 
medium performance (Swain, 2012b) 
as described above. However, with the 
consistency of modern culture media, the 
stabilizing effect of bicarbonate buffering, 
compromised measuring resolution and 
inter-measurement variation, routine 
single pH measurements may be of 
questionable value. Hand-held pH meters 
need to be calibrated before each use. 
Furthermore, one must ensure that the 
pH probe has a meaningful resolution and 
range for IVF applications, is designed for 
IVF micro-volumes, and that an immediate 
reading at 37°C can be obtained. 
Continuous measurement of pH in situ 
(inside the incubator) is possible using 
continuous sensors with certification 
and calibrations determined by the 
manufacturer. One example of continuous 
pH monitoring is SAFE Sens® (Blood 
Cell Storage Inc., Seattle, WA, USA), 
which employs an optical fluorescent 
measurement technology. Each disposable 
sensor contains a proprietary pH-sensitive 
fluorescent dye; the fluorescent signal 
is read continually at a set frequency 
and converted to a pH value. Each lot of 
sterile sensors lasts 7 days and is certified 
by the manufacturer.
Blood-gas analyzers: These instruments 
provide instant and accurate pH readings 
without having to rely on inaccurate 
hand-held pH meters or more expensive 
continuous monitoring devices (Swain, 
2013). In addition, blood-gas analyzers 
provide helpful pCO2, pO2 and 
electrolyte information that can aid in the 
overall quality management of the culture 
system. The hospital-type analyzers are 
expensive and require daily maintenance 
and calibration. Newer handheld devices 
allow for pH, pCO2, pO2, and electrolyte 
readings, using disposable cartridges with 
integrated calibrators.
Oxygen: O2 can be measured reliably 
with mechanical devices, electronic 
measuring devices, or the pO2 can 
be determined with a blood gas 
analyser. Electronic hand-held devices 
should be calibrated regularly (daily, 
monthly, periodically) as specified by 
the manufacturer. A calibration gas 
mixture is frequently required for proper 
calibration. In a growing number of 
countries, the classic Fyrite® fluid for 
measuring O2 or CO2 requires hazardous 
goods shipment or is not even available.
Amperometric (galvanized or voltage-
sensitive) and optical sensors are used 
in these applications, with an optical 
sensor requiring the least maintenance. 
Over time, both types of O2 sensors 
can suffer from ageing effects leading 
to measurement drifts. A reference 
electrode (amphoteric) or reference LED 
(optical) or backup control unit is always 
advisable.
Laboratory equipment and real-time 
monitoring
Real-time monitoring (RTM) has long 
been considered impractical because of 
18 RBMO  VOLUME 00  ISSUE 0  2019
the lack of accurate CO2 sensors, the 
difficulty of connecting a large number 
of sensors, and the cost of cabling and 
adding sensors and data transmitters. 
Today, with the universal availability of 
low-cost wireless technology, internet, 
smart phones and tablets this is no 
longer the case, and there are now 
affordable solutions that provide vital 
information in real time. RTM systems 
can reduce ‘loss’ by equipment failure 
and thus provide the Embryology 
Laboratory Manager with increased 
safety and reliability. Also, regulators 
see the benefits of monitoring and 
this requirement is now integrated 
in professional guidelines (Magli 
et al., 2008), regulatory requirements 
(Commission Directive 2006/86/EC) and 
accreditation standards (ISO 15189:2012).
It is possible to connect analogue 
sensors for temperature and gas levels 
(CO2, O2 and VOC). If feasible, sensors 
independent from the equipment being 
monitored should be used. This makes it 
possible to detect equipment sensor drift 
and allows verification of a manufacturer’s 
performance claims and may detect 
environmental factors such as electrical 
failure.
Air pressure, relative humidity, air flow 
sensors and particle counters can be 
connected to an RTM system but these 
parameters are usually integrated into 
a building management or monitoring 
system (BMS). Laboratory ambient 
air monitoring should be part of the 
laboratory’s RTM system because 
deviations in ambient temperature have 
consequences on the temperature 
regulation of microscope heated stages.
Digital signals that can be monitored in 
real time are door status, equipment 
alarm signals. It is even possible to read 
digital RS232 or RS485 interfaces.
Modern web-based systems provide 
accurate and effective control of 
equipment, the data are accessible 
remotely over a secure internet 
connection and intelligent alarms warn 
the Laboratory Manager in case of 
an unexpected event or equipment 
malfunction or failure. To increase 
reliability, technical alarms (sensor 
break or monitoring equipment failure, 
network failure) should be possible and 
this aspect should be taken into account 
when a monitoring system is chosen. 
With modern technology it is possible to 
send alarm notifications by telephone, 
email or SMS, but the alarm messaging 
program should be bidirectional so that 
alarm acknowledgement is possible (and 
logged). In case of no reaction within 
a predefined timeframe, an automatic 
cascading system should be activated.
Blood gas analysers provide instant and 
accurate pH readings without having 
to rely on inaccurate hand-held pH 
meters or more expensive continuous 
monitoring devices (Swain, 2013). In 
addition, blood gas analysers provide 
helpful pCO2, pO2 and electrolyte 
information that can aid in the overall 
quality management of the culture 
system. The hospital-type analysers are 
expensive and require daily maintenance 
and calibration. Newer hand-held devices 
allow for pH, pCO2, pO2 and electrolyte 
readings, using disposable cartridges with 
integrated calibrators.
Validation: In ISO 15189:2012, the 
international standard for accreditation of 
medical laboratories, validation is defined 
as ‘confirmation, through the provision of 
objective evidence, that the requirements 
for a specific intended use or application 
have been fulfilled’. IVF is a process, and 
a basic objective of validation is to ensure 
that each step and each variable of the 
process is identified and controlled, and 
process variability is reduced so that 
the finished product meets customer 
requirements (consistent high pregnancy 
rates). Certainly, in IVF the quality 
of the ‘end product’ cannot itself be 
measured, so each contributing factor 
(infrastructure, equipment, utilities) and 
all the steps of the process need to be 
known and controlled.
Validation should be performed for new 
premises, laboratory equipment, utilities 
and processes and procedures and 
should result in written reports. During 
the validation, in-process controls should 
be defined to monitor the process.
Equipment needs to be validated to 
provide a high degree of assurance that it 
will consistently meet its predetermined 
specifications with minimal variation. 
Equipment validation is broken down into 
three phases: ‘Installation Qualification’ 
(IQ), ‘Operational Qualification’ (OQ), 
and ‘Performance Qualification’ (PQ). 
As the first step, IQ ensures that 
the equipment is correctly installed 
according to the manufacturer’s 
specifications, e.g. a new incubator 
needs be installed on a solid, vibration-
free surface, the room temperature 
should be within a defined range, the 
instrument should be connected to 
CO2 and mains power. During the next 
step, OQ, the equipment is calibrated 
and tests are performed to document 
a baseline of the critical parameters of 
the equipment. For the incubator, this is 
defining set-points for CO2, temperature, 
O2 and a verification of these parameters 
with independent, calibrated measuring 
equipment. The PQ phase then tests 
the ability of the incubator to perform 
over long periods within an acceptable 
tolerance range.
The equipment, utility and system 
should then be maintained, monitored 
and calibrated according to a regular 
schedule by responsible personnel with 
appropriate qualifications and training. 
Parameters of calibration and equipment 
verification should be traceable to 
international standards. Calibrated 
equipment should be labelled, coded 
or otherwise identified so that the 
calibration status and recalibration due 
date are clear. If equipment is not used 
for a certain period of time then the 
calibration status needs to be verified 
before use.
Consensus guidelines
During the consensus meeting, the 
attendees formed statements based 
on the best available evidence and, if 
lacking, their expert opinion. In our 
deliberations it was not possible to 
conclude that there were certain aspects 
which were more important than others. 
Rather we agreed on an important 
fact first formulated by Don Rieger, 
that everything is important in the IVF 
laboratory. In TABLE 2 we summarize some 
of the points we focused on. General 
recommendations were aimed at creating 
a scenario whereby the laboratory or 
culture of eggs and embryos is more 
a case of limiting the cumulation of 
stresses. It is accepted that the whole 
process may not be optimal, however, 
the fewer the stresses the higher the 
chance of normal offspring. In many 
discussions, it was noted that high-
level evidence was lacking. It was also 
a general observation that properly 
designed, conducted and reported 
RCT were lacking. This is unfortunate, 
especially because randomizing what 
we do in the IVF laboratory should not 
be considered a ‘scientific experiment’, 
but a mere evaluation of what we do 
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every day. When discussing what is best 
to do in the IVF laboratory, the group 
considered cumulative live birth rate to 
be the outcome of interest (Maheshwari 
et al., 2015; Wilkinson et al., 2016). 
Ultimately not only the cumulative live 
birth rate, but also data on safety (for 
both the woman and the forthcoming 
child), time to pregnancy, and costs 
need to be taken into account. For 
many of the topics discussed, high-level 
evidence on outcomes was lacking. 
Also, the group primarily relied on data 
reported per woman or per started 
cycle, rather than per embryo or per 
transfer, as the latter could be misleading 
when evaluating any part of the IVF 
treatment (Griesinger, 2016). Examples 
mentioned during the meeting were 
reports on increased fertilization rates, 
and increased implantation rates, while 
in these same studies a decrease of live 
birth rate was reported (Kleijkers et al., 
2016b; Mastenbroek et al., 2007). The 
group acknowledged the shortcomings 
of these outcome measures in evaluation 
of laboratory treatment efficacy, while 
at the same time recognizing their 
value for validation and monitoring of 
laboratory performance (ESHRE Special 
Interest Group of Embryology and Alpha 
Scientists in Reproductive Medicine, 
2017). Validation and monitoring are used 
to ensure laboratory performance within 
predefined limits, but the decision on 
what to do comes down to treatment 
efficacy.
Assessment practices
It is critical to select and follow evidence-
based guidelines for good laboratory 
and assessment practice. Gamete and 
TABLE 2 ALTHOUGH EVERYTHING IS IMPORTANT IN THE IVF CULTURE SYSTEM, A LIST OF 20 SUGGESTIONS IS 
 PRESENTED HERE; THESE ARE NOT PRESENTED IN ORDER OF IMPORTANCE, NOR ARE THESE THE ONLY POINTS 
 COVERED IN THE CONSENSUS DOCUMENT
IVF culture aspect Consensus suggestion
1 The chance of every patient having a healthy baby is the most important outcome. Cumulative live birth rate per woman or started 
cycle and other parameters should be monitored. High-level evidence is still lacking.
2 Gamete and embryo assessment practice should be based on expert or professional body, peer-reviewed, published and evi-
dence-based guidelines.
3 Physicochemical conditions must be maintained during assessment, but evidence for optimal timing and frequency is lacking.
4 Evaluation of embryo culture must include embryo viability (in-vivo development) after transfer. Appropriate measures are implan-
tation rate, live babies born per embryo transferred, embryo and fetal loss rate.
5 Temperature validation is critical for each step of IVF. Evidence supports maintenance of 37°C during all aspects of culture, but 
humidified and non-humidified incubator environments may both be supportive depending on conditions.
6 Measurement of pH and of CO2 concentration can provide effective QC. Evidence supports culture of embryos in a low oxygen 
(normally 5% O2) iso-atmospheric condition.
7 Micromanipulation validation should include temperature mapping of the stage (dish) to determine the maximum period the 
oocyte can be maintained at ∼37°C and the lowest light setting should be chosen.
8 It is critical that mechanical (shear) stresses, as well as temperature changes and pH shifts, be minimized during all assessment and 
pipetting procedures.
9 Validated QM (SOP) programmes for routine monitoring of incubator performance should include daily assessment of tempera-
ture, CO2, O2 and humidity. Pre-established targets with tolerances (warning and control limits) for each variable are required as 
benchmarks.
10 Incubator supply gases should be filtered to remove particulates and contaminants. For pre-mixed incubator supply gases, the 
individual gas levels in the mixture should be verified and liquefied CO2 level must be monitored.
11 Select buffers (i.e. HEPES and MOPS) appear to be safe for stabilizing pHe outside the culture incubator, but consequences of 
prolonged exposure are unknown.
12 Commercially manufactured culture medium intended for human ART should be used with adherence to protein supplementation 
guidelines from manufacturers.
13 There is currently insufficient evidence to support the addition of bioactive compounds, such as growth factors, to gamete and 
embryo culture medium. Further safety and efficacy studies are required before their routine inclusion.
14 SOP to verify acceptability for receipt and use of all contact materials, in accordance with best practice and local regulations. 
This includes keeping permanent records of Certificates of Analysis, lot/batch numbers. The laboratory should monitor ongoing 
performance of these materials.
15 Single-step media and sequential culture are both supportive of development and high outcomes. Current evidence is limited, and 
insufficient to demonstrate one culture system to be superior over the other.
16 Culture media must be kept and monitored under manufacturer’s recommended storage conditions. Appropriately maintained and 
manufactured storage refrigerators must be monitored diligently.
17 Independent continuous monitoring of critical parameters of laboratory infrastructure and equipment is desirable and may be 
mandatory in certain countries.
18 Culture media batches can be validated by using accepted KPIs such as the Vienna consensus.a
19 Spermatozoa for ART must be efficiently separated from the seminal plasma environment as soon as possible after ejaculation.
20 Spermatozoa preparation for ICSI should be held at ambient temperature to minimize ROS generation.
ART = assisted reproductive technology; ICSI = intracytoplasmic sperm injection; KPI = key performance indicator; QC = quality control; QM = quality management; 
ROS = reactive oxygen species; SOP = standard operating procedure.
a ESHRE Special Interest Group of Embryology and Alpha Scientists in Reproductive Medicine, 2017.
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embryo assessment practice should be 
based on expert or professional body, 
peer-reviewed, published, evidence-based 
guidelines that are the most appropriate 
for each setting.
All possible measures should be taken 
to maintain physcochemical conditions 
during assessment (considering 
assessment timing and frequency, dish 
set-up/oil overlay, buffering, temperature 
control, consumables, equipment and 
laboratory environment).
It was agreed that at present there is 
no evidence for the optimal timing 
and frequency of assessments. Until 
RCT data are available, these practices 
should be established for each individual 
laboratory considering risks and benefits. 
In doing so, each laboratory should 
define, monitor and validate that their 
assessment practice is effective and 
fit for purpose within their operating 
environment, using published KPI.
Ultimately, the evaluation of embryo culture 
must include embryo viability (in-vivo 
development) after transfer. Appropriate 
measures of in-vivo development include 
implantation rate, live babies born per 
embryo transferred, embryo loss rate and 
fetal loss rate. Conversely, pregnancy rate, 
clinical pregnancy rate, live birth rate, 
miscarriage rate and any cumulative rate 
do not account for the number of embryos 
transferred and/or the number of transfers, 
and thus are not appropriate measures of 
embryo viability.
Temperature
Available evidence supports the 
maintenance of human oocytes and 
embryos at 37°C during culture. It could 
be that there is a range of acceptable 
temperatures, but this range has not 
yet been determined. If the available 
equipment cannot provide a tight 
temperature control, then a slightly lower 
temperature is probably better than a 
slightly higher one.
Humidity
Humidified and non-humidified 
incubators can both yield acceptable 
clinical results, but currently available 
comparisons in humans seem to 
demonstrate a benefit of humidified 
culture (Fawzy et al., 2017a); specific 
culture conditions, such as oil volume/
depth, medium surface area to oil 
interface, ratio of oil to medium, 
room humidity, pre-humidification of 
oil, medium droplet size, as well as 
medium changes, can affect individual 
results (Mortimer et al., 2018). As 
part of the validation of their systems, 
individual laboratories are encouraged to 
determine whether humidity is required 
in their culture system, while respecting 
local legislation and regulations.
Further research is encouraged to identify 
the critical parameters in defining these 
systems.
CO2 and medium pH
Technically, it is the partial pressure of 
CO2, rather than its proportion of the 
gas mixture, that maintains the pH of a 
bicarbonate-buffered solution. Therefore, 
if reporting % CO2 it should be clarified 
whether this measurement is at sea level, 
as the relative proportion is affected by 
altitude.
Medium pH is a critical factor in embryo 
culture. Because pH is dependent upon 
the CO2 concentration in a bicarbonate-
buffered solution, then the measurement 
of pH and of CO2 concentration can 
provide effective QC.
The decision about which of these 
parameters to measure and the frequency 
of measurement should be based on 
the laboratory’s policies and SOP (with 
reference to established targets and 
tolerances). Measurements should 
be conducted using calibrated and 
validated sensors that are independent 
of the incubator (i.e. in addition to the 
incubator’s displays).
Oxygen
It was the general consensus that there 
is robust evidence to support culture 
of embryos in a 5% O2 atmosphere 
(although one expert noted that they 
felt the evidence is equivocal for Day 3 
culture). There is evidence that there is 
greater efficiency in embryo culture with 
5% O2, but no studies have compared 
the health trajectories of children born 
from embryos cultured in 5% versus 
20% O2, and it was the consensus that 
these studies should be performed using 
retrospective data.
Micromanipulation
There are very few studies that address 
the optimization of sperm preparation 
methods for ICSI, although there 
is evidence that direct pelleting of 
spermatozoa from whole semen should 
be avoided if possible.
During the ICSI procedure, the aim is 
to maintain the temperature of each 
oocyte in the dish as close to 37°C 
as possible throughout the duration 
of the procedure, regardless of 
microscope stage temperature. This is 
best achieved with the use of a heated 
stage or warming plate. Validation of the 
micromanipulation rig should include 
temperature mapping of the stage and 
the dish to determine the maximum 
period that an oocyte can be maintained 
at 37°C in the injection area. Achieving 
this is only possible if the ambient 
environment is constant. If the external 
environmental conditions are changed, 
the system must be revalidated. For this 
reason, micromanipulation rigs should 
not be located in areas of active air flow.
Oocytes are sensitive to the blue-green 
end of the visible light spectrum, so these 
wavelengths should be avoided where 
possible. The ICSI procedure should be 
performed at the lowest intensity of light 
possible while still being able to visualize 
the gametes precisely.
It is critical that mechanical (shear) 
stresses be minimized. Preparation 
of oocytes for ICSI requires removal 
of cumulus oophorus and corona 
radiata cells. To minimize exposure to 
mechanical (shear) stress, complete 
removal of these cells is unnecessary 
beyond that required to perform the task 
effectively. In addition, the diameter of 
the stripping tip should be appropriate 
for the diameter of the particular 
oocytes.
Workstations
Workstations should be designed and 
operated to maintain oocytes and 
embryos as close to 37°C as possible 
while also minimizing pH shifts. When 
working with dishes without oil, every 
possible precaution must be taken to 
minimize evaporative cooling.
Travel distances between workstations 
and incubators should be as short as 
possible. This is an important matter of 
ergonomics in laboratory design.
Incubators
A validated QM programme for regular, 
routine monitoring of incubator 
performance should use independently 
calibrated devices for daily assessment 
of temperature and CO2, with O2 and 
humidity monitored as appropriate 
according to SOP.
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Pre-established targets with tolerances 
(warning and control limits) for each 
variable are required as benchmarks 
for assessing performance. Data should 
be captured with dataloggers or hand-
entered into control charts. Readings 
that cross warning or control limits 
should be investigated promptly.
The use of incubators that have 
thermal conductivity sensors for CO2 
measurement is discouraged. If incubators 
with thermal conductivity CO2 sensors 
are used, humidity measurement and 
management are mandatory.
Incubator supply gases should be 
filtered before they enter the incubator, 
to remove particulates and gaseous 
contaminants. For pre-mixed incubator 
supply gases, the individual gas levels 
in the mixture should be verified. For 
incubators with internal gas mixers, there 
must be verification of the gas mixture 
achieved within the incubator.
CO2 supply pressure must be monitored 
to ensure that there is always liquefied 
gas in the supply cylinder. This is critical 
to reduce the risk of release of VOC that 
are dissolved in the liquid CO2 (Mortimer 
et al., 2018).
Handling practices
Every attempt should be made to 
maintain the temperature of the oocytes 
and embryos as close as possible to 
37°C in every step of the IVF and in 
vitro culture process. This could be 
achieved through the use of a controlled 
environment chamber, but there are 
no RCT data available at this time to 
establish this benefit.
Care should be taken to manage heat 
loss in pipettes and oocyte collection 
needle sets. For example, holding 
multiple COC in the pipette while 
searching for other oocytes during the 
retrieval procedure should be avoided.
If a carrier is to be used when moving 
dishes between an incubator and a 
workstation, the choice of carrier type 
should be based on results from simulated 
procedures in which temperature of the 
dish contents was assessed.
The frequency of oocyte and embryo 
assessment has already been addressed 
in other consensus publications (Alpha 
Scientists in Reproductive Medicine 
and ESHRE Special Interest Group 
of Embryology, 2011; ESHRE Special 
Interest Group of Embryology and Alpha 
Scientists in Reproductive Medicine, 2017).
Culture media – buffering and pH
Maintaining a narrow and stable pHe 
is important for gamete and embryo 
quality. Ideal pHe is difficult to define and 
may vary based on media and ingredients 
(single versus sequential media; 7.20–
7.35), as well as temperature. The CO2 
level appropriate for each laboratory’s 
culture conditions must be determined 
and maintained closely. The appropriate 
CO2 level will vary based on elevation 
and media composition.
Select buffers (i.e. HEPES and MOPS) 
appear to be safe for stabilizing pHe 
outside the culture incubator.
Culture media – general composition 
and protein supplementation
IVF laboratories should use products in 
general conformance to the manufacturer’s 
instructions, and to local regulations.
Culture and micromanipulation media 
should contain protein, carbohydrates, 
a complex mixture of amino acids with 
glutamine in the form of a dipeptide, and 
usually antibiotic(s). The use of phenol 
red as a pH indicator is optional.
For reasons of quality, consistency and 
reproducibility, laboratories should use 
commercially-manufactured culture 
medium intended for human ART 
use. In certain jurisdictions this is a 
regulatory requirement. It should be 
noted that supplementation of media 
with exogenous protein beyond the 
manufacturer’s recommendations 
could change the composition and 
performance of media.
A majority of the practising embryologists 
in the group expressed a belief that 
manufacturers should provide the 
formulations of culture media based on 
the need for a consensus regarding what 
constituent should be added to a culture 
medium and at what concentration; 
there were concerns that undeclared 
constituents of a culture medium can 
lead to unpredictable harm to future 
generations. Several members of the 
consensus, including Dr Don Rieger, 
abstained from this discussion due to 
potential conflicts and for other reasons.
It was the panel’s opinion that there is 
currently insufficient evidence to support 
the addition of bioactive compounds, 
such as growth factors or complex 
proteins, to gamete and embryo culture 
medium, and that safety and efficacy 
studies are required before their routine 
inclusion.
IVF laboratories must have policies 
and SOP to verify acceptability for 
receipt and use of all contact materials, 
in accordance with best practice and 
local regulations. This includes keeping 
permanent records of certificates of 
analysis, and lot/batch numbers. The 
laboratory should monitor ongoing 
performance of these materials.
Culture media – sequential or ‘single-
step’ media for embryo culture
A recent Cochrane Review (Youssef 
et al., 2015) concludes that there are no 
differences in outcomes between the 
two culture systems, and this conclusion 
is supported by other systematic reviews 
(Dieamant et al., 2017; Sfontouris et al., 
2016). However, Sfontouris et al. (2016) 
concluded that: ‘Although using a single 
medium for extended culture has some 
practical advantages and blastocyst 
formation rates appear to be higher, there 
is insufficient evidence to recommend 
either sequential or single-step media as 
being superior for the culture of embryos 
to days 5/6. Future studies comparing 
these two media systems in well-designed 
trials should be performed.’
The studies suggesting effects on 
mosaicism and follow-up cognition were 
judged to be of low quality. Further, the 
panel found no evidence of a difference 
between cleavage- versus blastocyst-stage 
transfer for cumulative pregnancy rates 
derived from fresh and frozen–thawed 
cycles following a single oocyte retrieval, 
but cautioned that the evidence for this 
outcome was very low quality.
Culture media – use and 
management/cold chain/storage
Culture media must be:
– stored refrigerated at 2–8°C (https://www.
cdc.gov/vaccines/hcp/admin/storage/
toolkit/index.html);
– kept away from light (and particularly 
direct sunlight);
– discarded when shelf life (i.e. expiry 
date) has been exceeded;
– labelled with expiry date and storage 
conditions; this information should 
also be on all product inserts;
– used in order of their lot/batch numbers
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Light: To protect gametes and embryos 
from exposure to potentially damaging 
wavelengths of light, use filters in 
microscopes to block ultraviolet. Relative 
to microscope illuminations, the effect of 
ambient light stress is low, and this could 
be taken into account when planning a 
new laboratory.
Temperature and transportation:
– Any culture medium that has been 
frozen must be discarded.
– Culture oil will not freeze but oil can 
show cloudiness, which usually reflects 
reduced solubility of water or other 
molecules at low temperatures; this 
should be reversible at ambient tem-
perature. If so, the oil does not need 
to be discarded.
Elevated temperature can lead to:
– Degradation through oxidation (relative 
loss of active ingredients).
– Amino acids and proteins may un-
dergo deamination (ammonium ions; 
main sources of ammonia are unstable 
monopeptides of glutamine and pro-
tein sources).
Refrigerated storage of culture media 
(https://www.cdc.gov/vaccines/hcp/admin/
storage/toolkit/index.html):
It was the consensus that IVF laboratories 
should use ‘clinical grade’ refrigerators 
with wire shelves for circulation, no 
closed bins, and no door shelves. The 
use of combined freezer/refrigerator 
units with no compartment control 
is discouraged. The efficiency of a 
refrigerator, in terms of maintenance of 
a stable temperature, is dependent on 
load, which should be in the range of 
30–80% of its storage capacity.
Independent monitoring and logging of 
refrigerator temperature is vital, using a 
certified, calibrated thermometer, with 
remote monitoring and automatic alarm.
Equipment monitoring and validation
Independent continuous monitoring 
of critical parameters of laboratory 
infrastructure and equipment is desirable 
at the very least, and is mandatory for 
some accrediting/licensing authorities.
Validation that the equipment performs 
as per its specifications is normally 
performed by the manufacturer or 
their agent, at the time of installation 
(‘Installation Qualification’). Verification 
of user requirement specifications 
and equipment performance is 
undertaken by the user after installation 
and before first use (‘Operational 
Qualification’) and again at regular 
intervals, including after servicing or 
repair (‘Performance Qualification’). In 
these cases, the purpose is to establish 
that the equipment’s performance is 
within accepted tolerance ranges of its 
specifications (ISO 15189:2012; Mortimer 
and Mortimer, 2015).
Culture medium validation and 
monitoring
There are different types of KPI that 
monitor different aspects of laboratory 
performance, as per the Vienna 
consensus (ESHRE Special Interest 
Group of Embryology and Alpha 
Scientists in Reproductive Medicine, 
2017).
Test equipment – calibration and 
certification
Test equipment for the laboratory and/
or culture environment should be 
certified and calibrated according to 
the manufacturer’s recommendations. 
In the absence of recommendations, 
calibrations should be conducted at least 
twice per year, or more often if required 
to ensure ongoing fitness for purpose.
Accurate pH measurements may be 
difficult to achieve due to calibration 
with buffers not designed for use at 37°C 
and therefore should be interpreted with 
caution. Point-of-care blood gas analysers 
with autocalibration function could 
provide more accurate measurements. It 
should be noted that blood gas analysers 
do not measure the pH of zwitterion-
buffered media reliably.
Sperm preparation for IVF
Spermatozoa for ART must be separated 
from the seminal plasma environment 
not only as soon as possible after 
ejaculation (allowing for liquefaction), but 
also as efficiently as possible (Björndahl 
et al., 2010; Mortimer, 2000). Depending 
on intended use, the spermatozoa 
are then suspended in culture media 
either capable of supporting in-vitro 
capacitation (e.g. for IVF) or not (ICSI).
For IVF sperm preparations a balance 
is required between achieving in-vitro 
capacitation and avoiding premature 
acrosome loss and sperm senescence 
that can occur in men who are ‘fast 
capacitators’ when their spermatozoa are 
incubated for prolonged periods under 
capacitating conditions. So, if there will 
be a long delay before IVF insemination 
(e.g. >2.5 h) then the prepared 
spermatozoa could be resuspended in 
modified medium (e.g. HEPES-buffered) 
and held at ambient temperature until 
about 2.5 h before insemination and then 
washed and resuspended in fertilization 
medium and incubated in a CO2 
incubator for the final 120 min before 
inseminating the oocytes.
Spermatozoa being prepared for ICSI 
can be processed and resuspended using 
a sperm ‘buffer’ because capacitation is 
irrelevant for fertilization using ICSI. The 
preparation should be held at ambient 
temperature to minimize ROS generation 
(e.g. in a Styrofoam box to protect it 
from light and cold drafts) until the ICSI 
dish is prepared.
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Introduction 
Intrinsic and extrinsic factors may affect the morphokinetics (developmental pattern/shape over time) of an 
embryo in vitro and these can be studied using time lapse imaging technology.  For example, aneuploidy  
can delay blastulation (Campbell et al, 2013 a,b) and culture conditions, such as gas composition and culture 
media, have also been shown to have an impact on morphokinetics (MK) (Meseguer et al 2012 ; Ciray et al., 
2012). For such reasons, the development of embryo selection algorithms in one clinic may not be 
transferrable to another setting, particularly if laboratory practice differs. Also, with a lack of consensus on time 
lapse annotation practice between clinics, inter-clinic differences in MKs, may even be artefactual. In a 
retrospective exercise, we previously demonstrated how a published time lapse model required  modification 
in order to improve clinical outcome for CARE Fertility patients and was not directly transferrable (Best et al 
2013). 
Objective 
As part of an embryo selection algorithm validation and implementation process, following the development 
of an algorithm in clinic M, we compared the distribution of five MK variables, used in our in –house developed 
models, from 859 ICSI blastocysts selected for transfer or vitrification. These variables were compared between 
three CARE Fertility clinics (L (15%), M (62%), N (23%)), with closely defined embryo culture practice and strict 
annotation policies, in order to establish whether the distributions of MKs were similar in selected embryos on 
three sites.   
 
  
Materials and Method 
The EmbryoScope™ time lapse imaging system and 
EmbryoViewer (Unisense Fertilitech, Denmark) was  
used to culture embryos, following ICSI, at 5%O2, 
5.5% CO2 and 89.5N2 at 37.0ºC.  
Images were captured every 10-15 minutes through 
7-9 focal planes during the culture period.  
Images were studied by embryologists and the time 
points that the embryo reached developmental 
milestones, degree of fragmentation, evenness and 
anomalies were recorded (annotated).  
MK variables compared 
Time of ICSI to 2 cells (t2); 5 
cells (t5); start of blastulation 
(tSB); full blastocyst (tB) and  
duration of second cell cycle 
(CC2). CC2=t3-t2. 
The distributions (median and 
quartiles) were compared 
between each pair of clinics, 
using Wilcoxon signed rank 
test.  
Figure 1. Time lapse images showing 




Performing inter clinic comparisons, along 
with retrospective testing of algorithms, is 
essential for effective use of embryo selection 
models and scrutiny of best clinical practice.  
 
The cause of variation in tB and CC2 median 
values in clinic L has been considered and 
may be due to a difference in selection of 
embryos for cryopreservation in clinic L 
compared to M and N. MK distributions for all 
(unselected) embryos and those with positive 
and negative outcome will be compared in 
further studies with larger data and may 
highlight other possible causes, such as 
patient profile or annotation practice, and to 
fine-tune algorithms. 
  t2 t5 tSB tB CC2 
Clinic L 24.5 47.8 95.7 107.8 10.5 
Clinic M 24.5 48.5 96.2 105.9 11.2 
Clinic N 24.9 48.8 95.2 108.9 11.2 





















7.0 General discussion 
 
7.1 Progress in relation to specific aims  
This thesis was largely successful in the pursuit of its specific aims, namely: 
1. A retrospective time lapse analysis of euploid and aneuploid human embryos was 
performed and significant differences in their morphokinetic profiles noted. Although 
morphokinetics is not diagnostic of aneuploidy, a classification model to rank embryos 
according to their risk of aneuploidy was nonetheless developed. 
2. The clinical relevance of this aneuploidy risk model was evaluated and put into clinical 
practice to aid non-invasive embryo selection with the aim of enhancing implantation 
and live birth rates. 
3. Probably the largest body of quality assured time lapse data with clinical outcomes, to 
date, was collated during IVF treatments to make novel observations and develop in 
house embryo selection algorithms. Their efficacy in predicting implantation and live 
birth rates was established to show a significant improvement on conventional 
morphological selection, benefitting many thousands of patients. 
4. A collaborative effort was undertaken to generate a multicentre outcome analysis that 
considered the limitations of a published and promoted time-lapse blastocyst 
prediction model. The main findings were that to adhere strictly to a specific algorithm 
predictive of blastulation could potentially result in the disposal of viable embryos, 
and that prediction of live birth was a more robust outcome measure to aim for.  
5. Finally, I successfully published several book chapters and engaged with the scientific 
community in the development of guidelines for the nomenclature and annotation of 
dynamic human embryo monitoring. Significant outcomes were also a set of IVF 




performance indicators, an “Atlas of time lapse embryology” and two consensus 
documents developing performance indicators and guidelines for IVF culture 
conditions. 
  
At the outset of this thesis, the most commonly used methods of ‘grading’ embryos were 
according to a range of microscopic, morphological criteria that were either semi-quantitative 
at best or highly subjective at worst. Moreover, all had varying degrees of reported 
correlation to viability and, as such, were largely unsatisfactory (Centre for Disease Control 
and Prevention, 2014). The embryo, once in vitro, is an independent entity, separated from 
the complexity of female physiology and on a somewhat predetermined metabolic path, with 
its parental-derived genetic make-up, and its maternal cytoplasm providing some 
predetermining features. The work encapsulated in this thesis has made significant advances 
in the examination of several aspects of these elements within its defined culture 
environment, allowing for the prospect of a more meaningful and quantitative assessment. 
  
The provision of such a quantitative assessment is perhaps the crux to the philosophy not 
only of this thesis, but of embryo selection in general. Essentially, we have two options: a 
binary option – the embryo is viable or non-viable; normal or abnormal. Or, a probability 
statistic; a ranking of one embryo over another, often based on putative data indicative of a 
particular propensity to implantation or delivery. A commentary by Mastenbroek and 
colleagues suggested that because all embryos can be frozen there is no need for embryo 
selection as this could “never lead to improved live birth rates” (Mastenbroek, et al 2011). 
They argue that as long as we can freeze and serially transfer all embryos – now that 
cryopreservation is efficient and endometrial receptivity is better understood – “the live birth 




rate per cycle can never be improved”. I would argue that the results herein encapsulated, 
largely dispel this notion. Efficient IVF is about maximising the chance of a live birth per single 
attempt – be that cycle started, egg collection or embryo transfer. Consideration must be 
given to patient welfare and most patients wish to avoid multiple visits to an IVF clinic – either 
for reasons of cost, social and emotional stress or all of these. Mastenbroek et al (2011) do, 
at least, concede that “the only parameter that could possibly be improved by embryo 
selection would be time to pregnancy”. Time, as all practitioners of reproductive medicine are 
aware, is a valuable commodity, it is inversely related to reproductive efficiency – indeed, it 
should be reduced at all cost. 
  
Selecting viable embryos at each attempt, therefore, ought to be beneficial to the patients 
for many reasons. Hence, for several decades, there has been determined work by scientists 
the world over to find ways to do this efficaciously. For embryo selection to be reliable and 
enduring, we require both the robust technology and its direct relevance to biological 
outcome to be established and constantly reassessed. 
  
7.2. Thoughts on embryo selection 
Arguably, the best means of embryo selection is non-invasive, either by harmless observation 
of the embryo itself or analysis of its environs. The information obtained should be precise, 
and preferably binary. Ranking is a more realistic approach but is always likely to create 
dilemmas and by definition reduced efficiency. Most biological data will inevitably be 
graduated, and therefore any ranking would need to generate highly correlative data for 
specific parameters. Ideally, data should be obtained independent of the influential 
reproductive tract. With all possible selection methods, patient cohort and the potential 




dysfunction of the endometrium, impaired decidualisation and engaging theories on embryo 
selection by endometrial stroma (Salker et al, 2010; Teklenburg et al, 2010) will compound 
the analysis of singular screening events ranking embryo viability. 
 
With regard to these criteria, we are currently faced with few useful technologies that can 
help practitioners make choices and patients achieve maximum success at each attempt. 
Currently, fully automated time lapse systems are not proven and validated as effective for 
embryo assessment and selection. There is, therefore, a reliance on manual assessment and 
annotation of time lapse image data, along with the possibility to derive algorithms in house 
(as described within this thesis) to provide a more precise, and non-invasive method of 
embryo assessment. 
 
7.3 Second opinions and training 
One of the key practical advantages of time lapse systems in the IVF laboratory is the facility 
to allow clinical embryologists to rewind, pause and review photographic frames in order to 
consider the detail and context of embryo development with flexibility and without 
interruption of embryo culture. The storage of images also allows them to be reviewed 
retrospectively in order to re-annotate or study in further detail. It can be particularly 
worthwhile to annotate additional variables, outside of standard operating procedure for a 
specific research interest or, for example, for embryos with known outcome only. This has 
been demonstrated within this thesis and has provided clinical relevance and aided the search 
for morphokinetic biomarkers for the ultimate outcome measure – healthy live birth.  
 
 




7.4 Quality control and assurance 
As with many aspects of the embryologist’s role, there are practical and efficiency benefits if 
multiple individuals are trained and competent in routine daily tasks. Time lapse annotation 
is no exception and once introduced into the laboratory, review, annotation and 
interpretation of time lapse images can be considered a daily task. Where there are multiple 
practitioners involved, the risk of subjectivity and inconsistency is highest, although intra-
practitioner annotation variation may also exist. Ensuring the most accurate and objective 
record of dynamic, often anomalous, embryo development brings challenges whether using 
automatic detection software, solo or collective manual methods. In order to minimise 
subjectivity, key variables for annotation were defined within the standard operating 
procedure (SOP) developed and used within the research studies described within this thesis. 
In general, SOP in IVF laboratories should be based on published best practice guidelines, 
adhered to, monitored and refined where required. Core morphokinetic variables need to be 
identified and annotated from the outset, following rigorous training and competency 
assessment. Some morphokinetic variables are more at risk of subjective interpretation than 
others; the appearance of pronuclei and time of compaction, for example. The use of 
reference images can be beneficial in assuring annotation quality. 
 
The most commonly recorded morphokinetic variables follow the basic principles of 
embryology and mitosis and include timing of pronuclear appearance and fading, increasing 
cell numbers (time to 2, 3, 4, 5, 6 cells etc.) and times of embryo differentiation to the morula 
and blastocyst stages. Durations of mitotic cycles and synchronicity, can then be calculated 
from these. Additional to these, specific anomalies or associated phenomena can also be 
annotated, depending on the customisability of the time lapse system available. Once 




established, regular audit of annotation completion and quality and adherence to SOP is 
essential in order to maintain high quality data to allow analysis and opportunity for 
identification of significant selection or deselection morphokinetic criteria. 
 
There is evidence that many of the morphokinetic events are recorded objectively but it is 
critical that regular review and assessment exercises should be undertaken to assure quality. 
The work of Sundvall and colleagues demonstrated a close correlation between both 
experienced and new time lapse users for most morphokinetic variables but highlighted that 
some ‘static morphologic parameters’ such as multinucleation and blastomere evenness, 
remained at risk of subjectivity. With ongoing assessment, clear definitions and SOP, this can 
be minimised. In summary, best practice should ensure that time lapse culture dishes or slides 
are prepared in a standard and precise fashion, and that annotation of time lapse images, 
where performed manually, is performed with objectivity by all practitioners, audited and 
quality assured. 
 
7.5 Flexibility and opportunity 
Due to the great interest in time lapse technology by professionals in the field of IVF, 
promising clinical results, opportunities to broaden knowledge of the preimplantation 
embryo’s development and its visual nature; which appeals to clinic staff and patients, swift 
advances in this technology and the application of it are inevitable. Computer servers, rather 
than standalone devices allow the support of new applications such as a patient interface, 
improved data collection, secure data storage, sharing and remote access.  
 




Within this rapidly progressing and promising area of reproductive medicine, practitioners 
working with time lapse imaging have an additional and increasingly reliable tool for non-
invasively studying the human preimplantation embryo and importantly - for improving 
embryo selection (Pribensky et al., 2017). Despite it making practical and scientific sense to 
utilise this technology which without intervention, enables the collection of vast image and 
kinetic data for analysis alongside clinical outcomes, time lapse imaging is considered new 
and unproven by many, and there are calls for more large-scale randomised controlled trials 
(Armstrong et al., 2018). One of the main challenges with such trials is the differing clinical, 
laboratory and embryo selection practice, which may introduce skew and affect reliability of 
the findings. Several large fertility clinic groups have published their own positive experiences 
using time lapse and developed selection algorithms which have been validated in house and 
are in clinical use. Several commercially available generic algorithms are also available 
through time lapse device manufacturers (Fishel et al., 2018; Peterson et al., 2016). 
 
7.6 Morphokinetics and PGT-A 
Time lapse technology alone and in conjunction with PGT-A, has the potential to provide 
continuously improving embryo selection algorithms which could incorporate numerous 
criteria resulting in algorithms defined for a range of varying circumstances, from individual 
patient criteria to generalised laboratory conditions. In time, the optimal ranges for defined 
dynamic events such as those directly associated with the ‘normal’, or euploid, cell cycle, may 
be elucidated and further novel morphokinetic markers of embryo viability identified (Gallego 
et al., 2019).  
 
As mentioned above, the ultimate embryo selection tool will be reliable, reproducible, cost 




effective, proven, non-invasive and have direct clinical relevance. When considering these 
ideals alongside standard morphological parameters, this routine practice is somewhat 
limited by subjectivity and reproducibility. IVF professionals continually search for alternative 
or complementary technologies to enable improved embryo selection and, given that 
chromosome constitution is critical to successful outcome, selection for euploidy is 
increasingly sought. The most reliable method for selection of euploid embryos is currently 
PGT-A. Several studies using time lapse imaging in vitro (including, significantly, in this thesis) 
have looked at the precise patterns and timings of preimplantation embryo development in 
relation to chromosome abnormality and studied whether aneuploid and euploid embryos 
have different morphokinetic profiles. As a result of this thesis and other studies, 
morphokinetic profiling has been proposed as a method to increase the probability of 
selecting chromosomally normal embryos, non-invasively, and also to classify an embryo’s 
risk of aneuploidy.  
 
As early adopters of time lapse for clinical IVF, Campbell and colleagues, considered whether 
there was a difference in the morphokinetics of euploid and aneuploid embryos, by 
comparing data from blastocysts which had undergone PGT-A (Campbell et al., 2013). This 
work did not identify any early morphokinetic markers associated with ploidy, as Chavez had 
done, and Basile went onto do. However, as is discussed in detail in section 2.0 of this thesis, 
from more than 20 variables compared, Campbell’s group detected significant peri-
blastulation delays in aneuploid embryos, compared with sibling euploid counterparts at the 
start of compaction (tSC), start of blastulation (tSB) and to the full blastocyst stage (tB). The 
authors devised an aneuploidy risk classification model based on their findings, incorporating 
the two most significant morphokinetic variables. 





The clinical effectiveness of this model, was retrospectively evaluated for the potential impact 
on unselected IVF patients not undertaking PGT-A, as discussed in detail in section 3.0 of this 
thesis. In summary, following the transfer of 88 blastocysts, embryo fate, up to live birth, was 
compared according to calculated aneuploidy risk classes (low, medium, high). A significant 
difference was seen for implantation and live birth ratios between embryos classified with 
low and medium risk for aneuploidy, with relative increases of 74% and 56%, for embryos 
within the low risk class, compared to overall ratios, for foetal heart beat and live birth 
respectively (Campbell et al., 2013b). This study demonstrated, albeit on a small scale, the 
potential clinical relevance of such aneuploidy risk classification and introduced a novel, non-
invasive method of embryo selection to yield higher implantation and live birth rates. This 
model was fine-tuned with a larger dataset and also assessed according to female age. This is 
discussed in more detail in section 3.0 of this thesis (Campbell et al., 2014). 
 
There was some criticism of this aneuploidy risk classification model by Ottolini et al., who 
proposed that the delays observed in the aneuploid cohort were not the result of aneuploidy, 
but rather associated with maternal age (Ottolini et al., 2014). Campbell, however, published 
further analyses, in response, which described how age alone could not account for the 
different proportions of euploid embryos with advancing maternal age, and suggested that 
embryo ploidy is a key factor controlling human embryo morphokinetics. This debate is 
discussed in more detail within section 2.0 of this thesis (Campbell et al., 2014). 
More recent larger scale studies described within this thesis further demonstrate that 
morphokinetic algorithm ranking correlates to blastocyst ploidy. 
Figure 4 summarises an in house unpublished analysis of over 1500 PGT-A embryos at CARE 




Fertility and demonstrates that top scoring ‘A’ embryos (according to the morphokinetic 
algorithm described within the published manuscripts detailed within this thesis) are 
significantly more likely to be euploid than the lower scoring embryos ‘B’ or ‘C’ (Figure 3). 
 
 
Figure 4: CARE Fertility unpublished data demonstrating that top morphokinetic grade (A) 
blastocysts are significantly more likely to be euploid than lower grades (B and C) 
 
Time-lapse imaging is unlikely to ever be as absolute at elucidating ploidy from biopsied cells, 
or perhaps even by non-invasive PGT-A, but it is an important tool, which when utilised with 
precision and consistency, has been reported to enhance the chances of selecting an embryo, 
from a cohort, most likely to result in a live birth following IVF by non-invasive means (Fishel 
et al., 2019). It may also prove to be a useful tool for ranking or prioritising embryos for PGT-
A, and for assisting in setting patient expectations, or for selecting between euploid embryos. 
Whilst euploidy is a requirement for optimal healthy live birth outcome, there are many 
additional factors necessary within the embryo itself, and maternally, to ensure successful 
** 
** 




outcomes in ART and it is expected that time-lapse imaging, amongst other viability embryo 
assessment methods, will increasingly be used, in ART settings, in combination with PGT-A 
(Figure 5).  
 
 
*Some circumstances may warrant mosaic embryo transfers 
Figure 5: Proposed strategy incorporating PGT-A and time lapse monitoring (TLM) in ART 
 
7.7 Future work 
At CARE Fertility, we have compiled a database of over 500,000 fully annotated human 
embryos along with their fate (discarded, vitrified, transferred), and the clinical outcomes of 
over 10,000 time lapse annotated embryos, which have been transferred, and have a known 
outcome (implanted; ongoing clinical pregnancy; live birth; biochemical pregnancy; 
miscarriage). These data can also be linked to patient demographic, medical history, 
medication, laboratory treatment, providing huge potential to conduct further studies.  
 




The future of IVF will almost certainly involve automation of time lapse image assessment, in 
real time, with degrees of certainty set by practitioners and used for discussions with patients 
and clinical decision making. It is hoped that this level of standardisation supported by large 
datasets will result in increased reliability in embryo selection and improved clinical 
outcomes, with shorter times to delivery of healthy babies for IVF patients.  
 
Image analysis and artificial intelligence (AI) technologies are developing rapidly and it is likely 
that alongside automated assessment, semi or fully-automated AI objective algorithms will 
be introduced within IVF facilities over the next few years to further enhance clinical 
outcomes for patients by improving accuracy and objectivity. 
 
7.8 Personal perspectives  
 When I was first introduced to time lapse imaging, and set about introducing it into the IVF 
laboratories which I oversee, I could hardly imagine how much it would impact patient 
treatments and our understanding of the nuances and patterns of the early human 
preimplantation embryo’s development. The concept of time lapse is not new, it has been 
used by cinematographers for many decades, but it had not been available for routine clinical 
IVF until around 2011, when the EmbryoScope was introduced into our laboratory in 
Manchester. The first time lapse videos of embryos made a huge impression on the 
embryology team and wider staff, and the fact that the developing embryos remained 
undisturbed gave a more stable incubation, and enabled new flexible approaches in the 
laboratory. Patients were, and still are, thrilled to be able to receive time lapse videos of their 
embryos; starting their photo album of their baby sooner than ever before.  
 




The main achievement of this thesis is that it has contributed to an evidence-based scientific 
framework through which time lapse monitoring can be structured and standardised in order 
to generate precise morphokinetic data, demonstrating differences in the development of 
viable embryos, upon which selection algorithms can be derived and applied to enhance 
outcomes for IVF patients.   
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9.1 Appendix 1 
9.1.1 Log of media activity (radio, tv and articles) starting with the publication of the 
aneuploidy risk classification model described within section 2 of this thesis.  
 
  




9.1.2 The thesis author, Alison Campbell, with the UK’s first baby in her arms and also on the 
screen (Bella) following the implementation of time lapse imaging for embryo selection 











9.1.3 Section from Reproductive BioMedicine Online Editor’s report of 2017 showing the two 









9.2 Appendix 2 
A selection of posters by the author and colleagues, associated with the work described 
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Abstract 
Time lapse imaging of the preimplantation embryo allows embryologists to make more precise measurements of events in embryo development 
compared to the discontinuous methods most commonly used. The EmbryoScope™ was used to capture images every 20 minutes and in 7 focal 
planes throughout the culture period. 
 
The time of the first cleavage to 2 cells (t2) was compared to oocyte ploidy following array CGH of the first polar body in 92 normally fertilised 
oocytes (2PNs). Of the 50 embryos developed from aneuploid oocytes, the mean t2 was 26.42hpi (min 19.27, max: 39.63). Of the 30 embryos 
developed from euploid oocytes, mean t2 was 26.38hpi (min 20.48, max 34.15). The polar bodies of the remaining 12 embryos did not amplify and 
so ploidy status was unavailable. Mean t2 for these was 25.87 (min 21.49, max: 30.48) 
There appears to be no difference in the timing of the first cleavage of embryos developed from oocytes inferred as euploid or aneuploid 
following first polar body biopsy and aCGH. Our study continues the search for such non invasive temporal morphokinetic indicators of oocyte 



















































Time lapse monitoring using the EmbryoScope 
The EmbryoScope exists of an in-built tri-gas incubator with HEPA and active carbon filters with a 
20x HMC custom-made Leica objective providing a resolution of 3 pixels per µm. The 
EmbryoScope is connected to the Viewer; a Mac computer with EmbryoScope software and 
internet link. 
The EmbryoScope allows ‘continuous monitoring’ of embryo development using time lapse 
microscopy at multiple focal planes. It can be set to take images at different time intervals and 
through different planes so that the user can view these images and focus through planes of the 
oocyte or embryo. Images are viewed individually as stills or as a video which can be rewound, 
played or paused. Annotation of morphokinetic events are performed by the Embryologist and 
these data collected and organised using the software. 
The EmbryoScope accommodates up to 72 embryos -  6 patient 'slides' each containing up to 12 
embryos in micro-wells approximately 250um in diameter.  
 
Aim of the Study 
To investigate whether  there  is a difference between the timing of the first cleavage (t2) following the fertilisation of oocytes inferred to be 
aneuploid or euploid, following polar body removal and array CGH. 
Results 
Following ICSI and first polar body removal, normal fertilisation occurred in 166 
oocytes (2PNs).   
Of the 77 embryos developed from oocytes inferred to be aneuploid, the mean 
t2 was 26.14hpi (stdev 3.40, min 19.27, max: 37.96).  
Of the 60 embryos developed from oocytes inferred to be euploid, the mean t2 
was 26.43hpi (stdev 3.92, min 20.47, max 39.07).  
The polar bodies of the remaining 29 embryos did not amplify and so ploidy status 
was unavailable. Mean t2 for these was 25.13 (stdev 4.36, min 7.97, max: 34.49). 
Data were compared using 2 sample t-test. 
Method 
Following ICSI and first polar body biopsy, oocytes were placed into EmbryoScope slides and cultured in the EmbryoScope until embryo transfer 
or cycle cancellation. Time lapse images  were viewed and annotated for first cleavage t2, and further developmental  morphological and 
kinetic events, by an experienced embryologist and the data reviewed retrospectively and according to oocyte ploidy inferred by array CGH 
of the first polar body.  
Conclusion 
There appears to be no difference in the timing of the first cleavage of  
embryos developed from oocytes inferred as euploid or aneuploid following first 
polar body biopsy and array CGH, p=0.7.  
Our study continues the search for such non invasive temporal morphokinetic 
indicators of oocyte and embryo ploidy.   
The use of live birth as an outcome measure for a new 
morphokinetic based blastocyst selection algorithm
Rachel Smith1, Alison Campbell1,3,4,5, Mette Laegdsmand2, Sue Montgomery3;  Louise Best3;  Samantha Duffy3, Davina 
Hulme 4, Devi Sivanantham5, Lucy Jenner 4, Lynne Nice 5and Simon Fishel 1,3,4,5.
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Introduction
Time lapse monitoring (TLM) allows the detailed comparison of morphokinetic variables between embryos, according 
to their fate following transfer. Data can be used to develop clinical evidence-based embryo selection algorithms. To 
date only a few embryo selection models have been published and it has yet to be established whether models are 
transferrable between centres. The only published morphokinetic model for blastocyst selection was based on 
aneuploidy risk classification (Campbell et al 2013). This new model introduces live birth outcome from transferred 
blastocysts.
Participants/materials, setting, methods 
Morphokinetic variables and outcome to fetal heart beat (FHB) n = 314 or to live birth (LB) n =80, for ICSI embryos 
following blastocyst transfer, were measured and annotated using EmbryoScope™ (Fertilitech, Denmark). Data were 
collected between May 2011 and August 2013. Time, in hours from pronuclear fading (pnf) to - all cleavage stages 
(relt2 to relt9); morula formation (reltM); start of blastulation (reltSB) and full blastocyst (reltB) were annotated using the 
EmbryoViewer software. The prefix ‘rel’ means that the variable is measured from PN fading to devise a model 
applicable to both IVF and ICSI. Where the number of transferred embryo(s) at least equaled the number of FHB(s) or 
LB(s), known implantation data (KID)of all embryos per treatment was positive, otherwise negative. KID rates were 









A Not grade C & 
reltM>= 52.6h and < 
61.4h
89 64% 39 71%
B Not grade C & 
reltM < 52.6 h or reltM >= 
61.4H
128 39% 24 38%
C reltSB>= 75.8h 97 11% 17 8%
Results
An algorithm was derived using recursive partitioning of 
KID (based on FHB and LB) which ranked embryos 
according to their implantation potential calculated using 
KID rate (KID positive/(KID negative + KID positive) x 100. 
From 10 studied variables two were found to be significant  
reltM and reltSB. The Blastocysts were classified from A – C.
Conclusion
Two morphokinetic variables (time to morula and start of blastulation both from PN fading) were found to have 
significant effect in a tree model of the implantation potential of transferred blastocysts, defined by foetal heart beat 
(FHB) and live birth (LB). The importance of  reltSB corresponds to earlier published models where tSB was identified as a 
strong predictor for implantation potential (Campbell et al .,2013). The model is to be used for prospective clinical 
evaluation of embryos transferred after 96hrs post insemination. This model can be applied to both IVF and ICSI cycles by 
using the relative time from pronuclear fade widening the scope of the model. Care must be taken as selection models 
may not be transferrable to different clinic settings without adaptation ( Best et al., 2013)
LB ROC AUCFHB ROC AUC
Definitions
tpnf - Time to PN fade
tM - Time to Morula
tSB - Time to start Blastulation
rtSB - (tSB-tpnf)
rtM - (tM-tpnf)
KID – Known implantation data
FHB- Foetal Heart beat
LB – Live birth
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Methods – Annotation of morphokinetics
Mean values in hours(h) and standard deviations 
were calculated for the following: 
pronuclear fading (PNf);  
time to 2 cells (t2) from PNf (d1); 
Cell cycle lengths - t3-t2 (cc2a); t5-t4 (cc3a); 
Synchronicity of divisions - t4-t3 (s2); t8-t5 (s3); 
Duration of late stages (time to start compaction 
(tSC) from t8) (dLS); 
Duration of compaction (dCom) and blastulation 
(dB).
Large scale comparison of morphokinetic timings of over 12,500 IVF and ICSI 
embryos from insemination to blastulation. 
Alison Campbell1; Mette Laegdsmand2; Simon Fishel1; Rachel Smith1; Sue Montgomery1; Kathryn 
Berrisford1; Rob Smith1; Lynne Nice1 and Darren K Griffin3.
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Introduction
Time-lapse imaging has now been widely introduced in IVF clinics across the world. It is considered, by many, to be a superior tool, than morphology
alone, for embryo selection and a recent randomised controlled trial has provided clinical validation (Rubio et al 2014). Several studies have 
compared the precise timings and durations, which embryos reach specific cleavage stages and developmental milestones, between transferred 
embryos resulting in successful pregnancy, or birth outcome, with those which failed to implant. Such morphokinetic studies have identified significant 
differences in timings of specific variables and identified these as candidates for embryo selection criteria and developed algorithms in order to 
improve the chance of selecting a viable embryo. 
Information comparing developmental timings in IVF and ICSI embryos using time lapse imaging is limited although one study suggests that there 
exists an initial delay to early cleavage milestones, in IVF compared with ICSI, but that this is short-lived and that mean values for IVF embryos, 
reaching consecutive later cell stages, align with those of ICSI embryos after the 8 cell stage (Dal Canto et al 2012).
Time lapse imaging studies have demonstrated that ICSI embryos display earlier times ,from insemination, to first cleavage than conventional IVF 
embryos (Lemmen et al 2008; Dal Canto et al 2012).  Such a difference could not be detected using standard IVF laboratory practice, of course. This 
difference in timings can probably be attributed to the time for fertilisation to occur; taking longer for IVF due to the time required for sperm binding 
and internalisation.  An adjustment factor, to allow for this, if known, may provide additional accuracy and avoid current, and potentially flawed, 
practice which often involves comparison of absolute time-points (such as time to reach two cells (t2) or three cells (t3) between IVF and ICSI 
populations. An alternative approach, which has been utilised,  may be to  compare intervals between these time points (such as CC2; t3-t2) . 
Methods – embryo imaging and culture
Morphokinetic data was retrospectively collected from 12,939 embryos 
using EmbryoScope™ time lapse imaging from multiple sites using 
standardised laboratory practice and culture conditions (5%O2; 
5.5%CO2), between May 2011 and December 2013. Insemination times 
were recorded: IVF time when gametes were mixed and ICSI time 
midway through the ICSI procedure.
Figure 1: Schematic of morphokinetic variables from Atlas of Time Lapse 
Embryology
Results
A difference in means of 2.3h between ICSI and IVF 
was observed in PNf. The mean (h) and standard 
deviation (in brackets) for ICSI and IVF PNf was 
23.7(5.1) (n=9619) and 26.0(4.2) (n=3320) 
respectively. The delay was maintained as ongoing 
morphokinetics were similar , with no significances 
found, when comparing cell cycle, synchronicity 
and durations through to blastulation. Mean values 
and standard deviations were respectively as 
follows for 
ICSI: d1 3.0(2.4); cc2 9.2(5.2); S2 2.7(4.8); cc3 
9.5(6.6); S3 11.3(9.1); dLS 28.6 (11.2); dCom 12.3 
(7.7);  dB 11.2 (5.5) and
IVF: d1 3.3(2.6); cc2 9.3(4.8); S2 2.7(5.1); cc3 
10.1(6.6); S3 11.0(9.1); dLS 28.1 (10.2) ;dCom 10.3 









d1 CC2 S2 CC3 S3 dLS dCom dB
IVF (hrs)
ICSI (hrs)
Figure 2: Graph of mean morphokinetic timings of IVF and ICSI 
embryos
Conclusions
Morphokinetic algorithms, in order to be applicable to 
both IVF and ICSI embryos should avoid using time of 
insemination (t0), or direct derivatives of this, to assure 
accuracy. Durations, or relative time from pronuclear 
fading, provide more reliable variables for time lapse 
algorithm development considering the inevitable, 
but now measurable, delay in IVF embryos observed 
up to pronuclear fading. 
References. 
Dal Canto M, Coticchio G.,et al. Cleavage kinetics analysis of human embryos predicts development to blastocyst and 
implantation. Reprod Biomed Online. 2012;25(5):474-80.  
Lemmen JG, Agerholm I, et al. Kinetic markers of human embryo quality using time-lapse recordings of IVF/ICSI-fertilized 
oocytes. Reprod Biomed Online. 2008;17(3):385-91.
Rubio I, Galan et al. Clinical validation of embryo culture and selection by morphokinetic analysis: a randomised 
controlled trial of the EmbryoScope. Fertility and Sterility. 2014: 102(5):1285-1294
Atlas of Time Lapse Embryology edited by Alison Campbell and Simon Fishel, CRC Press 2015. ISBN: 978-1-4822-1446-8
Outcomes - Late morphokinetics (Fig.2) 
7 abstracts additionally considered late morphokinetics.  
5 (71%) reported peri-compaction and/or blastulation 
initiation and completion delays in aneuploid embryos 
compared with euploid, 2 (29%) found no differences. 
Significant peri-blastulation delays in aneuploid embryos 
were found in one original article but not in another.  
 
Difference reported are highlighted in the figures below 
Ploidy, morphokinetics and time lapse imaging: The story so far. 
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Introduction 
 
Time-lapse imaging has the potential to be either complementary or even an alternative option to PGS; it is reported to 
improve the chances of viable or euploid embryo selection. Here, we review, categorise and summarize scientific 
material (2012-2014) using citation databases and conference proceedings that consider the association between 
embryo ploidy and morphokinetic criteria, revealed by  time lapse imaging. A brief overview of studies is provided and 
common or conflicting findings highlighted and discussed.  
Aneuploidy in preimplantation embryos is a leading cause of IVF failure. Preimplantation genetic screening can be used 
to infer embryo ploidy following biopsy. However PGS has limitations of accessibility, acceptability, invasiveness and cost. 
Embryo morphology remains the most commonly used embryo selection criterion in IVF treatment. Non invasive markers 




21 relevant studies were identified.17 abstracts compared pre-compaction (early) parameters in euploid and aneuploid 
embryos. Seven abstracts additionally considered late morphokinetics ,according to embryo ploidy. Four original articles 
were identified.  
Outcomes - Early morphokinetics (to 8 cells) (Fig.1) 
Five abstracts from 17 (29%) reported significant differences in morphokinetics of 
euploid and aneuploit embryos. Aneuploid embryos had increased multinucleation (2 
studies); more irregular cleavage (one study); prolonged transition 2 to 4 cells (one 
study) and 5 to 8 cells (one study), compared with euploid. The remaining 12 (71%) 
abstracts reported no differences in early morphokinetics. 
Two original articles considered early morphokinetic parameters of aneuploidy. One 
reported faster times to 5, from 2 and 3 cells in aneuploid embryos. The other 
concluded that cell cycle (prolonged first, and time between first and second 




Findings from the multiple small investigations into ploidy and morphokinetics, presented as abstracts, are mixed. When 
considering early cleavage stage associations with ploidy, most studies did not report differences whereas, most of the abstracted 
data looking at later developmental associations did find delays in aneuploid embryos compared with euploid. Numbers remain 
small however and consensus has not been reached. Original articles, in this area, also remain few and findings are conflicting. 
 
Associations between morphokinetics and ploidy require careful interpretation due to lack of consensus for definitions, variable 
PGS methodologies, sample sizes and time lapse devices used. Larger studies are needed but time lapse imaging remains a 
promising tool to enhance clinical outcome.  
Figure 1. Reported early markers of embryo ploidy.  Figure 2. Reported late markers of embryo ploidy  
Full reference list available upon request 
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Abstract 
Time lapse imaging of the preimplantation embryo allows embryologists to make more precise measurements of events in embryo development 
compared to the discontinuous methods most commonly used. The EmbryoScope™ was used to capture images every 20 minutes and in 7 focal 
planes throughout the culture period. 
 
The time of the first cleavage to 2 cells (t2) was compared to oocyte ploidy following array CGH of the first polar body in 92 normally fertilised 
oocytes (2PNs). Of the 50 embryos developed from aneuploid oocytes, the mean t2 was 26.42hpi (min 19.27, max: 39.63). Of the 30 embryos 
developed from euploid oocytes, mean t2 was 26.38hpi (min 20.48, max 34.15). The polar bodies of the remaining 12 embryos did not amplify and 
so ploidy status was unavailable. Mean t2 for these was 25.87 (min 21.49, max: 30.48) 
There appears to be no difference in the timing of the first cleavage of embryos developed from oocytes inferred as euploid or aneuploid 
following first polar body biopsy and aCGH. Our study continues the search for such non invasive temporal morphokinetic indicators of oocyte 



















































Time lapse monitoring using the EmbryoScope 
The EmbryoScope exists of an in-built tri-gas incubator with HEPA and active carbon filters with a 
20x HMC custom-made Leica objective providing a resolution of 3 pixels per µm. The 
EmbryoScope is connected to the Viewer; a Mac computer with EmbryoScope software and 
internet link. 
The EmbryoScope allows ‘continuous monitoring’ of embryo development using time lapse 
microscopy at multiple focal planes. It can be set to take images at different time intervals and 
through different planes so that the user can view these images and focus through planes of the 
oocyte or embryo. Images are viewed individually as stills or as a video which can be rewound, 
played or paused. Annotation of morphokinetic events are performed by the Embryologist and 
these data collected and organised using the software. 
The EmbryoScope accommodates up to 72 embryos -  6 patient 'slides' each containing up to 12 
embryos in micro-wells approximately 250um in diameter.  
 
Aim of the Study 
To investigate whether  there  is a difference between the timing of the first cleavage (t2) following the fertilisation of oocytes inferred to be 
aneuploid or euploid, following polar body removal and array CGH. 
Results 
Following ICSI and first polar body removal, normal fertilisation occurred in 166 
oocytes (2PNs).   
Of the 77 embryos developed from oocytes inferred to be aneuploid, the mean 
t2 was 26.14hpi (stdev 3.40, min 19.27, max: 37.96).  
Of the 60 embryos developed from oocytes inferred to be euploid, the mean t2 
was 26.43hpi (stdev 3.92, min 20.47, max 39.07).  
The polar bodies of the remaining 29 embryos did not amplify and so ploidy status 
was unavailable. Mean t2 for these was 25.13 (stdev 4.36, min 7.97, max: 34.49). 
Data were compared using 2 sample t-test. 
Method 
Following ICSI and first polar body biopsy, oocytes were placed into EmbryoScope slides and cultured in the EmbryoScope until embryo transfer 
or cycle cancellation. Time lapse images  were viewed and annotated for first cleavage t2, and further developmental  morphological and 
kinetic events, by an experienced embryologist and the data reviewed retrospectively and according to oocyte ploidy inferred by array CGH 
of the first polar body.  
Conclusion 
There appears to be no difference in the timing of the first cleavage of  
embryos developed from oocytes inferred as euploid or aneuploid following first 
polar body biopsy and array CGH, p=0.7.  
Our study continues the search for such non invasive temporal morphokinetic 
indicators of oocyte and embryo ploidy.   
Results table 
Median values for the five variables and summary of 
differences between each pair of clinics (times in 
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Introduction 
Intrinsic and extrinsic factors may affect the morphokinetics (developmental pattern/shape over time) of an 
embryo in vitro and these can be studied using time lapse imaging technology.  For example, aneuploidy  
can delay blastulation (Campbell et al, 2013 a,b) and culture conditions, such as gas composition and culture 
media, have also been shown to have an impact on morphokinetics (MK) (Meseguer et al 2012 ; Ciray et al., 
2012). For such reasons, the development of embryo selection algorithms in one clinic may not be 
transferrable to another setting, particularly if laboratory practice differs. Also, with a lack of consensus on time 
lapse annotation practice between clinics, inter-clinic differences in MKs, may even be artefactual. In a 
retrospective exercise, we previously demonstrated how a published time lapse model required  modification 
in order to improve clinical outcome for CARE Fertility patients and was not directly transferrable (Best et al 
2013). 
Objective 
As part of an embryo selection algorithm validation and implementation process, following the development 
of an algorithm in clinic M, we compared the distribution of five MK variables, used in our in –house developed 
models, from 859 ICSI blastocysts selected for transfer or vitrification. These variables were compared between 
three CARE Fertility clinics (L (15%), M (62%), N (23%)), with closely defined embryo culture practice and strict 
annotation policies, in order to establish whether the distributions of MKs were similar in selected embryos on 
three sites.   
 
  
Materials and Method 
The EmbryoScope™ time lapse imaging system and 
EmbryoViewer (Unisense Fertilitech, Denmark) was  
used to culture embryos, following ICSI, at 5%O2, 
5.5% CO2 and 89.5N2 at 37.0ºC.  
Images were captured every 10-15 minutes through 
7-9 focal planes during the culture period.  
Images were studied by embryologists and the time 
points that the embryo reached developmental 
milestones, degree of fragmentation, evenness and 
anomalies were recorded (annotated).  
MK variables compared 
Time of ICSI to 2 cells (t2); 5 
cells (t5); start of blastulation 
(tSB); full blastocyst (tB) and  
duration of second cell cycle 
(CC2). CC2=t3-t2. 
The distributions (median and 
quartiles) were compared 
between each pair of clinics, 
using Wilcoxon signed rank 
test.  
Figure 1. Time lapse images showing 




Performing inter clinic comparisons, along 
with retrospective testing of algorithms, is 
essential for effective use of embryo selection 
models and scrutiny of best clinical practice.  
 
The cause of variation in tB and CC2 median 
values in clinic L has been considered and 
may be due to a difference in selection of 
embryos for cryopreservation in clinic L 
compared to M and N. MK distributions for all 
(unselected) embryos and those with positive 
and negative outcome will be compared in 
further studies with larger data and may 
highlight other possible causes, such as 
patient profile or annotation practice, and to 
fine-tune algorithms. 
  t2 t5 tSB tB CC2 
Clinic L 24.5 47.8 95.7 107.8 10.5 
Clinic M 24.5 48.5 96.2 105.9 11.2 
Clinic N 24.9 48.8 95.2 108.9 11.2 
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Introduction 
 Culturing human embryos in an incubator that incorporates time lapse microscopy enables embryologists to observe, record and analyse 
standard and novel developmental parameters without removing them from the controlled environment.  
The EmbryoScopeTM (Unisense Fertilitech, Denmark) is a tri-gas incubator with built-in camera, designed to automatically acquire images of 
embryos at specific time points.  Images are taken several times per hour through multiple focal planes using a 20x Hoffman Modulation contrast 
objective. This novel incubation system enables simultaneous monitoring of up to 72 embryos with virtually uninterrupted culture conditions.  
Divisional events and morphological appearance  can be reviewed and such variables annotated using the EmbryoViewer workstation, 
enabling embryologists to compile a dynamic morphokinetic history of each embryo. These variables can be compared between transferred 







Image Acquisition and Annotation.  
The built in microscope was used to acquire images of each 
inseminated oocyte every 10-20 minutes through 7 focal planes. The 
EmbryoViewer® image analysis software was used to log and display 
the precise timing and detail of developmental events both 
automatically and as they were annotated by the embryologists 
studying the time-lapse images. All annotations were made prior to 
embryo transfer and the outcome of treatment being known and 
therefore were blind to implantation outcome. Of 2365 standard ICSI 
embryos, 400 were transferred at <96 hpi and 121 embryos >/=96hpi. 
The variables tabulated above in table 1 were compared. 
Known Implantation Data value (KID)  
KID was defined for each embryo from the number of successes 
(either as the number of gestational sacs (GS), number of foetal heart 
beat (FHB) or number of live born (LB)). The value of KID was 1 if the 
number of successes was equal to or exceeded the number of 
transferred embryos for that particular treatment. The value of KID was 
0 if the number of successes was zero. The KID ratio (calculated as the 
number of embryos with known implantation/birth divided by the total 
number of transferred embryos with known implantation) does not 
reflect the overall success rate. KID-ratio is lower than the implantation 
rate with multiple transfers.  
Figure 1: The EmbryoscopeTM and  
EmbryoSlideTM incubation trays 
Results 
Table 2. The mean implantation rate (IR) (calculated as the number of embryos that 
implanted to produce foetal heart beat divided by the number of embryos 





Table 3. The KID ratio and the number of embryos in each group of the early and late 











Fisher’s test was used for significance of KID-R of  embryos within and outside the  group.  
Discussion 
Application of the exclusion criteria t2 > 32 hours and cc2 < 5 hours 
increased the KID-R from 0.12 (all) to 0.18 (selected) for early, and 
0.37 to 0.43 for late, transfers. For early ETs, this gives a significant 
difference in KID-R  between embryos deselected (excluded) by 
these criteria and those not. The difference in the late group is likely 
to be less significant due to the subset of embryos that reach this 
later developmental stage, in this better prognosis group. The 
improvement potential from using de-selection criteria may not be 
fully attainable in clinical practice due to lack of alternative 
embryos for some patients.  
Contact: Alison Campbell, CARE Fertility, 0115 8528100  Alison.Campbell@carefertility.com 
Variables Definition                                                                    Table 1 
t2 Time from ICSI to division to two cells completed (hours). 
t3 Time from ICSI to division to three cells complete d(hours). 
t4 Time from ICSI to division to four cells completed (hours). 
t5 Time from ICSI to division to five cells completed (hours). 
t8 Time from ICSI to division to eight cells completed (hours). 
cc2 The duration of the second cell cycle (t3-t2) (hours). 
cc3 The duration of the third cell cycle (t5-t3) (hours). 
MN2 Multinuclearity at the two cell stage (true/false) 
MN4 Multinuclearity at the four cell stage (true/false) 
1->3 Direct cleavage from one to three cells (cc2<5hours) 
2->5 Direct cleavage from two to five cells (cc3<5 hours) 
Materials and Method 
Data were obtained from EmbryoScopeTM  ICSI treatment at CARE Fertility, Manchester from May 2011 to October 2012.  Following ICSI, oocytes 
were placed individually in microwells of the EmbryoSlide in 25µl Global IVF medium (LifeGlobal®) supplemented with 10% Dextran serum 
supplement (Irvine Scientific), overlaid with 1.4ml mineral oil (Fertipro, Belgium) in the EmbryoScope™. These were cultured at 37°C in 5.5% CO2, 5% 
O2 and 89.5% N2 for up to 6 days. Culture was interrupted for a few minutes on day 3 to refresh the medium for cases for extended culture. Data 
was grouped according to the time of ET. ET <96 hours post ICSI (hpi) was considered ‘early’ and >/=96hpi, ‘late’ for the purpose of this analysis. 







< 96h 0.23 400 0.13 240 0.11 237 0.06 196 
>/= 
96h 




criteria definition ET < 96 hours ET >= 96 hours 
  KID-R n p KID-R n P 
  all 0.12 208   0.37 67   
1 t2 <= 32 hours 0.13 192 0.03 
* 
0.41 94 0.51 
ns   t2 > 32 hours 0.00 33 0.00 2 
2 cc2 >= 5 hours 0.14 168 0.04 
* 
0.42 83 0.55 
ns   1->3 (cc2 < 5 hours) 0.05 64 0.31 13 
3 cc3 >= 5 hours 0.13 180 0.14 
ns 
0.42 92 0.14 
ns   2 ->5 (cc3 < 5 hours) 0.03 32 0.00 4 
  not MN2 0.12 206 0.55 
ns 
0.41 87 0.73 
ns   MN2 0.06 31 0.33 9 
  not MN4 0.11 232 1 
ns 
0.40 96 - 
ns   MN4 0.00 5 - 0 
selected  
(not fulfilling any of the 
criteria 1 or 2) 
0.18 104 0.009 
** 






  deselected  
(fulfilling criteria 1 or 2) 
0.04 120 0.20 16 
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Introduction
The impact of female age on outcome of IVF is well documented and this has mostly been attributed to elevated rate of
aneuploidy with increasing age (1). Aneuploidy has been linked with delayed development of blastocysts, and there is
current debate regarding whether this may be confounded by age (2,3). Selection models based on the comparison of
morphokinetic variables have been used to develop clinical evidence-based embryo selection algorithms which to date
have not been age specific.
Study design 
A novel morphokinetic selection algorithm was
retrospectively applied to 795 transferred blastocysts of
which 502 blastocysts had known implantation data (KID
+ or -) (May 2011 to March 2014). KID+ is defined by foetal
heart at 6weeks +/- week.
Blastocysts were classified as low, medium or high
implantation potential. KID+ rates (KID+/KID+ plus KID – x
100%) for each class, were compared between four age
groups.
Blastocyst grading
Grade A blastocyst – high potential (n=159)
Grade B blastocyst – medium potential (n=185)
Grade C blastocyst – low potential (n=158)
Scored according to CARE Fertility in house algorithm
based on durations from pn fading to time of morula
stage and time to start blastulation.
Ages groups <30, 30-<35, 35-<40, >/=40
795 transferred blastocysts
Probability of having a Grade C blastocyst transferred is
significantly higher in the >40 group compared with the
<35 age groups combined: 42.4% vs 27.2% (p=0.05).
There is no significant difference between the percentage
of grade A+B blastocysts transferred between age groups.
Relative uplift in KID ratio with grading of embryo 
From 502 blastocysts with known implantation 
Transfer of grade A or B blastocysts, compared with
transfer of grade C, demonstrated relative increases in all
age groups, ranging from 83 to 301%. The relative uplifts
increased with advancing maternal age groups, however





















This work supports the use of a single morphokinetic
blastocyst selection model, irrespective of age.
The outcome measure used to evaluate the potential
impact of age on morphokinetics and hence to validate
the effectiveness of a novel model, was blastocyst
implantation. The optimal outcome measure is healthy live
birth and further work is required to strengthen this data
and evolve the model based on live birth.
Such models may not be transferrable between different
settings and confounders may exist.
It is necessary to validate models prior to use and to

















n= 49 n= 171 n= 189 n= 93
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Retrospective assessment of second polar body alignment 
using time lapse imaging 
 
Regueira M.; Cater E.; Jenner L.; Woodhead G.; Lynch C.; Campbell A.; Fishel S. 
CARE Fertility, John Webster House, 6 Lawrence Drive Nottingham Business Park, Nottingham NG8 6PZ 
Introduction 
 
Early episodes of embryonic development have been suggested to be 
related to later embryo quality and pregnancy outcomes 1, 2. One such 
episode is the extrusion site of second polar body (PB2) in relation to the 
first (PB1), which is not always adjacent 3. In a previous study the 
magnitude of the angle between PB1 and PB2 at fertilization check 
showed no significant difference for embryo morphological grade on 
day 2 after ICSI or IVF 2. Another study suggested that time of PB2 
extrusion is important for embryo implantation on day 3 transfers, but 
the position of extrusion is not 3.  
 
This study aims to analyse the relative position of PB2, at the time of 
extrusion, to PB1 and assess if it could be used to predict embryo 
development and implantation potential.   
Our results demonstrate that an increased distance between PB1 and 
PB2, at extrusion, is correlated with poor embryo quality morphokinetic 
markers, and with decreased positive hCG and clinical pregnancy 





Blinded retrospective analysis of bi-dimensional time-lapse imaging was 
performed on 212 embryos (141 ICSI cycles) with known implantation 
data (KID) (positive and negative), 120 embryos (56.6%) were 
transferred on day 3 (D3) and 92 (43.4%) on day 5 (D5) (Table 1). The 
study did not exclude any form of infertility presentation or age. 
Estimated measurement, using photographic time lapse images of the 
distance between PB1 and PB2 was recorded at the time of PB2 
extrusion (PB2ext), pronuclear appearance (PNa), and  pronuclear 
fading (PNf). Embryos were divided into four groups (pictorially 
demonstrated in figure 1).  
- 1 = PB2 adjacent to PB1 
- 2 = PB2 ≤ 45° to PB1  
- 3 = PB2 between 45°-90° to PB1  




The majority of PB2 were extruded within 45o of PB1. A non significant 










Embryos with a greater distance between PB1 and PB2 at PB2 extrusion 
showed a significant delay at tSB (P = 0.001) and tB (P = 0.004)(figure 2). 
Adapted embryo score based on morphokinetic parameters as 
described in Campbell et al. (2013) showed to be lower on day 5 for 
embryos whose PB2 was extruded more than 45° from PB1 (P < 0.001) 
(Figure 3). Also the analysis of PB2 movement demonstrates that 
embryos whose PB2 moved more than 45° following the extrusion have 
lower score on day 3 (P = 0.049) compared to these that do not (Fig 4).  
A significant difference between positive hCG rate (P = 0.02), and FHB 
per embryo transferred (P = 0.02) on embryos transferred at the 
blastocyst stage, was observed as the distance of PB2 increases from 
PB1 (fig 5).  
It was also noted that as distance between PB1 and PB2 increases, there 
was a trend to delayed tPNf, t2, t4, and shortened CC2. 
 
Conclusion and discussion 
 
The current study has demonstrated that, in a two-dimensional profile, 
but using focal planes to assess, embryos with a greater distance 
between PB1 and PB2 tend to have specific delayed morphokinetic 
previously associated with reduced embryo viability, and lower 
implantation rates at blastocyst stage. Further data is needed to 
consider whether this parameter can be incorporated into an embryo 
scoring systems or morphokinetic selection model.  
As only embryos of known implantation were analysed, the number of 
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PB alignment groups 1 2 3 4 NA P val 
N embryos (%) 124 (58%) 49 (23%) 21 (10%) 4 (2%) 14 (7%) 
Mean age ±SD 36.2 ±4.86 37.44 ±4.94 37.66 ±5.44 39.46 ±2.69 0.22 
D3 ET 68 31 12 2 
D5 ET 56 18 9 2 
Table 1; Number of embryos in each group at PB2 extrusion; mean age of woman in 
each group; number of embryos transferred on D3 and D5. 
Figure 1; Diagram of measurement of distance between PBs. Examples of oocytes in 
each group depending of PB2 alignment to PB1. Black arrows indicates PB1; White 
arrows indicates PB2. 






















































Figure 2; Comparison of tsB and tB between 
embryos in each PB2 group.  
Figure 3; Percentage of 
different quality blastocyst for 





















Figure 4; Percentage of 
different quality embryo on D3 
depending of quantity of PB2 



































Figure 5; Percentage of positive results of hCG and 
FHB after blastocyst transfer for embryos in each 
PB2 group.    
Kinetic events such as time of pronuclear fading (PNf), time to two cell 
(t2), second cell cycle (CC2), time to four cell (t4), time to start of 
blastulation (tsB) and time to blastocyst (tB), embryo grading based in 
morphokinetic parametres described in Campbell et al. (2013), and 
implantation were compared between the four groups. ANOVA, 
Student’s t-test and χ2 test were used to determine significance. P <0.05 
was considered to be significant. 
Effective use of preimplantation genetic screening following thawing, 
biopsy and re-vitrification of previously untested cryopreserved embryos. 
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Introduction 
Preimplantation genetic screening (PGS) has become a popular option 
for patients undergoing assisted reproductive treatment. Several studies 
showed that selecting euploid embryos for transfer, increases success 
rates, and reduces the risk of miscarriage and chromosomal 
abnormalities where clinically indicated. 
Recently, there has been an increasing interest for patients to perform 
PGS on embryos frozen in previous cycles, when PGS was not available 
or it was considered not necessary. However such a technique has not 
been implemented routinely in IVF clinics. 
This study analyses the effectiveness of performing biopsy on 
cryopreserved embryos.
Method 
207 blastocysts from 59 patients were warmed for PGS from January 
2016 to August 2017. If embryos survived, trophectoderm biopsy was 
performed as per routine protocol, and embryos were re-vitrified post-
biopsy. 
Samples were analysed for all the chromosomes with Next Generation 
Sequencing (NGS) and euploid embryos were replaced in single 
embryo transfers on subsequent ‘frozen’ cycles.
Outcome 
196 blastocysts (94.7%) survived the warming process and were 
considered suitable for biopsy.  
96% of the samples yielded conclusive PGS results, and 4% failed to 
give a result due to DNA quantity or quality. 63 of the embryos 
were reported euploid (32%).  
To date, 25 euploid embryos have been warmed, all survived, and 
were replaced in single embryo transfers, resulting in 13 clinical 
pregnancies (52%).
Discussion 
This small study suggests that PGS may be effective in enhancing selection of cryopreserved embryos. Our results 
support previous publications (1, 2) showing that double vitrification and biopsy does not seem to be detrimental. 
PGS on frozen embryos could be a viable option for patients with recurrent implantation failure, or for patients with a 
large number of embryos cryopreserved, with the aim of reduce the number of embryo transfers required to achieve 
a live birth.
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Euploid Aneuploid Mosaic No result




Several non time-lapse studies have reported faster human 
preimplantation in vitro development of male embryos 
compared with female, whilst others found no difference. 
However, studies have been limited by static daily, as 
opposed to frequent dynamic assessments, possible with 
time-lapse monitoring.  
Published time-lapse studies comparing morphokinetic 
timings, by gender are few, have contrary findings and are 
limited by the size of the datasets.  
Time lapse analysis of 1185 human blastocysts resulting in live birth to assess 
whether gender affects the timing of preimplantation embryo development. 
 
Alison Campbell, Louise Best, Rachel Smith, Kathryn Berrisford, Sue Montgomery, Audrey Wachter, 
Stacy Wheat, Fiona Foad, Lynne Nice, Ellen Armstrong and Simon Fishel. 
 
CARE Fertility Group, John Webster House, 6 Lawrence Drive Nottingham Business Park, Nottingham NG8 6PZ 
Methods 
Using EmbryoScope (Vitrolife, Sweden), all embryos were cultured and assessed similarly, using strict and quality 
assured time-lapse annotation practice and were selected for blastocyst transfer according to standard laboratory 
protocol.  
Mean timings for 14 preimplantation morphokinetic variables  of 1185 singly transferred blastocysts, from an unselected 
IVF patient population, resulting in 606 (51%) female and 579 (49%) male babies were retrospectively compared 
according to gender designated at birth.  T-test was used to assess significance.  
 
Results 
Definitions and mean timings ±sd, in hours post 
insemination, (female; male) were: Extrusion of second polar 
body [2.93±0.93; 2.91±0.93]; pronuclear appearance [6.79±1.73; 
6.61±1.72]] and fading [22.64±2.62; 22.71±2.67]; two to nine cells 
[t2: 25.40±3.23; 25.28±3.05], [t3: 36.07±3.70; 36.03±3.55], [t4: 
37.15±3.50; 37.04±3.70], [t5: 48.32±5.32; 48.41±5.09], [t6: 
50.21±4.84; 50.2±4.70], [t7: 52.23±5.51; 51.68±5.34], [t8: 55.18±6.97; 
54.66±7.17], [t9+66.68±7.28; 66.17±6.95]; morula [81.90± 6.68; 
81.58± 7.32]; start blastulation [91.35±5.69; 91.43±5.86] and full 
blastocyst [101.25±5.88; 100.74±5.98].  
72.2% of female and 69.4% of male babies resulted from 
ICSI. Mean patient ages delivering either female or male 
babies were 35.1±5.24 and 35.45±5.17 years.  
No significant differences were found between any of the 












This large retrospective analysis of gender specific human 
preimplantation development indicates that gender does 
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depending on their 
gender designated 
at birth? 





resulting in male or 
female babies 
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Morphokinetics of ‘Aneuploid’ and ‘Euploid’ human embryos,  
inferred by polar body or trophectoderm biopsy
Objective
To determine 
whether the ploidy 
of an embryo, 
determined by 
trophectoderm 
or polar body 




Following ICSI, 339 zygotes were cultured in a time lapse incubator (Embryoscope, Unisense, Denmark). The mean female age was 39+/-4 
years.  The morphokinetic timings [i.e. mean timing of second polar body (PB2) extrusion, cleavage to two-, three-, four-, five-, six- and eight-
cell stage, start of compaction, formation of morula and blastocyst, and hatching (hpi: hours post insemination)] was compared between 
embryos reported as aneuploid (n=167) or euploid (n=119) following Preimplantation Genetic Screening (PGS) by trophectoderm biopsy or 
polar body biopsy using either array CGH or SNP microarray analysis. ‘No result’ was defined as ploidy being unreported by the analysing 
laboratory. Where embryo ploidy was stated, this was inferred from oocyte or embryo ploidy, following polar body or trophectoderm biopsy, 
respectively. The second cell cycle (cc2) of an embryo was defined as the time it reached 3 cells minus the time that it reached 2 cells. 
Blastocyst rate was calculated as the proportion of cleaved embryos that reached blastocyst stage by 144hpi.  Normal embryo development 
was defined as sequential cleavage pattern with t5<70hpi, abnormal  development was defined as very short second or third cell cycles 
(<5hours) and slow was defined as undergoing first cleavage or cleavage to 5 cells (t5) very late (>32 and >70hpi respectively).  Embryos with 
slow or abnormal developmental patterns were removed from the data for analysis in fig 4 and 5 below, due to their distortive effect on the 
means. Data were presented as mean hpi+-standard deviation and the means for each stage of development were tested for significance 
using the paired t-test. Proportion data were tested for significance using the chi-square test. 
*  significant difference.
Further Work
Differences between euploid and aneuploid embryos are being observed in the timing of 
later developmental events and will be scrutinised as numbers increase. Further work will  
involve more detailed assessment of the second cell cycle length and embryo ploidy.
The ploidy status of the embryo in this study was inferred from analysis of either the polar 
body or the trophectoderm. When sample numbers are increased, these will be looked  
at independently.
Conclusion
Euploid and aneuploid embryos have similar morphokinetics, 
degree of fragmentation, evenness and multi nucleation. While 
aberrant morphokinetic parameters may indicate a higher 
probability of aneuploidy, morphokinetics parameters alone are 
not sufficient to ensure selection of an euploid embryo for transfer. 
PGS remains a more definitive tool for euploid embryo selection 








































































Euploid and Aneuploid embryos have similar:
>  Morphokinetic timings 
Stimulation protocol did  
not significantly affect the 
























The proportion of ‘No Result’ embryos with: 
  More than 75% fragmentation was greater 
(16%, n=44, p<0.05) than Aneuploid (5%, 
n=128)or Euploid (5%, n=93) embryos
2   Direct division from 1 to 3 cells  was 
greater(40%, n=42, p=0.03) than Aneuploid 
(18%, n=82) or Euploid (28%, n=120)
3
Results
  Two pronuclei were observed in 89% of 
Aneuploid embryos, 99% of Euploid embryos 







Aneuploid Euploid No Result 
3PN 2PN 1PN 0PN 
* 
Aneuploid Euploid No Result 
Fragm 75% Fragm 35% Fragm 15% Fragm 5% 
* 
Aneuploid Euploid No Result 
Direct Division 1 to 3 cells Normal 
* 
 Fig 2  Fig 3 Fig 1
With thanks to Niels Birger Ramsing for assistance with JMP data analysis
 Fig 4
Second cell cycle (cc2) is faster 
for aneuploid embryos than for 
euploid embryos (p=0.047)
5
Common (fragmentation and multinucleation) and novel markers of embryo 
development (irregular division, ‘direct’ or rapid cleavage from 1 to 3 or 2 to 5 cells 
and very slow development t2>32hpi, t5>70hpi) appear to be linked to a higher 



















>  Blastulation rate (43%, n=143 Aneuploid vs 40%, n=98 Euploid)
> Fragmentation at 2, 4 and 8 cell stages
> Cell evenness at 2, 4 and 8 cell stages
> Multinucleation 
>  Incidence of direct division from 1 to 3 cells and from 2 to 5 cells







A morphokinetic selection model designed for early 
cleavage stage embryos using live birth as the 
successful measure of outcome. 
 
Rachel Smith1, Alison Campbell2, Sue Montgomery3 , Rob Smith4, Lucy 
Jenner2, Lynne Nice5, Mette Laegdsmand6 
1 CARE Sheffield, 26 Glen Road, Sheffield S71RA 
2 CARE Fertility, John Webster House, 6 Lawrence Drive Nottingham Business Park, Nottingham, NG8 6PZ 
3 CARE Manchester , 108-112 Daisy Bank Road , Victoria park, Manchester, M145QH 
4 CARE London Park Lorne, 111 Park Road, London, NW8 7JL  
5 CARE Northampton, 67 The Avenue, Northampton, NN15BT 
6 Intus Analytics, Denmark 
References:Ciray,N., Campbell,A., Agerholm,I., Aquilar,J., Chamayou,S., Esbert,M., Sayed,S., 2014. Proposed Guidelines on the nomenclature and 
annotation of dynamic human embryo monitoring by timelapse user group. Hreprd 0, pp.1-11 
Herrero,J., Messeguer,M., 2013. Selection of high potential embryos using timelapse imaging: the era of morhokinetics. Fert and Steril 99, 4, 1030-1034. 
Rubio,I., Galan,A., Larreategui,Z., Ayerdi,F., Bellver,J., Herrero,J., Meseguer,M.,2014. Clinical validation of embryo culture and selection by morphokinetic 





A novel approach to creating a predictive algorithm based on live birth outcome derived from  linear combinations of morphokinetic 
variables for 713 early cleavage embryos using principle component analysis (PCA). 
Background 
Timelapse monitoring of embryos and the use of defined morphokinetic markers to improve embryo selection is well documented, (Herrero et al 
2013).  Published evidence that a model based on such markers can distinguish between embryos with different implantation potential, and 
significantly improve ongoing pregnancy rate over standard incubation,(Rubio et al 2015). 
This algorithm uses live birth outcome  in preference to foetal heart as the outcome measure of success for early cleavage (day 3) embryos. The 
algorithm can be applied to both IVF and ICSI cycles by adopting the corrective value (delta IVF); the time taken for the sperm to travel to the 
oocyte and penetrate the oolema. Principle component  analysis identifies variables within the data with a strong linear correlation that are 




Morphokinetic variables and 713  known live birth (LB) outcomes, following day 3 transfer, (positive 
or negative) for IVF and ICSI embryos were annotated using the EmbryoscopeTM (Vitrolife, 
Sweden) between 2012 and 2014. The validation data set of foetal heart outcome (n=519), from 
1.12.13 to 1.10.14 ,was used to validate the model built on the live birth training dataset.  
The principle component coefficients was derived from the training data set and recursive 
partitioning performed.  The following morphokinetic variables were used in the creation of the 
principle components in line with published guidelines for time lapse nomenclature (Ciray et al 
2014) : tPNF (time to PN Fading), cell division events of t2,t3,t4,t5, and dynamic events of 
dPN(tPNF-deltaIVF) where delta IVF equals 1.95hrs for IVF insemination and 0hrs for ICSI 
insemination, D1(t2-tPNf), CC2a(t3-t2), S2(t4-t3), CC3a(t5-t4) and cells D3(64) cell stage at 64hrs 
post insemination(hpi) see  figure1.  
Principle components (PC) are linear combinations of these variables. 
PC=a*dPN+b*d1+c*cc2a+d*s2…….. where a,b,c,d... are constant coeffiecients.  
 
This PCA results in 5 principle components (PC1 to PC5) which under went recrusive partitioning to 
classify the PC’s in a decision tree. To strenghten the classification model 5 fold validation (Figure 
2) was performed, reducing the classification set to PC1,PC2 and PC4.  The classification was  
validated against the foetal heart data not used in the model building (Figure 3). This produced 








Three classes were identified in the model (Figure 4) Class A =0.24 KID ratio, Class B=0.12 KID ratio and Class C= 0.067 KID ratio, with the area under 













This model is derived from data from known live birth outcomes. The model uses a novel  combinations of morphokinetic variables to generate  
principle components used in a predictive classification model. A model devised from live birth outcome may be seen as the ultimate measure 
for prediction of an embryo’s success but the model could be limited by patient factors such as the uterine environment which  may prevent a 




  FHB 
n in bracket 
LB 
n in bracket 
KIDr Class A 0.293(92) 0.24(100) 
KIDr Class B 0.164(110) 0.124(113) 
KIDr Class C 0.086(486) 0.067 (518) 
 AUC 0.641 0.641 









Figure 1 :Timelapse Nomenclature  
Figure 4: Early Cleavage (Day 3) Model Figure 3: 
Figure 5 
Morphokinetic comparison of 1620 human 
embryos resulting in, or failing to reach, live birth. 
 
Alison Campbell1, Simon Fishel1, Efstathios Theodorou1, Sue Montgomery1, 
Rachel Smith1, Darren Griffin2, Mette Laegdsmand3  
1 CARE Fertility Group, Nottingham, UK  
2 University of Kent, Canterbury, UK 
3  Inctus Analytics, Arhus, Denmark 
 
Study question: How do the timings and distributions of morphokinetic variables of human embryos 
resulting in, or failing to reach, live birth compare with each other and the entire unselected cohort of 
time lapse monitored embryos? 
  
Answer: Significant differences exist in the distribution of specific morphokinetic variables of 
transferred embryos resulting in live birth, and those that did not; these differed depending on the stage 
of embryo transfer. 
 
What is known already? 
Several time lapse derived morphokinetic variables have been proposed as indicators of embryo viability, and algorithms publi shed to predict 
blastulation, aneuploidy risk or implantation potential. A randomized controlled trial has demonstrated the positive impact of morphokinetic 
based, compared with standard morphological, embryo selection. Morphokinetic information derived from transferred embryos where birth 
outcome is known, is limited, but may offer the most clinical value. 
Study design 
This is a retrospective, descriptive, multi-centre cohort study of morphokinetic variables from 15,485 embryos, in 3101 treatments including 1620 
transferred embryos with known birth outcome cultured and time-lapse monitored following a standardised culture and annotation protocol, 
between 7/5/11 and 1/5/14. Data was compiled from six IVF clinics, following the same operating procedures for embryo culture, time lapse 







There is a wide distribution of morphokinetic parameters during the preimplantation development of human IVF embryos, even in controlled, 
standardised culture conditions. 
For 1042 day 3 selected and transferred embryos, the distributions differed significantly between embryos failing (KIDneg), or succeeding 
(KIDLB), to reach live birth (p<0.0001) for the duration of pronuclear appearance (dPN), calculated from second polar body extrusion to 
pronuclear fading. For this morphokinetic variable, the variance in KIDneg embryos was greater than for KIDLB. Interquartile ranges were 4.33 
hours and 3.28 hours respectively. Figure 1. For 630 day 5 selected and transferred embryos, the distribution of dPN, did not differ significantly 
between the two groups. 
Duration of the second cell cycle (time to reach three cells minus the time to reach two cells) was compared for 1692 embryos with known 
outcome. For day 3 and day 5 selected and transferred embryos, there was no significant difference between the bimodal distributions of KIDneg 
and KIDLB transferred embryos (p=0.45 and 0.74 respectively). Variance, in KIDneg was greater than in KIDLB embryos. Interquartile ranges were 
4.08 hours and 1.66 hours for day 3 transferred embryos and 2.02 hours and 1.84 hours for day 5 transferred embryos (KIDneg;KIDLB respectively).  
The time from pronuclear fading to start of blastulation (relSB) (Figure 2), and to the full blastocyst stage (relB) (Figure 3) were highly significantly 
different between embryos KIDneg and KIDLB embryos. (p< 0.00001 and <0.001 respectively). The variance in KIDneg was greater than in KIDLB 
embryos. Interquartile ranges were 10.12 hours and 7.17 hours respectively for relSB and 8.15 hours and 6.64 hours respectively. 
No significant differences were found between the two embryo groups for the time from pronuclear fading to the time to reach five cells (rel5), 




This study helps elucidate the broad distribution and variance of cleavage and developmental timings in 
human preimplantation embryos, and identifies morphokinetic candidates for human embryo selection in IVF 
treatment. Using healthy live birth as the outcome measure allows a more robust embryo selection and has 










Figure 1, for duration of pronuclear stage (dPN), shows the 
distribution and interquartile range of KID negative (red),  
KID positive live birth (green) and all embryos created 
(dashed black line), by day of embryo transfer (day 3 or day 5).   
For day 5, the distributions were not significantly different. 
 
 







Figure 2, for time from pronucler fading to start of blastulation (relSB), 
shows the distribution and interquartile range of KID negative (red), 
KID positive live birth (green) and all embryos created (dashed black 
line).    
   
    
   
   
   
   
   
   
   
   
   
   
  
   
                         
 Figure 3, for time from pronuclear appearance 
to full                           blastocyst stage (relB) shows the distribution 
 and interquartile rang of KID positive live birth 
 (green) and all embryos created (dashed black 
 line).   
  




9.3 Appendix 3 
Standard operating procedures for use of the EmbryoScope, annotation and application of 
algorithms for selection (CAREmaps) and quality assurance of annotation, devised and used 
at all CARE Fertility laboratories. 
 
9.3.1  EmbryoScope Annotations and CAREmaps  
 
 
EmbryoscopeTM Annotations and CAREMaps 
 
 Applies to: Embryology 
 Written by: 
Samantha Duffy/Louise 
Best/Alison Campbell 
 Issued by: Alison Campbell 
 Approved by: Executive Directors 
 Issue date: 17 September 2019  
 Review date: 16 September 2021  




















All staff must have password access to the viewer to help track annotations. 
Designated staff should have administrator access to allow the user defined 
settings and models to be created or altered. 
 (For detailed use of the EmbryoViewer please refer to the EmbryoViewer Software v 4.1 
User manual). 
• The home screen on the EmbryoViewer corresponds to the EmbryoSlide arm, 
showing the location of each patient culture dish within the EmbryoScope. 
• Select a patient record on the viewer screen then the “patient details” tab on 
the left to input patient information. Complete patient details for each new slide 
that is inserted into the EmbryoScope via the EmbryoViewer at the time of slide 
insertion. This information is vital for future data analysis. 
(Whilst populating the fields in the patient details section duplicates the information 
we collect on CIS, a ‘data for slides’ agreement has been signed between CARE 
and Vitrolife Fertilitech so that they can use the unidentifiable patient data for 
evaluation). 
• Once patient details have been completed, press “View running” tab to return to 
the home screen. 
Patient confidentiality 




• Identifying patient information must only be added to the ‘Patient name’ box on 
the EmbryoScope and EmbryoViewer. Comments boxes should not be used for 
identifying comments or details. 
• The EmbryoViewer is automatically set to never export identifying patient 
information to Vitrolife. This can be seen by opening the “Settings” tab from the 
home screen and then clicking on the “FTP” tab. 
• When the ‘Team Viewer’ icon is opened and used by Vitrolife Fertilitech to 
trouble shoot or upgrade the system, identifying patient data is not available for 
viewing and will not appear on the EmbryoViewer. 





Each patient embryo must be annotated daily during its development.  
• Once an embryo is selected on the viewer its development can be viewed by 
either clicking the play button, or by rolling to a particular time point using the 
“Griffin technology” hand tool.  
• Highlight any developmental changes that occur in the oocyte/embryo using 
the annotation tools at the specific time point they took place.  
• Should one embryologist question the detail/timing or type of annotation, of a 
developmental event made by a colleague, a second opinion should be 
requested before the annotation is altered. 
The minutes/hours post fertilisation are shown in the bottom left hand side of the embryo 
images and is logged chronologically when an annotation is added either:- 
 
1. Automatic - Using the automatic buttons (shown in blue column below).  
2. Fixed term comments - Entering them in the comments field (shown in peach column 
below). Comments added via the comments box should always use the same terms, as 
shown in the peach column below to allow sorting of data. 
3. User defined variables - In the EmbryoViewer software version 4.0 additional comments 
that are used regularly can be made into dropdown options to aid annotation speed 
and ensure consistency across CARE units. These can only be set by an administrator by 
going into “Settings” from the home screen and then clicking on the “Annotations” tab. 
Up to five “user defined variables” are available with 5 values possible for each variable. 
More values can be added but only the first five are visible on a data export. 
  
 Currently (June 2014) these are:- 
 
 Parameter Value 
1 ICM 1 
  2 
  3 
  Necrosis 
2 Trophectoderm 1 
  2 
  3 
  Necrosis 
  Collapse 
3 Early Obs. Merged cells 
  PB2/PB1 over 45o apart 
  4 Cell planar 
  Single vacuoles  (measure if large) 




  Multiple Vacuoles (measure largest) 
4 Compaction Start compaction 
  M1 
  M2 (score % frags) 
  Recompaction post decompaction 
5 Approved study Variables must be agreed by Director of 
Embryology 
   
 
 
User defined variables are set by the CAREMaps focus group only and local variations 
cannot be introduced without prior approval from this group. 
 
 
The table below is a summary of agreed annotations/ comments to ensure 
standardisation:- 
 
Annotation summary table SEE SOP APPENDIX 2 for images 
 
Observation to annotate 
on the embryo viewer 




variable or Exact 
phrase for 
‘comment’ box 
Then press return to 
log.  
Comment/Detail 
1. Appearance of second 
polar body 
PB2  Click when PB2 appears fully 
extruded with discrete membrane 
1a. Non adjacent PB2/PB1 
extrusion 
User defined 
variable: Early obs 
Early obs 
PB1/PB2 over 45o 
apart 
Click at time of extrusion when PB2 
is over  45o apart from PB1 see 
diagram appendix 4 
 
2. Appearance of 
pronuclei 
PN appeared  Click the automatic button to 
record as soon as the first PN is 
visible 
3. Appearance of 
pronuclei 
Record only when clearly 
visible – the first frame that 
there is no doubt of the 







 Record as soon as clearly visible. 
Or 0pn at 18hours hpi. 
If degenerate, there is an option to 
record ‘dead’. Scroll up past HB in 
the “Cells” automatic tab 
Record for 2pn only even or 
uneven based on the size of the 
PN’s in relation to each other 
4. Fading of pronuclei PN faded  Click the automatic button to 
record as soon as PNs are no 
longer visible 
5. Record when each 
cleavage is completed 
2 cell – 9+ cell  Blastomeres appear to have a 
discrete membrane. Do not wait 
for cells to round up  
5a Record evenness of 
blastomeres 
Even/uneven 
(2 cell, 4 cell and 8 
cell only) 
 Score at the time point of new cell 
number 
Score as even if the smallest and 
largest cells less than 20% different 




(2 cell, 4 cell 8 cell 
and M2 only) 
  Score at the time point of new cell 
number at 2,4,8, cells and M2 






 Total number of cells with more 
than one nucleus within it 
Multinucleation is assumed to be 
absent if not annotated 
6. Compaction starts  Start compaction Use user defined variable button to 
record when the very first signs of 
compaction are visible 
7. Morula formation  Morula (‘M’)   




7a Grading  Compaction: M1 or 
M2 
 
If M2 score the % 
fragments see 5a  
User defined button record the 
appearance of the morula 
according to CARE’s grading 
scheme- M1 no excluded material/ 
M2 excluded material present 
8. Blastulation starts tSb (time start 
blastulation) 
 Record when the very first signs of 
a cavity forming are visible. Rewind 
images to check 
9. Full Blastocyst B (Blastocyst)  
 
Fluid filled cavity present. Last 
frame before it begins to increase 
the embryo diameter.i.e. as full as 
it can get without any size increase 




where areas of 
necrosis seen for 
ICM and T  
Using user defined variables 
Grade ICM and Trophectoderm  
as per Corp Lab 14. Can be 
entered in same time frame 
10. Expanded blastocyst EB (Expanded 
blastocyst) 
  




where areas of 
necrosis seen for 
ICM and T  
Using user defined variables Grade 
ICM and T as per Corp Lab 14. Can 
be entered in same time frame 
11. Hatching blastocyst HB (Hatching 
blastocyst) 
 When herniation begins 




where areas of 
necrosis seen for 
ICM and T  
Using user defined variables Grade 
ICM and T as per Corp Lab 14. Can 
be entered in same time frame 
12. Hatched blastocyst  Hatched When (if) out of zona 
13. Other observations; 
Merging cells, 
reduction in cell 










Early obs:  




Use the user defined variable 
button to record merged cells. This 
is not compaction but ‘reverse 
cleavage’ 
When merged cells are observed 
• Click merged cells 
• Do not alter cell number 
• Next cell division do not 
annotate as no cell 
number increase – 
embryo has returned to 




     4 cell Planar division  Early obs: 
4 cell planar 
Use user defined variable to 
highlight flat or one plane divisions 
from 2cell to 4cell. Normal division 
is tetrahedral where the plane of 
cleavage are at right angles to 
each other see pictures appendix 
2, figure 5 
 
Single Vacuoles  Early Obs: Single 
vacs (measure)  
Annotate the presence of one 
vacuole at any stage of 
development, measure the size 
using the tool on the viewer page 
Multiple Vacuoles  Early Obs: Multiple 
vacuoles (measure 
the largest) 
Annotate the presence of 
vacuoles at any stage of 
development, measure the size of 
the largest vacuole using the tool 
on the viewer page.  










When has been classed as M but 
has decompacted. Annotate 
once recompacted can rescore 
Morula if change in appearance 
see 7a grade  
 
Expanded blast 






Use the user defined variable 
button to record full collapse of the 
blastocoel cavity in B or greater 
classified embryos. Record at end 
of collapse before rexpansion 
 
Necrosis in the ICM or 
trophectoderm cells 
 ICM: necrosis 
Trophectoderm 
:necrosis 
User defined variable button to 











comments box if 
more than one) 
Filopodia - 
additional appear 














Use the user defined variable 5 
button to record the presence/ 









results, give detail 
only e.g. +21, -14 
Type the outcome of PGS for each 
oocyte/embryo on the bottom of  




Use icons * ? etc to mark 
the fate of each embryo 
 
Colour coding denotes transferred, frozen, to be decided and discarded 
(green, blue, yellow/orange, and red respectively). 
User defined values in Early obs should be highlighted as amber for easy 
reference. 
Selection of embryo(s) for 
ET 
When the CAREMaps models has been used to overrule regular morphological 
selection this must be recorded (on the excel spreadsheet) 
Peculiarity When a rare and strange phenomenon or artifact is observed, in order to allow 
these to be retrieved in the future for study or presentation, in the comments 
box at the time of the event, enter peculiarity - ************* (give brief detail) 
 
 




3.0  Interruption - Pausing/ending a slide  
 
• If the slide needs to be removed from the EmbryoScope temporarily i.e. to 
remove bubbles affecting the image or to remove embryos for transfer, the slide 
is selected on the EmbryoScope touch screen followed by the Pause button.  
• The slide will be moved to the correct position for removal and the door LED will 
show green. 
• On returning the slide select re-insert. 
• If a slide must be ended and reinserted (e.g. for a service), on returning to the 
EmbryoScope, the same treatment number cannot be used. The suffix ‘int’ must 
be used in these cases, as described below. 
 
 
Test or research slides must be given a suffix in order to identify them (as above). 
Deletion of slides or data from the EmbryoViewer should be undertaken with extreme 
caution, with a witness and following authorisation. It may only be performed by the 
designated administrator or Laboratory Manager. It must always be justified and 
documented. The automatic data extraction under development will remove erroneous 
slides and data and as a result, negate the need for such deletion of information. 
  


















































Grade embryos cultured in the EmbryoScope, as per Corp lab 14, this should be used in 
conjunction with the CAREMaps models.  
 
Click ‘compare and select’ and record the score for each cultured 2pn. The embryo/s 
with the highest score should be selected for transfer, whilst also considering morphology 
and any other ‘peculiarities’ seen during development. 
 
For day 2 and day 3 transfers use the current EC (early cleavage) model in the compare 




EC 4- Day 2  
Cleavage stage The model was created using the following variables dPN, D1, cc2a, S2 
and cellsD2 
Uses principal component analysis of the training data resulted in new variables 
(PC1,PC2,PC3…)   
PC are linear combinations of the original variables 
  PC=a*dPN+b*d1+c*cc2a+…….. 









n in bracket 
LB 
n in bracket 
 Score  
KIDr (High) Class A  0.159 (176) 0.139 (193) 2  
KIDr (Low) Class C 0.045(133) 0.007 (142) 0  
AUC  0.643 0.712  






EC4 Day 3  










n in bracket 
LB 
n in bracket 
 Score 
KIDr (High) Class A  0.293(92) 0.24(100) 2 
KIDr (medium) Class B 0.164(110) 0.124(113) 1 
KIDr Low Class C 0.086(486) 0.067 (518) 0 
AUC  0.641 0.641  




Custom Expressions for use with model Blast 4 (Feb 15) 
 
Model uses insemination time as start time for the model so different models 
are required for ICSI and IVF  
 








2 rtSB ≤ 93.1hrs   
 
A High 
1 rtSB  > 93.1hrs   
dB ≤ 12.5hrs  
B Medium 
0 rtSB > 93.1hrs 






Blast 4 ICSI 
var Min max Weight 
tSB 0 93.1 2 
dB 0 12.5 1 
 
Blast 4 IVF 
 
var Min max Weight 
relSBIVF 0 93.1 2 
dB 0 12.5 1 
 








At the end of the culture period slides are removed from the EmbryoScope by selecting 
the slide on the touch screen and press ‘end’. The arm will move the slide to the 
correction position at the door for removal.  
 
The colour of the embryo image on the viewer should reflect the embryo’s fate: 
• Green tick: transferred  
• Blue snow flake: cryopreserved  
• Red cross: discarded  




• Amber question mark: undecided, i.e. irregular development pattern - any 
embryos that are coded as yellow during their culture period should be coded 
with the appropriate ‘fate’ colour at the end of their culture, i.e., red if discarded. 
During EmbryoScope monitoring, 2PN embryos should be either grey or amber. Do not 




Video uploading and sending CARE MAPS patients their videos via EmbryoScopeTM 
Producer 
The time lapse microscopy incorporated in the EmbryoScope culture system enables 
embryologists to upload videos of embryos at any time. 
• Select an embryo using the EmbryoViewer 
• Click on the “video” tab to the left of the embryo image 
• Select the start and finish time of the video 
• Click “generate” 
• If the video is for patient use it should be saved in the “Patient videos” folder 
(under the patient video), currently found in the “Exported video” folder on the 
embryo viewer desktop.  
 
Patients who have requested CARE MAPS/EmbryoScope culture have the opportunity to 
gain access to video footage of their transfer embryos either via an emailed web link or 
via the Patient Portal set up by CARE. 
• Videos of the transferred embryo/s are created. If a patient has undergone a 
D.E.T. it is useful to name one embryo video (1) and the other (2) after the patient 
CARE no. 
• The EmbryoScope producer software can be found on the EmbryoViewer 
desktop. Once opened, input the patient CARE no and press “Start”.  
• Clicking the “Select” tab will allow the relevant embryo video(s) to be chosen 
from the Patient Videos folder. Click “Go” and wait for the producer to generate 
a PIN.  
• The Embryoscope producer software will alert the user to patient portal 
registration status once their CARE number is inputted and “Start” is pressed. (see 
relevant graphics in ”Using the Embryoscope Video Producer Software” 
document no.15385)  
• The Embryoscope producer will automatically link portal registered patients’ 
CARE MAPS videos to their secure portal under the ‘Videos’ menu option at 
my.carefertility.com, in addition to uploading them to the original area at 
http://es.carefertility.com/). No PIN code needs to be sent to these patients via 
email unless specifically requested. 
1 Patient feedback submitted from the automated questionnaire will be saved in 








The data produced by the EmbryoScope can be exported in excel spreadsheet, or csv, 
format at any point by following the instructions below:- 
 
• Click the “View all slides” tab found on the EmbryoViewer home page. 




• The patient slides appear in a list. Select the records required for export by 
highlighting the rows.  
• Once the relevant slides have been selected (usually all, selected by pressing Ctrl 
and A), click “Export” tab. 
• Follow the instructions to create an excel spreadsheet or csv file.  
• Name the file with the export date and save in the “Exported data” folder found 





• EmbryoViewer Software v 4.1 User manual revision 2012.12/EU 
• Using the Embryoscope Video Producer Software, document no.15385 
  




SOP Appendix 1 – images of annotation timings 
Series of example time lapse images for morphokinetic variables tPN, t2, tSC, tSB and tB, from 
the same embryo. 
Figure 1 – Pronuclear fading 
 
Figure 2 – Completion of the first mitosis 
 
Figure 3 – Initiation of compaction 
 
Figure 4 – Initiation of blastulation, and full blastocyst (images not sequential) 
 
Figure 5 – Planar division at 4 cell stage 
     










L i n k  t o  p l a y  v i d e o : -  156497well 3 planar video.wmv




SOP Appendix 2 – Models on EmbryoScope  
 
EC4- Day 2 
EC4 Day3  
 
Blastocyst selection model 















































SOP Appendix 3 -User defined variables 
 
Exert taken from Staff Tech notes – user defined variables– document manager 




Early Observations table- research evidence for deselection criteria 
 
Parameter  Further information and training tips 
Early obs. 
 
CA R E  Med i a  L i b r a r y  >  
E m br yo l o g y  >  E m br yo Sco pe  
Im ag es  f o r  A TLA S  >  07-
ACLK-Book 
Images>reverse 






Merged cells- abstract in 
appendix. Merged cells 
appear in lower model score. 
 KID LB lower when seen (15.7 v 
28.7%).  
De-select after model application if 
choice remains. 








Record at time of PB2 extrusion. 
 
ICSI study of PB2 at time of extrusion 
at CARE. n=198 KID embryos. 
CPR sig higher when PB2 extruded 
adjacent to PB1.  
 
4cell planar Small (none CARE) study showed 
Tetrahedral 4 cell embryos have sig 
higher implantation rate (38 v 21%) 






Poorly understood. ESHRE/Alpha 
consensus reported >14um can 
impact developmental potential.  
Time of presentation – late stage 
more detrimental 
Abstract BFS 2020 – extract 
. From 4462 transferred blastocysts, 
the incidence of single vacuoles was 
2.6% (n=119) and multiple vacuoles 
5.3%, (n=239). The live birth rate (LBR) 
for transferred blastocysts where 
multiple vacuoles were present was 
significantly lower than when no 
vacuoles were recorded, 20.9% vs 
31.5% (p=0.01). Single vacuolated 
transferred blastocysts LBR was  28.5% 
vs 31.5% (NS). The appearance of 
both vacuole types in the late stage 
(>72hpi) resulted in significantly lower 
LBR compared to the rest of the 
cohort 12.3% vs 31.5% (p=0.01). Early 
appearance of vacuolation was not 
shown to be associated with 
reduced viability, LBRs were 27.1% vs 
31.5%. see full abstract below. 
 


















   





EC4- Day 2 
EC4 Day3  
 
Blastocyst selection model 

















































SOP Appendix 3 -User defined variables 
 
Exert taken from Staff Tech notes – user defined variables– document manager 








Early Observations table- research evidence for deselection criteria 
 
Parameter  Further information and training tips 
Early obs. 
 
CA R E  Med i a  L i b r a r y  >  
E m br yo l o g y  >  E m br yo Sco pe  
Im ag es  f o r  A TLA S  >  07-
ACLK-Book 
Images>reverse 






Merged cells- abstract in 
appendix. Merged cells 
appear in lower model score. 
 KID LB lower when seen (15.7 v 
28.7%).  
De-select after model application if 
choice remains. 








Record at time of PB2 extrusion. 
 
ICSI study of PB2 at time of extrusion 
at CARE. n=198 KID embryos. 
CPR sig higher when PB2 extruded 
adjacent to PB1.  
 
4cell planar Small (none CARE) study showed 
Tetrahedral 4 cell embryos have sig 
higher implantation rate (38 v 21%) 






Poorly understood. ESHRE/Alpha 
consensus reported >14um can 
impact developmental potential.  
Time of presentation – late stage 
more detrimental 
Abstract BFS 2020 – extract 
. From 4462 transferred blastocysts, 
the incidence of single vacuoles was 
2.6% (n=119) and multiple vacuoles 
5.3%, (n=239). The live birth rate (LBR) 
for transferred blastocysts where 
multiple vacuoles were present was 
significantly lower than when no 
vacuoles were recorded, 20.9% vs 
31.5% (p=0.01). Single vacuolated 
transferred blastocysts LBR was  28.5% 
vs 31.5% (NS). The appearance of 
both vacuole types in the late stage 
(>72hpi) resulted in significantly lower 
LBR compared to the rest of the 
cohort 12.3% vs 31.5% (p=0.01). Early 
appearance of vacuolation was not 
shown to be associated with 
reduced viability, LBRs were 27.1% vs 
31.5%. see full abstract below. 
 



















SOP Appendix 4  
Historic Modelling 
2 EC3 (December 2013) 
 
Custom Expressions for use with model EC3 (Dec 13) 
Expression Name  
CC2 t3-t2 
CC3 t5- t3 
relCC2 (t3-t2)/(t5-t2)*100 
 
Model weightings- Day2 ICSI (EC3 Dec 13) 
 
MULTIPLICATIVE model 
Score  Day3 ICSI EC3(Dec 13)  
 Expression Min value Max Value 
0 CC2 0.0 2.0 
0.25 T2 27.1 300.0 
1 MN4 Info only  
 
Model weightings- Day3 ICSI (EC3 Dec 13) 
 
MULTIPLICATIVE model 
Score  Day3 ICSI EC3(Dec 13)  
 Expression Min value Max Value 
0 CC2 0.0 2.0 
0 CC3 0.0 5.0 
0.25 T2 27.1 300.0 
2 relCC2 44.0 47.0 
1 MN4 Info only  
 
Model weightings- Day2 IVF (EC3 Jan 14) 
 
MULTIPLICATIVE model 
Score  Day3 ICSI EC3(Jan14)  
 Expression Min value Max Value 
0 CC2 0.0 2.0 
0.25 T2 29.1 300.0 
1 MN4 Info only  
 
Model weightings- Day3 IVF (EC3 Jan 14) 
 
MULTIPLICATIVE model 
Score  Day3 ICSI EC3(Jan14)  
 Expression Min value Max Value 
0 CC2 0.0 2.0 
0 CC3 0.0 5.0 
0.25 T2 29.1 300.0 
2 relCC2 44.0 47.0 
1 MN4 Info only  
 
Copy these models exactly as above (see appendix for photographs of model page on the 
EmbryoViewer). 
 
Day 2 ICSI or IVF (+2.0h) 
 




Score  Classification 
0 Deselected if  




0.25 T2 >=27.1h  Low 
1 T2 < 27.1h Medium or High 
If no 5 cell division 
If have 5 cell embryos on day 2 move to the day 3 model for improved selection 
 
Day 3 ICSI or IVF (+2.0h)  
 
Score  Classification 
0 Deselected if  




0.25-0.5 T2 >=27.1h relCC2 between 0-100% Low 
1 relCC2 0-43.9% or 47.1%-100% Medium 
2 relCC2 44%-47% High 
  
  








CAREmaps Quality Assurance 
 
 Applies to: Embryology 
 Written by: Davina Hulme 
 Issued by: Alison Campbell 
 Approved by: Executive directors 
 Issue date: 28 March 2018  
 Review date:  28 March 2020  
 Reference: Corp lab 59c 
 
 
1.0 A CAREMaps quality assurance exercise should be completed by all embryologists 
within each unit quarterly to be presented by the lead embryologist at the 
CAREMaps focus group meetings. 
2.0 Choose 3 embryos for all embryologists within your unit to annotate using the Corp 
Lab 61h Embryoscope annotation review sheet. Embryologists should annotate fully 
and write any user defined variable comments in the box provided so that timings 
as well as other observations can be monitored. 
  
3.0 Collate the answers for your team into the template excel table saved in G: 
Embryology CARE: Embryoscope CAREMaps: quality assurance: QA tools: QA 
template excel sheet. There are 3 tabs to complete (timings, embryo descriptions & 
traffic light). This will allow direct comparison between embryologists and highlight 
any discrepancies that should be discussed at an internal QA meeting.  
The first tab (timings) is set up to look at the annotated times for each embryologist. 
Enter your teams answers into the excel table which is automatically set up to show 
the mean, maximum and minimum ranges for all of the timings. Highlight any 
atypical answers to be discussed at your own internal CAREmaps QA meeting. 
The second tab looks at the observations made whilst annotating. Please enter your 
teams’ answers and highlight any discrepancies where some may have missed a 
particular user defined variable or embryo grading is different. 
The third tab (traffic light) looks at how closely the answers recorded 
are to the mean i.e. + or – 10% and + or – 20% (ranges can be 
amended accordingly). This may highlight areas for discussion. 
  
4.0 Calculate the intra class coefficient of variation (ICC) for the timings you wish to 
assess. This can be decided at each focus group meeting ready for the next QA 
exercise so that all timings are monitored regularly.  
4.1 Open the ICC calculator located in G: Embryology CARE: Embryoscope 
CAREMaps: quality assurance: QA tools: ICC Calculator. 





To calculate the ICC; e.g. for the 2 cell stage for the 3 embryos enter each 
embryologists (A-Z) annotated time for 2 cell for embryo 1 in the top row, embryo 2 
in the next row and so on. The ICC value will be shown in the box to the right of the 
table, ICC (2, 4) is the average value. An ICC value of > 0.8 is considered strong 
agreement (Sundvall et al. 2013). 
  
5.0 
Upload the results into the CAREMaps focus group folder ready for 
discussion at the next global meeting. 
  
6.0 An internal QA meeting should follow within each unit to discuss any 
discrepancies identified whilst observing the embryo videos as a 







• Corp Lab 59a, issue 17 EmbryoscopeTM Culture 
• Corp Lab 59b, issue 15 EmbryoscopeTM Annotations and CAREMaps 





Sundvall, L et al. (2013) Inter - and Intra -observer variability of time lapse annotations. Human 
Reproduction vol28 no12 pp3215-3221. 
 
 
 
 
